0001414932ocsl:InvestmentOwnedAtCostMemberocsl:InvestmentSectorConcentrationRiskMemberocsl:HealthCareDistributorsMember2021-10-012022-09-300001414932us-gaap:AdditionalPaidInCapitalMember2021-10-012021-12-31


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Form 10-Q
(Mark One)

þQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 20222023
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NUMBER: 1-33901
Oaktree Specialty Lending Corporation


(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWAREDelaware
(State or jurisdiction of

incorporation or organization)
26-1219283
(I.R.S. Employer

Identification No.)
333 South Grand Avenue, 28th Floor
Los Angeles, CA
(Address of principal executive office)
90071
(Zip Code)
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:
(213) 830-6300




SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
Title of Each ClassTrading Symbol(s)Name of Each Exchange

on Which Registered
Common Stock, par value $0.01 per shareOCSLThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  Yes  þ     NO       No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    YES  Yes  þ   No  ¨   NO  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer  þ
Accelerated filer  ¨
Non-accelerated filer  ¨
Smaller reporting company  ¨
Emerging growth company  ¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ¨


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)    YES  Yes  ¨     NO       No  þ
The registrant had 183,374,25077,079,811 shares of common stock outstanding as of August 2, 2022.1, 2023.







OAKTREE SPECIALTY LENDING CORPORATION
FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 20222023






TABLE OF CONTENTS


PART I — FINANCIAL INFORMATION
Consolidated Financial Statements:



















1





PART I — FINANCIAL INFORMATION


Item 1.Consolidated Financial Statements.
Item 1. Consolidated Financial Statements.


Oaktree Specialty Lending Corporation
Consolidated Statements of Assets and Liabilities
(in thousands, except per share amounts)
June 30, 2022 (unaudited)September 30, 2021June 30, 2023 (unaudited)September 30, 2022
ASSETSASSETSASSETS
Investments at fair value:Investments at fair value:Investments at fair value:
Control investments (cost June 30, 2022: $262,244; cost September 30, 2021: $283,599)$222,858 $270,765 
Affiliate investments (cost June 30, 2022: $24,617; cost September 30, 2021: $18,763)23,427 18,289 
Non-control/Non-affiliate investments (cost June 30, 2022: $2,378,626; cost September 30, 2021: $2,236,759)2,319,104 2,267,575 
Total investments at fair value (cost June 30, 2022: $2,665,487; cost September 30, 2021: $2,539,121)2,565,389 2,556,629 
Control investments (cost June 30, 2023: $285,236; cost September 30, 2022: $260,305)Control investments (cost June 30, 2023: $285,236; cost September 30, 2022: $260,305)$238,196 $214,165 
Affiliate investments (cost June 30, 2023: $25,370; cost September 30, 2022: $27,353)Affiliate investments (cost June 30, 2023: $25,370; cost September 30, 2022: $27,353)23,911 26,196 
Non-control/Non-affiliate investments (cost June 30, 2023: $2,985,679; cost September 30, 2022: $2,330,096)Non-control/Non-affiliate investments (cost June 30, 2023: $2,985,679; cost September 30, 2022: $2,330,096)2,873,512 2,253,750 
Total investments at fair value (cost June 30, 2023: $3,296,285; cost September 30, 2022: $2,617,754)Total investments at fair value (cost June 30, 2023: $3,296,285; cost September 30, 2022: $2,617,754)3,135,619 2,494,111 
Cash and cash equivalentsCash and cash equivalents34,306 29,334 Cash and cash equivalents59,704 23,528 
Restricted cashRestricted cash2,009 2,301 Restricted cash12,956 2,836 
Interest, dividends and fees receivableInterest, dividends and fees receivable29,130 22,125 Interest, dividends and fees receivable29,457 35,598 
Due from portfolio companiesDue from portfolio companies6,881 1,990 Due from portfolio companies2,080 22,495 
Receivables from unsettled transactionsReceivables from unsettled transactions3,274 8,150 Receivables from unsettled transactions39,261 4,692 
Due from brokerDue from broker36,340 1,640 Due from broker39,990 45,530 
Deferred financing costsDeferred financing costs7,918 9,274 Deferred financing costs13,284 7,350 
Deferred offering costsDeferred offering costs32 34 Deferred offering costs186 32 
Deferred tax asset, netDeferred tax asset, net1,698 714 Deferred tax asset, net2,695 1,687 
Derivative assets at fair valueDerivative assets at fair value1,134 1,912 Derivative assets at fair value49 6,789 
Other assetsOther assets1,267 2,284 Other assets693 1,665 
Total assetsTotal assets$2,689,378 $2,636,387 Total assets$3,335,974 $2,646,313 
LIABILITIES AND NET ASSETSLIABILITIES AND NET ASSETSLIABILITIES AND NET ASSETS
Liabilities:Liabilities:Liabilities:
Accounts payable, accrued expenses and other liabilitiesAccounts payable, accrued expenses and other liabilities$2,324 $3,024 Accounts payable, accrued expenses and other liabilities$3,412 $3,701 
Base management fee and incentive fee payableBase management fee and incentive fee payable15,563 32,649 Base management fee and incentive fee payable20,072 15,940 
Due to affiliateDue to affiliate3,540 4,357 Due to affiliate7,724 3,180 
Interest payableInterest payable8,356 4,597 Interest payable12,907 7,936 
Director fees payable38 — 
Payables from unsettled transactionsPayables from unsettled transactions8,556 8,086 Payables from unsettled transactions2,785 26,981 
Derivative liability at fair valueDerivative liability at fair value30,866 2,108 Derivative liability at fair value39,567 41,969 
Credit facilities payableCredit facilities payable745,000 630,000 Credit facilities payable1,135,000 700,000 
Unsecured notes payable (net of $5,390 and $6,501 of unamortized financing costs as of June 30, 2022 and September 30, 2021, respectively)611,606 638,743 
Unsecured notes payable (net of $3,909 and $5,020 of unamortized financing costs as of June 30, 2023 and September 30, 2022, respectively)Unsecured notes payable (net of $3,909 and $5,020 of unamortized financing costs as of June 30, 2023 and September 30, 2022, respectively)605,066 601,043 
Total liabilitiesTotal liabilities1,425,849 1,323,564 Total liabilities1,826,533 1,400,750 
Commitments and contingencies (Note 13)Commitments and contingencies (Note 13)Commitments and contingencies (Note 13)
Net assets:Net assets:Net assets:
Common stock, $0.01 par value per share, 250,000 shares authorized; 183,374 and 180,361 shares issued and outstanding as of June 30, 2022 and September 30, 2021, respectively1,834 1,804 
Common stock, $0.01 par value per share, 250,000 shares authorized; 77,080 and 61,125 shares issued and outstanding as of June 30, 2023 and September 30, 2022, respectively (1)Common stock, $0.01 par value per share, 250,000 shares authorized; 77,080 and 61,125 shares issued and outstanding as of June 30, 2023 and September 30, 2022, respectively (1)771 611 
Additional paid-in-capitalAdditional paid-in-capital1,826,498 1,804,354 Additional paid-in-capital2,163,528 1,827,721 
Accumulated overdistributed earningsAccumulated overdistributed earnings(564,803)(493,335)Accumulated overdistributed earnings(654,858)(582,769)
Total net assets (equivalent to $6.89 and $7.28 per common share as of June 30, 2022 and September 30, 2021, respectively) (Note 11)1,263,529 1,312,823 
Total net assets (equivalent to $19.58 and $20.38 per common share as of June 30, 2023 and September 30, 2022, respectively) (Note 11) (1)Total net assets (equivalent to $19.58 and $20.38 per common share as of June 30, 2023 and September 30, 2022, respectively) (Note 11) (1)1,509,441 1,245,563 
Total liabilities and net assetsTotal liabilities and net assets$2,689,378 $2,636,387 Total liabilities and net assets$3,335,974 $2,646,313 

 __________
(1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The issued and outstanding shares and net asset value per share reflect the reverse stock split on a retroactive basis.


See notes to Consolidated Financial Statements.
2



Oaktree Specialty Lending Corporation
Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)
Three months ended June 30, 2022Three months ended June 30, 2021Nine months ended
June 30, 2022
Nine months ended
June 30, 2021
Interest income:
Control investments$3,400 $3,405 $10,214 $8,122 
Affiliate investments470 189 1,170 437 
Non-control/Non-affiliate investments50,707 48,403 155,656 110,720 
Interest on cash and cash equivalents151 157 
Total interest income54,728 51,999 167,197 119,287 
PIK interest income:
Non-control/Non-affiliate investments5,178 4,597 14,515 11,487 
Total PIK interest income5,178 4,597 14,515 11,487 
Fee income:
Control investments12 13 38 46 
Affiliate investments15 15 
Non-control/Non-affiliate investments2,258 7,805 5,039 13,392 
Total fee income2,275 7,823 5,092 13,453 
Dividend income:
Control investments875 1,019 5,491 1,358 
Non-control/Non-affiliate investments81  81 — 
Total dividend income956 1,019 5,572 1,358 
Total investment income63,137 65,438 192,376 145,585 
Expenses:
Base management fee9,819 8,905 29,853 22,520 
Part I incentive fee6,497 6,990 19,658 15,583 
Part II incentive fee(6,796)2,837 (8,791)15,986 
Professional fees885 1,059 3,029 2,943 
Directors fees160 147 443 447 
Interest expense11,870 8,823 31,178 21,486 
Administrator expense271 421 968 1,047 
General and administrative expenses811 716 2,217 2,009 
Total expenses23,517 29,898 78,555 82,021 
Fees waived(750)(750)(2,250)(858)
Net expenses22,767 29,148 76,305 81,163 
Net investment income before taxes40,370 36,290 116,071 64,422 
(Provision) benefit for taxes on net investment income— (358)(3,308)(358)
Net investment income40,370 35,932 112,763 64,064 
Unrealized appreciation (depreciation):
Control investments(16,991)3,590 (26,552)30,336 
Affiliate investments(328)109 (716)213 
Non-control/Non-affiliate investments(67,806)(898)(90,333)83,842 
Foreign currency forward contracts(1,630)1,116 (778)2,226 
Net unrealized appreciation (depreciation)(86,755)3,917 (118,379)116,617 
Realized gains (losses):
Control investments— — 1,868 — 
Non-control/Non-affiliate investments416 9,350 5,888 26,267 
Foreign currency forward contracts8,796 (740)12,179 (3,586)
Net realized gains (losses)9,212 8,610 19,935 22,681 
(Provision) benefit for taxes on realized and unrealized gains (losses)(661)(1,421)1,696 (2,663)
Net realized and unrealized gains (losses), net of taxes(78,204)11,106 (96,748)136,635 
Net increase (decrease) in net assets resulting from operations$(37,834)$47,038 $16,015 $200,699 
Net investment income per common share — basic and diluted$0.22 $0.20 $0.62 $0.41 
Earnings (loss) per common share — basic and diluted (Note 5)$(0.21)$0.26 $0.09 $1.29 
Weighted average common shares outstanding — basic and diluted183,370 180,361 181,778 155,970 


Three months ended June 30, 2023Three months ended June 30, 2022Nine months ended
June 30, 2023
Nine months ended
June 30, 2022
Interest income:
Control investments$5,568 $3,400 $15,326 $10,214 
Affiliate investments681 470 1,970 1,170 
Non-control/Non-affiliate investments88,069 50,707 234,516 155,656 
Interest on cash and cash equivalents992 151 2,221 157 
Total interest income95,310 54,728 254,033 167,197 
PIK interest income:
Non-control/Non-affiliate investments3,967 5,178 14,220 14,515 
Total PIK interest income3,967 5,178 14,220 14,515 
Fee income:
Control investments13 12 38 38 
Affiliate investments15 15 
Non-control/Non-affiliate investments1,555 2,258 5,921 5,039 
Total fee income1,573 2,275 5,974 5,092 
Dividend income:
Control investments1,050 875 3,150 5,491 
Non-control/Non-affiliate investments— 81 81 
Total dividend income1,050 956 3,154 5,572 
Total investment income101,900 63,137 277,381 192,376 
Expenses:
Base management fee11,983 9,819 33,383 29,853 
Part I incentive fee9,590 6,497 26,300 19,658 
Part II incentive fee— (6,796)— (8,791)
Professional fees1,387 885 4,962 3,029 
Directors fees160 160 480 443 
Interest expense30,793 11,870 79,316 31,178 
Administrator expense322 271 935 968 
General and administrative expenses752 811 2,753 2,217 
Total expenses54,987 23,517 148,129 78,555 
Fees waived(1,500)(750)(4,025)(2,250)
Net expenses53,487 22,767 144,104 76,305 
Net investment income before taxes48,413 40,370 133,277 116,071 
(Provision) benefit for taxes on net investment income— — — (3,308)
Excise tax— — (78)— 
Net investment income48,413 40,370 133,199 112,763 
Unrealized appreciation (depreciation):
Control investments734 (16,991)(900)(26,552)
Affiliate investments149 (328)(302)(716)
Non-control/Non-affiliate investments(6,497)(67,806)(36,296)(90,333)
Foreign currency forward contracts4,575 (1,630)(4,802)(778)
Net unrealized appreciation (depreciation)(1,039)(86,755)(42,300)(118,379)
Realized gains (losses):
Control investments— — — 1,868 
Non-control/Non-affiliate investments(4,294)416 (14,404)5,888 
Foreign currency forward contracts(6,309)8,796 (5,513)12,179 
Net realized gains (losses)(10,603)9,212 (19,917)19,935 
(Provision) benefit for taxes on realized and unrealized gains (losses)(86)(661)397 1,696 
Net realized and unrealized gains (losses), net of taxes(11,728)(78,204)(61,820)(96,748)
Net increase (decrease) in net assets resulting from operations$36,685 $(37,834)$71,379 $16,015 
Net investment income per common share — basic and diluted (1)$0.63 $0.66 $1.89 $1.86 
Earnings (loss) per common share — basic and diluted (Note 5) (1)$0.48 $(0.62)$1.01 $0.26 
Weighted average common shares outstanding — basic and diluted (1)77,080 61,123 70,431 60,593 

__________
(1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.


See notes to Consolidated Financial Statements.
3



Oaktree Specialty Lending Corporation
Consolidated Statements of Changes in Net Assets
(in thousands, except per share amounts)
(unaudited)


Three months ended June 30, 2022Three months ended June 30, 2021Nine months ended June 30, 2022Nine months ended June 30, 2021
Operations:
Net investment income$40,370 $35,932 $112,763 $64,064 
Net unrealized appreciation (depreciation)(86,755)3,917 (118,379)116,617 
Net realized gains (losses)9,212 8,610 19,935 22,681 
(Provision) benefit for taxes on realized and unrealized gains (losses)(661)(1,421)1,696 (2,663)
Net increase (decrease) in net assets resulting from operations(37,834)47,038 16,015 200,699 
Stockholder transactions:
Distributions to stockholders(30,256)(23,447)(87,483)(55,868)
Net increase (decrease) in net assets from stockholder transactions(30,256)(23,447)(87,483)(55,868)
Capital share transactions:
Issuance of common stock in connection with the Mergers— — — 242,704 
Issuance of common stock under dividend reinvestment plan874 520 2,426 1,559 
Repurchases of common stock under dividend reinvestment plan(874)(520)(874)(1,559)
Issuance of common stock in connection with the "at the market" offering1,243 — 20,622 — 
Net increase (decrease) in net assets from capital share transactions1,243  22,174 242,704 
Total increase (decrease) in net assets(66,847)23,591 (49,294)387,535 
Net assets at beginning of period1,330,376 1,278,823 1,312,823 914,879 
Net assets at end of period$1,263,529 $1,302,414 $1,263,529 $1,302,414 
Net asset value per common share$6.89 $7.22 $6.89 $7.22 
Common shares outstanding at end of period183,374 180,361 183,374 180,361 


Three months ended June 30, 2023Three months ended June 30, 2022Nine months ended
June 30, 2023
Nine months ended
June 30, 2022
Operations:
Net investment income$48,413 $40,370 $133,199 $112,763 
Net unrealized appreciation (depreciation)(1,039)(86,755)(42,300)(118,379)
Net realized gains (losses)(10,603)9,212 (19,917)19,935 
(Provision) benefit for taxes on realized and unrealized gains (losses)(86)(661)397 1,696 
Net increase (decrease) in net assets resulting from operations36,685 (37,834)71,379 16,015 
Stockholder transactions:
Distributions to stockholders(42,394)(30,256)(143,468)(87,483)
Net increase (decrease) in net assets from stockholder transactions(42,394)(30,256)(143,468)(87,483)
Capital share transactions:
Issuance of common stock in connection with the OSI2 Merger— — 334,034 — 
Issuance of common stock under dividend reinvestment plan1,123 874 4,351 2,426 
Repurchase of common stock under dividend reinvestment plan(1,123)(874)(2,418)(874)
Issuance of common stock in connection with the "at the market" offering— 1,243 — 20,622 
Net increase (decrease) in net assets from capital share transactions 1,243 335,967 22,174 
Total increase (decrease) in net assets(5,709)(66,847)263,878 (49,294)
Net assets at beginning of period1,515,150 1,330,376 1,245,563 1,312,823 
Net assets at end of period$1,509,441 $1,263,529 $1,509,441 $1,263,529 
Net asset value per common share (1)$19.58 $20.67 $19.58 $20.67 
Common shares outstanding at end of period (1)77,080 61,125 77,080 61,125 



__________
(1) As discussed in Note 2, the Company completed a 1-for-3 reverse stock split on January 20, 2023, effective as of the commencement of trading on January 23, 2023. The weighted average common shares outstanding and per share information reflect the reverse stock split on a retroactive basis.


See notes to Consolidated Financial Statements.
4

Oaktree Specialty Lending Corporation
Consolidated Statements of Cash Flows
(in thousands)
(unaudited)










Nine months ended
June 30, 2022
Nine months ended
June 30, 2021
Nine months ended
June 30, 2023
Nine months ended
June 30, 2022
Operating activities:Operating activities:Operating activities:
Net increase (decrease) in net assets resulting from operationsNet increase (decrease) in net assets resulting from operations$16,015 $200,699 Net increase (decrease) in net assets resulting from operations$71,379 $16,015 
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Net unrealized (appreciation) depreciationNet unrealized (appreciation) depreciation118,379 (116,617)Net unrealized (appreciation) depreciation42,300 118,379 
Net realized (gains) lossesNet realized (gains) losses(19,935)(22,681)Net realized (gains) losses19,917 (19,935)
PIK interest incomePIK interest income(14,515)(11,487)PIK interest income(14,220)(14,515)
Accretion of original issue discount on investmentsAccretion of original issue discount on investments(22,707)(18,032)Accretion of original issue discount on investments(15,554)(22,707)
Accretion of original issue discount on unsecured notes payableAccretion of original issue discount on unsecured notes payable509 403 Accretion of original issue discount on unsecured notes payable509 509 
Amortization of deferred financing costsAmortization of deferred financing costs2,801 3,030 Amortization of deferred financing costs3,407 2,801 
Deferred taxesDeferred taxes(984)112 Deferred taxes(1,030)(984)
Purchases of investmentsPurchases of investments(620,843)(714,791)Purchases of investments(597,662)(620,843)
Proceeds from the sales and repayments of investmentsProceeds from the sales and repayments of investments554,933 586,812 Proceeds from the sales and repayments of investments521,163 554,933 
Cash acquired in the Mergers— 20,945 
Cash received in the OSI2 MergerCash received in the OSI2 Merger22,317 — 
Changes in operating assets and liabilities:Changes in operating assets and liabilities:Changes in operating assets and liabilities:
(Increase) decrease in interest, dividends and fees receivable(Increase) decrease in interest, dividends and fees receivable(9,456)(3,434)(Increase) decrease in interest, dividends and fees receivable12,866 (9,456)
(Increase) decrease in due from portfolio companies(Increase) decrease in due from portfolio companies(4,891)1,956 (Increase) decrease in due from portfolio companies20,520 (4,891)
(Increase) decrease in receivables from unsettled transactions(Increase) decrease in receivables from unsettled transactions4,876 8,199 (Increase) decrease in receivables from unsettled transactions(34,562)4,876 
(Increase) decrease in due from broker(Increase) decrease in due from broker(34,700)(1,640)(Increase) decrease in due from broker5,540 (34,700)
(Increase) decrease in other assets(Increase) decrease in other assets1,017 (1,444)(Increase) decrease in other assets(548)1,017 
Increase (decrease) in accounts payable, accrued expenses and other liabilitiesIncrease (decrease) in accounts payable, accrued expenses and other liabilities(700)476 Increase (decrease) in accounts payable, accrued expenses and other liabilities(52,290)(700)
Increase (decrease) in base management fee and incentive fee payableIncrease (decrease) in base management fee and incentive fee payable(17,086)17,994 Increase (decrease) in base management fee and incentive fee payable37 (17,086)
Increase (decrease) in due to affiliateIncrease (decrease) in due to affiliate(817)1,773 Increase (decrease) in due to affiliate3,823 (817)
Increase (decrease) in interest payableIncrease (decrease) in interest payable3,759 1,844 Increase (decrease) in interest payable1,278 3,759 
Increase (decrease) in payables from unsettled transactionsIncrease (decrease) in payables from unsettled transactions470 10,110 Increase (decrease) in payables from unsettled transactions(24,196)470 
Increase (decrease) in director fees payableIncrease (decrease) in director fees payable38 (90)Increase (decrease) in director fees payable(9)38 
Net cash provided by (used in) operating activitiesNet cash provided by (used in) operating activities(43,837)(35,863)Net cash provided by (used in) operating activities(15,015)(43,837)
Financing activities:Financing activities:Financing activities:
Distributions paid in cashDistributions paid in cash(85,057)(54,309)Distributions paid in cash(139,117)(85,057)
Borrowings under credit facilitiesBorrowings under credit facilities290,000 325,000 Borrowings under credit facilities572,000 290,000 
Repayments of borrowings under credit facilitiesRepayments of borrowings under credit facilities(175,000)(515,525)Repayments of borrowings under credit facilities(362,000)(175,000)
Issuance of unsecured notes— 349,020 
Repayments of secured borrowings— (9,341)
Shares issued under the "at the market" offeringShares issued under the "at the market" offering— 20,839 
Repurchases of common stock under dividend reinvestment planRepurchases of common stock under dividend reinvestment plan(874)(1,559)Repurchases of common stock under dividend reinvestment plan(2,418)(874)
Shares issued under the "at the market" offering20,839 — 
Deferred financing costs paidDeferred financing costs paid(334)(7,844)Deferred financing costs paid(7,314)(334)
Offering costs paidOffering costs paid(215)— Offering costs paid(186)(215)
Net cash provided by (used in) financing activitiesNet cash provided by (used in) financing activities49,359 85,442 Net cash provided by (used in) financing activities60,965 49,359 
Effect of exchange rate changes on foreign currencyEffect of exchange rate changes on foreign currency(842)(1,146)Effect of exchange rate changes on foreign currency346 (842)
Net increase (decrease) in cash and cash equivalents and restricted cashNet increase (decrease) in cash and cash equivalents and restricted cash4,680 48,433 Net increase (decrease) in cash and cash equivalents and restricted cash46,296 4,680 
Cash and cash equivalents and restricted cash, beginning of periodCash and cash equivalents and restricted cash, beginning of period31,635 39,096 Cash and cash equivalents and restricted cash, beginning of period26,364 31,635 
Cash and cash equivalents and restricted cash, end of periodCash and cash equivalents and restricted cash, end of period$36,315 $87,529 Cash and cash equivalents and restricted cash, end of period$72,660 $36,315 
Supplemental information:Supplemental information:Supplemental information:
Cash paid for interestCash paid for interest$24,109 $15,583 Cash paid for interest$70,429 $24,109 
Non-cash financing activities:Non-cash financing activities:Non-cash financing activities:
Issuance of shares of common stock under dividend reinvestment planIssuance of shares of common stock under dividend reinvestment plan$2,426 $1,560 Issuance of shares of common stock under dividend reinvestment plan1,933 $2,426 
Deferred financing costs— (592)
Issuance of shares in connection with the Mergers— 242,704 
Deferred Financing costsDeferred Financing costs125 — 
Issuance of shares in connection with the OSI2 MergerIssuance of shares in connection with the OSI2 Merger334,034 — 
Reconciliation to the Consolidated Statements of Assets and LiabilitiesReconciliation to the Consolidated Statements of Assets and LiabilitiesJune 30, 2022September 30, 2021Reconciliation to the Consolidated Statements of Assets and LiabilitiesJune 30,
2023
September 30,
2022
Cash and cash equivalentsCash and cash equivalents$34,306 $29,334 Cash and cash equivalents$59,704 $23,528 
Restricted cashRestricted cash2,009 2,301 Restricted cash12,956 2,836 
Total cash and cash equivalents and restricted cashTotal cash and cash equivalents and restricted cash$36,315 $31,635 Total cash and cash equivalents and restricted cash$72,660 $26,364 


See notes to Consolidated Financial Statements.


5

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Control Investments(8)(9)
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— (15)
34,984,460.37 Preferred Units34,984 27,638 (15)
34,984 27,638 
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20247.26 %$16,074 16,074 16,074 (6)(15)
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — — (6)(15)(19)
30,030.8 Common Units in DD Healthcare Services Holdings, LLC15,222 9,267 (15)
31,296 25,341 
OCSI Glick JV LLCMulti-Sector Holdings(14)
Subordinated Debt, LIBOR+4.50% cash due 10/20/20284.94 %60,274 50,392 50,606  (6)(11)(15)(19)
87.5% equity interest— —  (11)(16)(19)
50,392 50,606 
Senior Loan Fund JV I, LLCMulti-Sector Holdings(14)
Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.00 %96,250 96,250 96,250 (6)(11)(15)(19)
87.5% LLC equity interest49,322 23,023 (11)(12)(16)(19)
145,572 119,273 
 Total Control Investments (17.6% of net assets)$262,244 $222,858 
Affiliate Investments(17)
Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.75% cash due 10/17/20239.00 %$21,754 $21,754 $21,260 (6)(15)(19)
1,609,201 Class A Units764 563 (15)
1,019,168.80 Preferred Units, 6%1,019 1,203 (15)
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — (15)
23,537 23,026 
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%1,080 401 (15)
1,080 401 
 Total Affiliate Investments (1.9% of net assets)$24,617 $23,427 
Non-Control/Non-Affiliate Investments(18)
109 Montgomery Owner LLCReal Estate Operating Companies
First Lien Term Loan, LIBOR+7.00% cash due 2/2/20238.33 %$2,178 $2,161 $2,306 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash due 2/2/2023— (27)30 (6)(15)(19)
2,134 2,336 
A.T. Holdings II SÀRLBiotechnology
First Lien Term Loan, 9.50% PIK due 12/22/202233,200 33,122 33,283 (11)(15)
33,122 33,283 
Access CIG, LLCDiversified Support Services
Second Lien Term Loan, LIBOR+7.75% cash due 2/27/20269.32 %20,000 19,921 19,200 (6)
19,921 19,200 
Accupac, Inc.Personal Products
First Lien Term Loan, SOFR+5.50% cash due 1/16/20267.59 %16,017 15,704 15,977 (6)(15)
First Lien Delayed Draw Term Loan, SOFR+5.50% cash due 1/16/2026— — (8)(6)(15)(19)
First Lien Revolver, SOFR+5.50% cash due 1/16/20267.59 %91 51 86 (6)(15)(19)
15,755 16,055 
Acquia Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 10/31/20258.12 %27,349 27,012 27,213 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 10/31/20259.08 %269 243 257 (6)(15)(19)
27,255 27,470 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
Control Investments(8)(9)
C5 Technology Holdings, LLCData Processing & Outsourced ServicesCommon Stock829$— $— (15)
C5 Technology Holdings, LLCData Processing & Outsourced ServicesPreferred Equity34,984,46034,984 27,638 (15)
Dominion Diagnostics, LLCHealth Care ServicesFirst Lien Term LoanSOFR+5.00%10.39%8/28/2025$14,102 14,102 14,102 (6)(15)
Dominion Diagnostics, LLCHealth Care ServicesFirst Lien Term LoanSOFR+5.00%8/28/2025— — — (6)(15)(19)
Dominion Diagnostics, LLCHealth Care ServicesFirst Lien RevolverSOFR+5.00%10.24%8/28/20253,484 3,484 3,484 (6)(15)(19)
Dominion Diagnostics, LLCHealth Care ServicesCommon Stock30,03115,222 2,711 (15)
OCSI Glick JV LLCMulti-Sector HoldingsSubordinated DebtL+4.50%9.36%10/20/202858,349 49,997 49,632 (6)(11)(14)(15)(19)
OCSI Glick JV LLCMulti-Sector HoldingsMembership Interest87.5 %— — (11)(14)(16)(19)
Senior Loan Fund JV I, LLCMulti-Sector HoldingsSubordinated DebtL+7.00%11.86%12/29/2028112,656 112,656 112,656 (6)(11)(14)(15)(19)
Senior Loan Fund JV I, LLCMulti-Sector HoldingsMembership Interest87.5 %54,791 27,973 (11)(12)(14)(16)(19)
Total Control Investments (15.8% of net assets)$285,236 $238,196 
Affiliate Investments(17)
Assembled Brands Capital LLCSpecialized FinanceFirst Lien RevolverL+6.75%12.29%10/17/2023$22,304 $22,327 $22,186 (6)(15)(19)
Assembled Brands Capital LLCSpecialized FinanceCommon Stock1,783,332 804 — (15)
Assembled Brands Capital LLCSpecialized FinancePreferred Equity1,129,453 1,159 1,412 (15)
Assembled Brands Capital LLCSpecialized FinanceWarrants78,045— — (15)
Caregiver Services, Inc.Health Care ServicesPreferred Equity1,080,399 1,080 313 (15)
Total Affiliate Investments (1.6% of net assets)$25,370 $23,911 
Non-Control/Non-Affiliate Investments(18)
107-109 Beech OAK22 LLCReal Estate DevelopmentFirst Lien Revolver11.00%2/27/2026$14,916 $14,770 $14,489 (15)(19)
107 Fair Street LLCReal Estate DevelopmentFirst Lien Term Loan12.50%5/31/20241,174 1,133 1,112 (10)(15)(19)
112-126 Van Houten Real22 LLCReal Estate DevelopmentFirst Lien Term Loan12.00%5/4/20243,710 3,664 3,645 (10)(15)(19)
A.T. Holdings II Ltd.BiotechnologyFirst Lien Term Loan14.25%9/13/202921,434 21,620 21,434 (11)(15)(22)
A.T. Holdings II SÀRLBiotechnologyFirst Lien Term Loan20.00%2/6/20245,576 5,561 5,464 (11)(15)
Access CIG, LLCDiversified Support ServicesSecond Lien Term LoanL+7.75%12.94%2/27/202620,000 19,943 18,883 (6)(15)
Accupac, Inc.Personal Care ProductsFirst Lien Term LoanSOFR+5.50%10.86%1/16/202620,286 20,193 20,246 (6)(15)
Accupac, Inc.Personal Care ProductsFirst Lien Term LoanSOFR+5.50%1/16/2026— (2)(8)(6)(15)(19)
Accupac, Inc.Personal Care ProductsFirst Lien RevolverSOFR+5.50%10.86%1/16/20262,033 2,011 2,027 (6)(15)(19)
Acquia Inc.Application SoftwareFirst Lien Term LoanL+7.00%12.34%10/31/20256,400 6,327 6,374 (6)(15)
Acquia Inc.Application SoftwareFirst Lien Term LoanL+7.00%12.34%10/31/202525,332 25,283 25,230 (6)(15)
Acquia Inc.Application SoftwareFirst Lien RevolverL+7.00%12.05%10/31/20252,113 2,101 2,102 (6)(15)(19)
ADB Companies, LLCConstruction & EngineeringFirst Lien Term LoanSOFR+6.50%12.00%12/18/20253,520 3,480 3,455 (6)(15)
ADB Companies, LLCConstruction & EngineeringFirst Lien Term LoanSOFR+6.50%12.00%12/18/202518,271 18,091 17,935 (6)(15)
ADB Companies, LLCConstruction & EngineeringFirst Lien Term LoanSOFR+6.50%11.66%12/18/20251,000 983 982 (6)(15)
ADC Therapeutics SABiotechnologyFirst Lien Term LoanSOFR+7.50%12.89%8/15/20296,589 6,292 6,267 (6)(11)(15)
ADC Therapeutics SABiotechnologyFirst Lien Term LoanSOFR+7.50%8/15/2029— (38)(38)(6)(11)(15)(19)
ADC Therapeutics SABiotechnologyWarrants28,948 174 18 (11)(15)
6

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
ADB Companies, LLCConstruction & Engineering
First Lien Term Loan, LIBOR+6.25% cash due 12/18/20258.50 %$14,896 $14,384 $14,650 (6)(15)
14,384 14,650 
Aden & Anais Merger Sub, Inc.Apparel, Accessories & Luxury Goods
51,645 Common Units in Aden & Anais Holdings, Inc.5,165 — (15)
5,165  
AI Sirona (Luxembourg) Acquisition S.a.r.l.Pharmaceuticals
Second Lien Term Loan, EURIBOR+7.25% cash due 9/28/20267.25 %24,838 27,748 23,760 (6)(11)(15)
27,748 23,760 
AIP RD Buyer Corp.Distributors
Second Lien Term Loan, SOFR+7.75% cash due 12/23/20299.35 %$14,414 14,145 13,880 (6)(15)
14,410 Common Units in RD Holding LP1,352 1,295 (15)
15,497 15,175 
AirStrip Technologies, Inc.Application Software
5,715 Common Stock Warrants (exercise price $139.99) expiration date 5/11/202590 — (15)
90  
All Web Leads, Inc.Advertising
First Lien Term Loan, LIBOR+6.50% cash due 12/29/20238.07 %23,124 21,584 22,060 (6)(15)
21,584 22,060 
Altice Financing S.A.Integrated Telecommunication Services
Fixed Rate Bond, 5.75% cash due 8/15/2029300 248 242 (11)
248 242 
Altice France S.A.Integrated Telecommunication Services
Fixed Rate Bond, 5.50% cash due 10/15/20293,800 3,309 2,915 (11)
3,309 2,915 
Alvogen Pharma US, Inc.Pharmaceuticals
First Lien Term Loan, LIBOR+5.25% cash due 12/31/20237.50 %13,300 12,981 11,751 (6)
12,981 11,751 
Alvotech Holdings S.A.Biotechnology(13)
Tranche A Fixed Rate Bond 10.00% cash due 6/24/202524,043 23,720 24,043 (11)(15)
Tranche B Fixed Rate Bond 10.00% cash due 6/24/202523,522 23,240 23,522 (11)(15)
587,930 Common Shares in Alvotech SA5,349 4,827 
124,780 Seller Earn Out Shares in Alvotech SA444 309 (15)
52,753 52,701 
American Auto Auction Group, LLCConsumer Finance
Second Lien Term Loan, SOFR+8.75% cash due 1/2/202910.80 %14,760 14,481 14,317 (6)(15)
14,481 14,317 
American Tire Distributors, Inc.Distributors
First Lien Term Loan, LIBOR+6.25% cash due 10/20/20287.00 %9,920 9,796 9,404 (6)
9,796 9,404 
Amplify Finco Pty Ltd.Movies & Entertainment
First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.92 %15,259 13,933 14,890 (6)(11)(15)
Second Lien Term Loan, LIBOR+8.00% cash due 11/26/20279.67 %12,500 12,188 12,063 (6)(11)(15)
26,121 26,953 
Anastasia Parent, LLCPersonal Products
First Lien Term Loan, LIBOR+3.75% cash due 8/11/20256.00 %2,494 2,070 2,001 (6)
2,070 2,001 
Ankura Consulting Group LLCResearch & Consulting Services
Second Lien Term Loan, LIBOR+8.00% cash due 3/19/20299.18 %5,316 5,236 4,784 (6)(15)
5,236 4,784 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
AI Sirona (Luxembourg) Acquisition S.a.r.l.PharmaceuticalsSecond Lien Term LoanE+7.25%10.67%9/28/202629,985 $33,119 $32,128 (6)(11)(15)
AIP RD Buyer Corp.DistributorsSecond Lien Term LoanSOFR+7.75%12.95%12/21/2029$17,873 17,646 17,533 (6)(15)
AIP RD Buyer Corp.DistributorsCommon Stock17,870 1,733 2,578 (15)
AirStrip Technologies, Inc.Application SoftwareWarrants5,715 90 — (15)
All Web Leads, Inc.AdvertisingFirst Lien Term LoanSOFR+8.50%12/29/202323,562 22,795 16,880 (6)(15)(20)
Altice France S.A.Integrated Telecommunication ServicesFixed Rate Bond5.50%10/15/20294,050 3,561 2,900 (11)
Alto Pharmacy Holdings, Inc.Health Care TechnologyFirst Lien Term LoanSOFR+8.00%13.34%3.50%10/14/20278,794 8,132 8,011 (6)(15)
Alto Pharmacy Holdings, Inc.Health Care TechnologyWarrants166,414 642 518 (15)
Alvogen Pharma US, Inc.PharmaceuticalsFirst Lien Term LoanSOFR+7.50%12.89%6/30/202517,280 17,197 16,503 (6)(15)
Alvotech Holdings S.A.BiotechnologyFixed Rate Bond8.50%3.50%11/16/202628,464 28,363 27,682 (11)(15)
Alvotech Holdings S.A.BiotechnologyFixed Rate Bond8.50%3.50%11/16/20262,121 1,945 2,063 (11)(15)
Alvotech Holdings S.A.BiotechnologyFixed Rate Bond8.50%3.50%11/16/202627,692 27,612 26,930 (11)(15)
Alvotech Holdings S.A.BiotechnologyFixed Rate Bond8.50%3.50%11/16/20262,064 1,891 2,007 (11)(15)
Alvotech Holdings S.A.BiotechnologyCommon Stock824,197 2,426 6,379 (11)
Alvotech Holdings S.A.BiotechnologyCommon Stock141,640 566 339 (11)(13)(15)
American Auto Auction Group, LLCConsumer FinanceSecond Lien Term LoanSOFR+8.75%13.99%1/2/202917,048 16,411 12,616 (6)(15)
American Tire Distributors, Inc.DistributorsFirst Lien Term LoanSOFR+6.25%11.49%10/20/202819,163 18,289 16,718 (6)
Amplify Finco Pty Ltd.Movies & EntertainmentSecond Lien Term LoanSOFR+8.00%13.39%11/26/202712,500 12,188 11,865 (6)(11)(15)
Anastasia Parent, LLCPersonal Care ProductsFirst Lien Term LoanSOFR+3.75%9.25%8/11/20253,710 3,075 2,863 (6)
Apptio, Inc.Application SoftwareFirst Lien Term LoanL+5.00%10.20%1/10/20259,280 9,189 9,280 (6)(15)
Apptio, Inc.Application SoftwareFirst Lien Term LoanL+5.00%10.20%1/10/202532,308 31,999 32,308 (6)(15)
Apptio, Inc.Application SoftwareFirst Lien RevolverL+5.00%10.20%1/10/2025808 792 808 (6)(15)(19)
Ardonagh Midco 3 PLCInsurance BrokersFirst Lien Term LoanE+7.25%10.07%7/14/20263,017 3,341 3,321 (6)(11)(15)
Ardonagh Midco 3 PLCInsurance BrokersFirst Lien Term LoanSOFR+6.00%11.25%7/14/2026$10,519 10,389 10,614 (6)(11)(15)
Ardonagh Midco 3 PLCInsurance BrokersFirst Lien Term LoanSONIA+7.25%12.18%7/14/2026£4,949 6,364 6,348 (6)(11)(15)
Ardonagh Midco 3 PLCInsurance BrokersFirst Lien Term LoanSONIA+7.25%12.45%7/14/2026£23,675 28,939 30,370 (6)(11)(15)
Ardonagh Midco 3 PLCInsurance BrokersFirst Lien Term LoanSONIA+5.75%8.57%7/14/2026£3,649 3,927 4,027 (6)(11)(15)
ASP-R-PAC Acquisition Co LLCPaper & Plastic Packaging Products & MaterialsFirst Lien Term LoanSOFR+6.00%11.31%12/29/2027$3,284 3,276 3,120 (6)(11)(15)
ASP-R-PAC Acquisition Co LLCPaper & Plastic Packaging Products & MaterialsFirst Lien RevolverSOFR+6.00%12/29/2027— (14)(20)(6)(11)(15)(19)
Astra Acquisition Corp.Application SoftwareFirst Lien Term LoanL+5.25%10.44%10/25/20288,490 8,153 5,983 (6)
athenahealth Group Inc.Health Care TechnologyPreferred Equity21,523 20,789 18,821 (15)
Athenex, Inc.PharmaceuticalsFirst Lien Term Loan11.00%6/19/20261,338 1,257 1,257 (11)(15)(20)
Athenex, Inc.PharmaceuticalsFirst Lien Term Loan11.00%6/19/20261,338 1,241 1,257 (11)(15)(20)
Athenex, Inc.PharmaceuticalsFirst Lien Term Loan11.00%6/19/20265,350 4,951 5,029 (11)(15)(20)
Athenex, Inc.PharmaceuticalsWarrants10,634 — 488 — (11)(15)
Athenex, Inc.PharmaceuticalsWarrants10,634 488 — (11)(15)
ATNX SPV, LLCPharmaceuticalsFirst Lien Term Loan5/31/203111,683 11,723 11,274 (11)(15)(22)
Aurora Lux Finco S.À.R.L.Airport ServicesFirst Lien Term LoanL+6.00%11.27%12/24/202629,509 29,137 28,299 (6)(11)(15)
7

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Apptio, Inc.Application Software
First Lien Term Loan, LIBOR+6.00% cash due 1/10/20257.25 %$34,458 $33,657 $33,680 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 1/10/20257.25 %892 859 842 (6)(15)(19)
34,516 34,522 
APX Group Inc.Electrical Components & Equipment
Fixed Rate Bond, 5.75% cash due 7/15/20292,075 1,724 1,610 (11)
1,724 1,610 
Ardonagh Midco 3 PLCInsurance Brokers
First Lien Term Loan, EURIBOR+7.00% cash due 7/14/20268.00 %1,964 $2,178 $2,053 (6)(11)(15)
First Lien Term Loan, SONIA+7.00% cash due 7/14/20268.19 %£18,636 23,172 22,633 (6)(11)(15)
First Lien Term Loan, LIBOR+5.75% cash due 7/14/20266.50 %$10,519 10,346 10,309 (6)(11)(15)
First Lien Delayed Draw Term Loan, SONIA+5.75% cash due 7/14/2026£— (44)— (6)(11)(15)(19)
35,652 34,995 
ASP Unifrax Holdings, Inc.Trading Companies & Distributors
Fixed Rate Bond, 7.50% cash due 9/30/2029$5,500 5,406 3,828 
Fixed Rate Bond, 5.25% cash due 9/30/20282,500 2,210 2,000 
7,616 5,828 
Associated Asphalt Partners, LLCConstruction Materials
First Lien Term Loan, LIBOR+5.25% cash due 4/5/20246.92 %2,509 2,309 1,791 (6)
2,309 1,791 
Astra Acquisition Corp.Application Software
First Lien Term Loan, LIBOR+5.25% cash due 10/25/20286.92 %8,563 8,314 7,485 (6)
8,314 7,485 
athenahealth Group Inc.Health Care Technology
18,635 Shares of Series A Preferred Stock in Minerva Holdco, Inc., 10.75%18,264 17,153 (15)
18,264 17,153 
Athenex, Inc.Pharmaceuticals
First Lien Term Loan, 11.00% cash due 6/19/202616,155 15,617 15,751 (11)(15)
First Lien Delayed Draw Term Loan, 11.00% cash due 6/19/2026— (274)(527)(11)(15)(19)
First Lien Revenue Interest Financing Term Loan due 5/31/20317,926 7,881 7,881 (6)(11)(15)
328,149 Common Stock Warrants (exercise price $0.4955) expiration date 6/19/2027973 43 (11)(15)
24,197 23,148 
Aurora Lux Finco S.À.R.L.Airport Services
First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.63 %22,483 22,123 21,336 (6)(11)(15)
22,123 21,336 
The AveryReal Estate Operating Companies
First Lien Term Loan in T8 Urban Condo Owner, LLC, LIBOR+7.30% cash due 2/17/20239.09 %15,874 15,757 16,040 (6)(15)
Subordinated Debt in T8 Senior Mezz LLC, LIBOR+12.50% cash due 2/17/202314.53 %3,834 3,808 3,865 (6)(15)
19,565 19,905 
BAART Programs, Inc.Health Care Services
First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20276.60 %2,269 2,226 2,204 (6)(15)(19)
Second Lien Term Loan, LIBOR+8.50% cash due 6/11/202810.17 %7,166 7,059 7,059 (6)(15)
Second Lien Delayed Draw Term Loan, LIBOR+8.50% cash due 6/11/202810.17 %3,596 3,437 3,430 (6)(15)(19)
12,722 12,693 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
Avalara, Inc.Application SoftwareFirst Lien Term LoanSOFR+7.25%12.49%10/19/2028$50,470 $49,639 $49,461 (6)(15)
Avalara, Inc.Application SoftwareFirst Lien RevolverSOFR+7.25%10/19/2028— (113)(101)(6)(15)(19)
The AveryReal Estate Operating CompaniesFirst Lien Term LoanL+7.30%2/17/202319,163 19,163 18,286 (6)(15)(20)
The AveryReal Estate Operating CompaniesSubordinated Debt Term LoanL+12.50%2/17/20234,641 4,641 4,164 (6)(15)(20)
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanSOFR+5.00%10.50%6/11/20273,258 3,227 3,173 (6)(15)
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanSOFR+5.00%10.50%6/11/20271,264 1,273 1,232 (6)(15)
BAART Programs, Inc.Health Care ServicesSecond Lien Term LoanSOFR+8.50%14.00%6/11/20288,920 8,819 8,661 (6)(15)
BAART Programs, Inc.Health Care ServicesSecond Lien Term LoanSOFR+8.50%14.00%6/11/20282,091 2,067 2,030 (6)(15)
BAART Programs, Inc.Health Care ServicesSecond Lien Term LoanSOFR+8.50%14.00%6/11/20284,361 4,296 4,235 (6)(15)
Berner Food & Beverage, LLCSoft Drinks & Non-alcoholic BeveragesFirst Lien Term LoanSOFR+5.50%10.70%7/30/202740,764 40,529 40,316 (6)(15)
Berner Food & Beverage, LLCSoft Drinks & Non-alcoholic BeveragesFirst Lien RevolverPRIME+4.50%12.50%7/30/20262,528 2,492 2,482 (6)(15)(19)
BioXcel Therapeutics, Inc.PharmaceuticalsFirst Lien Term Loan8.00%2.25%4/19/20276,719 6,508 6,282 (11)(15)
BioXcel Therapeutics, Inc.PharmaceuticalsFirst Lien Term Loan9/30/20323,210 3,230 3,130 (11)(15)(22)
BioXcel Therapeutics, Inc.PharmaceuticalsFirst Lien Term Loan8.00%2.25%4/19/2027— — — (11)(15)(19)
BioXcel Therapeutics, Inc.PharmaceuticalsFirst Lien Term Loan8.00%2.25%4/19/2027— — — (11)(15)(19)
BioXcel Therapeutics, Inc.PharmaceuticalsFirst Lien Term Loan9/30/2032— — — (11)(15)(19)(22)
BioXcel Therapeutics, Inc.PharmaceuticalsFirst Lien Term Loan9/30/2032— — — (11)(15)(19)(22)
BioXcel Therapeutics, Inc.PharmaceuticalsWarrants26,131 225 34 (11)(15)
Blackhawk Network Holdings, Inc.Data Processing & Outsourced ServicesSecond Lien Term LoanL+7.00%12.25%6/15/202630,625 30,346 29,385 (6)
Blumenthal Temecula, LLCAutomotive RetailFirst Lien Term Loan9.00%9/24/20234,994 5,006 4,969 (15)
Blumenthal Temecula, LLCAutomotive RetailPreferred Equity1,708,618 1,711 2,085 (15)
Blumenthal Temecula, LLCAutomotive RetailPreferred Equity394,297 395 481 (15)
Blumenthal Temecula, LLCAutomotive RetailCommon Stock394,297 424 355 (15)
Cadence Aerospace, LLCAerospace & DefenseFirst Lien Term LoanSOFR+6.50%11.91%2.00%11/14/202413 13 13 (6)(15)
Cadence Aerospace, LLCAerospace & DefenseFirst Lien Term LoanSOFR+6.50%11.91%2.00%11/14/20243,031 2,971 3,031 (6)(15)
Cadence Aerospace, LLCAerospace & DefenseFirst Lien Term LoanSOFR+6.50%11.91%2.00%11/14/20241,557 1,526 1,557 (6)(15)
Cadence Aerospace, LLCAerospace & DefenseFirst Lien Term LoanSOFR+6.50%11.91%2.00%11/14/20241,024 1,002 1,024 (6)(15)
CircusTrix Holdings, LLCLeisure FacilitiesFirst Lien Term LoanSOFR+5.50%10.70%7/14/2023130 130 130 (6)(15)
CircusTrix Holdings, LLCLeisure FacilitiesFirst Lien Term LoanSOFR+5.50%10.70%7/14/2023129 129 129 (6)(15)
CircusTrix Holdings, LLCLeisure FacilitiesFirst Lien Term LoanSOFR+5.50%10.70%1/16/20241,084 1,103 1,084 (6)(15)
CircusTrix Holdings, LLCLeisure FacilitiesFirst Lien Term LoanSOFR+5.50%10.70%1/16/20249,002 9,003 9,002 (6)(15)
Clear Channel Outdoor Holdings, Inc.AdvertisingFixed Rate Bond7.50%6/1/20292,632 2,632 1,951 (11)
Clear Channel Outdoor Holdings, Inc.AdvertisingFixed Rate Bond7.75%4/15/2028176 170 138 (11)
Condor Merger Sub Inc.Systems SoftwareFixed Rate Bond7.38%2/15/20308,420 8,257 7,330 
Continental Intermodal Group LPOil & Gas Storage & TransportationFirst Lien Term LoanL+8.50%13.69%1/28/202524,350 23,525 21,506 (6)(15)
Continental Intermodal Group LPOil & Gas Storage & TransportationWarrants706 154 (15)
8

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Berner Food & Beverage, LLCSoft Drinks
First Lien Term Loan, LIBOR+6.50% cash due 7/30/20277.50 %$33,162 $32,671 $32,034 (6)(15)
First Lien Revolver, PRIME+5.50% cash due 7/30/202610.25 %1,980 1,936 1,884 (6)(15)(19)
34,607 33,918 
BioXcel Therapeutics, Inc.Pharmaceuticals
First Lien Term Loan, 10.25% cash due 4/19/20275,322 5,099 5,109 (11)(15)
First Lien Delayed Draw Term Loan, 10.25% cash due 4/19/2027— — — (11)(15)(19)
First Lien Revenue Interest Financing Delayed Draw Term Loan due 9/30/2032— — — (6)(11)(15)(19)
21,177 Common Stock Warrants (exercise price $20.04) expiration date 4/19/2029125 120 (15)
5,224 5,229 
Blackhawk Network Holdings, Inc.Data Processing & Outsourced Services
Second Lien Term Loan, LIBOR+7.00% cash due 6/15/20268.31 %30,625 30,252 30,038 (6)
30,252 30,038 
Blumenthal Temecula, LLCAutomotive Retail
First Lien Term Loan, 9.00% cash due 9/24/20233,979 3,980 3,960 (15)
1,293,324 Preferred Units in Unstoppable Automotive AMV, LLC1,293 1,280 (15)
298,460 Preferred Units in Unstoppable Automotive VMV, LLC298 295 (15)
298,460 Common Units in Unstoppable Automotive AMV, LLC298 373 (12)(15)
5,869 5,908 
Cadence Aerospace, LLCAerospace & Defense
First Lien Term Loan, LIBOR+6.50% cash 2.00% PIK due 11/14/20237.74 %14,256 13,246 13,093 (6)(15)
13,246 13,093 
Carvana Co.Automotive Retail
Fixed Rate Bond, 5.625% cash due 10/1/20256,700 5,765 5,155 (11)
5,765 5,155 
CCO Holdings LLCCable & Satellite
Fixed Rate Bond, 4.50% cash due 5/1/20322,097 1,739 1,705 (11)
1,739 1,705 
CircusTrix Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+5.50% cash 1.50% PIK due 7/16/20237.17 %10,739 10,198 9,761 (6)(15)
10,198 9,761 
CITGO Holding, Inc.Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+7.00% cash due 8/1/20238.67 %8,998 8,940 8,901 (6)
Fixed Rate Bond, 9.25% cash due 8/1/202410,672 10,672 10,345 
19,612 19,246 
CITGO Petroleum Corp.Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.92 %8,268 8,074 8,219 (6)
8,074 8,219 
Clear Channel Outdoor Holdings Inc.Advertising
Fixed Rate Bond, 7.50% cash due 6/1/20296,476 6,476 4,676 (11)
Fixed Rate Bond, 5.125% cash due 8/15/20271,374 1,223 1,164 (11)
Fixed Rate Bond, 7.75% cash due 4/15/2028676 647 494 (11)
8,346 6,334 
CommScope Technologies LLCCommunications Equipment
Fixed Rate Bond, 5.00% cash due 3/15/20271,000 848 741 (11)
Fixed Rate Bond, 6.00% cash due 6/15/20253,250 2,926 2,818 (11)
3,774 3,559 
Condor Merger Sub Inc.Systems Software
Fixed Rate Bond, 7.375% cash due 2/15/20308,420 8,239 6,868 
8,239 6,868 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
Convergeone Holdings, Inc.IT Consulting & Other ServicesFirst Lien Term LoanL+5.00%10.37%1/4/2026$17,506 $15,434 $11,176 (6)
Conviva Inc.Application SoftwarePreferred Equity417,851 605 894 (15)
CorEvitas, LLCHealth Care TechnologyFirst Lien Term LoanSOFR+6.13%11.33%12/13/202513,671 13,633 13,408 (6)(15)
CorEvitas, LLCHealth Care TechnologyFirst Lien Term LoanSOFR+6.13%11.33%12/13/20254,903 4,853 4,809 (6)(15)
CorEvitas, LLCHealth Care TechnologyFirst Lien RevolverPRIME+5.75%14.00%12/13/20251,250 1,226 1,202 (6)(15)(19)
CorEvitas, LLCHealth Care TechnologyCommon Stock1,500 1,574 3,299 (15)
Coupa Holdings, LLCApplication SoftwareFirst Lien Term LoanSOFR+7.50%12.60%2/27/203013,157 12,843 12,852 (6)(15)
Coupa Holdings, LLCApplication SoftwareFirst Lien Term LoanSOFR+7.50%2/27/2030— (15)(14)(6)(15)(19)
Coupa Holdings, LLCApplication SoftwareFirst Lien RevolverSOFR+7.50%2/27/2029— (21)(21)(6)(15)(19)
Covetrus, Inc.Health Care DistributorsFirst Lien Term LoanSOFR+5.00%10.24%10/13/202914,787 14,186 13,807 (6)
Coyote Buyer, LLCSpecialty ChemicalsFirst Lien Term LoanL+6.00%11.10%2/6/202618,060 17,715 17,706 (6)(15)
Coyote Buyer, LLCSpecialty ChemicalsFirst Lien RevolverSOFR+6.00%11.20%2/6/2025533 520 507 (6)(15)(19)
CPC Acquisition Corp.Specialty ChemicalsSecond Lien Term LoanSOFR+7.75%12/29/2028727 462 325 (6)(15)(20)
Delta Leasing SPV II LLCSpecialized FinanceSubordinated Debt Term Loan3.00%7.00%8/31/202913,043 13,043 13,043 (11)(15)(19)
Delta Leasing SPV II LLCSpecialized FinancePreferred Equity419 419 419 (11)(15)
Delta Leasing SPV II LLCSpecialized FinanceCommon Stock(11)(15)
Delta Leasing SPV II LLCSpecialized FinanceWarrants31 — — (11)(15)
Dialyze Holdings, LLCHealth Care EquipmentFirst Lien Term LoanSOFR+9.00%14.42%8/4/202620,757 20,092 20,705 (6)(15)
Dialyze Holdings, LLCHealth Care EquipmentSubordinated Debt Term Loan8.00%9/30/2027641 640 611 (15)
Dialyze Holdings, LLCHealth Care EquipmentWarrants6,397,254 1,642 1,215 (15)
Digital.AI Software Holdings, Inc.Application SoftwareFirst Lien Term LoanSOFR+7.00%12.34%2/10/202712,418 12,226 12,120 (6)(15)
Digital.AI Software Holdings, Inc.Application SoftwareFirst Lien RevolverSOFR+6.75%12.09%2/10/2027204 184 172 (6)(15)(19)
DirecTV Financing, LLCCable & SatelliteFirst Lien Term LoanSOFR+5.00%10.22%8/2/20274,769 4,687 4,672 (6)
DTI Holdco, Inc.Research & Consulting ServicesFirst Lien Term LoanSOFR+4.75%9.80%4/26/20294,963 4,879 4,632 (6)
Eagleview Technology CorporationApplication SoftwareSecond Lien Term LoanL+7.50%13.04%8/14/20268,974 8,884 7,359 (6)(15)
EOS Fitness Opco Holdings, LLCLeisure FacilitiesPreferred Equity488 488 1,160 (15)
EOS Fitness Opco Holdings, LLCLeisure FacilitiesCommon Stock12,500 — — (15)
Establishment Labs Holdings Inc.Health Care TechnologyFirst Lien Term Loan3.00%6.00%4/21/202710,899 10,779 10,463 (11)(15)
Establishment Labs Holdings Inc.Health Care TechnologyFirst Lien Term Loan3.00%6.00%4/21/20271,746 1,720 1,676 (11)(15)
Establishment Labs Holdings Inc.Health Care TechnologyFirst Lien Term Loan3.00%6.00%4/21/2027— — (11)(15)(19)
Establishment Labs Holdings Inc.Health Care TechnologyFirst Lien Term Loan3.00%6.00%4/21/2027— — (11)(15)(19)
Fairbridge Strategic Capital Funding LLCReal Estate Operating CompaniesFirst Lien Term Loan9.00%12/24/202852,658 52,658 52,658 (15)(19)
Fairbridge Strategic Capital Funding LLCReal Estate Operating CompaniesWarrants2,500 — (11)(15)
FINThrive Software Intermediate Holdings, Inc.Health Care TechnologySecond Lien Term LoanL+6.75%11.94%12/17/202931,074 29,063 18,664 (6)
Fortress Biotech, Inc.BiotechnologyFirst Lien Term Loan11.00%8/27/202511,918 11,572 11,173 (11)(15)
Fortress Biotech, Inc.BiotechnologyWarrants417,011 427 113 (11)(15)
Frontier Communications Holdings, LLCIntegrated Telecommunication ServicesFixed Rate Bond6.00%1/15/20304,881 4,456 3,595 (11)
Galileo Parent, Inc.Aerospace & DefenseFirst Lien Term LoanSOFR+7.25%12.34%5/3/202923,774 23,080 23,094 (6)(15)
Galileo Parent, Inc.Aerospace & DefenseFirst Lien RevolverSOFR+7.25%12.34%5/3/20291,638 1,530 1,532 (6)(15)(19)
Gibson Brands, Inc.Leisure ProductsFirst Lien Term LoanSOFR+5.00%10.25%8/11/20282,463 2,039 1,995 (6)(15)
9

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Continental Intermodal Group LPOil & Gas Storage & Transportation
First Lien Term Loan, LIBOR+8.50% cash due 1/28/202510.17 %$32,188 $30,771 $27,372 (6)(15)
Common Stock Warrants expiration date 7/28/2025648 673 (15)
31,419 28,045 
Convergeone Holdings, Inc.IT Consulting & Other Services
First Lien Term Loan, LIBOR+5.00% cash due 1/4/20266.67 %11,944 11,711 10,272 (6)
11,711 10,272 
Conviva Inc.Application Software
517,851 Shares of Series D Preferred Stock605 894 (15)
605 894 
CorEvitas, LLCHealth Care Technology
First Lien Term Loan, SOFR+5.75% cash due 12/13/20257.38 %13,747 13,581 13,618 (6)(15)
First Lien Revolver, PRIME+4.75% cash due 12/13/20259.50 %305 287 288 (6)(15)(19)
1,099 Class A2 Common Units in CorEvitas Holdings, L.P.690 2,340 (15)
14,558 16,246 
Coyote Buyer, LLCSpecialty Chemicals
First Lien Term Loan, LIBOR+6.00% cash due 2/6/20267.00 %18,247 17,814 17,889 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 2/6/20257.67 %400 387 374 (6)(15)(19)
18,201 18,263 
Delivery Hero FinCo LLCInternet & Direct Marketing Retail
First Lien Term Loan, SOFR+5.75% cash due 8/12/20276.88 %5,000 4,894 4,713 (6)(11)
4,894 4,713 
Delta Topco, Inc.Systems Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/1/20289.34 %6,680 6,647 5,845 (6)
6,647 5,845 
Dialyze Holdings, LLCHealth Care Equipment
First Lien Term Loan, LIBOR+9.00% cash 2.00% PIK due 8/4/202611.25 %24,272 22,873 22,629 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+9.00% cash 2.00% PIK due 8/4/2026— (144)(175)(6)(15)(19)
5,403,823 Class A Warrants (exercise price $1.00) expiration date 8/4/20281,405 1,351 (15)
24,134 23,805 
Digital.AI Software Holdings, Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 2/10/20278.40 %9,927 9,606 9,705 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 2/10/20277.90 %251 227 217 (6)(15)(19)
9,833 9,922 
DirecTV Financing, LLCCable & Satellite
First Lien Term Loan, LIBOR+5.00% cash due 8/2/20276.67 %17,718 17,540 16,363 (6)
17,540 16,363 
DTI Holdco, Inc.Research & Consulting Services
First Lien Term Loan, SOFR+4.75% cash due 4/26/20296.28 %5,000 4,902 4,695 (6)
4,902 4,695 
Eagleview Technology CorporationApplication Software
Second Lien Term Loan, LIBOR+7.50% cash due 8/14/20269.17 %8,974 8,884 8,413 (6)(15)
8,884 8,413 
EOS Fitness Opco Holdings, LLCLeisure Facilities
487.5 Class A Preferred Units, 12%488 966 (15)
12,500 Class B Common Units— — (15)
488 966 
Establishment Labs Holdings Inc.Health Care Technology
First Lien Term Loan, 9.00% cash due 4/21/202710,151 9,999 9,998 (11)(15)
First Lien Delayed Draw Term Loan, 9.00% cash due 4/21/2027(11)(15)(19)
10,002 10,001 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
GoldenTree Loan Management EUR CLO 2 DACMulti-Sector HoldingsCLO NotesE+2.85%6.05%1/20/20321,000 $872 $970 (6)(11)
Grove Hotel Parcel Owner, LLCHotels, Resorts & Cruise LinesFirst Lien Term LoanSOFR+8.00%13.39%6/21/2027$17,488 17,308 17,314 (6)(15)
Grove Hotel Parcel Owner, LLCHotels, Resorts & Cruise LinesFirst Lien Term LoanSOFR+8.00%6/21/2027— (58)(35)(6)(15)(19)
Grove Hotel Parcel Owner, LLCHotels, Resorts & Cruise LinesFirst Lien RevolverSOFR+8.00%6/21/2027— (29)(18)(6)(15)(19)
Harbor Purchaser Inc.Education ServicesFirst Lien Term LoanSOFR+5.25%10.45%4/9/202914,383 13,885 12,352 (6)
Harrow Health, Inc.PharmaceuticalsFirst Lien Term LoanSOFR+6.50%11.74%1/19/20267,448 7,279 7,295 (6)(11)(15)
Harrow Health, Inc.PharmaceuticalsFirst Lien Term LoanSOFR+6.50%1/19/2026— (91)(83)(6)(11)(15)(19)
Horizon Aircraft Finance I Ltd.Specialized FinanceCLO Notes4.46%12/15/20386,932 5,577 6,001 (11)
IAMGOLD CorporationGoldSecond Lien Term LoanSOFR+8.25%13.30%5/16/202823,975 23,274 23,292 (6)(11)(15)
iCIMs, Inc.Application SoftwareFirst Lien Term LoanSOFR+7.25%8.50%3.88%8/18/202824,188 23,876 23,235 (6)(15)
iCIMs, Inc.Application SoftwareFirst Lien Term LoanSOFR+7.25%12.38%8/18/20283,636 3,600 3,563 (6)(15)
iCIMs, Inc.Application SoftwareFirst Lien Term LoanSOFR+7.25%8/18/2028— — — (6)(15)(19)
iCIMs, Inc.Application SoftwareFirst Lien RevolverSOFR+6.75%11.99%8/18/2028377 331 288 (6)(15)(19)
Impel Neuropharma, Inc.Health Care TechnologyFirst Lien Term Loan2/15/203115,302 15,341 14,269 (15)(22)
Impel Neuropharma, Inc.Health Care TechnologyFirst Lien Term LoanSOFR+8.75%14.14%3/17/202713,109 12,939 12,617 (6)(15)
Innocoll Pharmaceuticals LimitedHealth Care TechnologyFirst Lien Term Loan11.00%1/26/20278,452 8,185 7,730 (11)(15)
Innocoll Pharmaceuticals LimitedHealth Care TechnologyFirst Lien Term Loan11.00%1/26/2027— — — (11)(15)(19)
Innocoll Pharmaceuticals LimitedHealth Care TechnologyFirst Lien Term Loan11.00%1/26/2027— — — (11)(15)(19)
Innocoll Pharmaceuticals LimitedHealth Care TechnologyWarrants112,990 300 172 (11)(15)
Integral Development CorporationDiversified Financial ServicesWarrants1,078,284 113 — (15)
Inventus Power, Inc.Electrical Components & EquipmentFirst Lien Term LoanSOFR+7.50%12.72%6/30/202533,498 32,494 32,493 (6)(15)
Inventus Power, Inc.Electrical Components & EquipmentFirst Lien RevolverSOFR+7.50%6/30/2025— (114)(114)(6)(15)(19)
INW Manufacturing, LLCPersonal Care ProductsFirst Lien Term LoanL+5.75%11.29%3/25/202745,169 43,394 35,834 (6)(15)
IPC Corp.Application SoftwareFirst Lien Term LoanSOFR+6.50%11.57%10/1/202640,484 39,779 38,662 (6)(15)
Ivanti Software, Inc.Application SoftwareSecond Lien Term LoanL+7.25%12.42%12/1/202813,939 12,601 9,252 (6)
Jazz Acquisition, Inc.Aerospace & DefenseFirst Lien Term LoanSOFR+7.50%12.70%1/29/202717,069 17,053 16,966 (6)(15)
Jazz Acquisition, Inc.Aerospace & DefenseFirst Lien Term LoanSOFR+7.50%12.70%1/29/202727,360 26,872 27,488 (6)(15)
Jazz Acquisition, Inc.Aerospace & DefenseFirst Lien Term LoanSOFR+5.50%10.60%1/29/202715,150 14,331 14,924 (6)(15)
Jazz Acquisition, Inc.Aerospace & DefenseSecond Lien Term LoanSOFR+8.00%13.20%6/18/2027666 616 652 (6)
Kings Buyer, LLCEnvironmental & Facilities ServicesFirst Lien Term LoanSOFR+6.50%11.84%10/29/202716,765 16,636 16,511 (6)(15)
Kings Buyer, LLCEnvironmental & Facilities ServicesFirst Lien RevolverSOFR+6.50%11.84%10/29/2027545 517 510 (6)(15)(19)
Latam Airlines Group S.A.Passenger AirlinesFirst Lien Term LoanSOFR+9.50%14.61%10/12/202726,489 24,888 26,985 (6)(11)
Lift Brands Holdings, Inc.Leisure FacilitiesCommon Stock2,000,000 1,399 — (15)
Lightbox Intermediate, L.P.Real Estate ServicesFirst Lien Term LoanSOFR+5.00%10.50%5/9/202645,361 44,783 44,227 (6)(15)
Liquid Environmental Solutions CorporationEnvironmental & Facilities ServicesSecond Lien Term LoanSOFR+8.50%13.84%11/30/20265,403 5,344 5,173 (6)(15)
Liquid Environmental Solutions CorporationEnvironmental & Facilities ServicesSecond Lien Term LoanSOFR+8.50%13.84%11/30/20262,939 2,883 2,755 (6)(15)(19)
10

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Fairbridge Strategic Capital Funding LLCReal Estate Operating Companies(20)
First Lien Delayed Draw Term Loan, 9.00% cash due 12/24/2028$17,750 $17,750 $17,750 (15)(19)
2,500 Warrant Units (exercise price $0.01) expiration date 11/24/2031— (11)(12)(15)
17,750 17,753 
FINThrive Software Intermediate Holdings, Inc.Health Care Technology
Second Lien Term Loan, LIBOR+6.75% cash due 12/17/20298.42 %25,061 24,685 22,430 (6)
24,685 22,430 
Fortress Biotech, Inc.Biotechnology
First Lien Term Loan, 11.00% cash due 8/27/20259,466 9,037 9,111 (11)(15)
331,200 Common Stock Warrants (exercise price $3.20) expiration date 8/27/2030405 56 (11)(15)
9,442 9,167 
Frontier Communications Holdings, LLCIntegrated Telecommunication Services
Fixed Rate Bond, 6.00% cash due 1/15/20304,881 4,408 3,769 (11)
4,408 3,769 
GKD Index Partners, LLCSpecialized Finance
First Lien Term Loan, LIBOR+8.00% cash due 6/29/202310.25 %25,436 25,148 25,029 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 6/29/202310.10 %1,280 1,263 1,254 (6)(15)(19)
26,411 26,283 
Global Medical Response, Inc.Health Care Services
First Lien Term Loan, LIBOR+4.25% cash due 3/14/20255.92 %5,587 5,434 5,212 (6)
5,434 5,212 
Grove Hotel Parcel Owner, LLCHotels, Resorts & Cruise Lines
First Lien Term Loan, SOFR+8.00% cash due 6/21/20279.45 %14,311 14,026 14,025 (6)(15)
First Lien Delayed Draw Term Loan, SOFR+8.00% cash due 6/21/2027— (57)(57)(6)(15)(19)
First Lien Revolver, SOFR+8.00% cash due 6/21/2027— (28)(29)(6)(15)(19)
13,941 13,939 
Harbor Purchaser Inc.Education Services
First Lien Term Loan, SOFR+5.25% cash due 4/9/20296.88 %9,392 9,068 8,541 (6)
9,068 8,541 
iCIMs, Inc.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 9/12/20247.72 %25,635 25,179 25,548 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 9/12/20247.72 %1,176 1,154 1,172 (6)(15)
26,333 26,720 
Immucor, Inc.Health Care Supplies
First Lien Term Loan, LIBOR+5.75% cash due 7/2/20258.00 %8,591 8,407 8,419 (6)(15)
Second Lien Term Loan, LIBOR+8.00% cash 3.50% PIK due 10/2/202510.25 %22,418 21,923 22,026 (6)(15)
30,330 30,445 
Impel Neuropharma, Inc.Health Care Technology
First Lien Revenue Interest Financing Term Loan due 2/15/203112,161 12,161 12,161 (6)(15)
First Lien Term Loan, SOFR+8.75% cash due 3/17/202710.95 %12,161 11,931 11,942 (6)(15)
24,092 24,103 
Innocoll Pharmaceuticals LimitedHealth Care Technology
First Lien Term Loan, 11.00% cash due 1/26/20276,817 6,538 6,391 (11)(15)
First Lien Delayed Draw Term Loan, 11.00% cash due 1/26/2027— — — (11)(15)(19)
56,999 Tranche A Warrant Shares (exercise price $4.23) expiration date 1/26/2029135 125 (11)(15)
6,673 6,516 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
Liquid Environmental Solutions CorporationEnvironmental & Facilities ServicesCommon Stock559 $563 $487 (15)
LSL Holdco, LLCHealth Care DistributorsFirst Lien Term LoanSOFR+6.00%11.20%1/31/2028$2,742 2,594 2,592 (6)(15)
LSL Holdco, LLCHealth Care DistributorsFirst Lien Term LoanSOFR+6.00%11.20%1/31/202823,554 23,166 22,258 (6)(15)
LSL Holdco, LLCHealth Care DistributorsFirst Lien RevolverSOFR+6.00%1/31/2028— (44)(146)(6)(15)(19)
LTI Holdings, Inc.Electronic ComponentsSecond Lien Term LoanSOFR+6.75%11.97%9/6/20262,140 2,101 1,834 (6)
Marinus Pharmaceuticals, Inc.PharmaceuticalsFirst Lien Term Loan11.50%5/11/20268,568 8,488 8,225 (11)(15)
Marinus Pharmaceuticals, Inc.PharmaceuticalsFirst Lien Term Loan11.50%5/11/20264,284 4,244 4,112 (11)(15)
Marinus Pharmaceuticals, Inc.PharmaceuticalsFirst Lien Term Loan11.50%5/11/20268,568 8,488 8,225 (11)(15)
Marinus Pharmaceuticals, Inc.PharmaceuticalsFirst Lien Term Loan11.50%5/11/2026— — — (11)(15)(19)
Mesoblast, Inc.BiotechnologyFirst Lien Term Loan8.00%1.75%11/19/20269,066 8,496 8,114 (11)(15)
Mesoblast, Inc.BiotechnologyFirst Lien Term Loan8.00%1.75%11/19/2026— — (11)(15)(19)
Mesoblast, Inc.BiotechnologyFirst Lien Term Loan8.00%1.75%11/19/2026— — — (11)(15)(19)
Mesoblast, Inc.BiotechnologyWarrants259,877 545 437 (11)(15)
Mesoblast, Inc.BiotechnologyWarrants66,817 23 153 (11)(15)
MHE Intermediate Holdings, LLCDiversified Support ServicesFirst Lien Term LoanSOFR+6.00%11.20%7/21/202720,176 19,949 19,648 (6)(15)
MHE Intermediate Holdings, LLCDiversified Support ServicesFirst Lien Term LoanSOFR+6.00%11.20%7/21/20272,637 2,594 2,568 (6)(15)
MHE Intermediate Holdings, LLCDiversified Support ServicesFirst Lien RevolverSOFR+6.00%11.25%7/21/2027250 220 203 (6)(15)(19)
Mindbody, Inc.Internet Services & InfrastructureFirst Lien Term LoanL+7.00%12.19%2/14/20257,464 7,416 7,352 (6)(15)
Mindbody, Inc.Internet Services & InfrastructureFirst Lien Term LoanL+7.00%12.19%2/14/202546,687 46,157 45,987 (6)(15)
Mindbody, Inc.Internet Services & InfrastructureFirst Lien RevolverL+7.00%2/14/2025— (51)(71)(6)(15)(19)
MND Holdings III CorpOther Specialty RetailFirst Lien Term LoanSOFR+7.50%12.74%5/9/202840,640 39,937 39,937 (6)(15)
MND Holdings III CorpOther Specialty RetailFirst Lien RevolverSOFR+7.50%12.58%5/9/20282,118 1,853 1,853 (6)(15)(19)
Mosaic Companies, LLCHome Improvement RetailFirst Lien Term LoanL+6.75%11.97%7/2/202655,297 54,939 54,235 (6)(15)
MRI Software LLCApplication SoftwareFirst Lien Term LoanSOFR+5.50%10.84%2/10/202612,397 12,357 12,056 (6)(15)
MRI Software LLCApplication SoftwareFirst Lien Term LoanSOFR+5.50%10.84%2/10/202621,383 21,055 20,795 (6)(15)
MRI Software LLCApplication SoftwareFirst Lien Term LoanSOFR+5.50%10.83%2/10/2026570 559 526 (6)(15)(19)
MRI Software LLCApplication SoftwareFirst Lien RevolverSOFR+5.50%2/10/2026— (29)(62)(6)(15)(19)
Navisite, LLCData Processing & Outsourced ServicesSecond Lien Term LoanL+8.50%14.04%12/30/202630,339 30,002 29,125 (6)(15)
NeuAG, LLCFertilizers & Agricultural ChemicalsFirst Lien Term LoanL+10.50%16.04%9/11/202464,606 64,750 63,185 (6)(15)
NFP Corp.Diversified Financial ServicesFixed Rate Bond6.88%8/15/202810,191 9,816 8,860 
NN, Inc.Industrial Machinery & Supplies & ComponentsFirst Lien Term LoanSOFR+6.88%12.08%2.00%9/19/202673,178 72,195 69,885 (6)(11)(15)
NN, Inc.Industrial Machinery & Supplies & ComponentsWarrants487,870 — — 1,161 (11)(15)
NN, Inc.Industrial Machinery & Supplies & ComponentsWarrants487,870 — — 1,161 (11)(15)
OEConnection LLCApplication SoftwareSecond Lien Term LoanSOFR+7.00%12.34%9/25/20279,323 9,203 9,090 (6)(15)
Oranje Holdco, Inc.Systems SoftwareFirst Lien Term LoanSOFR+7.75%12.79%2/1/202915,231 $14,876 $14,882 (6)(15)
Oranje Holdco, Inc.Systems SoftwareFirst Lien RevolverSOFR+7.75%2/1/2029— (44)(44)(6)(15)(19)
OTG Management, LLCAirport ServicesFirst Lien Term LoanL+10.00%15.50%9/2/202525,712 25,603 25,712 (6)(15)
OTG Management, LLCAirport ServicesFirst Lien Term LoanL+10.00%9/2/2025— (13)— (6)(15)(19)
OTG Management, LLCAirport ServicesFirst Lien Term LoanL+10.00%15.39%9/2/20251,210 1,192 1,210 (6)(15)(19)
P & L Development, LLCPharmaceuticalsFixed Rate Bond7.75%11/15/20257,480 7,514 6,090 
11

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Integral Development CorporationOther Diversified Financial Services
1,078,284 Common Stock Warrants (exercise price $0.9274) expiration date 7/10/2024$113 $— (15)
113  
Inventus Power, Inc.Electrical Components & Equipment
First Lien Term Loan, SOFR+5.00% cash due 3/29/20247.32 %$18,707 18,598 18,099 (6)(15)
Second Lien Term Loan, LIBOR+8.50% cash due 9/29/202410.75 %13,674 13,494 13,093 (6)(15)
32,092 31,192 
INW Manufacturing, LLCPersonal Products
First Lien Term Loan, LIBOR+5.75% cash due 3/25/20278.00 %36,094 35,217 34,109 (6)(15)
35,217 34,109 
IPC Corp.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 10/1/20267.50 %34,357 33,565 33,220 (6)(15)
33,565 33,220 
Itafos Inc.Fertilizers & Agricultural Chemicals
First Lien Term Loan, LIBOR+8.25% cash due 8/25/20249.82 %17,017 16,529 16,423 (6)(15)
16,529 16,423 
Ivanti Software, Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/1/20288.85 %10,247 10,196 9,410 (6)
10,196 9,410 
Jazz Acquisition, Inc.Aerospace & Defense
First Lien Term Loan, LIBOR+7.50% cash due 1/29/20279.17 %36,326 35,200 36,411 (6)(15)
Second Lien Term Loan, LIBOR+8.00% cash due 6/18/202710.03 %528 475 483 (6)
35,675 36,894 
Kings Buyer, LLCEnvironmental & Facilities Services
First Lien Term Loan, LIBOR+6.50% cash due 10/29/20278.75 %13,658 13,521 13,316 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 10/29/20278.75 %659 640 612 (6)(15)(19)
14,161 13,928 
LaserShip, Inc.Air Freight & Logistics
Second Lien Term Loan, LIBOR+7.50% cash due 5/7/202910.38 %4,787 4,739 4,536 (6)(15)
4,739 4,536 
Lift Brands Holdings, Inc.Leisure Facilities
2,000,000 Class A Common Units in Snap Investments, LLC1,399 — (15)
1,399  
Lightbox Intermediate, L.P.Real Estate Services
First Lien Term Loan, LIBOR+5.00% cash due 5/9/20267.25 %41,114 40,293 40,086 (6)(15)
40,293 40,086 
Liquid Environmental Solutions CorporationEnvironmental & Facilities Services
Second Lien Term Loan, LIBOR+8.50% cash due 11/30/202610.17 %4,357 4,280 4,226 (6)(15)
Second Lien Delayed Draw Term Loan, LIBOR+8.50% cash due 11/30/202610.17 %1,162 1,139 1,057 (6)(15)(19)
5,419 5,283 
LSL Holdco, LLCHealth Care Distributors
First Lien Term Loan, LIBOR+6.00% cash due 1/31/20287.67 %19,236 18,878 18,659 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 1/31/20287.67 %855 815 791 (6)(15)(19)
19,693 19,450 
LTI Holdings, Inc.Electronic Components
Second Lien Term Loan, LIBOR+6.75% cash due 9/6/20268.42 %2,140 2,090 1,957 (6)
2,090 1,957 
Marinus Pharmaceuticals, Inc.Pharmaceuticals
First Lien Term Loan, 11.50% cash due 5/11/202617,203 16,937 16,558 (11)(15)
First Lien Delayed Draw Term Loan, 11.50% cash due 5/11/2026— — — (11)(15)(19)
16,937 16,558 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
Park Place Technologies, LLCInternet Services & InfrastructureFirst Lien Term LoanSOFR+5.00%10.20%11/10/2027$9,701 $9,535 $9,458 (6)
Performance Health Holdings, Inc.Health Care DistributorsFirst Lien Term LoanSOFR+6.00%10.96%7/12/202722,375 22,177 21,829 (6)(15)
Planview Parent, Inc.Application SoftwareSecond Lien Term LoanSOFR+7.25%12.59%12/18/202836,499 35,427 32,606 (6)(15)
Pluralsight, LLCApplication SoftwareFirst Lien Term LoanSOFR+8.00%13.04%4/6/202767,244 66,290 64,756 (6)(15)
Pluralsight, LLCApplication SoftwareFirst Lien RevolverSOFR+8.00%13.04%4/6/20272,395 2,312 2,218 (6)(15)(19)
PPW Aero Buyer, Inc.Aerospace & DefenseFirst Lien Term LoanSOFR+7.00%12.10%2/15/202910,923 10,513 10,497 (6)(15)
PPW Aero Buyer, Inc.Aerospace & DefenseFirst Lien RevolverSOFR+7.00%2/15/2029— (55)(57)(6)(15)(19)
PRGX Global, Inc.Data Processing & Outsourced ServicesFirst Lien Term LoanL+6.50%11.73%3/3/202638,521 38,018 38,205 (6)(15)
PRGX Global, Inc.Data Processing & Outsourced ServicesFirst Lien RevolverL+6.50%3/3/2026— (37)(26)(6)(15)(19)
PRGX Global, Inc.Data Processing & Outsourced ServicesCommon Stock100,000 109 221 (15)
Profrac Holdings II, LLCIndustrial Machinery & Supplies & ComponentsFirst Lien Term LoanSOFR+7.25%12.42%3/4/202524,537 24,245 24,047 (6)(15)
Profrac Holdings II, LLCIndustrial Machinery & Supplies & ComponentsFirst Lien Term LoanSOFR+7.25%12.42%3/4/20252,823 2,797 2,767 (6)(15)
Project Boost Purchaser, LLCApplication SoftwareSecond Lien Term LoanSOFR+8.00%13.22%5/31/20276,750 6,652 6,235 (6)(15)
Quantum Bidco LimitedFood DistributorsFirst Lien Term LoanSONIA+5.68%10.88%1/31/2028£4,626 5,900 5,296 (6)(11)(15)
QuorumLabs, Inc.Application SoftwarePreferred Equity64,887,669 375 — (15)
Relativity ODA LLCApplication SoftwareFirst Lien Term LoanSOFR+7.50%11.70%5/12/2027$32,329 32,052 31,715 (6)(15)
Relativity ODA LLCApplication SoftwareFirst Lien RevolverSOFR+6.50%5/12/2027— (46)(52)(6)(15)(19)
Renaissance Holding Corp.Education ServicesSecond Lien Term LoanL+7.00%12.19%5/29/20261,789 1,775 1,764 (6)
RumbleOn, Inc.Automotive RetailFirst Lien Term LoanSOFR+8.25%13.75%8/31/202644,602 43,077 41,815 (6)(11)(15)
RumbleOn, Inc.Automotive RetailFirst Lien Term LoanSOFR+8.25%13.75%8/31/202613,495 13,010 12,651 (6)(11)(15)
RumbleOn, Inc.Automotive RetailWarrants204,454 1,202 — (11)(15)
Salus Workers' Compensation, LLCDiversified Financial ServicesFirst Lien Term LoanSOFR+10.00%15.24%10/7/202625,558 24,711 24,791 (6)(15)
Salus Workers' Compensation, LLCDiversified Financial ServicesFirst Lien RevolverSOFR+10.00%10/7/2026— (103)(93)(6)(15)(19)
Salus Workers' Compensation, LLCDiversified Financial ServicesWarrants991,019 327 1,883 (15)
Scilex Holding CoBiotechnologyCommon Stock9,307 78 52 (11)
SCP Eye Care Services, LLCHealth Care ServicesSecond Lien Term LoanSOFR+8.75%14.00%10/7/20308,010 7,792 7,770 (6)(15)
SCP Eye Care Services, LLCHealth Care ServicesSecond Lien Term LoanSOFR+8.75%10/7/2030— (35)(71)(6)(15)(19)
SCP Eye Care Services, LLCHealth Care ServicesCommon Stock1,037 1,037 1,024 (15)
scPharmaceuticals Inc.PharmaceuticalsFirst Lien Term LoanSOFR+8.75%11.75%10/13/20275,212 4,973 5,034 (6)(15)
scPharmaceuticals Inc.PharmaceuticalsFirst Lien Term LoanSOFR+8.75%10/13/2027— — — (6)(15)(19)
scPharmaceuticals Inc.PharmaceuticalsFirst Lien Term LoanSOFR+8.75%10/13/2027— — — (6)(15)(19)
scPharmaceuticals Inc.PharmaceuticalsWarrants53,700 175 407 (15)
Seres Therapeutics, Inc.BiotechnologyFirst Lien Term LoanSOFR+7.88%12.95%4/27/20297,191 6,923 6,931 (6)(11)(15)
Seres Therapeutics, Inc.BiotechnologyFirst Lien Term LoanSOFR+7.88%12.88%4/27/20292,697 2,596 2,599 (6)(11)(15)
Seres Therapeutics, Inc.BiotechnologyFirst Lien Term LoanSOFR+7.88%4/27/2029— — — (6)(11)(15)(19)
Seres Therapeutics, Inc.BiotechnologyFirst Lien Term LoanSOFR+7.88%4/27/2029— — — (6)(11)(15)(19)
Seres Therapeutics, Inc.BiotechnologyWarrants58,210 182 202 (11)(15)
ShareThis, Inc.Application SoftwareWarrants345,452 367 — (15)
SiO2 Medical Products, Inc.Metal, Glass & Plastic ContainersFirst Lien Term Loan14.00%12/21/202654,730 41,705 25,997 (15)(20)
SiO2 Medical Products, Inc.Metal, Glass & Plastic ContainersFirst Lien Term Loan14.00%7/27/202314,993 11,582 13,923 (15)(20)
SiO2 Medical Products, Inc.Metal, Glass & Plastic ContainersFirst Lien Term Loan14.00%7/27/20234,813 3,935 4,034 (15)(19)(20)
SIO2 Medical Products, Inc.Metal, Glass & Plastic ContainersWarrants491 727 — (15)
12

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Mesoblast, Inc.Biotechnology
First Lien Term Loan, 8.00% cash 1.75% PIK due 11/19/2026$7,183 $6,583 $6,357 (11)(15)
First Lien Delayed Draw Term Loan, 8.00% cash 1.75% PIK due 11/19/2026— (11)(15)(19)
209,588 Warrant Shares (exercise price $7.26) expiration date 11/19/2028480 138 (11)(15)
7,064 6,496 
MHE Intermediate Holdings, LLCDiversified Support Services
First Lien Term Loan, LIBOR+6.00% cash due 7/21/20277.29 %18,437 18,120 17,979 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 7/21/2027— (24)(35)(6)(15)(19)
18,096 17,944 
Mindbody, Inc.Internet Services & Infrastructure
First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/20258.38 %45,487 44,407 44,623 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 2/14/2025— (58)(76)(6)(15)(19)
44,349 44,547 
Mosaic Companies, LLCHome Improvement Retail
First Lien Term Loan, LIBOR+6.75% cash due 7/2/20268.36 %46,796 46,046 45,907 (6)(15)
46,046 45,907 
MRI Software LLCApplication Software
First Lien Term Loan, LIBOR+5.50% cash due 2/10/20267.75 %28,037 27,574 27,476 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026— (13)(100)(6)(15)(19)
First Lien Revolver, LIBOR+5.50% cash due 2/10/2026— (13)(36)(6)(15)(19)
27,548 27,340 
Navisite, LLCData Processing & Outsourced Services
Second Lien Term Loan, LIBOR+8.50% cash due 12/30/202610.75 %22,560 22,222 21,432 (6)(15)
22,222 21,432 
NeuAG, LLCFertilizers & Agricultural Chemicals
First Lien Term Loan, LIBOR+5.50% cash 7.00% PIK due 9/11/20247.75 %49,572 48,069 48,142 (6)(15)
48,069 48,142 
NFP Corp.Other Diversified Financial Services
Fixed Rate Bond 6.875% cash due 8/15/202810,191 9,759 8,437 
9,759 8,437 
NN, Inc.Industrial Machinery
First Lien Term Loan, LIBOR+6.88% cash due 9/19/20268.54 %58,862 57,734 56,802 (6)(11)(15)
57,734 56,802 
OEConnection LLCApplication Software
First Lien Term Loan, LIBOR+4.00% cash due 9/25/20265.67 %3,332 3,160 3,107 (6)
Second Lien Term Loan, LIBOR+7.00% cash due 9/25/20278.60 %7,519 7,383 7,218 (6)(15)
10,543 10,325 
OTG Management, LLCAirport Services
First Lien Term Loan, LIBOR+2.00% cash 8.00% PIK due 9/1/20254.63 %21,125 20,810 20,703 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+2.00% cash 8.00% PIK due 9/1/2025— (33)(38)(6)(15)(19)
20,777 20,665 
P & L Development, LLCPharmaceuticals
Fixed Rate Bond, 7.75% cash due 11/15/20257,776 7,823 5,455 
7,823 5,455 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
SM Wellness Holdings, Inc.Health Care ServicesFirst Lien Term LoanSOFR+4.75%9.97%4/17/2028$4,463 $3,780 $4,139 (6)(15)
SM Wellness Holdings, Inc.Health Care ServicesSecond Lien Term LoanSOFR+8.00%13.22%4/16/202912,034 11,220 9,387 (6)(15)
SonicWall US Holdings Inc.Technology DistributorsSecond Lien Term LoanL+7.50%12.69%5/18/20261,095 1,084 1,024 (6)(15)
Sorenson Communications, LLCCommunications EquipmentFirst Lien Term LoanL+5.50%10.69%3/17/20261,054 1,053 980 (6)
Sorrento Therapeutics, Inc.BiotechnologyCommon Stock66,000 139 24 (11)
Spanx, LLCApparel RetailFirst Lien Term LoanSOFR+5.50%10.70%11/20/20284,500 4,431 4,393 (6)(15)
Spanx, LLCApparel RetailFirst Lien RevolverL+5.25%10.35%11/18/2027907 862 837 (6)(15)(19)
SumUp Holdings Luxembourg S.À.R.L.Diversified Financial ServicesFirst Lien Term LoanE+8.50%11.97%3/10/202623,731 26,829 25,632 (6)(11)(15)
Superior Industries International, Inc.Auto Parts & EquipmentFirst Lien Term LoanSOFR+7.75%12.85%12/16/2028$49,645 48,611 49,128 (6)(15)
Supreme Fitness Group NY Holdings, LLCLeisure FacilitiesFirst Lien Term LoanSOFR+7.00%12.18%12/31/202632,185 31,923 30,495 (6)(15)(21)
Supreme Fitness Group NY Holdings, LLCLeisure FacilitiesFirst Lien Term LoanSOFR+7.00%12.18%12/31/20262,756 2,728 2,593 (6)(15)(19)(21)
Supreme Fitness Group NY Holdings, LLCLeisure FacilitiesFirst Lien Term LoanSOFR+7.00%12.18%12/31/20261,099 1,059 926 (6)(15)(19)(21)
Supreme Fitness Group NY Holdings, LLCLeisure FacilitiesFirst Lien RevolverSOFR+7.00%12.18%12/31/20261,552 1,539 1,471 (6)(15)(21)
SVP-Singer Holdings Inc.Home FurnishingsFirst Lien Term LoanL+6.75%12.29%7/28/202825,592 23,832 19,514 (6)(15)
Swordfish Merger Sub LLCAuto Parts & EquipmentSecond Lien Term LoanL+6.75%11.94%2/2/202612,500 12,480 11,681 (6)(15)
Tacala, LLCRestaurantsSecond Lien Term LoanL+7.50%12.69%2/4/202812,843 12,589 12,168 (6)
Tahoe Bidco B.V.Application SoftwareFirst Lien Term LoanL+6.00%11.15%9/29/202828,826 28,583 28,537 (6)(11)(15)
Tahoe Bidco B.V.Application SoftwareFirst Lien RevolverL+6.00%10/1/2027— (31)(24)(6)(11)(15)(19)
Tecta America Corp.Construction & EngineeringSecond Lien Term LoanSOFR+8.50%13.72%4/9/20294,755 4,677 4,529 (6)(15)
Telestream Holdings CorporationApplication SoftwareFirst Lien Term LoanSOFR+9.75%14.99%10/15/202523,483 23,239 22,919 (6)(15)
Telestream Holdings CorporationApplication SoftwareFirst Lien RevolverSOFR+9.75%14.93%10/15/20251,590 1,572 1,535 (6)(15)(19)
Ten-X LLCInteractive Media & ServicesFirst Lien Term LoanSOFR+6.00%11.09%5/26/202819,947 18,963 19,000 (6)(15)
TGNR HoldCo LLCIntegrated Oil & GasSubordinated Debt11.50%5/14/20264,984 4,887 4,810 (10)(11)(15)
THL Zinc Ventures LtdDiversified Metals & MiningFirst Lien Term Loan13.00%5/23/202650,419 49,787 49,809 (11)(15)
Thrasio, LLCBroadline RetailFirst Lien Term LoanSOFR+7.00%12.50%12/18/202646,832 45,609 41,919 (6)(15)
Thrasio, LLCBroadline RetailPreferred Equity10,616 120 55 (15)
Thrasio, LLCBroadline RetailPreferred Equity358,299 2,912 1,526 (15)
Thrasio, LLCBroadline RetailPreferred Equity60,862 1,207 795 (15)
Thrasio, LLCBroadline RetailPreferred Equity32,447 33,353 36,587 (15)
TIBCO Software Inc.Application SoftwareFirst Lien Term LoanSOFR+4.50%9.84%3/30/202917,213 15,952 16,141 (6)
Touchstone Acquisition, Inc.Health Care SuppliesFirst Lien Term LoanSOFR+6.00%11.20%12/29/202811,701 11,675 11,408 (6)(15)
Trinitas CLO XV DACMulti-Sector HoldingsCLO NotesL+7.45%12.72%4/22/20341,000 814 929 (6)(11)
Uniti Group LPOther Specialized REITsFixed Rate Bond6.50%2/15/20294,500 4,101 3,189 (11)
Uniti Group LPOther Specialized REITsFixed Rate Bond4.75%4/15/2028300 263 249 (11)
Virgin Pulse, Inc.Application SoftwareSecond Lien Term LoanSOFR+7.25%12.47%4/6/20291,540 1,239 1,279 (6)(15)
Win Brands Group LLCHousewares & SpecialtiesFirst Lien Term LoanL+15.00%21.22%1/23/20261,565 1,551 1,475 (6)(15)
WIN Brands Group LLCHousewares & SpecialtiesFirst Lien Term LoanL+15.00%21.22%1/23/20261,323 1,311 1,247 (6)(15)
Win Brands Group LLCHousewares & SpecialtiesWarrants4,871 46 136 (15)
Windstream Services II, LLCIntegrated Telecommunication ServicesFirst Lien Term LoanSOFR+6.25%11.45%9/21/202724,419 23,589 22,862 (6)
Windstream Services II, LLCIntegrated Telecommunication ServicesCommon Stock127,452 2,057 1,565 (15)
WP CPP Holdings, LLCAerospace & DefenseFirst Lien Term LoanL+3.75%9.03%4/30/202511,822 11,228 10,743 (6)
WPEngine, Inc.Application SoftwareFirst Lien Term LoanL+6.50%11.38%3/27/202635,853 35,764 35,495 (6)(15)
13

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Park Place Technologies, LLCInternet Services & Infrastructure
First Lien Term Loan, SOFR+5.00% cash due 11/10/20276.63 %$9,875 $9,465 $9,521 (6)
9,465 9,521 
Performance Health Holdings, Inc.Health Care Distributors
First Lien Term Loan, LIBOR+6.00% cash due 7/12/20278.88 %17,976 17,675 17,537 (6)(15)
17,675 17,537 
PFNY Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+7.00% cash due 12/31/20268.00 %26,220 25,750 25,695 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash due 12/31/20269.25 %2,228 2,183 2,178 (6)(15)(19)
First Lien Revolver, LIBOR+7.00% cash due 12/31/2026— (22)(25)(6)(15)(19)
27,911 27,848 
Planview Parent, Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.92 %28,627 28,198 27,482 (6)(15)
28,198 27,482 
PLNTF Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+8.00% cash due 3/22/202610.10 %3,035 2,990 2,944 (6)(15)
2,990 2,944 
Pluralsight, LLCApplication Software
First Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00 %48,689 47,910 47,325 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 4/6/2027— (56)(99)(6)(15)(19)
47,854 47,226 
PRGX Global, Inc.Data Processing & Outsourced Services
First Lien Term Loan, LIBOR+6.75% cash due 3/3/20268.95 %33,861 32,952 33,200 (6)(15)
First Lien Revolver, LIBOR+6.75% cash due 3/3/2026— (36)(49)(6)(15)(19)
80,515 Class B Common Units79 89 (15)
32,995 33,240 
Profrac Holdings II, LLCIndustrial Machinery
First Lien Term Loan, SOFR+8.50% cash due 3/4/202510.01 %21,137 20,572 20,714 (6)(15)
20,572 20,714 
Project Boost Purchaser, LLCApplication Software
Second Lien Term Loan, LIBOR+8.00% cash due 5/31/20279.67 %5,250 5,164 5,079 (6)(15)
5,164 5,079 
Quantum Bidco LimitedFood Distributors
First Lien Term Loan, SONIA+6.00% cash due 1/29/20287.31 %£3,501 4,643 3,540 (6)(11)(15)
4,643 3,540 
QuorumLabs, Inc.Application Software
64,887,669 Junior-2 Preferred Stock375 — (15)
375  
Radiology Partners Inc.Health Care Distributors
First Lien Term Loan, LIBOR+4.25% cash due 7/9/20255.89 %$3,400 3,200 3,066 (6)
Fixed Rate Bond, 9.25% cash due 2/1/20284,755 4,718 3,578 
7,918 6,644 
Relativity ODA LLCApplication Software
First Lien Term Loan, LIBOR+7.50% PIK due 5/12/202724,075 23,626 23,498 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 5/12/2027— (45)(53)(6)(15)(19)
23,581 23,445 
Renaissance Holding Corp.Diversified Banks
Second Lien Term Loan, LIBOR+7.00% cash due 5/29/20268.67 %3,542 3,515 3,310 (6)
3,515 3,310 
RP Escrow Issuer LLCHealth Care Distributors
Fixed Rate Bond, 5.25% cash due 12/15/20251,325 1,211 1,147 
1,211 1,147 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
WPEngine, Inc.Application SoftwareFirst Lien Term LoanL+6.50%12.00%3/27/2026$19,306 $19,258 $19,113 (6)(15)
WWEX Uni Topco Holdings, LLCAir Freight & LogisticsSecond Lien Term LoanSOFR+7.00%12.50%7/26/20295,000 4,925 4,025 (6)(15)
Zep Inc.Specialty ChemicalsSecond Lien Term LoanL+8.25%13.79%8/11/202519,578 19,551 13,693 (6)(15)
Zephyr Bidco LimitedSpecialized FinanceSecond Lien Term LoanSONIA+7.50%12.46%7/23/2026£20,000 25,857 23,270 (6)(11)(15)
Total Non-Control/Non-Affiliate Investments (190.4% of net assets)$2,985,679 $2,873,512 
Total Portfolio Investments (207.7% of net assets)$3,296,285 $3,135,619 
Cash and Cash Equivalents and Restricted Cash
JP Morgan Prime Money Market Fund, Institutional Shares$5,193 $5,193 
Other cash accounts67,467 67,467 
Total Cash and Cash Equivalents and Restricted Cash (4.8% of net assets)$72,660 $72,660 
Total Portfolio Investments and Cash and Cash Equivalents and Restricted Cash (212.5% of net assets)$3,368,945 $3,208,279 
14

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
RumbleOn, Inc.Automotive Retail
First Lien Term Loan, LIBOR+8.25% cash due 8/31/20269.25 %$37,751 $35,744 $36,275 (6)(11)(15)
First Lien Delayed Draw Term Loan, LIBOR+8.25% cash due 8/31/20269.25 %11,421 10,558 10,786 (6)(11)(15)(19)
164,660 Class B Common Stock Warrants (exercise price $33.00) expiration date 2/28/20231,202 77 (11)(15)
47,504 47,138 
Sabert CorporationMetal & Glass Containers
First Lien Term Loan, LIBOR+4.50% cash due 12/10/20266.19 %1,727 1,640 1,645 (6)
1,640 1,645 
Scilex Pharmaceuticals Inc.Pharmaceuticals
Fixed Rate Zero Coupon Bond due 8/15/20262,960 2,666 2,916 (15)
2,666 2,916 
ShareThis, Inc.Application Software
345,452 Series C Preferred Stock Warrants (exercise price $3.0395) expiration date 3/4/2024367 — (15)
367  
SiO2 Medical Products, Inc.Metal & Glass Containers
First Lien Term Loan, 5.50% cash 8.50% PIK due 12/21/202645,140 44,390 44,332 (15)
Common Stock Warrants (exercise price $0.75) expiration date 7/31/2028681 681 (15)
45,071 45,013 
SM Wellness Holdings, Inc.Health Care Services
Second Lien Term Loan, LIBOR+8.00% cash due 4/16/20299.04 %9,109 8,972 8,927 (6)(15)
8,972 8,927 
SonicWall US Holdings Inc.Technology Distributors
Second Lien Term Loan, LIBOR+7.50% cash due 5/18/20269.01 %3,195 3,163 3,069 (6)(15)
3,163 3,069 
Sorrento Therapeutics, Inc.Biotechnology
50,000 Common Stock Units197 101 (11)
197 101 
Spanx, LLCApparel Retail
First Lien Term Loan, LIBOR+5.50% cash due 11/20/20287.10 %4,546 4,463 4,438 (6)(15)
First Lien Revolver, LIBOR+5.25% cash due 11/18/2027— (55)(70)(6)(15)(19)
4,408 4,368 
SumUp Holdings Luxembourg S.À.R.L.Other Diversified Financial Services
First Lien Term Loan, EURIBOR+8.50% cash due 3/10/202610.00 %16,911 19,414 17,186 (6)(11)(15)
19,414 17,186 
Sunland Asphalt & Construction, LLCConstruction & Engineering
First Lien Term Loan, LIBOR+6.00% cash due 1/13/20268.88 %$42,727 41,686 41,787 (6)(15)
41,686 41,787 
Supermoose Borrower, LLCApplication Software
First Lien Term Loan, LIBOR+3.75% cash due 8/29/20256.00 %3,475 3,121 3,155 (6)
3,121 3,155 
SVP-Singer Holdings Inc.Home Furnishings
First Lien Term Loan, LIBOR+6.75% cash due 7/28/20289.00 %20,819 19,547 18,802 (6)(15)
19,547 18,802 
Swordfish Merger Sub LLCAuto Parts & Equipment
Second Lien Term Loan, LIBOR+6.75% cash due 2/2/20266.75 %12,500 12,472 11,833 (6)(15)
12,472 11,833 

Derivative InstrumentNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateCounterpartyCumulative Unrealized Appreciation /(Depreciation)
Foreign currency forward contract$78,866 71,658 8/10/2023JPMorgan Chase Bank, N.A.$531 
Foreign currency forward contract$71,438 £56,556 8/10/2023JPMorgan Chase Bank, N.A.(482)
$49 


Derivative InstrumentCompany ReceivesCompany PaysCounterpartyMaturity DateNotional AmountFair Value
Interest rate swapFixed 2.7%Floating 3-month LIBOR +1.658%Royal Bank of Canada1/15/2027$350,000$(39,567)
15

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 20222023
(dollar amounts in thousands)
(unaudited)











Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Tacala, LLCRestaurants
Second Lien Term Loan, LIBOR+7.50% cash due 2/4/20289.17 %$9,448 $9,333 $8,865 (6)
9,333 8,865 
Tahoe Bidco B.V.Application Software
First Lien Term Loan, LIBOR+6.00% cash due 9/29/20287.12 %23,215 22,799 22,843 (6)(11)(15)
First Lien Revolver, LIBOR+6.00% cash due 10/1/2027— (31)(30)(6)(11)(15)(19)
22,768 22,813 
Tecta America Corp.Construction & Engineering
Second Lien Term Loan, LIBOR+8.50% cash due 4/9/202910.17 %5,203 5,125 5,099 (6)(15)
5,125 5,099 
Telestream Holdings CorporationApplication Software
First Lien Term Loan, SOFR+9.25% cash due 10/15/202510.59 %18,370 17,971 17,984 (6)(15)
First Lien Revolver, SOFR+9.25% cash due 10/15/202510.59 %703 681 667 (6)(15)(19)
18,652 18,651 
TerSera Therapeutics LLCPharmaceuticals
Second Lien Term Loan, LIBOR+9.50% cash due 3/30/202611.75 %29,663 29,330 28,912 (6)(15)
668,879 Common Units of TerSera Holdings LLC2,125 3,487 (15)
31,455 32,399 
TGNR HoldCo LLCIntegrated Oil & Gas
Subordinated Debt, 11.50% cash due 5/14/20264,984 4,860 4,859 (10)(11)(15)
4,860 4,859 
Thrasio, LLCInternet & Direct Marketing Retail
First Lien Term Loan, LIBOR+7.00% cash due 12/18/20269.25 %37,590 36,606 36,274 (6)(15)
8,434 Shares of Series C-3 Preferred Stock in Thrasio Holdings, Inc.101 124 (15)
284,650.32 Shares of Series C-2 Preferred Stock in Thrasio Holdings, Inc.2,409 4,196 (15)
48,352 Shares of Series D Preferred Stock in Thrasio Holdings, Inc.979 979 (15)
23,201 Shares of Series X Preferred Stock in Thrasio Holdings, Inc.22,986 26,487 (15)(19)
63,081 68,060 
TIBCO Software Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 3/3/20288.92 %14,788 14,695 14,592 (6)
14,695 14,592 
Touchstone Acquisition, Inc.Health Care Supplies
First Lien Term Loan, LIBOR+6.00% cash due 12/29/20287.67 %6,031 5,918 5,850 (6)(15)
5,918 5,850 
Uniti Group LPSpecialized REITs
Fixed Rate Bond, 6.50% cash due 2/15/20294,500 4,047 3,309 (11)
Fixed Rate Bond, 4.75% cash due 4/15/2028300 256 247 (11)
4,303 3,556 
Veritas US Inc.Application Software
First Lien Term Loan, LIBOR+5.00% cash due 9/1/20257.25 %5,876 5,602 4,852 (6)
5,602 4,852 
Win Brands Group LLCHousewares & Specialties
First Lien Term Loan, LIBOR+9.00% cash 5.00% PIK due 1/22/202612.00 %3,791 3,755 3,753 (6)(15)
181 Class F Warrants in Brand Value Growth LLC (exercise price $0.01) expiration date 1/25/2027— 195 (15)
3,755 3,948 
Windstream Services II, LLCIntegrated Telecommunication Services
First Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.92 %25,565 24,652 24,018 (6)
18,032 Shares of Common Stock in Windstream Holdings II, LLC216 328 (15)
109,420 Warrants in Windstream Holdings II, LLC1,842 1,992 (15)
26,710 26,338 
16

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 2022
(dollar amounts in thousands)
(unaudited)



Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
WP CPP Holdings, LLCAerospace & Defense
First Lien Term Loan, LIBOR+3.75% cash due 4/30/20254.99 %$10,590 $9,849 $8,900 (6)
Second Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.99 %16,000 15,797 13,240 (6)(15)
25,646 22,140 
WPEngine, Inc.Application Software
First Lien Term Loan, LIBOR+6.00% cash due 3/27/20267.50 %40,536 39,905 40,057 (6)(15)
39,905 40,057 
WWEX Uni Topco Holdings, LLCAir Freight & Logistics
Second Lien Term Loan, LIBOR+7.00% cash due 7/26/20299.25 %5,000 4,925 4,538 (6)(15)
4,925 4,538 
Zayo Group Holdings IncAlternative Carriers
Fixed Rate Bond, 6.125% cash due 3/1/20282,166 1,910 1,570 
Fixed Rate Bond, 4.00% cash due 3/1/2027250 210 208 
2,120 1,778 
Zep Inc.Specialty Chemicals
Second Lien Term Loan, LIBOR+8.25% cash due 8/11/202510.50 %19,578 19,539 17,130 (6)(15)
19,539 17,130 
Zephyr Bidco LimitedSpecialized Finance
Second Lien Term Loan, SONIA+7.50% cash due 7/23/20268.72 %£18,000 23,809 19,547 (6)(11)(15)
23,809 19,547 
Total Non-Control/Non-Affiliate Investments (183.5% of net assets)$2,378,626 $2,319,104 
Total Portfolio Investments (203.0% of net assets)$2,665,487 $2,565,389 
Cash and Cash Equivalents and Restricted Cash
JP Morgan Prime Money Market Fund, Institutional Shares $8,657 $8,657 
Other cash accounts27,658 27,658 
Total Cash and Cash Equivalents and Restricted Cash (2.9% of net assets)$36,315 $36,315 
Total Portfolio Investments and Cash and Cash Equivalents and Restricted Cash (205.9% of net assets)$2,701,802 $2,601,704 


Derivative InstrumentNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateCounterpartyCumulative Unrealized Appreciation /(Depreciation)
Foreign currency forward contract$46,196 43,643 8/11/2022JPMorgan Chase Bank, N.A.$440 
Foreign currency forward contract$49,442 £40,109 8/11/2022JPMorgan Chase Bank, N.A.694 
$1,134 


Derivative InstrumentCompany ReceivesCompany PaysCounterpartyMaturity DateNotional AmountFair Value
Interest rate swapFixed 2.7%Floating 3-month LIBOR +1.658%Royal Bank of Canada1/15/2027$350,000$(30,866)
17

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
June 30, 2022
(dollar amounts in thousands)
(unaudited)



(1)All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.
(2)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.
(3)Equity ownership may be held in shares or units of companies related to the portfolio companies.
(4)Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.
(5)Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
(5)Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.
(6)The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to the secured overnight financing rate ("SOFR"), the London Interbank Offered Rate ("LIBOR" or "L"), the sterling overnight index average ("SONIA") and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to the secured overnight financing rate ("SOFR") or the sterling overnight index average ("SONIA"). The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of June 30, 2022,2023, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 1.67%5.19%, the 90-day LIBOR at 2.25%5.54%, the 180-day LIBOR at 2.88%, the 360-day LIBOR at 3.61%5.73%, the PRIME at 4.75%8.25%, the 30-day SOFR at 1.53%5.10%, the 90-day SOFR at 2.05%5.24%, the 180-day SOFR at 5.34%, the SONIA at 1.19%3.47%, the 30-day EURIBOR at (0.54)%3.42%, the 90-day EURIBOR at (0.30)%3.49% and the 180-day EURIBOR at (0.38)%2.82%. Most loans include an interest floor, which generally ranges from 0% to 1%2%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(7)Principal includes accumulated payment in kind ("PIK") interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
(8)Control Investments generally are defined by the Investment Company Act of 1940, as amended (the "Investment Company Act"), as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
(9)As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the accompanying notes to the Consolidated Financial Statements for transactions during the nine months ended June 30, 20222023 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
(10)This investment represents a participation interest in the underlying securities shown.
(11)Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of June 30, 2022,2023, qualifying assets represented 75.9%73.7% of the Company's total assets and non-qualifying assets represented 24.1%26.3% of the Company's total assets.
(12)Income producing through payment of dividends or distributions.
(13)This investment represents Seller Earn Out Shares in Alvotech SA. One half of the Seller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a volume weighted average price ("VWAP") of $15.00 per share for any ten trading days within any twenty trading day period, and the other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
(14)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
(15)As of June 30, 2022,2023, these investments were categorized as Level 3 within the fair value hierarchy established by Financial Accounting Standards Board ("FASB") guidance under Accounting Standards Codification ("ASC") Topic 820, Fair Value Measurements and Disclosures ("ASC 820").
(16)This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
(17)Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
(18)Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.
(19)Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
(20)This investment was on non-accrual status as of June 30, 2023.
(21)This investment was renamed during the three months ended March 31, 2022.2023. For periods prior to March 31, 2022,2023, this investment was referenced as Realfi Strategic Capital FundingPFNY Holdings, LLC.

(22)This investment represents a revenue interest financing term loan in which the Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

See notes to Consolidated Financial Statements.

1816

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Control Investments(8)(9)
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— (15)
34,984,460.37 Preferred Units34,984 27,638 (15)
34,984 27,638 
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20246.00 %$27,381 27,381 27,381 (6)(15)
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — — (6)(15)(19)
30,030.8 Common Units in DD Healthcare Services Holdings, LLC18,625 18,065 (12)(15)
46,006 45,446 
First Star Speir Aviation LimitedAirlines(10)
First Lien Term Loan, 9.00% cash due 12/15/20257,500 — 7,500 (11)(15)
100% equity interest6,332 698 (11)(12)(15)
6,332 8,198 
OCSI Glick JV LLCMulti-Sector Holdings(14)
Subordinated Debt, LIBOR+4.50% cash due 10/20/20284.60 %61,709 50,705 55,582  (6)(11)(15)(19)
87.5% equity interest— —  (11)(16)(19)
50,705 55,582 
Senior Loan Fund JV I, LLCMulti-Sector Holdings(14)
Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.00 %96,250 96,250 96,250 (6)(11)(15)(19)
87.5% LLC equity interest49,322 37,651 (11)(12)(16)(19)
145,572 133,901 
 Total Control Investments (20.6% of net assets)$283,599 $270,765 
Affiliate Investments(17)
Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.00% cash due 10/17/20237.00 %$15,899 $15,900 $15,712 (6)(15)(19)
1,609,201 Class A Units764 587 (15)
1,019,168.80 Preferred Units, 6%1,019 1,152 (15)
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — (15)
17,683 17,451 
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%1,080 838 (15)
1,080 838 
 Total Affiliate Investments (1.4% of net assets)$18,763 $18,289 
Non-Control/Non-Affiliate Investments(18)
4 Over International, LLCCommercial Printing
First Lien Term Loan, LIBOR+6.00% cash due 6/7/20227.00 %$10,927 $10,524 $10,484 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 6/7/2022— (24)(93)(6)(15)(19)
10,500 10,391 
109 Montgomery Owner LLCReal Estate Operating Companies
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash due 2/2/20237.50 %3,102 2,984 3,153 (6)(15)(19)
2,984 3,153 
A.T. Holdings II SÀRLBiotechnology
First Lien Term Loan, 9.50% cash due 12/22/202237,158 36,930 36,972 (11)(15)
36,930 36,972 
Access CIG, LLCDiversified Support Services
First Lien Term Loan, LIBOR+3.75% cash due 2/27/20253.83 %5,352 5,021 5,332 (6)
Second Lien Term Loan, LIBOR+7.75% cash due 2/27/20267.83 %17,000 16,923 17,028 (6)
21,944 22,360 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
Control Investments(8)(9)
C5 Technology Holdings, LLCData Processing & Outsourced ServicesCommon Stock829$— $— (15)
C5 Technology Holdings, LLCData Processing & Outsourced ServicesPreferred Equity34,984,460 34,984 27,638 (15)
Dominion Diagnostics, LLCHealth Care ServicesFirst Lien Term LoanL+5.00%8.68%2/28/2024$14,333 14,333 14,333 (6)(15)
Dominion Diagnostics, LLCHealth Care ServicesFirst Lien RevolverL+5.00%2/28/2024— — — (6)(15)(19)
Dominion Diagnostics, LLCHealth Care ServicesCommon Stock30,031 15,222 4,946 (15)
OCSI Glick JV LLCMulti-Sector HoldingsSubordinated DebtL+4.50%6.30%10/20/202859,662 50,194 50,283 (6)(11)(14)(15)(19)
OCSI Glick JV LLCMulti-Sector HoldingsMembership Interest87.5 %— — (11)(14)(16)(19)
Senior Loan Fund JV I, LLCMulti-Sector HoldingsSubordinated DebtL+7.00%8.80%12/29/202896,250 96,250 96,250 (6)(11)(14)(15)(19)
Senior Loan Fund JV I, LLCMulti-Sector HoldingsMembership Interest87.5 %49,322 20,715 (11)(12)(14)(16)(19)
 Total Control Investments (17.2% of net assets)$260,305 $214,165 
Affiliate Investments(17)
Assembled Brands Capital LLCSpecialized FinanceFirst Lien RevolverL+6.75%10.42%10/17/2023$24,490 $24,490 $24,225 (6)(15)(19)
Assembled Brands Capital LLCSpecialized FinanceCommon Stock1,609,201 764 370 (15)
Assembled Brands Capital LLCSpecialized FinancePreferred Equity1,019,169 1,019 1,223 (15)
Assembled Brands Capital LLCSpecialized FinanceWarrants70,425 — — (15)
Caregiver Services, Inc.Health Care ServicesPreferred Equity1,080,399 1,080 378 (15)
 Total Affiliate Investments (2.1% of net assets)$27,353 $26,196 
Non-Control/Non-Affiliate Investments(18)
109 Montgomery Owner LLCReal Estate Operating CompaniesFirst Lien Term LoanL+7.00%9.80%2/2/2023$389 $387 $727 (6)(15)
109 Montgomery Owner LLCReal Estate Operating CompaniesFirst Lien Term LoanL+7.00%2/2/2023— (31)— (6)(15)(19)
A.T. Holdings II SÀRLBiotechnologyFirst Lien Term Loan10.50%12/22/202233,997 33,960 34,891 (11)(15)
Access CIG, LLCDiversified Support ServicesSecond Lien Term LoanL+7.75%10.82%2/27/202620,000 19,927 19,075 (6)
Accupac, Inc.Personal ProductsFirst Lien Term LoanSOFR+5.50%9.12%1/16/202615,976 15,686 15,944 (6)(15)
Accupac, Inc.Personal ProductsFirst Lien Term LoanSOFR+5.50%1/16/2026— — (6)(6)(15)(19)
Accupac, Inc.Personal ProductsFirst Lien RevolverSOFR+5.50%9.14%1/16/2026500 462 495 (6)(15)(19)
Acquia Inc.Application SoftwareFirst Lien Term LoanL+7.00%9.63%10/31/202527,349 27,038 27,158 (6)(15)
Acquia Inc.Application SoftwareFirst Lien RevolverL+7.00%10.64%10/31/2025914 890 898 (6)(15)(19)
ADB Companies, LLCConstruction & EngineeringFirst Lien Term LoanSOFR+6.25%9.80%12/18/202514,685 14,217 14,431 (6)(15)
ADC Therapeutics SABiotechnologyFirst Lien Term LoanSOFR+7.50%11.20%8/15/20296,589 6,256 6,262 (6)(11)(15)
ADC Therapeutics SABiotechnologyFirst Lien Term LoanSOFR+7.50%8/15/2029— (38)(37)(6)(11)(15)(19)
ADC Therapeutics SABiotechnologyWarrants28,948 174 73 (11)(15)
Aden & Anais Merger Sub, Inc.Apparel, Accessories & Luxury GoodsCommon Stock51,645 5,165 — (15)
AI Sirona (Luxembourg) Acquisition S.a.r.l.PharmaceuticalsSecond Lien Term LoanE+7.25%7.94%9/28/202624,838 27,752 22,143 (6)(11)(15)
AIP RD Buyer Corp.DistributorsSecond Lien Term LoanSOFR+7.75%10.88%12/21/2029$14,414 14,154 13,910 (6)(15)
AIP RD Buyer Corp.DistributorsCommon Stock14,410 1,352 1,291 (15)
AirStrip Technologies, Inc.Application SoftwareWarrants5,715 90 — (15)
All Web Leads, Inc.AdvertisingFirst Lien Term LoanL+8.50%11.64%12/29/202323,338 22,057 22,141 (6)(15)
17

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 2022
(dollar amounts in thousands)

Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
Altice France S.A.Integrated Telecommunication ServicesFixed Rate Bond5.50%10/15/2029$4,050 $3,518 $3,057 (11)
Alvogen Pharma US, Inc.PharmaceuticalsFirst Lien Term LoanSOFR+7.50%11.20%6/30/202513,134 12,847 13,068 (6)(15)
Alvotech Holdings S.A.BiotechnologyFixed Rate Bond10.00%6/24/202524,043 23,747 23,923 (11)(15)
Alvotech Holdings S.A.BiotechnologyFixed Rate Bond10.00%6/24/202523,522 23,264 23,404 (11)(15)
Alvotech Holdings S.A.BiotechnologyCommon Stock587,930 5,308 3,974 (11)
Alvotech Holdings S.A.BiotechnologyCommon Stock124,780 485 212 (11)(13)(15)
American Auto Auction Group, LLCConsumer FinanceSecond Lien Term LoanSOFR+8.75%12.30%1/2/202914,760 14,492 13,284 (6)(15)
American Tire Distributors, Inc.DistributorsFirst Lien Term LoanL+6.25%9.03%10/20/20289,895 9,772 9,293 (6)
Amplify Finco Pty Ltd.Movies & EntertainmentFirst Lien Term LoanL+4.25%7.92%11/26/202615,220 13,973 14,687 (6)(11)(15)
Amplify Finco Pty Ltd.Movies & EntertainmentSecond Lien Term LoanL+8.00%11.67%11/26/202712,500 12,188 11,958 (6)(11)(15)
Anastasia Parent, LLCPersonal ProductsFirst Lien Term LoanL+3.75%7.42%8/11/20252,736 2,260 2,189 (6)
Ankura Consulting Group LLCResearch & Consulting ServicesSecond Lien Term LoanL+8.00%10.78%3/19/20294,346 4,281 3,813 (6)(15)
Apptio, Inc.Application SoftwareFirst Lien Term LoanL+6.00%8.46%1/10/202534,458 33,737 33,738 (6)(15)
Apptio, Inc.Application SoftwareFirst Lien RevolverL+6.00%8.46%1/10/2025892 863 846 (6)(15)(19)
APX Group Inc.Electrical Components & EquipmentFixed Rate Bond5.75%7/15/20292,075 1,733 1,645 (11)
Ardonagh Midco 3 PLCInsurance BrokersFirst Lien Term LoanE+7.00%8.00%7/14/20261,964 2,176 1,927 (6)(11)(15)
Ardonagh Midco 3 PLCInsurance BrokersFirst Lien Term LoanSONIA+7.00%9.19%7/14/2026£18,636 23,139 20,826 (6)(11)(15)
Ardonagh Midco 3 PLCInsurance BrokersFirst Lien Term LoanL+5.75%8.81%7/14/2026$10,519 10,357 10,328 (6)(11)(15)
Ardonagh Midco 3 PLCInsurance BrokersFirst Lien Term LoanSONIA+5.75%7/14/2026£— (44)— (6)(11)(15)(19)
ASP Unifrax Holdings, Inc.Trading Companies & DistributorsFixed Rate Bond7.50%9/30/2029$5,500 5,408 3,641 
ASP Unifrax Holdings, Inc.Trading Companies & DistributorsFixed Rate Bond5.25%9/30/20282,500 2,220 1,926 
Associated Asphalt Partners, LLCConstruction MaterialsFirst Lien Term LoanL+5.25%8.06%4/5/20242,501 2,331 1,934 (6)
Astra Acquisition Corp.Application SoftwareFirst Lien Term LoanL+5.25%8.37%10/25/20285,640 5,482 4,822 (6)
athenahealth Group Inc.Health Care TechnologyPreferred Equity18,635 18,264 16,575 (15)
Athenex, Inc.PharmaceuticalsFirst Lien Term Loan11.00%6/19/202613,346 12,929 12,812 (11)(15)
Athenex, Inc.PharmaceuticalsFirst Lien Term Loan5/31/20318,309 8,264 8,309 (11)(15)(21)
Athenex, Inc.PharmaceuticalsWarrants328,149 973 16 (11)(15)
Aurora Lux Finco S.À.R.L.Airport ServicesFirst Lien Term LoanL+6.00%8.78%12/24/202622,425 22,086 21,326 (6)(11)(15)
The AveryReal Estate Operating CompaniesFirst Lien Term LoanL+7.30%10.44%2/17/202315,674 15,605 15,682 (6)(15)
The AveryReal Estate Operating CompaniesSubordinated Debt Term LoanL+12.50%16.17%2/17/20233,789 3,774 3,800 (6)(15)
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanL+5.00%8.12%6/11/20272,546 2,503 2,395 (6)(15)(19)
BAART Programs, Inc.Health Care ServicesSecond Lien Term LoanL+8.50%11.62%6/11/20287,166 7,059 6,915 (6)(15)
BAART Programs, Inc.Health Care ServicesSecond Lien Term LoanL+8.50%11.62%6/11/20284,227 4,070 3,839 (6)(15)(19)
Berner Food & Beverage, LLCSoft DrinksFirst Lien Term LoanL+5.50%8.31%7/30/202733,078 32,612 32,053 (6)(15)
Berner Food & Beverage, LLCSoft DrinksFirst Lien RevolverPRIME+4.50%10.75%7/30/20261,702 1,660 1,617 (6)(15)(19)
BioXcel Therapeutics, Inc.PharmaceuticalsFirst Lien Term Loan10.25%4/19/20275,322 5,111 5,114 (11)(15)
BioXcel Therapeutics, Inc.PharmaceuticalsFirst Lien Term Loan10.25%4/19/2027— — — (11)(15)(19)
BioXcel Therapeutics, Inc.PharmaceuticalsFirst Lien Term Loan9/30/20322,353 2,353 2,353 (11)(15)(21)
18

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 2022
(dollar amounts in thousands)

Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
BioXcel Therapeutics, Inc.PharmaceuticalsFirst Lien Term Loan9/30/2032$— $— $— (11)(15)(19)(21)
BioXcel Therapeutics, Inc.PharmaceuticalsWarrants21,177 125 98 (11)(15)
Blackhawk Network Holdings, Inc.Data Processing & Outsourced ServicesSecond Lien Term LoanL+7.00%9.50%6/15/202630,625 30,276 29,017 (6)
Blumenthal Temecula, LLCAutomotive RetailFirst Lien Term Loan9.00%9/24/20233,979 3,980 3,960 (15)
Blumenthal Temecula, LLCAutomotive RetailPreferred Equity1,293,324 1,293 1,280 (15)
Blumenthal Temecula, LLCAutomotive RetailPreferred Equity298,460 298 295 (15)
Blumenthal Temecula, LLCAutomotive RetailCommon Stock298,460 298 349 (15)
Cadence Aerospace, LLCAerospace & DefenseFirst Lien Term LoanL+6.50%9.31%2.00%11/14/202314,294 13,471 13,143 (6)(15)
Carvana Co.Automotive RetailFixed Rate Bond5.63%10/1/20256,700 5,825 4,724 (11)
CCO Holdings LLCCable & SatelliteFixed Rate Bond4.50%5/1/20322,097 1,746 1,603 (11)
CircusTrix Holdings, LLCLeisure FacilitiesFirst Lien Term LoanL+5.50%8.62%7/16/202310,692 10,004 10,209 (6)(15)
CITGO Holding, Inc.Oil & Gas Refining & MarketingFixed Rate Bond9.25%8/1/20247,857 7,857 7,807 
CITGO Petroleum Corp.Oil & Gas Refining & MarketingFirst Lien Term LoanL+6.25%9.37%3/28/2024795 770 797 (6)
Clear Channel Outdoor Holdings, Inc.AdvertisingFixed Rate Bond7.50%6/1/20294,311 4,311 3,132 (11)
Clear Channel Outdoor Holdings, Inc.AdvertisingFixed Rate Bond5.13%8/15/20271,374 1,229 1,163 (11)
Clear Channel Outdoor Holdings, Inc.AdvertisingFixed Rate Bond7.75%4/15/2028676 648 512 (11)
Condor Merger Sub Inc.Systems SoftwareFixed Rate Bond7.38%2/15/20308,420 8,243 6,900 
Continental Intermodal Group LPOil & Gas Storage & TransportationFirst Lien Term LoanL+8.50%11.62%1/28/202522,537 21,642 20,396 (6)(15)
Continental Intermodal Group LPOil & Gas Storage & TransportationWarrants648 457 (15)
Convergeone Holdings, Inc.IT Consulting & Other ServicesFirst Lien Term LoanL+5.00%8.12%1/4/202611,913 11,697 8,596 (6)
Conviva Inc.Application SoftwarePreferred Equity417,851 605 894 (15)
CorEvitas, LLCHealth Care TechnologyFirst Lien Term LoanSOFR+5.75%8.88%12/13/202513,712 13,554 13,583 (6)(15)
CorEvitas, LLCHealth Care TechnologyFirst Lien RevolverPRIME+4.75%11.00%12/13/2025916 898 898 (6)(15)(19)
CorEvitas, LLCHealth Care TechnologyCommon Stock1,099 690 2,340 (15)
Covetrus, Inc.Health Care DistributorsFirst Lien Term LoanSOFR+5.00%7.65%10/13/202910,336 9,716 9,681 (6)
Coyote Buyer, LLCSpecialty ChemicalsFirst Lien Term LoanL+6.00%8.81%2/6/202618,200 17,790 17,843 (6)(15)
Coyote Buyer, LLCSpecialty ChemicalsFirst Lien RevolverL+6.00%2/6/2025— (13)(26)(6)(15)(19)
Delivery Hero FinCo LLCInternet & Direct Marketing RetailFirst Lien Term LoanSOFR+5.75%8.49%8/12/20274,988 4,882 4,757 (6)(11)
Delta Leasing SPV II LLCSpecialized FinanceSubordinated Debt Term Loan10.00%8/31/20294,183 4,183 4,183 (11)(15)(19)
Delta Leasing SPV II LLCSpecialized FinancePreferred Equity419 419 419 (11)(15)
Delta Leasing SPV II LLCSpecialized FinanceCommon Stock(11)(15)
Delta Leasing SPV II LLCSpecialized FinanceWarrants31 — — (11)(15)
Delta Topco, Inc.Systems SoftwareSecond Lien Term LoanL+7.25%9.34%12/1/20286,680 6,647 5,934 (6)
Dialyze Holdings, LLCHealth Care EquipmentFirst Lien Term LoanL+9.00%12.67%2.00%8/4/202624,396 23,083 22,993 (6)(15)
Dialyze Holdings, LLCHealth Care EquipmentFirst Lien Term LoanL+9.00%8/4/2026— (135)(129)(6)(15)(19)
Dialyze Holdings, LLCHealth Care EquipmentWarrants5,403,823 1,405 1,297 (15)
Digital.AI Software Holdings, Inc.Application SoftwareFirst Lien Term LoanL+7.00%9.91%2/10/20279,902 9,599 9,793 (6)(15)
Digital.AI Software Holdings, Inc.Application SoftwareFirst Lien RevolverL+6.50%9.41%2/10/2027251 228 239 (6)(15)(19)
19

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Accupac, Inc.Personal Products
First Lien Term Loan, LIBOR+6.00% cash due 1/17/20267.00 %$16,140 $15,758 $16,140 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+6.00% cash due 1/17/2026— (29)— (6)(15)(19)
First Lien Revolver, LIBOR+6.00% cash due 1/17/20267.00 %1,838 1,789 1,838 (6)(15)(19)
17,518 17,978 
Acquia Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 10/31/20258.00 %27,349 26,936 27,295 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 10/31/20258.00 %179 148 175 (6)(15)(19)
27,084 27,470 
ADB Companies, LLCConstruction & Engineering
First Lien Term Loan, LIBOR+6.25% cash due 12/18/20257.25 %15,463 14,817 15,287 (6)(15)
14,817 15,287 
Aden & Anais Merger Sub, Inc.Apparel, Accessories & Luxury Goods
51,645 Common Units in Aden & Anais Holdings, Inc.5,165 — (15)
5,165  
AI Sirona (Luxembourg) Acquisition S.a.r.l.Pharmaceuticals
Second Lien Term Loan, EURIBOR+7.25% cash due 9/28/20267.25 %24,838 27,720 28,738 (6)(11)(15)
27,720 28,738 
AirStrip Technologies, Inc.Application Software
5,715 Common Stock Warrants (exercise price $139.99) expiration date 5/11/202590 — (15)
90  
All Web Leads, Inc.Advertising
First Lien Term Loan, LIBOR+6.50% cash due 12/29/20237.50 %$23,899 21,512 22,992 (6)(15)
21,512 22,992 
Alvogen Pharma US, Inc.Pharmaceuticals
First Lien Term Loan, LIBOR+5.25% cash due 12/31/20236.25 %13,825 13,329 13,383 (6)
13,329 13,383 
Alvotech Holdings S.A.Biotechnology(13)
Fixed Rate Bond 15% PIK Tranche A due 6/24/202520,967 20,576 20,967 (11)(15)
Fixed Rate Bond 15% PIK Tranche B due 6/24/202520,512 20,169 20,512 (11)(15)
27,308 Common Shares6,322 6,322 (15)
47,067 47,801 
Amplify Finco Pty Ltd.Movies & Entertainment
First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.00 %15,376 13,814 14,985 (6)(11)(15)
Second Lien Term Loan, LIBOR+8.00% cash due 11/26/20278.75 %12,500 12,188 12,063 (6)(11)(15)
26,002 27,048 
Ankura Consulting Group LLCResearch & Consulting Services
Second Lien Term Loan, LIBOR+8.00% cash due 3/19/20298.75 %7,466 7,354 7,606 (6)(15)
7,354 7,606 
Apptio, Inc.Application Software
First Lien Term Loan, LIBOR+7.25% cash due 1/10/20258.25 %34,458 33,420 33,922 (6)(15)
First Lien Revolver, LIBOR+7.25% cash due 1/10/20258.25 %892 849 858 (6)(15)(19)
34,269 34,780 
Ardonagh Midco 3 PLCInsurance Brokers
First Lien Term Loan, EURIBOR+7.25% cash due 7/14/20268.25 %1,964 2,179 2,283 (6)(11)(15)
First Lien Term Loan, UK LIBOR+7.25% cash due 7/14/20268.00 %£18,636 23,336 25,329 (6)(11)(15)
First Lien Delayed Draw Term Loan, LIBOR+6.00% cash due 7/14/2026$— — — (6)(11)(15)(19)
First Lien Delayed Draw Term Loan, SONIA+6.00% cash due 7/14/2026£— — — (6)(11)(15)(19)
25,515 27,612 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
DirecTV Financing, LLCCable & SatelliteFirst Lien Term LoanL+5.00%8.12%8/2/2027$19,242 $18,970 $17,973 (6)
DTI Holdco, Inc.Research & Consulting ServicesFirst Lien Term LoanSOFR+4.75%7.33%4/26/20295,000 4,906 4,760 (6)
Eagleview Technology CorporationApplication SoftwareSecond Lien Term LoanL+7.50%11.17%8/14/20268,974 8,884 8,503 (6)(15)
EOS Fitness Opco Holdings, LLCLeisure FacilitiesPreferred Equity488 488 966 (15)
EOS Fitness Opco Holdings, LLCLeisure FacilitiesCommon Stock12,500 — — (15)
Establishment Labs Holdings Inc.Health Care TechnologyFirst Lien Term Loan3.00%6.00%4/21/202710,418 10,275 10,231 (11)(15)
Establishment Labs Holdings Inc.Health Care TechnologyFirst Lien Term Loan3.00%4/21/2027— — (11)(15)(19)
Fairbridge Strategic Capital Funding LLCReal Estate Operating CompaniesFirst Lien Term Loan9.00%12/24/202827,850 27,850 27,850 (15)(19)(20)
Fairbridge Strategic Capital Funding LLCReal Estate Operating CompaniesWarrants2,500 — (11)(15)(20)
FINThrive Software Intermediate Holdings, Inc.Health Care TechnologySecond Lien Term LoanL+6.75%9.87%12/17/202925,061 24,685 21,646 (6)
Fortress Biotech, Inc.BiotechnologyFirst Lien Term Loan11.00%8/27/20259,466 9,071 9,008 (11)(15)
Fortress Biotech, Inc.BiotechnologyWarrants331,200 405 66 (11)(15)
Frontier Communications Holdings, LLCIntegrated Telecommunication ServicesFixed Rate Bond6.00%1/15/20304,881 4,420 3,845 (11)
GKD Index Partners, LLCSpecialized FinanceFirst Lien Term LoanL+7.00%10.67%6/29/202325,128 24,915 24,851 (6)(15)
GKD Index Partners, LLCSpecialized FinanceFirst Lien RevolverL+7.00%10.60%6/29/20231,280 1,268 1,262 (6)(15)(19)
Global Medical Response, Inc.Health Care ServicesFirst Lien Term LoanL+4.25%7.37%3/14/20255,572 5,435 4,848 (6)
Grove Hotel Parcel Owner, LLCHotels, Resorts & Cruise LinesFirst Lien Term LoanSOFR+8.00%11.04%6/21/202714,311 14,041 14,060 (6)(15)
Grove Hotel Parcel Owner, LLCHotels, Resorts & Cruise LinesFirst Lien Term LoanSOFR+8.00%6/21/2027— (54)(50)(6)(15)(19)
Grove Hotel Parcel Owner, LLCHotels, Resorts & Cruise LinesFirst Lien RevolverSOFR+8.00%6/21/2027— (27)(25)(6)(15)(19)
Harbor Purchaser Inc.Education ServicesFirst Lien Term LoanSOFR+5.25%8.38%4/9/20299,392 9,080 8,582 (6)
iCIMs, Inc.Application SoftwareFirst Lien Term LoanSOFR+6.75%9.49%8/18/202819,203 18,874 18,867 (6)(15)
iCIMs, Inc.Application SoftwareFirst Lien Term LoanSOFR+6.75%8/18/2028— — — (6)(15)(19)
iCIMs, Inc.Application SoftwareFirst Lien RevolverSOFR+6.75%8/18/2028— (31)(32)(6)(15)(19)
Immucor, Inc.Health Care SuppliesFirst Lien Term LoanL+5.75%9.42%7/2/20258,569 8,401 8,407 (6)(15)
Immucor, Inc.Health Care SuppliesSecond Lien Term LoanL+8.00%11.67%3.50%10/2/202522,619 22,162 22,275 (6)(15)
Impel Neuropharma, Inc.Health Care TechnologyFirst Lien Term Loan2/15/203113,083 13,083 13,083 (15)(21)
Impel Neuropharma, Inc.Health Care TechnologyFirst Lien Term LoanSOFR+8.75%12.45%3/17/202712,161 11,944 11,942 (6)(15)
Innocoll Pharmaceuticals LimitedHealth Care TechnologyFirst Lien Term Loan11.00%1/26/20276,817 6,553 6,408 (11)(15)
Innocoll Pharmaceuticals LimitedHealth Care TechnologyFirst Lien Term Loan11.00%1/26/2027— — — (11)(15)(19)
Innocoll Pharmaceuticals LimitedHealth Care TechnologyWarrants56,999 135 609 (11)(15)
Integral Development CorporationOther Diversified Financial ServicesWarrants1,078,284 113 — (15)
Inventus Power, Inc.Electrical Components & EquipmentFirst Lien Term LoanSOFR+5.00%8.55%3/29/202418,660 18,567 18,134 (6)(15)
Inventus Power, Inc.Electrical Components & EquipmentSecond Lien Term LoanL+8.50%12.17%9/29/202413,674 13,514 13,154 (6)(15)
INW Manufacturing, LLCPersonal ProductsFirst Lien Term LoanL+5.75%9.42%3/25/202735,625 34,806 31,528 (6)(15)
IPC Corp.Application SoftwareFirst Lien Term LoanL+6.50%9.44%10/1/202634,357 33,612 32,639 (6)(15)
Ivanti Software, Inc.Application SoftwareSecond Lien Term LoanL+7.25%10.33%12/1/202810,247 10,196 7,702 (6)
Jazz Acquisition, Inc.Aerospace & DefenseFirst Lien Term LoanL+7.50%10.62%1/29/202736,234 35,170 36,392 (6)(15)
Jazz Acquisition, Inc.Aerospace & DefenseSecond Lien Term LoanL+8.00%11.12%6/18/2027528 478 481 (6)
20

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Associated Asphalt Partners, LLCConstruction Materials
First Lien Term Loan, LIBOR+5.25% cash due 4/5/20246.25 %$2,531 $2,245 $2,350 (6)
2,245 2,350 
Athenex, Inc.Pharmaceuticals
First Lien Term Loan, 11.00% cash due 6/19/202642,145 40,475 41,845 (11)(15)
First Lien Delayed Draw Term Loan, 11.00% cash due 6/19/2026— (274)(150)(11)(15)(19)
328,149 Common Stock Warrants (exercise price $12.63) expiration date 6/19/2027973 95 (11)(15)
41,174 41,790 
Aurora Lux Finco S.À.R.L.Airport Services
First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.00 %22,655 22,232 21,318 (6)(11)(15)
22,232 21,318 
The AveryReal Estate Operating Companies
First Lien Delayed Draw Term Loan in T8 Urban Condo Owner, LLC, LIBOR+7.30% cash due 2/17/20237.55 %20,287 19,933 20,490 (6)(15)(19)
Subordinated Delayed Draw Debt in T8 Senior Mezz LLC, LIBOR+12.50% cash due 2/17/202312.75 %4,692 4,614 4,698 (6)(15)(19)
24,547 25,188 
BAART Programs, Inc.Health Care Services
Second Lien Term Loan, LIBOR+8.50% cash due 6/11/20289.50 %7,166 7,059 7,130 (6)(15)
Second Lien Delayed Draw Term Loan, LIBOR+8.50% cash due 6/11/2028— (52)(18)(6)(15)(19)
7,007 7,112 
Berner Food & Beverage, LLCSoft Drinks
First Lien Term Loan, LIBOR+6.50% cash due 7/30/20277.50 %33,412 32,844 32,844 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 7/30/20277.50 %619 566 566 (6)(15)(19)
33,410 33,410 
Blackhawk Network Holdings, Inc.Data Processing & Outsourced Services
Second Lien Term Loan, LIBOR+7.00% cash due 6/15/20267.13 %30,625 30,181 30,523 (6)
30,181 30,523 
Blumenthal Temecula, LLCAutomotive Retail
First Lien Term Loan, 9.00% cash due 9/24/20233,979 3,980 3,979 (15)
1,293,324 Preferred Units in Unstoppable Automotive AMV, LLC1,293 1,293 (15)
298,460 Preferred Units in Unstoppable Automotive VMV, LLC298 298 (15)
298,460 Common Units in Unstoppable Automotive AMV, LLC298 298 (15)
99,486 Common Units in Unstoppable Automotive VMV, LLC100 99 (15)
5,969 5,967 
Cadence Aerospace, LLCAerospace & Defense
First Lien Term Loan, LIBOR+6.50% cash 2.00% PIK due 11/14/20237.50 %14,146 12,574 12,992 (6)(15)
12,574 12,992 
Chief Power Finance II, LLCIndependent Power Producers & Energy Traders
First Lien Term Loan, LIBOR+6.50% cash due 12/31/20227.50 %23,850 23,458 23,552 (6)(15)
23,458 23,552 
CircusTrix Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+5.50% cash 2.50% PIK due 7/16/20236.50 %10,686 9,793 8,816 (6)(15)(19)
9,793 8,816 
CITGO Holding, Inc.Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+7.00% cash due 8/1/20238.00 %11,635 11,517 11,512 (6)
Fixed Rate Bond, 9.25% cash due 8/1/202410,672 10,672 10,765 
22,189 22,277 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
Kings Buyer, LLCEnvironmental & Facilities ServicesFirst Lien Term LoanL+6.50%10.17%10/29/2027$13,623 $13,487 $13,351 (6)(15)
Kings Buyer, LLCEnvironmental & Facilities ServicesFirst Lien RevolverL+6.50%10.17%10/29/2027329 311 292 (6)(15)(19)
LaserShip, Inc.Air Freight & LogisticsSecond Lien Term LoanL+7.50%10.38%5/7/20292,394 2,370 1,867 (6)(15)
Lift Brands Holdings, Inc.Leisure FacilitiesCommon Stock2,000,000 1,399 — (15)
Lightbox Intermediate, L.P.Real Estate ServicesFirst Lien Term LoanL+5.00%8.67%5/9/202641,008 40,243 39,573 (6)(15)
Liquid Environmental Solutions CorporationEnvironmental & Facilities ServicesSecond Lien Term LoanL+8.50%11.38%11/30/20264,357 4,285 4,226 (6)(15)
Liquid Environmental Solutions CorporationEnvironmental & Facilities ServicesSecond Lien Term LoanL+8.50%11.38%11/30/20262,370 2,323 2,265 (6)(15)(19)
Liquid Environmental Solutions CorporationEnvironmental & Facilities ServicesCommon Stock451 451 451 (15)
LSL Holdco, LLCHealth Care DistributorsFirst Lien Term LoanL+6.00%9.12%1/31/202819,236 18,894 18,707 (6)(15)
LSL Holdco, LLCHealth Care DistributorsFirst Lien RevolverL+6.00%9.12%1/31/20281,710 1,672 1,651 (6)(15)(19)
LTI Holdings, Inc.Electronic ComponentsSecond Lien Term LoanL+6.75%9.87%9/6/20262,140 2,092 1,890 (6)
Marinus Pharmaceuticals, Inc.PharmaceuticalsFirst Lien Term Loan11.50%5/11/202617,203 16,954 16,644 (11)(15)
Marinus Pharmaceuticals, Inc.PharmaceuticalsFirst Lien Term Loan11.50%5/11/2026— — — (11)(15)(19)
Mesoblast, Inc.BiotechnologyFirst Lien Term Loan8.00%1.75%11/19/20267,215 6,650 6,440 (11)(15)
Mesoblast, Inc.BiotechnologyFirst Lien Term Loan8.00%1.75%11/19/2026— — (11)(15)(19)
Mesoblast, Inc.BiotechnologyWarrants209,588 480 170 (11)(15)
MHE Intermediate Holdings, LLCDiversified Support ServicesFirst Lien Term LoanSOFR+6.00%9.50%7/21/202718,390 18,088 17,691 (6)(15)
MHE Intermediate Holdings, LLCDiversified Support ServicesFirst Lien RevolverSOFR+6.00%7/21/2027— (23)(54)(6)(15)(19)
Mindbody, Inc.Internet Services & InfrastructureFirst Lien Term LoanL+7.00%10.64%1.50%2/14/202545,665 44,689 44,523 (6)(15)
Mindbody, Inc.Internet Services & InfrastructureFirst Lien RevolverL+8.00%2/14/2025— (54)(100)(6)(15)(19)
Mosaic Companies, LLCHome Improvement RetailFirst Lien Term LoanL+6.75%9.89%7/2/202646,499 45,802 45,421 (6)(15)
MRI Software LLCApplication SoftwareFirst Lien Term LoanL+5.50%9.17%2/10/202629,565 29,128 28,734 (6)(15)
MRI Software LLCApplication SoftwareFirst Lien Term LoanL+5.50%2/10/2026— (12)(96)(6)(15)(19)
MRI Software LLCApplication SoftwareFirst Lien RevolverL+5.50%2/10/2026— (13)(51)(6)(15)(19)
Navisite, LLCData Processing & Outsourced ServicesSecond Lien Term LoanL+8.50%12.17%12/30/202622,560 22,241 21,524 (6)(15)
NeuAG, LLCFertilizers & Agricultural ChemicalsFirst Lien Term LoanL+10.50%14.17%9/11/202450,459 49,301 51,972 (6)(15)
NFP Corp.Other Diversified Financial ServicesFixed Rate Bond6.88%8/15/202810,191 9,773 7,966 
NN, Inc.Industrial MachineryFirst Lien Term LoanL+6.88%9.99%9/19/202658,713 57,655 56,805 (6)(11)(15)
OEConnection LLCApplication SoftwareFirst Lien Term LoanL+4.00%7.12%9/25/20263,323 3,162 3,207 (6)
OEConnection LLCApplication SoftwareSecond Lien Term LoanL+7.00%10.05%9/25/20277,519 7,389 7,237 (6)(15)
OTG Management, LLCAirport ServicesFirst Lien Term LoanL+2.00%5.08%8.00%9/2/202521,557 21,267 21,557 (6)(15)
OTG Management, LLCAirport ServicesFirst Lien Term LoanL+2.00%9/2/2025— (31)— (6)(15)(19)
P & L Development, LLCPharmaceuticalsFixed Rate Bond7.75%11/15/20257,776 7,820 5,846 
Park Place Technologies, LLCInternet Services & InfrastructureFirst Lien Term LoanSOFR+5.00%8.13%11/10/20279,850 9,460 9,374 (6)
Performance Health Holdings, Inc.Health Care DistributorsFirst Lien Term LoanL+6.00%8.88%7/12/202717,976 17,690 17,537 (6)(15)
PFNY Holdings, LLCLeisure FacilitiesFirst Lien Term LoanL+7.00%9.28%12/31/202626,154 25,712 25,893 (6)(15)
21

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
CITGO Petroleum Corp.Oil & Gas Refining & Marketing
First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.25 %$14,221 $13,855 $14,269 (6)
13,855 14,269 
Clear Channel Outdoor Holdings Inc.Advertising
Fixed Rate Bond, 7.50% cash due 6/1/20297,137 7,137 7,431 (11)
7,137 7,431 
Continental Intermodal Group LPOil & Gas Storage & Transportation
First Lien Term Loan, LIBOR+9.50% PIK due 1/28/202538,876 36,668 32,628 (6)(15)
Common Stock Warrants expiration date 7/28/2025648 1,909 (15)
37,316 34,537 
Convergeone Holdings, Inc.IT Consulting & Other Services
First Lien Term Loan, LIBOR+5.00% cash due 1/4/20265.08 %7,024 6,848 7,003 (6)
6,848 7,003 
Conviva Inc.Application Software
517,851 Shares of Series D Preferred Stock605 894 (15)
605 894 
CorEvitas, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.50% cash due 12/13/20256.50 %10,196 10,071 10,109 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 12/13/20256.50 %1,943 1,894 1,912 (6)(15)(19)
First Lien Revolver, PRIME+4.50% cash due 12/13/20257.75 %305 283 290 (6)(15)(19)
1,099 Class A2 Common Units in CorEvitas Holdings, L.P.1,038 1,177 (15)
13,286 13,488 
Coty Inc.Personal Products
First Lien Revolver, LIBOR+1.75% cash due 4/5/2023— (712)(395)(6)(11)(15)(19)
(712)(395)
Coyote Buyer, LLCSpecialty Chemicals
First Lien Term Loan, LIBOR+6.00% cash due 2/6/20267.00 %18,387 17,887 18,225 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 2/6/2025— (13)(12)(6)(15)(19)
17,874 18,213 
Curium Bidco S.à.r.l.Biotechnology
Second Lien Term Loan, LIBOR+7.75% cash due 10/27/20288.50 %16,787 16,535 17,070 (6)(11)(15)
16,535 17,070 
Delta Topco, Inc.Systems Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/1/20288.00 %6,680 6,647 6,769 (6)
6,647 6,769 
Dialyze Holdings, LLCHealth Care Equipment
First Lien Term Loan, LIBOR+7.00% cash 2.00% PIK due 8/4/20268.00 %24,093 22,439 22,467 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+7.00% cash 2.00% PIK due 8/4/2026— (170)(163)(6)(15)(19)
5,403,823 Class A Warrants (exercise price $1.00) expiration date 8/4/20281,405 1,459 (15)
23,674 23,763 
Digital.AI Software Holdings, Inc.Application Software
First Lien Term Loan, LIBOR+7.00% cash due 2/10/20278.00 %10,003 9,627 9,783 (6)(15)
First Lien Revolver, LIBOR+7.00% cash due 2/10/20278.00 %180 151 156 (6)(15)(19)
9,778 9,939 
DirecTV Financing, LLCCable & Satellite
First Lien Term Loan, LIBOR+5.00% cash due 8/2/20275.75 %27,000 26,730 27,048 (6)
26,730 27,048 
Eagleview Technology CorporationApplication Software
Second Lien Term Loan, LIBOR+7.50% cash due 8/14/20268.50 %8,974 8,884 8,918 (6)(15)
8,884 8,918 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
PFNY Holdings, LLCLeisure FacilitiesFirst Lien Term LoanL+7.00%9.25%12/31/2026$2,228 $2,186 $2,203 (6)(15)(19)
PFNY Holdings, LLCLeisure FacilitiesFirst Lien RevolverL+7.00%12/31/2026— (21)(13)(6)(15)(19)
Planview Parent, Inc.Application SoftwareSecond Lien Term LoanL+7.25%10.92%12/18/202828,627 28,198 27,482 (6)(15)
Pluralsight, LLCApplication SoftwareFirst Lien Term LoanL+8.00%10.68%4/6/202748,689 47,951 47,155 (6)(15)
Pluralsight, LLCApplication SoftwareFirst Lien RevolverL+8.00%4/6/2027— (53)(111)(6)(15)(19)
PRGX Global, Inc.Data Processing & Outsourced ServicesFirst Lien Term LoanL+6.75%10.42%3/3/202633,775 32,931 33,116 (6)(15)
PRGX Global, Inc.Data Processing & Outsourced ServicesFirst Lien RevolverL+6.75%3/3/2026— (34)(49)(6)(15)(19)
PRGX Global, Inc.Data Processing & Outsourced ServicesCommon Stock80,515 79 89 (15)
Profrac Holdings II, LLCIndustrial MachineryFirst Lien Term LoanSOFR+8.50%10.01%3/4/202523,275 22,722 22,810 (6)(15)
Project Boost Purchaser, LLCApplication SoftwareSecond Lien Term LoanL+8.00%11.12%5/31/20275,250 5,168 5,047 (6)(15)
Quantum Bidco LimitedFood DistributorsFirst Lien Term LoanSONIA+6.00%8.39%1/31/2028£3,501 4,646 3,367 (6)(11)(15)
QuorumLabs, Inc.Application SoftwarePreferred Equity64,887,669 375 — (15)
Radiology Partners, Inc.Health Care DistributorsFirst Lien Term LoanL+4.25%7.33%7/9/2025$3,400 3,202 2,880 (6)
Radiology Partners, Inc.Health Care DistributorsFixed Rate Bond9.25%2/1/20284,755 4,720 3,109 
Relativity ODA LLCApplication SoftwareFirst Lien Term LoanL+7.50%10.59%5/12/202724,692 24,265 24,101 (6)(15)
Relativity ODA LLCApplication SoftwareFirst Lien RevolverL+6.50%5/12/2027— (43)(64)(6)(15)(19)
Renaissance Holding Corp.Diversified BanksSecond Lien Term LoanL+7.00%10.12%5/29/20263,542 3,515 3,402 (6)
RP Escrow Issuer LLCHealth Care DistributorsFixed Rate Bond5.25%12/15/20251,325 1,218 1,097 
RumbleOn, Inc.Automotive RetailFirst Lien Term LoanL+8.25%11.92%8/31/202637,656 35,775 36,187 (6)(11)(15)
RumbleOn, Inc.Automotive RetailFirst Lien Term LoanL+8.25%11.92%8/31/202611,393 10,583 10,760 (6)(11)(15)(19)
RumbleOn, Inc.Automotive RetailWarrants164,660 1,202 74 (11)(15)
Sabert CorporationMetal & Glass ContainersFirst Lien Term LoanL+4.50%7.63%12/10/20261,691 1,610 1,623 (6)
ShareThis, Inc.Application SoftwareWarrants345,452 367 — (15)
SiO2 Medical Products, Inc.Metal & Glass ContainersFirst Lien Term Loan5.50%8.50%12/21/202646,121 45,413 45,295 (15)
SIO2 Medical Products, Inc.Metal & Glass ContainersWarrants415 681 681 (15)
SM Wellness Holdings, Inc.Health Care ServicesSecond Lien Term LoanL+8.00%10.74%4/16/20299,109 8,972 8,289 (6)(15)
SonicWall US Holdings Inc.Technology DistributorsSecond Lien Term LoanL+7.50%10.48%5/18/20263,195 3,163 2,997 (6)(15)
Sorrento Therapeutics, Inc.BiotechnologyCommon Stock50,000 197 79 (11)
Spanx, LLCApparel RetailFirst Lien Term LoanL+5.25%8.30%11/20/20284,534 4,455 4,427 (6)(15)
Spanx, LLCApparel RetailFirst Lien RevolverL+5.25%8.03%11/18/2027866 813 796 (6)(15)(19)
SPX Flow, Inc.Industrial MachineryFirst Lien Term LoanSOFR+4.50%7.63%4/5/20291,500 1,410 1,393 (6)
SumUp Holdings Luxembourg S.À.R.L.Other Diversified Financial ServicesFirst Lien Term LoanE+8.50%10.00%3/10/2026£16,911 19,414 16,360 (6)(11)(15)
Sunland Asphalt & Construction, LLCConstruction & EngineeringFirst Lien Term LoanL+6.00%8.88%1/13/2026$42,618 41,654 41,723 (6)(15)
Supermoose Borrower, LLCApplication SoftwareFirst Lien Term LoanL+3.75%7.42%8/29/20253,466 3,141 3,056 (6)
SVP-Singer Holdings Inc.Home FurnishingsFirst Lien Term LoanL+6.75%10.42%7/28/202820,766 19,550 18,188 (6)(15)
Swordfish Merger Sub LLCAuto Parts & EquipmentSecond Lien Term LoanL+6.75%9.81%2/2/202612,500 12,474 11,469 (6)(15)
Tacala, LLCRestaurantsSecond Lien Term LoanL+7.50%10.62%2/4/20289,448 9,338 8,692 (6)
Tahoe Bidco B.V.Application SoftwareFirst Lien Term LoanL+6.00%8.68%9/29/202823,215 22,815 22,843 (6)(11)(15)
Tahoe Bidco B.V.Application SoftwareFirst Lien RevolverL+6.00%10/1/2027— (29)(28)(6)(11)(15)(19)
Tecta America Corp.Construction & EngineeringSecond Lien Term LoanL+8.50%11.62%4/9/20295,203 5,125 5,034 (6)(15)
22

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
EHR Canada, LLCFood Retail
First Lien Term Loan, LIBOR+8.00% cash due 12/31/20219.00 %$3,750 $3,745 $3,750 (6)(15)
3,745 3,750 
EOS Fitness Opco Holdings, LLCLeisure Facilities
487.5 Class A Preferred Units, 12%488 274 (15)
12,500 Class B Common Units— — (15)
488 274 
Firstlight Holdco, Inc.Alternative Carriers
First Lien Term Loan, LIBOR+3.50% cash due 7/23/20253.58 %7,012 6,578 6,939 (6)
6,578 6,939 
Fortress Biotech, Inc.Biotechnology
First Lien Term Loan, 11.00% cash due 8/27/202511,359 10,722 11,075 (11)(15)
331,200 Common Stock Warrants (exercise price $3.20) expiration date 8/27/2030405 341 (11)(15)
11,127 11,416 
GI Chill Acquisition LLCManaged Health Care
First Lien Term Loan, LIBOR+3.75% cash due 8/6/20253.90 %12,653 12,442 12,621 (6)(15)
Second Lien Term Loan, LIBOR+7.50% cash due 8/6/20267.63 %6,250 6,212 6,219 (6)(15)
18,654 18,840 
GKD Index Partners, LLCSpecialized Finance
First Lien Term Loan, LIBOR+8.50% cash due 6/29/20239.50 %26,360 25,837 25,931 (6)(15)
First Lien Revolver, LIBOR+8.50% cash due 6/29/20239.50 %1,280 1,251 1,252 (6)(15)(19)
27,088 27,183 
Global Medical Response, Inc.Health Care Services
First Lien Term Loan, LIBOR+4.25% cash due 3/14/20255.25 %8,630 8,399 8,674 (6)
8,399 8,674 
Gulf Operating, LLCOil & Gas Storage & Transportation
First Lien Revolver, LIBOR+4.00% cash due 12/27/2021— (704)(75)(6)(15)(19)
(704)(75)
Houghton Mifflin Harcourt Publishers Inc.Education Services
First Lien Term Loan, LIBOR+6.25% cash due 11/22/20247.25 %1,007 981 1,009 (6)(11)
981 1,009 
iCIMs, Inc.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 9/12/20247.50 %25,635 25,024 25,525 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 9/12/20247.50 %1,176 1,147 1,171 (6)(15)
26,171 26,696 
Immucor, Inc.Health Care Supplies
First Lien Term Loan, LIBOR+5.75% cash due 7/2/20256.75 %8,657 8,425 8,570 (6)(15)
Second Lien Term Loan, LIBOR+8.00% cash 3.50% PIK due 10/2/20259.00 %21,834 21,225 21,616 (6)(15)
29,650 30,186 
Integral Development CorporationOther Diversified Financial Services
1,078,284 Common Stock Warrants (exercise price $0.9274) expiration date 7/10/2024113 — (15)
113  
Inventus Power, Inc.Electrical Components & Equipment
First Lien Term Loan, LIBOR+5.00% cash due 3/29/20246.00 %18,849 18,693 18,708 (6)(15)
Second Lien Term Loan, LIBOR+8.50% cash due 9/29/20249.50 %13,674 13,434 13,434 (6)(15)
32,127 32,142 
Portfolio CompanyIndustryType of Investment (1)(2)(3)(4)IndexSpreadCash Interest Rate (5)(6)PIKMaturity DateSharesPrincipal (7)CostFair ValueNotes
Telestream Holdings CorporationApplication SoftwareFirst Lien Term LoanSOFR+9.25%12.11%10/15/2025$18,323 $17,956 $17,865 (6)(15)
Telestream Holdings CorporationApplication SoftwareFirst Lien RevolverSOFR+9.25%12.20%10/15/20251,231 1,210 1,187 (6)(15)(19)
TerSera Therapeutics LLCPharmaceuticalsSecond Lien Term LoanL+9.50%13.17%3/30/202629,663 29,352 29,031 (6)(15)
TerSera Therapeutics LLCPharmaceuticalsCommon Stock668,879 2,028 4,077 (15)
TGNR HoldCo LLCIntegrated Oil & GasSubordinated Debt11.50%5/14/20264,984 4,866 4,872 (10)(11)(15)
Thrasio, LLCInternet & Direct Marketing RetailFirst Lien Term LoanL+7.00%11.17%12/18/202637,494 36,569 35,807 (6)(15)
Thrasio, LLCInternet & Direct Marketing RetailPreferred Equity8,434 101 69 (15)
Thrasio, LLCInternet & Direct Marketing RetailPreferred Equity284,650 2,409 2,320 (15)
Thrasio, LLCInternet & Direct Marketing RetailPreferred Equity48,352 979 979 (15)
Thrasio, LLCInternet & Direct Marketing RetailPreferred Equity23,201 22,986 26,487 (15)(19)
TIBCO Software Inc.Application SoftwareFirst Lien Term LoanSOFR+4.50%8.15%3/30/202912,032 10,949 10,827 (6)
Touchstone Acquisition, Inc.Health Care SuppliesFirst Lien Term LoanL+6.00%9.12%12/29/20286,016 5,908 5,895 (6)(15)
Uniti Group LPSpecialized REITsFixed Rate Bond6.50%2/15/20294,500 4,060 3,026 (11)
Uniti Group LPSpecialized REITsFixed Rate Bond4.75%4/15/2028300 258 238 (11)
Win Brands Group LLCHousewares & SpecialtiesFirst Lien Term LoanL+15.00%19.64%1/23/20262,316 2,293 2,264 (6)(15)
Win Brands Group LLCHousewares & SpecialtiesWarrants3,621 — 192 (15)
Windstream Services II, LLCIntegrated Telecommunication ServicesFirst Lien Term LoanL+6.25%9.37%9/21/202725,499 24,632 23,204 (6)
Windstream Services II, LLCIntegrated Telecommunication ServicesCommon Stock18,032 216 296 (15)
Windstream Services II, LLCIntegrated Telecommunication ServicesWarrants109,420 1,842 1,799 (15)
WP CPP Holdings, LLCAerospace & DefenseFirst Lien Term LoanL+3.75%6.56%4/30/20257,564 6,989 6,795 (6)
WP CPP Holdings, LLCAerospace & DefenseSecond Lien Term LoanL+7.75%10.56%4/30/20266,000 5,855 5,070 (6)(15)
WPEngine, Inc.Application SoftwareFirst Lien Term LoanL+6.00%10.19%3/27/202640,536 39,947 40,131 (6)(15)
WWEX Uni Topco Holdings, LLCAir Freight & LogisticsSecond Lien Term LoanL+7.00%10.67%7/26/20295,000 4,925 4,538 (6)(15)
Zayo Group Holdings, Inc.Alternative CarriersFixed Rate Bond4.00%3/1/2027250 212 201 
Zep Inc.Specialty ChemicalsSecond Lien Term LoanL+8.25%11.92%8/11/202519,578 19,542 16,152 (6)(15)
Zephyr Bidco LimitedSpecialized FinanceSecond Lien Term LoanSONIA+7.50%9.72%7/23/2026£18,000 23,804 16,552 (6)(11)(15)
Total Non-Control/Non-Affiliate Investments (180.9% of net assets)$2,330,096 $2,253,750 
Total Portfolio Investments (200.2% of net assets)$2,617,754 $2,494,111 
Cash and Cash Equivalents and Restricted Cash
JP Morgan Prime Money Market Fund, Institutional Shares$5,261 $5,261 
Other cash accounts21,103 21,103 
Total Cash and Cash Equivalents and Restricted Cash (2.1% of net assets)$26,364 $26,364 
Total Portfolio Investments and Cash and Cash Equivalents and Restricted Cash (202.4% of net assets)$2,644,118 $2,520,475 


23

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
INW Manufacturing, LLCPersonal Products
First Lien Term Loan, LIBOR+5.75% cash due 5/7/20276.50 %$37,031 $35,988 $36,291 (6)(15)
35,988 36,291 
Itafos Inc.Fertilizers & Agricultural Chemicals
First Lien Term Loan, LIBOR+8.25% cash due 8/25/20249.25 %22,506 21,636 21,651 (6)(15)
21,636 21,651 
Ivanti Software, Inc.Application Software
Second Lien Term Loan, LIBOR+8.50% cash due 12/1/20289.50 %17,346 16,864 17,368 (6)(15)
16,864 17,368 
Jazz Acquisition, Inc.Aerospace & Defense
First Lien Term Loan, LIBOR+7.50% cash due 1/29/20278.50 %36,603 35,292 36,531 (6)(15)
35,292 36,531 
Latam Airlines Group S.A.Airlines
First Lien Delayed Draw Term Loan, LIBOR+11.00% PIK due 3/29/202216,239 16,085 16,356 (6)(11)(15)(19)
16,085 16,356 
Lift Brands Holdings, Inc.Leisure Facilities
2,000,000 Class A Common Units in Snap Investments, LLC1,399 — (15)
1,399  
Lightbox Intermediate, L.P.Real Estate Services
First Lien Term Loan, LIBOR+5.00% cash due 5/9/20265.13 %41,432 40,445 41,225 (6)(15)
40,445 41,225 
LogMeIn, Inc.Application Software
First Lien Term Loan, LIBOR+4.75% cash due 8/31/20274.83 %3,970 3,720 3,973 (6)
3,720 3,973 
LTI Holdings, Inc.Electronic Components
Second Lien Term Loan, LIBOR+6.75% cash due 9/6/20266.83 %10,140 10,080 10,127 (6)
10,080 10,127 
Marinus Pharmaceuticals, Inc.Pharmaceuticals
First Lien Term Loan, 11.50% cash due 5/11/20263,441 3,377 3,389 (11)(15)
First Lien Delayed Draw Term Loan, 11.50% cash due 5/11/20266,881 6,755 6,778 (11)(15)(19)
10,132 10,167 
Mayfield Agency Borrower Inc.Property & Casualty Insurance
First Lien Term Loan, LIBOR+4.50% cash due 2/28/20254.58 %9,949 9,884 9,949 (6)
9,884 9,949 
MedAssets Software Intermediate Holdings, Inc.Health Care Technology
Second Lien Term Loan, LIBOR+7.75% cash due 1/29/20298.50 %14,137 13,877 13,960 (6)(15)
13,877 13,960 
MHE Intermediate Holdings, LLCDiversified Support Services
First Lien Term Loan, LIBOR+5.75% cash due 7/21/20276.75 %16,429 16,111 16,100 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.75% cash due 7/21/20276.75 %106 84 83 (6)(15)(19)
First Lien Revolver, LIBOR+5.75% cash due 7/21/2027— (27)(28)(6)(15)(19)
16,168 16,155 
Mindbody, Inc.Internet Services & Infrastructure
First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/20258.00 %38,774 37,513 38,038 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 2/14/2025— (75)(76)(6)(15)(19)
37,438 37,962 
Derivative InstrumentNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateCounterpartyCumulative Unrealized Appreciation /(Depreciation)
Foreign currency forward contract$43,179 41,444 11/10/2022JPMorgan Chase Bank, N.A.$2,466 
Foreign currency forward contract$45,692 £37,033 11/10/2022JPMorgan Chase Bank, N.A.4,323 
$6,789 

Derivative InstrumentCompany ReceivesCompany PaysCounterpartyMaturity DateNotional AmountFair Value
Interest rate swapFixed 2.7%Floating 3-month LIBOR +1.658%Royal Bank of Canada1/15/2027$350,000$(41,969)

24

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 20212022
(dollar amounts in thousands)


Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Ministry Brands, LLCApplication Software
First Lien Revolver, LIBOR+5.00% cash due 12/2/2022$— $(9)$(9)(6)(15)(19)
Second Lien Term Loan, LIBOR+9.25% cash due 6/2/202310.25 %11,000 10,844 10,906 (6)(15)
10,835 10,897 
Mosaic Companies, LLCHome Improvement Retail
First Lien Term Loan, LIBOR+6.75% cash due 7/2/20267.75 %47,388 46,487 46,488 (6)(15)
46,487 46,488 
MRI Software LLCApplication Software
First Lien Term Loan, LIBOR+5.50% cash due 2/10/20266.50 %27,352 26,815 27,335 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026— (25)— (6)(15)(19)
First Lien Revolver, LIBOR+5.50% cash due 2/10/2026— (13)(1)(6)(15)(19)
26,777 27,334 
Navisite, LLCData Processing & Outsourced Services
Second Lien Term Loan, LIBOR+8.50% cash due 12/30/20269.50 %22,560 22,165 22,176 (6)(15)
22,165 22,176 
NeuAG, LLCFertilizers & Agricultural Chemicals
First Lien Term Loan, LIBOR+5.50% cash 7.00% PIK due 9/11/20247.00 %47,031 45,279 45,996 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+5.50% cash 7.00% PIK due 9/11/2024— (202)(120)(6)(15)(19)
45,077 45,876 
NN, Inc.Industrial Machinery
First Lien Term Loan, LIBOR+6.88% cash due 9/19/20267.88 %59,309 57,971 58,419 (6)(11)(15)
57,971 58,419 
OEConnection LLCApplication Software
First Lien Term Loan, LIBOR+4.00% cash due 9/25/20264.08 %3,355 3,152 3,351 (6)
3,152 3,351 
Olaplex, Inc.Personal Products
First Lien Term Loan, LIBOR+6.25% cash due 1/8/20267.25 %52,122 50,906 51,731 (6)(15)
First Lien Revolver, LIBOR+6.25% cash due 1/8/2025— (58)(75)(6)(15)(19)
50,848 51,656 
OmniSYS Acquisition CorporationDiversified Support Services
100,000 Common Units in OSYS Holdings, LLC1,000 729 (15)
1,000 729 
Onvoy, LLCIntegrated Telecommunication Services
First Lien Term Loan, LIBOR+4.50% cash due 2/10/20245.50 %3,601 3,410 3,603 (6)
Second Lien Term Loan, LIBOR+10.50% cash due 2/10/202511.50 %9,277 9,277 9,277 (6)(15)
19,666.67 Class A Units in GTCR Onvoy Holdings, LLC1,967 2,372 (15)
13,664.73 Series 3 Class B Units in GTCR Onvoy Holdings, LLC— — (15)
14,654 15,252 
OTG Management, LLCAirport Services
First Lien Term Loan, LIBOR+10.00% cash due 9/1/202511.00 %19,894 19,504 19,496 (6)(15)
First Lien Delayed Draw Term Loan, LIBOR+10.00% cash due 9/1/2025— (37)(38)(6)(15)(19)
19,467 19,458 
P & L Development, LLCPharmaceuticals
Fixed Rate Bond, 7.75% cash due 11/15/20257,776 7,832 8,089 
7,832 8,089 
Park Place Technologies, LLCInternet Services & Infrastructure
First Lien Term Loan, LIBOR+5.00% cash due 11/10/20276.00 %9,950 9,479 9,961 (6)
9,479 9,961 
25

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 2021
(dollar amounts in thousands)

Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Performance Health Holdings, Inc.Health Care Distributors
First Lien Term Loan, LIBOR+6.00% cash due 7/12/20277.00 %$20,085 $19,698 $19,683 (6)(15)
19,698 19,683 
Pingora MSR Opportunity Fund I-A, LPThrifts & Mortgage Finance
1.86% limited partnership interest752 112 (11)(16)(19)
752 112 
Planview Parent, Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.00 %28,627 28,198 28,699 (6)(15)
28,198 28,699 
PLNTF Holdings, LLCLeisure Facilities
First Lien Term Loan, LIBOR+8.00% cash due 3/22/20269.00 %13,729 13,482 13,798 (6)(15)
13,482 13,798 
Pluralsight, LLCApplication Software
First Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00 %48,689 47,788 47,763 (6)(15)
First Lien Revolver, LIBOR+8.00% cash due 4/6/2027— (65)(67)(6)(15)(19)
47,723 47,696 
PRGX Global, Inc.Data Processing & Outsourced Services
First Lien Term Loan, LIBOR+6.75% cash due 3/3/20267.75 %34,118 33,016 33,547 (6)(15)
First Lien Revolver, LIBOR+6.75% cash due 3/3/2026— (44)(42)(6)(15)(19)
80,515 Class B Common Units79 81 (15)
33,051 33,586 
ProFrac Services, LLCIndustrial Machinery
First Lien Term Loan, LIBOR+8.50% cash due 9/15/20239.75 %30,910 29,146 30,600 (6)(15)
29,146 30,600 
Project Boost Purchaser, LLCApplication Software
Second Lien Term Loan, LIBOR+8.00% cash due 5/31/20278.08 %5,250 5,151 5,224 (6)(15)
5,151 5,224 
Quantum Bidco LimitedFood Distributors
First Lien Term Loan, UK LIBOR+6.00% cash due 1/29/20286.11 %£3,501 4,625 4,673 (6)(11)
4,625 4,673 
QuorumLabs, Inc.Application Software
64,887,669 Junior-2 Preferred Stock375 — (15)
375  
Relativity ODA LLCApplication Software
First Lien Term Loan, LIBOR+7.50% PIK due 5/12/2027$22,856 22,337 22,376 (6)(15)
First Lien Revolver, LIBOR+6.50% cash due 5/12/2027— (52)(47)(6)(15)(19)
22,285 22,329 
Renaissance Holding Corp.Diversified Banks
Second Lien Term Loan, LIBOR+7.00% cash due 5/29/20267.08 %3,542 3,515 3,562 (6)
3,515 3,562 
RevSpring, Inc.Commercial Printing
First Lien Term Loan, LIBOR+4.25% cash due 10/11/20254.38 %9,725 9,185 9,709 (6)
9,185 9,709 
RumbleOn, Inc.Automotive Retail
First Lien Term Loan, LIBOR+8.25% cash due 8/31/20269.25 %38,036 35,651 35,640 (6)(11)(15)
First Lien Delayed Draw Term Loan, LIBOR+8.25% cash due 8/31/2026— (1,022)(1,027)(6)(11)(15)(19)
164,660 Class B Common Stock Warrants (exercise price $33.00) expiration date 2/28/20231,202 1,553 (15)
35,831 36,166 
26

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 2021
(dollar amounts in thousands)

Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Sabert CorporationMetal & Glass Containers
First Lien Term Loan, LIBOR+4.50% cash due 12/10/20265.50 %$1,818 $1,711 $1,825 (6)
1,711 1,825 
Scilex Pharmaceuticals Inc.Pharmaceuticals
Fixed Rate Zero Coupon Bond due 8/15/20267,692 6,512 7,169 (15)
6,512 7,169 
ShareThis, Inc.Application Software
345,452 Series C Preferred Stock Warrants (exercise price $3.0395) expiration date 3/4/2024367 — (15)
367  
SIO2 Medical Products, Inc.Metal & Glass Containers
Subordinated Debt, 11.25% cash due 2/28/202215,896 15,161 15,022 (15)
Subordinated Delayed Draw Debt, 11.25% cash due 2/28/2022— (110)(119)(15)(19)
Common Stock Warrants (exercise price $0.75) expiration date 7/31/2028681 685 (15)
15,732 15,588 
Sirva Worldwide, Inc.Diversified Support Services
First Lien Term Loan, LIBOR+5.50% cash due 8/4/20255.58 %1,739 1,554 1,644 (6)
1,554 1,644 
SM Wellness Holdings, Inc.Health Care Services
Second Lien Term Loan, LIBOR+8.00% cash due 4/16/20298.75 %9,109 8,972 9,177 (6)(15)
8,972 9,177 
SonicWall US Holdings Inc.Technology Distributors
Second Lien Term Loan, LIBOR+7.50% cash due 5/18/20267.63 %3,195 3,163 3,178 (6)
3,163 3,178 
Sorrento Therapeutics, Inc.Biotechnology
50,000 Common Stock Units197 382 (11)
197 382 
Star US Bidco LLCIndustrial Machinery
First Lien Term Loan, LIBOR+4.25% cash due 3/17/20275.25 %1,194 1,114 1,199 (6)
1,114 1,199 
SumUp Holdings Luxembourg S.À.R.L.Other Diversified Financial Services
First Lien Delayed Draw Term Loan, EURIBOR+8.50% cash due 3/10/202610.00 %13,980 15,991 15,908 (6)(11)(15)(19)
15,991 15,908 
Sunland Asphalt & Construction, LLCConstruction & Engineering
First Lien Term Loan, LIBOR+6.00% cash due 1/13/20267.00 %$43,052 41,782 42,450 (6)(15)
First Lien Revolver, LIBOR+6.00% cash due 1/13/20227.00 %203 150 169 (6)(15)(19)
41,932 42,619 
Supermoose Borrower, LLCApplication Software
First Lien Term Loan, LIBOR+3.75% cash due 8/29/20253.88 %8,576 7,581 7,996 (6)
7,581 7,996 
SVP-Singer Holdings Inc.Home Furnishings
First Lien Term Loan, LIBOR+6.75% cash due 7/28/20287.50 %20,976 19,537 19,735 (6)(15)
19,537 19,735 
Swordfish Merger Sub LLCAuto Parts & Equipment
Second Lien Term Loan, LIBOR+6.75% cash due 2/2/20267.75 %12,500 12,466 12,365 (6)(15)
12,466 12,365 
Tacala, LLCRestaurants
Second Lien Term Loan, LIBOR+7.50% cash due 2/4/20288.25 %9,448 9,317 9,451 (6)
9,317 9,451 
27

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 2021
(dollar amounts in thousands)

Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Tecta America Corp.Construction & Engineering
Second Lien Term Loan, LIBOR+8.50% cash due 4/9/20299.25 %$5,203 $5,125 $5,203 (6)(15)
5,125 5,203 
Telestream Holdings CorporationApplication Software
First Lien Term Loan, LIBOR+8.75% cash due 10/15/20259.75 %18,510 18,017 18,250 (6)(15)
First Lien Revolver, LIBOR+8.75% cash due 10/15/20259.75 %492 464 468 (6)(15)(19)
18,481 18,718 
TerSera Therapeutics LLCPharmaceuticals
Second Lien Term Loan, LIBOR+9.50% cash due 3/30/202610.50 %29,663 29,359 29,371 (6)(15)
668,879 Common Units of TerSera Holdings LLC2,192 3,487 (15)
31,551 32,858 
TGNR HoldCo LLCIntegrated Oil & Gas
Subordinated Debt, 11.50% cash due 5/14/20264,984 4,842 4,884 (11)(15)(20)
4,842 4,884 
Thermacell Repellents, Inc.Leisure Products
First Lien Term Loan, LIBOR+5.75% cash due 12/4/20266.75 %6,636 6,603 6,603 (6)(15)
First Lien Revolver, LIBOR+5.75% cash due 12/4/2026— (4)(4)(6)(15)(19)
6,599 6,599 
Thrasio, LLCInternet & Direct Marketing Retail
First Lien Term Loan, LIBOR+7.00% cash due 12/18/20268.00 %37,876 36,736 37,686 (6)(15)
8,434 Shares of Series C-3 Preferred Stock in Thrasio Holdings, Inc.101 171 (15)
284,650.32 Shares of Series C-2 Preferred Stock in Thrasio Holdings, Inc.2,410 5,764 (15)
23,201 Shares of Series X Preferred Stock in Thrasio Holdings, Inc.22,986 24,803 (15)(19)
62,233 68,424 
TIBCO Software Inc.Application Software
Second Lien Term Loan, LIBOR+7.25% cash due 3/3/20287.34 %16,788 16,681 17,002 (6)
16,681 17,002 
TigerConnect, Inc.Application Software
299,110 Series B Preferred Stock Warrants (exercise price $1.3373) expiration date 12/8/202460 525 (15)
60 525 
Transact Holdings Inc.Application Software
First Lien Term Loan, LIBOR+4.75% cash due 4/30/20264.83 %6,860 6,757 6,809 (6)(15)
6,757 6,809 
Velocity Commercial Capital, LLCThrifts & Mortgage Finance
First Lien Term Loan, LIBOR+8.00% cash due 2/5/20269.00 %15,909 15,327 15,830 (6)(15)
15,327 15,830 
Veritas US Inc.Application Software
First Lien Term Loan, LIBOR+5.00% cash due 9/1/20256.00 %5,940 5,599 5,975 (6)
5,599 5,975 
Vitalyst Holdings, Inc.IT Consulting & Other Services
675 Series A Preferred Stock Units675 440 (15)
7,500 Class A Common Stock Units75 — (15)
750 440 
Win Brands Group LLCHousewares & Specialties
First Lien Term Loan, LIBOR+9.00% cash 5.00% PIK due 1/22/202610.00 %1,894 1,875 1,884 (6)(15)
181 Class F Warrants in Brand Value Growth LLC (exercise price $0.01) expiration date 1/25/2027— 119 (15)
1,875 2,003 
28

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 2021
(dollar amounts in thousands)

Portfolio Company/Type of Investment (1)(2)(3)(4)(5) Cash Interest Rate (6)IndustryPrincipal (7)CostFair ValueNotes
Windstream Services II, LLCIntegrated Telecommunication Services
First Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.25 %$31,598 $30,347 $31,793 (6)
18,032 Shares of Common Stock in Windstream Holdings II, LLC216 363 (15)
109,420 Warrants in Windstream Holdings II, LLC1,842 2,199 (15)
32,405 34,355 
WP CPP Holdings, LLCAerospace & Defense
First Lien Term Loan, LIBOR+3.75% cash due 4/30/20254.75 %4,369 4,005 4,264 (6)
Second Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.75 %16,000 15,758 15,815 (6)(15)
19,763 20,079 
WPEngine, Inc.Application Software
First Lien Term Loan, LIBOR+6.50% cash due 3/27/20267.50 %40,536 39,778 40,013 (6)(15)
39,778 40,013 
WWEX Uni Topco Holdings, LLCAir Freight & Logistics
Second Lien Term Loan, LIBOR+7.00% cash due 7/26/20297.75 %5,000 4,925 4,981 (6)
4,925 4,981 
Zep Inc.Specialty Chemicals
First Lien Term Loan, LIBOR+4.00% cash due 8/12/20245.00 %6,495 6,165 6,353 (6)
Second Lien Term Loan, LIBOR+8.25% cash due 8/11/20259.25 %22,748 22,692 21,993 (6)(15)
28,857 28,346 
Zephyr Bidco LimitedSpecialized Finance
Second Lien Term Loan, UK LIBOR+7.50% cash due 7/23/20267.55 %£18,000 23,783 24,210 (6)(11)
23,783 24,210 
Total Non-Control/Non-Affiliate Investments (172.7% of net assets)$2,236,759 $2,267,575 
Total Portfolio Investments (194.7% of net assets)$2,539,121 $2,556,629 
Cash and Cash Equivalents and Restricted Cash
JP Morgan Prime Money Market Fund, Institutional Shares $23,600 $23,600 
Other cash accounts8,035 8,035 
Total Cash and Cash Equivalents and Restricted Cash (2.4% of net assets)$31,635 $31,635 
Total Portfolio Investments and Cash and Cash Equivalents and Restricted Cash (197.2% of net assets)$2,570,756 $2,588,264 

Derivative InstrumentNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateCounterpartyCumulative Unrealized Appreciation /(Depreciation)
Foreign currency forward contract$52,186 £37,709 11/12/2021JPMorgan Chase Bank, N.A.$1,339 
Foreign currency forward contract$46,663 39,736 11/12/2021JPMorgan Chase Bank, N.A.573 
$1,912 

Derivative InstrumentCompany ReceivesCompany PaysCounterpartyMaturity DateNotional AmountFair Value
Interest rate swapFixed 2.7%Floating 3-month LIBOR +1.658%Royal Bank of Canada1/15/2027$350,000$(2,108)
29

Oaktree Specialty Lending Corporation
Consolidated Schedule of Investments
September 30, 2021
(dollar amounts in thousands)

(1)All debt investments are income producing unless otherwise noted. All equity investments are non-income producing unless otherwise noted.
(2)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition by geographic region.
(3)Equity ownership may be held in shares or units of companies related to the portfolio companies.
(4)Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.
(5)Interest rates may be adjusted from period to period on certain term loans and revolvers. These rate adjustments may be either temporary in nature due to tier pricing arrangements or financial or payment covenant violations in the original credit agreements or permanent in nature per loan amendment or waiver documents.
(5)Each of the Company's investments is pledged as collateral under one or more of its credit facilities. A single investment may be divided into parts that are individually pledged as collateral to separate credit facilities.
(6)The interest rate on the principal balance outstanding for allmost of the floating rate loans is indexed to LIBOR, SOFR, SONIA and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate basereference rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars unless otherwise noted. As of September 30, 2021,2022, the reference rates for the Company's variable rate loans were the 30-day LIBOR at 0.08%, the 60-day LIBOR at 0.11%3.12%, the 90-day LIBOR at 0.13%3.67%, the 180-day LIBOR at 0.16%4.17%, the 360-day LIBOR at 0.24%4.78%, the PRIME at 3.25%6.25%, the 30-day UK LIBORSOFR at 0.05%3.03%, the 180-day UK LIBOR90-day SOFR at 0.09%3.55%, the SONIA at 1.69%, the 30-day EURIBOR at (0.57)%0.69%, the 90-day EURIBOR at (0.56)%0.99% and the 180-day EURIBOR at (0.53)%0.38%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR and SONIA based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(7)Principal includes accumulated PIK interest and is net of repayments, if any. “£” signifies the investment is denominated in British Pounds. "€" signifies the investment is denominated in Euros. All other investments are denominated in U.S. dollars.
(8)Control Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns more than 25% of the voting securities or maintains greater than 50% of the board representation.
(9)As defined in the Investment Company Act, the Company is deemed to be both an "Affiliated Person" of and to "Control" these portfolio companies as the Company owns more than 25% of the portfolio company's outstanding voting securities or has the power to exercise control over management or policies of such portfolio company (including through a management agreement). See Schedule 12-14 in the Company's annual report on Form 10-K foraccompanying notes to the year ended September 30, 2021Consolidated Financial Statements for transactions during the year ended September 30, 20212022 in which the issuer was both an Affiliated Person and a portfolio company that the Company is deemed to control.
(10)First Star Speir Aviation 1 Limited isThis investment represents a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under accounting principles generally acceptedparticipation interest in the United States ("GAAP") and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities.underlying securities shown.
(11)Investment is not a "qualifying asset" as defined under Section 55(a) of the Investment Company Act. Under the Investment Company Act, the Company may not acquire any non-qualifying asset unless, at the time the acquisition is made, qualifying assets represent at least 70% of the Company's total assets. As of September 30, 2021,2022, qualifying assets represented 75.7% of the Company's total assets and non-qualifying assets represented 24.3% of the Company's total assets.
(12)Income producing through payment of dividends or distributions.
(13)PIK interest income for thisThis investment accrues at an annualized rate of 15%, however, the PIK interest is not contractually capitalized on the investment subsequent to a restructure that occurred during the year ended September 30, 2021. As a result, the principal amountrepresents Seller Earn Out Shares in Alvotech SA. One half of the investment does not increase overSeller Earn Out Shares will vest if, at any time through June 16, 2027, the Alvotech SA common share price is at or above a VWAP of $15.00 per share for accumulated PIK interest. As of September 30, 2021, the accumulated PIK interest balance for the A notesany ten trading days within any twenty trading day period, and the B notes was $0.9 million and $0.8 million, respectively.other half will vest, if at any time during such period, the common share price is at or above a VWAP of $20.00 per share for any ten trading days within any twenty trading day period.
(14)See Note 3 in the accompanying notes to the Consolidated Financial Statements for portfolio composition.
(15)As of September 30, 2021,2022, these investments were categorized as Level 3 within the fair value hierarchy established by FASB guidance under ASC 820.
(16)This investment was valued using net asset value as a practical expedient for fair value. Consistent with ASC 820, these investments are excluded from the hierarchical levels.
(17)Affiliate Investments generally are defined by the Investment Company Act as investments in companies in which the Company owns between 5% and 25% of the voting securities.
(18)Non-Control/Non-Affiliate Investments are investments that are neither Control Investments nor Affiliate Investments.
(19)Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
(20)This investment was renamed during the three months ended March 31, 2022. For periods prior to March 31, 2022, this investment was referenced as Realfi Strategic Capital Funding LLC.
(21)This investment represents a participationrevenue interest financing term loan in which the underlying securities shown.Company receives periodic interest payments based on a percentage of revenues earned at the respective portfolio company over the life of the loan.

See notes to Consolidated Financial Statements.


3025

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Note 1. Organization
Oaktree Specialty Lending Corporation (together with its consolidated subsidiaries, the "Company") is a specialty finance company that looks to provide customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The Company was formed in late 2007 and operates as a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act. The Company has qualified and elected to be treated as a regulated investment company ("RIC") under the Internal Revenue Code of 1986, as amended (the "Code"), for U.S. federal income tax purposes.
The Company's investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. The Company may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions.
The Company is externally managed by Oaktree Fund Advisors, LLC ("Oaktree"), a subsidiary of Oaktree Capital Group, LLC (“OCG”), pursuant to an investment advisory agreement between the Company and Oaktree (as amended and restated, the "Investment Advisory Agreement"). Oaktree is an affiliate of Oaktree Capital Management, L.P. ("OCM"), the Company's external investment adviser from October 17, 2017 through May 3, 2020 and also a subsidiary of OCG.2020. Oaktree Fund Administration, LLC ("Oaktree Administrator"), a subsidiary of OCM, provides certain administrative and other services necessary for the Company to operate pursuant to an administration agreement between the Company and Oaktree Administrator (the "Administration Agreement"). See Note 10. In 2019, Brookfield Corporation (f/k/a Brookfield Asset Management Inc.) ("Brookfield") acquired a majority economic interest in OCG. OCG operatesOaktree Capital Group, LLC. Oaktree and its affiliates operate as an independent business within Brookfield, with itstheir own product offerings and investment, marketing and support teams.
On March 19, 2021, the Company acquired Oaktree Strategic Income Corporation (“OCSI”), pursuant to that certain Agreement and Plan of Merger (the “Merger“OCSI Merger Agreement”), dated as of October 28, 2020, by and among OCSI, the Company, Lion Merger Sub, Inc., a wholly-owned subsidiary of the Company, (“Merger Sub”), and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, Merger Sub was first merged with and into OCSI, with OCSI as the surviving corporation (the “Merger”), and, immediately following the Merger, OCSI was then merged with and into the Company in a two-step transaction, with the Company as the surviving company (together(the "OCSI Merger”).
On January 23, 2023, the Company acquired Oaktree Strategic Income II, Inc. (“OSI2”) pursuant to that certain Agreement and Plan of Merger (the “OSI2 Merger Agreement”), dated as of September 14, 2022, by and among OSI2, the Company, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of the Company, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger Agreement, OSI2 was merged with and into the Company in a two-step transaction with the Merger,Company as the “Mergers”surviving company (the “OSI2 Merger”). In accordanceFor further information, see Note 14 "Merger with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of OCSI’s common stock was converted into the right to receive 1.3371 shares of the Company’s common stock (with OCSI’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Mergers, the Company issued an aggregate of 39,400,011 shares of its common stock to former OCSI stockholders.

OSI2."
Note 2. Significant Accounting Policies
Basis of Presentation:
The Consolidated Financial Statements of the Company have been prepared in accordance with GAAP and pursuant to the requirements for reporting on Form 10-Q and Regulation S-X. In the opinion of management, all adjustments of a normal recurring nature considered necessary for the fair presentation of the Consolidated Financial Statements have been made. All intercompany balances and transactions have been eliminated. The Company is an investment company following the accounting and reporting guidance in ASC Topic 946, Financial Services - Investment Companies ("ASC 946").
Certain prior period amounts have been reclassified to conform to the current period presentation. All per share amounts and common shares outstanding as of and for periods prior to March 31, 2023 reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
Use of Estimates:
The preparation of the financial statements in conformity with GAAPaccounting principles generally accepted in the United States ("GAAP") requires management to make certain estimates and assumptions affecting amounts reported in the financial statements and accompanying notes. These estimates are based on the information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Changes in the economic and political environments, financial markets and any other parameters used in determining these estimates could cause actual results to differ and such differences could be material. Significant estimates include the valuation of investments and revenue recognition.
26

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Consolidation:
The accompanying Consolidated Financial Statements include the accounts of Oaktree Specialty Lending Corporation and its consolidated subsidiaries. Each consolidated subsidiary is wholly-owned and, as such, consolidated into the Consolidated Financial Statements. Certain subsidiaries that hold investments are treated as pass through entities for U.S. federal income tax purposes. The assets of certain of the consolidated subsidiaries are not directly available to satisfy the claims of the creditors of Oaktree Specialty Lending Corporation or any of its other subsidiaries.
31

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




As an investment company, portfolio investments held by the Company are not consolidated into the Consolidated Financial Statements but rather are included on the Statements of Assets and Liabilities as investments at fair value.


Fair Value Measurements:
The Company values its investments in accordance with ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability's fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments' complexity.
Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:
 
Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.
Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities.
Level 3 — Unobservable inputs that reflect management'sOaktree's best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. The Company'sOaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions.
Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily available market quotations provided by pricing vendors and brokers for all of the Company's investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations.
The CompanyOaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If the CompanyOaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within the Company'sOaktree's set threshold, the CompanyOaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, the CompanyOaktree does not adjust any of the prices received from these sources.
If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, the CompanyOaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value ("EV") of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of
27

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that the Company is deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its
32

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company's assets and (vii) offers from third parties to buy the portfolio company. The CompanyOaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and the CompanyOaktree considers the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by the Company are substantially illiquid with no active transaction market, the CompanyOaktree depends on primary market data, including newly funded transactions and industry specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable.
In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable.
The CompanyOaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.
Rule 2a-5 under the Investment Company Act permits boards of directors of registered investment companies and Business Development Companies to either (i) choose to determine fair value in good faith or (ii) designate a valuation designee tasked with determining fair value in good faith, subject to the board’s oversight. The Company's Board of Directors has designated Oaktree to serve as its valuation designee effective September 8, 2022.
Oaktree undertakes a multi-step valuation process each quarter in connection with determining the fair value of the Company's investments:
The quarterly valuation process begins with each portfolio company or investment being initially valued by Oaktree's valuation team in conjunction with Oaktree's portfolio management team and investment professionals responsible for each portfolio investment;team;
Preliminary valuations are then reviewed and discussed with management of Oaktree;
Separately, independent valuation firms approved by the Board of Directors prepare valuations of the Company's investments, on a selected basis, for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment, and submit the reports to the Company and provide such reports to Oaktree and the Audit Committee of the Board of Directors;Oaktree;
Oaktree compares and contrasts its preliminary valuations to the valuations of the independent valuation firms and prepares a valuation report for the Audit Committee;
The Audit Committee reviews the preliminary valuationsvaluation report with Oaktree, and Oaktree responds and supplements the preliminary valuationsvaluation report to reflect any discussions between Oaktree and the Audit Committee; and
The Audit Committee makes a recommendation to the full Board of Directors regarding the fair value of the investments in the Company's portfolio; and
The Board of Directors discusses valuations andOaktree, as valuation designee, determines the fair value of each investment in the Company's portfolio.
The fair value of the Company's investments as of June 30, 20222023 and September 30, 20212022 was determined in good faith by Oaktree, as the Board of Directors.Company's valuation designee. The Company has and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of its portfolio securities for which market quotations are not readily available or are readily available but deemed not reflective of the fair value of the investment each quarter, and the Board of Directors may reasonably rely on that assistance. However, the Board of Directors is responsible for the ultimate valuation of the portfolio investments at fair value as determined in good faith pursuant to the Company's valuation policy and a consistently applied valuation process.quarter.
Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the Company’s investments may fluctuate from period to period. Because of the inherent uncertainty of valuation, these estimated values may differ significantly from the values that would have been reported had a ready market for the investments existed, and it is reasonably possible that the difference could be material.
28

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




With the exception of the line items entitled "deferred financing costs," "deferred offering costs," "other assets," "deferred tax asset, net," "credit facilities payable" and "unsecured notes payable," which are reported at amortized cost, all assets and liabilities approximate fair value on the Consolidated Statements of Assets and Liabilities. The carrying value of the line items titled "interest, dividends and fees receivable," "due from portfolio companies," "receivables from unsettled transactions," "due
33

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




from broker," "accounts payable, accrued expenses and other liabilities," "base management fee and incentive fee payable," "due to affiliate," "interest payable," "director fees payable" and "payables from unsettled transactions" approximate fair value due to their short maturities.
Foreign Currency Translation:
The accounting records of the Company are maintained in U.S. dollars. All assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the prevailing foreign exchange rate on the reporting date. The Company does not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. The Company’s investments in foreign securities may involve certain risks, including foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments and therefore the earnings of the Company.
Derivative Instruments:
Foreign Currency Forward Contracts
The Company uses foreign currency forward contracts to reduce the Company's exposure to fluctuations in the value of foreign currencies. In a foreign currency forward contract, the Company agrees to receive or deliver a fixed quantity of one currency for another at a pre-determined price at a future date. Foreign currency forward contracts are marked-to-market at the applicable forward rate. Unrealized appreciation (depreciation) on foreign currency forward contracts areis recorded within derivative assets or derivative liabilities on the Consolidated Statements of Assets and Liabilities by counterparty on a net basis, not taking into account collateral posted which is recorded separately, if applicable. Purchases and settlements of foreign currency forward contracts having the same settlement date and counterparty are generally settled net and any realized gains or losses are recognized on the settlement date. The Company does not utilize hedge accounting with respect to foreign currency forward contracts and as such, the Company recognizes its foreign currency forward contracts at fair value with changes included in the net unrealized appreciation (depreciation) on the Consolidated Statements of Operations.
Interest Rate Swaps
The Company uses an interest rate swap to hedge some of the Company's fixed rate debt. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship, and therefore the periodic payments are recognized as components of interest expense in the Consolidated Statements of Operations. Depending on the nature of the balance at period end, the fair value of the interest rate swap is either included as a derivative asset or derivative liability on the Company's Consolidated Statements of Assets and Liabilities. The change in fair value of the interest rate swap is offset by a change in the carrying value of the fixed rate debt. Any amounts paid to the counterparty to cover collateral obligations under the terms of the interest rate swap agreement are included in due from broker on the Company's Consolidated Statements of Assets and Liabilities.
Investment Income:
Interest Income
Interest income, adjusted for accretion of original issue discount ("OID"), is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of each of June 30, 20222023,
29

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




there were five investments on non-accrual status that in aggregate represented 3.6% and 3.1% of total debt investments at cost and fair value, respectively. As of September 30, 2021,2022, there were no investments on non-accrual status.
In connection with its investment in a portfolio company, the Company sometimes receives nominal cost equity that is valued as part of the negotiation process with the portfolio company. When the Company receives nominal cost equity, the Company allocates its cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.
34

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




PIK Interest Income
The Company's investments in debt securities may contain PIK interest provisions. PIK interest, which generally represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. The Company generally ceases accruing PIK interest if there is insufficient value to support the accrual or if the Company does not expect the portfolio company to be able to pay all principal and interest due. The Company's decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; the Company's assessment of the portfolio company's business development success; information obtained by the Company in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. The Company's determination to cease accruing PIK interest is generally made well before the Company's full write-down of a loan or debt security. In addition, if it is subsequently determined that the Company will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on the Company’s debt investments increases the recorded cost bases of these investments in the Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by the Company to Oaktree. To maintain its status as a RIC, certain income from PIK interest may be required to be distributed to the Company’s stockholders, even though the Company has not yet collected the cash and may never do so.
Fee Income
Oaktree or its affiliates may provide financial advisory services to portfolio companies and, in return, the Company may receive fees for capital structuring services. These fees are generally non-recurring and are recognized by the Company upon the investment closing date. The Company may also receive additional fees in the ordinary course of business, including servicing, amendment, exit and prepayment fees, which are classified as fee income and recognized as they are earned or the services are rendered.
The Company has also structured exit fees across certain of its portfolio investments to be received upon the future exit of those investments. These fees are typically paid to the Company upon the earliest to occur of (i) a sale of the borrower or substantially all of the assets of the borrower, (ii) the maturity date of the loan or (iii) the date when full prepayment of the loan occurs. The receipt of such fees is contingent upon the occurrence of one of the events listed above for each of the investments. These fees are included in net investment income over the life of the loan.
Dividend Income
The Company generally recognizes dividend income on the ex-dividend date for public securities and the record date for private equity investments. Distributions received from private equity investments are evaluated to determine if the distribution should be recorded as dividend income or a return of capital. Generally, the Company will not record distributions from private equity investments as dividend income unless there are sufficient earnings at the portfolio company prior to the distribution. Distributions that are classified as a return of capital are recorded as a reduction in the cost basis of the investment.
Cash and Cash Equivalents and Restricted Cash:
Cash and cash equivalents consist of demand deposits and highly liquid investments with maturities of three months or less when acquired. The Company places its cash and cash equivalents and restricted cash with financial institutions and, at times, cash held in bank accounts may exceedexceeds the Federal Deposit Insurance Corporation ("FDIC") insurance limit. Cash and cash equivalents are included on the Company's Consolidated Schedule of Investments and cash equivalents are classified as Level 1 assets.
30

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




As of JuneSeptember 30, 2022, and September 30, 2021, included in restricted cash was $2.0$2.8 million and $2.3 million, respectively, that was held at Wells Fargo Bank, N.A. in connection with the Citibank Facility (as defined in Note 6. Borrowings). Pursuant to the terms of the Citibank Facility, the Company was restricted in terms of access to $2.0 million and $2.3$2.8 million as of JuneSeptember 30, 2022, and September 30, 2021, respectively, until the occurrence of the periodic distribution dates and, in connection therewith, the Company’s submission of its required periodic reporting schedules and verifications of the Company’s compliance with the terms of the Citibank Facility.
35

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
( As of June 30, 2023, included in thousands, except sharerestricted cash was $13.0 million that was held at Deutsche Bank Trust Company Americas in connection with the Company’s OSI2 Citibank Facility (defined in Note 6. Borrowings). Pursuant to the terms of the OSI2 Citibank Facility, the Company was restricted in terms of access to the $13.0 million until the occurrence of the periodic distribution dates and, per share amounts, percentagesin connection therewith, the Company’s submission of its required periodic reporting schedules and as otherwise indicated)




verifications of the Company’s compliance with the terms of the OSI2 Citibank Facility.
Due from Portfolio Companies:
Due from portfolio companies consists of amounts payable to the Company from its portfolio companies, including proceeds from the sale of portfolio companies not yet received or being held in escrow and excluding those amounts attributable to interest, dividends or fees receivable. These amounts are recognized as they become payable to the Company (e.g., principal payments on the scheduled amortization payment date).
Receivables/Payables from Unsettled Transactions:
Receivables/payables from unsettled transactions consist of amounts receivable to or payable by the Company for transactions that have not settled at the reporting date.
Deferred Financing Costs:
Deferred financing costs consist of fees and expenses paid in connection with the closing or amending of credit facilities and debt offerings. Deferred financing costs in connection with credit facilities are capitalized as an asset when incurred. Deferred financing costs in connection with all other debt arrangements are a direct deduction from the related debt liability when incurred. Deferred financing costs are amortized using the effective interest method over the term of the respective debt arrangement. This amortization expense is included in interest expense in the Company's Consolidated Statements of Operations. Upon early termination or modification of a credit facility, all or a portion of unamortized fees related to such facility may be accelerated into interest expense. For extinguishments of the Company’s unsecured notes payable, any unamortized deferred financing costs are deducted from the carrying amount of the debt in determining the gain or loss from the extinguishment.


Deferred Offering Costs:
Legal fees and other costs incurred in connection with the Company’s shelf registration statement are capitalized as deferred offering costs in the Consolidated Statements of Assets and Liabilities. To the extent any such costs relate to equity offerings, these costs are charged as a reduction of capital upon utilization. To the extent any such costs relate to debt offerings, these costs are treated as deferred financing costs and are amortized over the term of the respective debt arrangement. Any deferred offering costs that remain at the expiration of the shelf registration statement or when it becomes probable that an offering will not be completed are expensed.
Income Taxes:
The Company has elected to be subject to tax as a RIC under Subchapter M of the Code and operates in a manner so as to qualify for the tax treatment applicable to RICs. In order to be subject to tax as a RIC, among other things, the Company is required to meet certain source of income and asset diversification requirements and timely distribute dividends to its stockholders of an amount generally at least equal to 90% of investment company taxable income, as defined by the Code and determined without regard to any deduction for dividends paid, for each taxable year. As a RIC, the Company is not subject to U.S. federal income tax on the portion of its taxable income and gains distributed currently to stockholders as a dividend. Depending on the level of taxable income earned during a taxable year, the Company may choose to retain taxable income in excess of current year dividend distributions and would distribute such taxable income in the next taxable year. The Company would then incur a 4% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income, determined on a calendar year basis, could exceed estimated current calendar year dividend distributions, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned. The Company anticipates timely distribution of its taxable income within the tax rules under Subchapter M of the Code. The Company did not incur a U.S. federal excise tax for calendar years 2020 and 2021 andyear 2021. For the calendar year 2022, the Company incurred $0.1 million of excise tax. The Company does not expect to incur a U.S. federal excise tax for calendar year 2022.2023.
31

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The Company holds certain portfolio investments through taxable subsidiaries. The purpose of the Company's taxable subsidiaries is to permit the Company to hold equity investments in portfolio companies which are "pass through" entities for U.S. federal income tax purposes in order to comply with the RIC tax requirements. The taxable subsidiaries are consolidated for financial reporting purposes, and portfolio investments held by them are included in the Company’s Consolidated Financial Statements as portfolio investments and recorded at fair value. The taxable subsidiaries are not consolidated with the Company for U.S. federal income tax purposes and may generate income tax expense, or benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. This income tax expense, if any, would be reflected in the Company's Consolidated Statements of Operations. The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net operating loss carry forwards that it may use to
36

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.
FASB ASC Topic 740, Accounting for Uncertainty in Income Taxes ("ASC 740"), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the Company's Consolidated Financial Statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether the tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions not deemed to meet the more-likely-than-not threshold are recorded as a tax benefit or expense in the current year. Management's determinations regarding ASC 740 may be subject to review and adjustment at a later date based upon factors including an ongoing analysis of tax laws, regulations and interpretations thereof. The Company recognizes the tax benefits of uncertain tax positions only where the position is "more-likely-than-not" to be sustained assuming examination by tax authorities. Management has analyzed the Company's tax positions and has concluded that no liability for unrecognized tax benefits should be recorded related to uncertain tax positions taken on returns filed for open tax years 2019, 2020, 2021 and 2021.2022. The Company identifies its major tax jurisdictions as U.S. Federal and California, and the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change materially in the next 12 months.
Recently Adopted Accounting Pronouncements
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients
32

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and exceptions for applying GAAP to contracts, hedging relationships,per share amounts, percentages and other transactions to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting if certain criteria are met. The guidance is effective from March 12, 2020 through December 31, 2022. As of June 30, 2022, the adoption of this guidance did not have an impact on the Company's Consolidated Financial Statements.as otherwise indicated)




Note 3. Portfolio Investments
As of June 30, 2022, 203.0%2023, 207.7%of net assets at fair value, or $2.6$3.1 billion, was invested in 151156 portfolio companies, including (i) $119.3$140.6 million in subordinated notes and limited liability company ("LLC") equity interests of Senior Loan Fund JV I, LLC ("SLF JV I"), a joint venture through which the Company and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation ("Kemper"), co-invest in senior secured loans of middle-market companies and other corporate debt securities and (ii) $50.6$49.6 million in subordinated notes and LLC equity interests of OCSI Glick JV LLC ("Glick JV" and, together with SLF JV I, the "JVs"), a joint venture through which the Company and GF Equity Funding 2014 LLC ("GF Equity Funding") co-invest primarily in senior secured loans of middle-market companies. As of June 30, 2022, 2.9%2023, 4.8% of net assets at fair value, or $36.3$72.7 million, was invested in cash and cash equivalents (including $2.0$13.0 million of restricted cash). In comparison, as of September 30, 2021, 194.7%2022, 200.2% of net assets at fair value, or $2.6$2.5 billion, was invested in 138149 portfolio investments, including (i) $133.9$117.0 million in subordinated notes and LLC equity interests of SLF JV I and (ii) $55.6$50.3 million in subordinated notes and LLC equity interests of Glick JV. As of September 30, 2021, 2.4%2022, 2.1% of net assets at fair value, or $31.6$26.4 million, was invested in cash and cash equivalents (including $2.3$2.8 million of restricted cash). As of June 30, 2022, 86.6%2023, 88.5% of the Company's portfolio at fair value consisted of senior secured debt investments and 8.2%6.8% consisted of subordinated debt investments, including the debt investments in the JVs. As of September 30, 2021, 86.7%2022, 86.9% of the Company's portfolio at fair value consisted of senior secured debt investments and 7.6%8.1% consisted of subordinated debt investments, including the debt investments in the JVs.
The Company also held equity investments in certain of its portfolio companies consisting of common stock, preferred stock, warrants, limited partnership interests or LLC equity interests. These instruments generally do not produce a current return but are held for potential investment appreciation and capital gain.
During the three and nine months ended June 30, 2023, the Company recorded net realized losses of $10.6 million and $19.9 million, respectively. During the three and nine months ended June 30, 2022, the Company recorded net realized gains of $9.2 million and $19.9 million, respectively. During the three and nine months ended June 30, 2021,2023, the Company recorded net realized gainsunrealized depreciation of $8.6$1.0 million and $22.7$42.3 million, respectively. During the three and nine months ended June 30, 2022, the Company recorded net unrealized depreciation of $86.8 million and $118.4 million, respectively. During
The composition of the three and nine months endedCompany's investments as of June 30, 2021, the Company recorded net unrealized appreciation of $3.9 million2023 and $116.6 million, respectively.September 30, 2022 at cost and fair value was as follows:
 June 30, 2023September 30, 2022
 CostFair ValueCostFair Value
Investments in debt securities$2,942,222 $2,826,369 $2,294,392 $2,223,329 
Investments in equity securities136,619 118,989 127,596 103,534 
Debt investments in the JVs162,653 162,288 146,444 146,533 
Equity investments in the JVs54,791 27,973 49,322 20,715 
Total$3,296,285 $3,135,619 $2,617,754 $2,494,111 
3733

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








The composition of the Company's investments as of June 30, 2022 and September 30, 2021 at cost and fair value was as follows:
 June 30, 2022September 30, 2021
 CostFair ValueCostFair Value
Investments in debt securities$2,342,876 $2,285,461 $2,222,223 $2,259,924 
Investments in equity securities126,647 110,049 120,621 107,222 
Debt investments in the JVs146,642 146,856 146,955 151,832 
Equity investments in the JVs49,322 23,023 49,322 37,651 
Total$2,665,487 $2,565,389 $2,539,121 $2,556,629 

The following table presents the composition of the Company's debt investments as of June 30, 20222023 and September 30, 20212022 at fixed rates and floating rates:
 June 30, 2023September 30, 2022
 Fair Value% of Debt
Portfolio
Fair Value% of Debt
Portfolio
Floating rate debt securities, including the debt investments in the JVs$2,571,458 86.04 %$2,049,644 86.49 %
Fixed rate debt securities417,199 13.96 320,218 13.51 
Total$2,988,657 100.00 %$2,369,862 100.00 %
 June 30, 2022September 30, 2021
 Fair Value% of Debt
Portfolio
Fair Value% of Debt
Portfolio
Floating rate debt securities, including the debt investments in the JVs$2,136,619 87.84 %$2,205,648 91.45 %
Fixed rate debt securities295,698 12.16 206,108 8.55 
Total$2,432,317 100.00 %$2,411,756 100.00 %


The following table presents the financial instruments carried at fair value as of June 30, 20222023 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:
Level 1Level 2Level 3Measured at Net Asset Value (a)TotalLevel 1Level 2Level 3Measured at Net Asset Value (a)Total
Investments in debt securities (senior secured)Investments in debt securities (senior secured)$— $290,889 $1,930,714 $— $2,221,603 Investments in debt securities (senior secured)$— $245,925 $2,528,448 $— $2,774,373 
Investments in debt securities (subordinated, including the debt investments in the JVs)Investments in debt securities (subordinated, including the debt investments in the JVs)— 55,134 155,580 — 210,714 Investments in debt securities (subordinated, including the debt investments in the JVs)— 29,368 184,916 — 214,284 
Investments in equity securities (preferred)Investments in equity securities (preferred)— — 81,616 — 81,616 Investments in equity securities (preferred)— — 92,186 — 92,186 
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)Investments in equity securities (common and warrants, including LLC equity interests of the JVs)4,928 — 23,505 23,023 51,456 Investments in equity securities (common and warrants, including LLC equity interests of the JVs)6,455 — 20,348 27,973 54,776 
Total investments at fair valueTotal investments at fair value4,928 346,023 2,191,415 23,023 2,565,389 Total investments at fair value6,455 275,293 2,825,898 27,973 3,135,619 
Cash equivalentsCash equivalents8,657 — — — 8,657 Cash equivalents5,193 — — — 5,193 
Derivative assets— 1,134 — — 1,134 
Derivative assetDerivative asset— 49 — — 49 
Total assets at fair valueTotal assets at fair value$13,585 $347,157 $2,191,415 $23,023 $2,575,180 Total assets at fair value$11,648 $275,342 $2,825,898 $27,973 $3,140,861 
Derivative liabilityDerivative liability$— $30,866 $— $— $30,866 Derivative liability$— $39,567 $— $— $39,567 
Total liabilities at fair valueTotal liabilities at fair value$ $30,866 $ $ $30,866 Total liabilities at fair value$ $39,567 $ $ $39,567 
__________ 
(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.
3834

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








The following table presents the financial instruments carried at fair value as of September 30, 20212022 on the Company's Consolidated Statement of Assets and Liabilities for each of the three levels of hierarchy established by ASC 820:
Level 1Level 2Level 3Measured at Net Asset Value (a)Total
Investments in debt securities (senior secured)$— $338,707 $1,878,536 $— $2,217,243 
Investments in debt securities (subordinated, including the debt investments in the JVs)— 18,196 176,317 — 194,513 
Investments in equity securities (preferred)— — 63,565 — 63,565 
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)382 — 43,163 37,763 81,308 
Total investments at fair value382 356,903 2,161,581 37,763 2,556,629 
Cash equivalents23,600 — — — 23,600 
Derivative assets— 1,912 — — 1,912 
Total assets at fair value$23,982 $358,815 $2,161,581 $37,763 $2,582,141 
Derivative liability$— $2,108 $— $— $2,108 
Total liabilities at fair value$ $2,108 $ $ $2,108 
Level 1Level 2Level 3Measured at Net Asset Value (a)Total
Investments in debt securities (senior secured)$— $255,803 $1,910,606 $— $2,166,409 
Investments in debt securities (subordinated, including the debt investments in the JVs)— 44,065 159,388 — 203,453 
Investments in equity securities (preferred)— — 79,523 — 79,523 
Investments in equity securities (common and warrants, including LLC equity interests of the JVs)4,053 — 19,958 20,715 44,726 
Total investments at fair value4,053 299,868 2,169,475 20,715 2,494,111 
Cash equivalents5,261 — — — 5,261 
Derivative assets— 6,789 — — 6,789 
Total assets at fair value$9,314 $306,657 $2,169,475 $20,715 $2,506,161 
Derivative liability$— $41,969 $— $— $41,969 
Total liabilities at fair value$ $41,969 $ $ $41,969 
__________ 
(a)In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. These investments are generally not redeemable. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities.


When a determination is made to classify a financial instrument within Level 3 of the valuation hierarchy, the determination is based upon the fact that the unobservable factors are significant to the overall fair value measurement. However, Level 3 financial instruments typically have both unobservable or Level 3 components and observable components (i.e. components that are actively quoted and can be validated by external sources). Accordingly, the appreciation (depreciation) in the tables below includes changes in fair value due in part to observable factors that are part of the valuation methodology. Transfers between levels are recognized at the beginning of the reporting period.
The following table provides a roll-forward in the changes in fair value from March 31, 2023 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors:
Investments
Senior Secured DebtSubordinated
Debt (including debt investments in the JVs)
Preferred
Equity
Common
Equity and Warrants
Total
Fair value as of March 31, 2023$2,493,622 $183,756 $91,447 $25,509 $2,794,334 
Purchases228,375 4,183 — 182 232,740 
Sales and repayments(191,409)(350)— (7,320)(199,079)
Transfers out (a)— (2,708)— — (2,708)
Capitalized PIK interest income3,610 358 — — 3,968 
Accretion of OID4,086 381 — — 4,467 
Net unrealized appreciation (depreciation)(8,027)(704)739 1,893 (6,099)
Net realized gains (losses)(1,809)— — 84 (1,725)
Fair value as of June 30, 2023$2,528,448 $184,916 $92,186 $20,348 $2,825,898 
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2023$(10,360)$(704)$739 $1,095 $(9,230)
__________
(a) There were transfers out of Level 3 to Level 2 for certain investments during the three months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity.

35

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The following table provides a roll-forward in the changes in fair value from March 31, 2022 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors:
Investments
Senior Secured DebtSubordinated
Debt (including debt investments in the JVs)
Preferred
Equity
Common
Equity and Warrants
Total
Fair value as of March 31, 2022$1,955,858 $160,727 $84,372 $33,588 $2,234,545 
Purchases 60,692 29 — 125 60,846 
Sales and repayments(91,730)(733)— (3,890)(96,353)
Transfers in (a)28,475 — — — 28,475 
Transfers out (b)— — — (5,838)(5,838)
Capitalized PIK interest income5,537 — — — 5,537 
Accretion of OID5,100 430 — — 5,530 
Net unrealized appreciation (depreciation)(33,208)(4,873)(2,756)(873)(41,710)
Net realized gains (losses)(10)— — 393 383 
Fair value as of June 30, 2022$1,930,714 $155,580 $81,616 $23,505 $2,191,415 
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2022$(33,199)$(4,873)$(2,756)$(917)$(41,745)
__________
(a) There were transferswas a transfer into Level 3 from Level 2 for certain investmentsan investment during the three months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.
(b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity
The following table provides a roll-forward in the changes in fair value from September 30, 2022 to June 30, 2023 for all investments for which the Company determined fair value using unobservable (Level 3) factors:
Investments
Senior Secured DebtSubordinated
Debt (including debt investments in the JVs)
Preferred
Equity
Common
Equity and Warrants
Total
Fair value as of September 30, 2022$1,910,606 $159,388 $79,523 $19,958 $2,169,475 
Purchases (a)980,595 26,508 14,296 5,610 1,027,009 
Sales and repayments(357,903)(1,396)— (8,295)(367,594)
Transfers in (b)19,075 — — — 19,075 
Capitalized PIK interest income12,549 376 — — 12,925 
Accretion of OID11,684 1,109 — — 12,793 
Net unrealized appreciation (depreciation)(45,019)(1,069)(1,633)2,804 (44,917)
Net realized gains (losses)(3,139)— — 271 (2,868)
Fair value as of June 30, 2023$2,528,448 $184,916 $92,186 $20,348 $2,825,898 
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2023 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2023$(46,680)$(1,069)$(1,633)$(355)$(49,737)
__________
(a) Includes Level 3 investments acquired in connection with the OSI2 Merger during the nine months ended June 30, 2023.
(b) There was a transfer into Level 3 from Level 2 for an investment during the nine months ended June 30, 2023 as a result of a change in the number of market quotes available and/or a change in market liquidity.
39
36

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








(b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity.
The following table provides a roll-forward in the changes in fair value from March 31, 2021 to June 30, 2021 for all investments for which the Company determined fair value using unobservable (Level 3) factors:
Investments
Senior Secured DebtSubordinated
Debt (including debt investments in the JVs)
Preferred
Equity
Common
Equity and Warrants
Total
Fair value as of March 31, 2021$1,590,290 $157,954 $51,796 $50,339 $1,850,379 
Purchases153,259 5,041 — — 158,300 
Sales and repayments(91,799)(2,977)— (22,422)(117,198)
Transfers in (a)— — — 6,322 6,322 
Transfers out (a)(6,322)— — — (6,322)
Capitalized PIK interest income4,243 — — — 4,243 
Accretion of OID7,383 297 — — 7,680 
Net unrealized appreciation (depreciation)4,585 781 664 (2,784)3,246 
Net realized gains (losses)(52)344 — 7,093 7,385 
Fair value as of June 30, 2021$1,661,587 $161,440 $52,460 $38,548 $1,914,035 
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2021 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the three months ended June 30, 2021$11,295 $1,085 $664 $656 $13,700 
(a) There was one transfer from senior secured debt to common equity and warrants during the three months ended June 30, 2021 as a result of an investment restructuring, in which $6.3 million of senior secured debt was exchanged for $6.3 million of common equity.

The following table provides a roll-forward in the changes in fair value from September 30, 2021 to June 30, 2022 for all investments for which the Company determined fair value using unobservable (Level 3) factors:
Investments
Senior Secured DebtSubordinated
Debt (including debt investments in the JVs)
Preferred
Equity
Common
Equity and Warrants
Total
Fair value as of September 30, 2021$1,878,536 $176,317 $63,565 $43,163 $2,161,581 
Purchases437,922 3,777 19,243 2,180 463,122 
Sales and repayments(391,959)(21,868)(163)(12,836)(426,826)
Transfers in (a)37,042 — — — 37,042 
Transfers out (a)(b)(17,070)— — (5,838)(22,908)
Capitalized PIK interest income16,653 313 — — 16,966 
Accretion of OID19,048 1,628 — — 20,676 
Net unrealized appreciation (depreciation)(57,909)(4,587)(517)(2,520)(65,533)
Net realized gains (losses)8,451 — (512)(644)7,295 
Fair value as of June 30, 2022$1,930,714 $155,580 $81,616 $23,505 $2,191,415 
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2022 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2022$(45,187)$(4,734)$(752)$(7,629)$(58,302)
__________
(a) There were transfers into/out of Level 3 from/to Level 2 for certain investments during the nine months ended June 30, 2022 as a result of a change in the number of market quotes available and/or a change in market liquidity.
(b) This transfer out was the result of a transaction in which Level 3 common equity was exchanged for Level 1 common equity.


40

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The following table provides a roll-forward in the changes in fair value from September 30, 2020 to June 30, 2021 for all investments for which the Company determined fair value using unobservable (Level 3) factors:
Investments
Senior Secured DebtSubordinated
Debt (including debt investment in the JVs)
Preferred
Equity
Common
Equity and Warrants
Total
Fair value as of September 30, 2020$904,237 $126,152 $29,959 $35,080 $1,095,428 
Purchases (a)923,185 51,327 19,958 2,377 996,847 
Sales and repayments(246,671)(44,191)(31)(28,622)(319,515)
Transfers in (b)(c)(d)18,458 — — 6,759 25,217 
Transfers out (d)(6,322)— — — (6,322)
Capitalized PIK interest income10,991 — — — 10,991 
Accretion of OID11,806 1,328 — — 13,134 
Net unrealized appreciation (depreciation)47,469 18,089 2,543 12,618 80,719 
Net realized gains (losses)(1,566)8,735 31 10,336 17,536 
Fair value as of June 30, 2021$1,661,587 $161,440 $52,460 $38,548 $1,914,035 
Net unrealized appreciation (depreciation) relating to Level 3 investments still held as of June 30, 2021 and reported within net unrealized appreciation (depreciation) in the Consolidated Statement of Operations for the nine months ended June 30, 2021$51,977 $4,770 $2,543 $12,429 $71,719 
__________
(a) Includes the Level 3 investments acquired in connection with the Mergers during the nine months ended June 30, 2021.
(b) There were transfers into Level 3 from Level 2 for certain investments during the nine months ended June 30, 2021 as a result of a change in the number of market quotes available and/or a change in market liquidity.
(c) There was a transfer into Level 3 from Level 2 as a result of an investment restructuring in which Level 2 senior secured debt was exchanged for Level 3 senior secured debt and common equity.
(d) There was one transfer from senior secured debt to common equity and warrants during the nine months ended June 30, 2021 as a result of an investment restructuring, in which $6.3 million of senior secured debt was exchanged for $6.3 million of common equity.

Significant Unobservable Inputs for Level 3 Investments
The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of June 30, 2022:2023:
AssetAssetFair ValueValuation TechniqueUnobservable InputRangeWeighted
Average (a)
AssetFair ValueValuation TechniqueUnobservable InputRangeWeighted
Average (a)
Senior Secured DebtSenior Secured Debt$1,559,851 Market YieldMarket Yield(b)7.0%-25.0%12.7%Senior Secured Debt$2,058,831 Market YieldMarket Yield(b)9.0%-38.0%14.1%
25,835 Enterprise ValueEBITDA Multiple(c)5.0x-7.0x6.0x43,954 Enterprise ValueRevenue Multiple(c)5.0x-7.0x6.0x
23,937 Transaction PrecedentTransaction Price(d)N/A-N/AN/A34,466 Enterprise ValueEBITDA Multiple(c)3.4x-5.4x5.2x
321,091 Broker QuotationsBroker Quoted Price(e)N/A-N/AN/A32,379 Transaction PrecedentTransaction Price(d)N/A-N/AN/A
358,818 Broker quotationsBroker Quoted Price(e)N/A-N/AN/A
Subordinated DebtSubordinated Debt8,724 Market YieldMarket Yield(b)13.0%-17.0%14.8%Subordinated Debt18,464 Market YieldMarket Yield(b)10.0%-22.0%11.4%
4,164 Broker QuotationsBroker Quoted Price(e)N/A-N/AN/A
Debt Investments in the JVsDebt Investments in the JVs146,856 Enterprise ValueN/A(f)N/A-N/AN/ADebt Investments in the JVs162,288 Enterprise ValueN/A(f)N/A-N/AN/A
Preferred & Common EquityPreferred & Common Equity63,662 Enterprise ValueRevenue Multiple(c)0.5x-8.4x4.5xPreferred & Common Equity70,852 Enterprise ValueRevenue Multiple(c)0.4x-6.0x1.4x
41,336 Enterprise ValueEBITDA Multiple(c)3.3x-17.7x10.5x37,322 Enterprise ValueEBITDA Multiple(c)1.7x-17.5x11.1x
Enterprise ValueAsset Multiple(c)0.9x-1.1x1.0x1,415 Enterprise ValueAsset Multiple(c)1.0x-1.4x1.4x
120 Transaction PrecedentTransaction Price(d)N/A-N/AN/A2,945 Transaction PrecedentTransaction Price(d)N/A-N/AN/A
TotalTotal$2,191,415 Total$2,825,898 
__________
(a)Weighted averages are calculated based on fair value of investments.
(b)Used when market participants would take into account market yield when pricing the investment.
(c)Used when market participants would use such multiples when pricing the investment.
(d)Used when there is an observable transaction or pending event for the investment.
(e)The CompanyOaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. The CompanyOaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated.
41

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




estimated. Each quoted price is evaluated by the Audit Committee of the Company's Board of Directors in conjunction with additional information compiled by Oaktree.
(f)The CompanyOaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.
37

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The following table provides quantitative information related to the significant unobservable inputs for Level 3 investments, which are carried at fair value, as of September 30, 2021:2022:
AssetAssetFair ValueValuation TechniqueUnobservable InputRangeWeighted
Average (a)
AssetFair ValueValuation TechniqueUnobservable InputRangeWeighted
Average (a)
Senior Secured DebtSenior Secured Debt$1,413,373 Market YieldMarket Yield(b)4.0%-30.0%10.4%Senior Secured Debt$1,599,148 Market YieldMarket Yield(b)9.0%-30.0%13.7%
36,197 Enterprise ValueEBITDA Multiple(c)3.0x-9.0x4.5x
7,500 Enterprise ValueAsset Multiple(c)0.9x-1.1x1.0x14,333 Enterprise ValueEBITDA Multiple(c)5.0x-7.0x6.0x
421,466 Broker QuotationsBroker Quoted Price(e)N/A-N/AN/A297,125 Broker QuotationsBroker Quoted Price(e)N/A-N/AN/A
Subordinated DebtSubordinated Debt24,485 Market YieldMarket Yield(b)12.0%-14.0%12.6%Subordinated Debt12,855 Market YieldMarket Yield(b)10.0%-19.0%13.8%
Debt Investments in the JVsDebt Investments in the JVs151,832 Enterprise ValueN/A(f)N/A-N/AN/ADebt Investments in the JVs146,533 Enterprise ValueN/A(f)N/A-N/AN/A
Preferred & Common EquityPreferred & Common Equity6,188 Enterprise ValueRevenue Multiple(c)0.9x-11.2x2.5xPreferred & Common Equity61,693 Enterprise ValueRevenue Multiple(c)0.4x-10.1x4.3x
93,520 Enterprise ValueEBITDA Multiple(c)3.0x-35.0x15.9x36,913 Enterprise ValueEBITDA Multiple(c)3.0x-20.0x11.4x
698 Enterprise ValueAsset Multiple(c)0.9x-1.1x1.0xEnterprise ValueAsset Multiple(c)0.9x-1.1x1.0x
6,322 Transactions PrecedentTransaction Price(d)N/A-N/AN/A872 Transaction PrecedentTransaction Price(d)N/A-N/AN/A
TotalTotal$2,161,581 Total$2,169,475 
__________
__________
(a)Weighted averages are calculated based on fair value of investments.
(b)Used when market participants would take into account market yield when pricing the investment.
(c)Used when market participants would use such multiples when pricing the investment.
(d)Used when there is an observable transaction or pending event for the investment.
(e)The CompanyOaktree generally uses prices provided by an independent pricing service which are non-binding indicative prices on or near the valuation date as the primary basis for the fair value determinations for quoted senior secured debt investments. Since these prices are non-binding, they may not be indicative of fair value. The CompanyOaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Each quoted price is evaluated by the Audit Committee of the Company's Board of Directors in conjunction with additional information compiled by Oaktree.
(f)The CompanyOaktree determined the value of its subordinated notes of each JV based on the total assets less the total liabilities senior to the subordinated notes held at such JV in an amount not exceeding par under the EV technique.
Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.
Under the EV technique, the significant unobservable input used in the fair value measurement of the Company's investments in debt or equity securities is the earnings before interest, taxes, depreciation and amortization ("EBITDA"), revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively.
 
Financial Instruments Disclosed, But Not Carried, At Fair Value
The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of June 30, 20222023 and the level of each financial liability within the fair value hierarchy:
 
Carrying
Value
Fair ValueLevel 1Level 2Level 3Carrying
Value
Fair ValueLevel 1Level 2Level 3
Syndicated Facility payableSyndicated Facility payable$575,000 $575,000 $— $— $575,000 Syndicated Facility payable$800,000 $800,000 $— $— $800,000 
Citibank Facility payable170,000 170,000 — — 170,000 
OSI2 Citibank Facility payableOSI2 Citibank Facility payable335,000 335,000 — — 335,000 
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)296,678 283,956 — 283,956 — 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)297,928 285,717 — 285,717 — 
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)314,928 301,144 — 301,144 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)307,138 302,260 — 302,260 — 
TotalTotal$1,356,606 $1,330,100 $ $585,100 $745,000 Total$1,740,066 $1,722,977 $ $587,977 $1,135,000 
4238

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)










The following table presents the carrying value and fair value of the Company's financial liabilities disclosed, but not carried, at fair value as of September 30, 20212022 and the level of each financial liability within the fair value hierarchy:
Carrying
Value
Fair ValueLevel 1Level 2Level 3Carrying
Value
Fair ValueLevel 1Level 2Level 3
Syndicated Facility payableSyndicated Facility payable$495,000 $495,000 $— $— $495,000 Syndicated Facility payable$540,000 $540,000 $— $— $540,000 
Citibank Facility payableCitibank Facility payable135,000 135,000 — — 135,000 Citibank Facility payable160,000 160,000 — — 160,000 
2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)295,740 314,541 — 314,541 — 2025 Notes payable (carrying value is net of unamortized financing costs and unaccreted discount)296,991 283,077 — 283,077 — 
2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)343,003 351,134 — 351,134 — 2027 Notes payable (carrying value is net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment)304,052 294,028 — 294,028 — 
TotalTotal$1,268,743 $1,295,675 $ $665,675 $630,000 Total$1,301,043 $1,277,105 $ $577,105 $700,000 
 
The principal values of the credit facilities payable approximate fair value due to their variable interest rates and are included in Level 3 of the hierarchy. The CompanyOaktree used market quotes as of the valuation date to estimate the fair value of itsthe Company's 3.500% notes due 2025 (the "2025 Notes") and 2.700% notes due 2027 (the "2027 Notes"), which are included in Level 2 of the hierarchy.


Portfolio Composition
Summaries of the composition of the Company's portfolio at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets are shown in the following tables:
June 30, 2022September 30, 2021 June 30, 2023September 30, 2022
Cost:Cost: % of Total Investments% of Total InvestmentsCost: % of Total Investments% of Total Investments
Senior secured debtSenior secured debt$2,269,332 85.14 %$2,179,907 85.85 %Senior secured debt$2,886,772 87.59 %$2,227,245 85.08 %
Debt investments in the JVsDebt investments in the JVs146,642 5.50 %146,955 5.79 %Debt investments in the JVs162,653 4.93 %146,444 5.59 %
Preferred equityPreferred equity84,881 3.18 %65,939 2.60 %Preferred equity99,597 3.02 %85,300 3.26 %
Subordinated debtSubordinated debt73,544 2.76 %42,316 1.67 %Subordinated debt55,450 1.68 %67,147 2.57 %
LLC equity interests of the JVsLLC equity interests of the JVs49,322 1.85 %49,322 1.94 %LLC equity interests of the JVs54,791 1.66 %49,322 1.88 %
Common equity and warrantsCommon equity and warrants41,766 1.57 %54,682 2.15 %Common equity and warrants37,022 1.12 %42,296 1.62 %
TotalTotal$2,665,487 100.00 %$2,539,121 100.00 %Total$3,296,285 100.00 %$2,617,754 100.00 %


June 30, 2022September 30, 2021 June 30, 2023September 30, 2022
Fair Value:Fair Value: % of Total Investments% of Net Assets% of Total Investments% of Net AssetsFair Value: % of Total Investments% of Net Assets% of Total Investments% of Net Assets
Senior secured debtSenior secured debt$2,221,603 86.60 %175.82 %$2,217,243 86.72 %168.89 %Senior secured debt$2,774,373 88.48 %183.80 %$2,166,409 86.86 %173.93 %
Debt investments in the JVsDebt investments in the JVs146,856 5.72 %11.63 %151,832 5.94 %11.56 %Debt investments in the JVs162,288 5.18 %10.75 %146,533 5.88 %11.77 %
Preferred equityPreferred equity81,616 3.18 %6.46 %63,565 2.49 %4.84 %Preferred equity92,186 2.94 %6.11 %79,523 3.19 %6.38 %
Subordinated debtSubordinated debt63,858 2.49 %5.05 %42,681 1.67 %3.25 %Subordinated debt51,996 1.66 %3.44 %56,920 2.28 %4.57 %
LLC equity interests of the JVsLLC equity interests of the JVs28,433 1.11 %2.25 %37,651 1.47 %2.87 %LLC equity interests of the JVs27,973 0.89 %1.85 %20,715 0.83 %1.66 %
Common equity and warrantsCommon equity and warrants23,023 0.90 %1.82 %43,657 1.71 %3.33 %Common equity and warrants26,803 0.85 %1.78 %24,011 0.96 %1.93 %
TotalTotal$2,565,389 100.00 %203.03 %$2,556,629 100.00 %194.74 %Total$3,135,619 100.00 %207.73 %$2,494,111 100.00 %200.24 %


4339

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








The geographic composition is determined by the location of the corporate headquarters of the portfolio company, which may not be indicative of the primary source of the portfolio company's business. The following tables show the composition of the Company's portfolio by geographic region at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets:
June 30, 2022September 30, 2021 June 30, 2023September 30, 2022
Cost:Cost: % of Total Investments % of Total InvestmentsCost: % of Total Investments % of Total Investments
NortheastNortheast$736,761 27.65 %$720,781 28.39 %Northeast$994,695 30.17 %$747,420 28.55 %
MidwestMidwest389,291 14.60 %385,846 15.20 %Midwest448,981 13.62 %373,236 14.26 %
SoutheastSoutheast446,546 13.55 %356,041 13.60 %
WestWest363,764 13.65 %365,471 14.39 %West440,634 13.37 %358,306 13.69 %
Southeast357,164 13.40 %294,339 11.59 %
InternationalInternational293,670 11.02 %268,817 10.59 %International434,844 13.19 %301,242 11.51 %
Southwest240,777 9.03 %256,227 10.09 %
SouthSouth192,806 7.23 %156,764 6.17 %South197,754 6.00 %168,819 6.45 %
NorthwestNorthwest91,254 3.42 %90,876 3.58 %Northwest168,992 5.13 %91,382 3.49 %
SouthwestSouthwest163,839 4.97 %221,308 8.45 %
TotalTotal$2,665,487 100.00 %$2,539,121 100.00 %Total$3,296,285 100.00 %$2,617,754 100.00 %


June 30, 2022September 30, 2021 June 30, 2023September 30, 2022
Fair Value:Fair Value: % of Total Investments% of Net Assets % of Total Investments% of Net AssetsFair Value: % of Total Investments% of Net Assets % of Total Investments% of Net Assets
NortheastNortheast$694,038 27.07 %54.92 %$721,647 28.24 %54.97 %Northeast$936,888 29.87 %62.07 %$696,368 27.93 %55.90 %
InternationalInternational432,986 13.81 %28.69 %279,646 11.21 %22.45 %
MidwestMidwest372,834 14.53 %29.51 %382,475 14.96 %29.13 %Midwest429,317 13.69 %28.44 %356,934 14.31 %28.66 %
WestWest355,367 13.85 %28.12 %371,257 14.52 %28.28 %West428,232 13.66 %28.37 %345,251 13.84 %27.72 %
SoutheastSoutheast349,474 13.62 %27.66 %299,486 11.71 %22.81 %Southeast406,523 12.96 %26.93 %344,567 13.82 %27.66 %
International280,481 10.93 %22.20 %275,904 10.79 %21.02 %
Southwest237,561 9.26 %18.80 %258,940 10.13 %19.72 %
SouthSouth185,473 7.23 %14.68 %155,526 6.08 %11.85 %South186,792 5.96 %12.37 %166,230 6.66 %13.35 %
NorthwestNorthwest90,161 3.51 %7.14 %91,394 3.57 %6.96 %Northwest166,089 5.30 %11.00 %90,131 3.61 %7.24 %
SouthwestSouthwest148,792 4.75 %9.86 %214,984 8.62 %17.26 %
TotalTotal$2,565,389 100.00 %203.03 %$2,556,629 100.00 %194.74 %Total$3,135,619 100.00 %207.73 %$2,494,111 100.00 %200.24 %
4440

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








The following tables show the composition of the Company's portfolio by industry at cost as a percentage of total investments and at fair value as a percentage of total investments and net assets as of June 30, 20222023 and September 30, 2021:2022:
June 30, 2022September 30, 2021June 30, 2023September 30, 2022
Cost:Cost: % of Total Investments % of Total InvestmentsCost: % of Total Investments % of Total Investments
Application SoftwareApplication Software$407,964 15.30 %$367,265 14.49 %Application Software$560,503 16.98 %$391,938 14.98 %
Multi-Sector Holdings (1)Multi-Sector Holdings (1)195,964 7.35 196,277 7.73 Multi-Sector Holdings (1)219,130 6.65 195,766 7.48 
Data Processing & Outsourced ServicesData Processing & Outsourced Services133,422 4.05 120,477 4.60 
Health Care TechnologyHealth Care Technology129,178 3.92 100,084 3.82 
BiotechnologyBiotechnology127,394 3.86 109,960 4.20 
PharmaceuticalsPharmaceuticals129,031 4.84 138,250 5.44 Pharmaceuticals121,497 3.69 126,508 4.83 
Data Processing & Outsourced Services120,453 4.52 120,381 4.74 
Biotechnology102,578 3.85 111,856 4.41 
Health Care Technology98,274 3.69 13,877 0.55 
Aerospace & DefenseAerospace & Defense110,680 3.36 61,963 2.37 
Industrial Machinery & Supplies & ComponentsIndustrial Machinery & Supplies & Components99,237 3.01 — — 
Broadline RetailBroadline Retail83,201 2.52 — — 
Health Care ServicesHealth Care Services77,364 2.35 58,674 2.24 
Real Estate Operating CompaniesReal Estate Operating Companies76,462 2.32 47,585 1.82 
Specialized FinanceSpecialized Finance69,188 2.10 80,864 3.09 
Personal Care ProductsPersonal Care Products68,671 2.08 — — 
Automotive RetailAutomotive Retail64,825 1.97 59,254 2.26 
Fertilizers & Agricultural ChemicalsFertilizers & Agricultural Chemicals64,750 1.96 49,301 1.88 
Internet Services & InfrastructureInternet Services & Infrastructure63,057 1.91 54,095 2.07 
Health Care DistributorsHealth Care Distributors62,079 1.88 57,112 2.18 
Diversified Financial ServicesDiversified Financial Services61,693 1.87 — — 
Auto Parts & EquipmentAuto Parts & Equipment61,091 1.85 12,474 0.48 
Metal, Glass & Plastic ContainersMetal, Glass & Plastic Containers57,949 1.76 — — 
Airport ServicesAirport Services55,919 1.70 43,322 1.65 
Home Improvement RetailHome Improvement Retail54,939 1.67 45,802 1.75 
Insurance BrokersInsurance Brokers52,960 1.61 35,628 1.36 
Diversified Metals & MiningDiversified Metals & Mining49,787 1.51 — — 
Leisure FacilitiesLeisure Facilities49,501 1.50 39,768 1.52 
Real Estate ServicesReal Estate Services44,783 1.36 40,243 1.54 
Soft Drinks & Non-alcoholic BeveragesSoft Drinks & Non-alcoholic Beverages43,021 1.31 — — 
Diversified Support ServicesDiversified Support Services42,706 1.30 37,992 1.45 
Other Specialty RetailOther Specialty Retail41,790 1.27 — — 
Specialty ChemicalsSpecialty Chemicals38,248 1.16 37,319 1.43 
DistributorsDistributors37,668 1.14 25,278 0.97 
Integrated Telecommunication ServicesIntegrated Telecommunication Services33,663 1.02 34,628 1.32 
Electrical Components & EquipmentElectrical Components & Equipment32,380 0.98 33,814 1.29 
Construction & EngineeringConstruction & Engineering27,231 0.83 60,996 2.33 
Environmental & Facilities ServicesEnvironmental & Facilities Services25,943 0.79 20,857 0.80 
AdvertisingAdvertising25,597 0.78 28,245 1.08 
Passenger AirlinesPassenger Airlines24,888 0.76 — — 
Oil & Gas Storage & TransportationOil & Gas Storage & Transportation24,231 0.74 22,290 0.85 
Home FurnishingsHome Furnishings23,832 0.72 19,550 0.75 
GoldGold23,274 0.71 — — 
Systems SoftwareSystems Software23,089 0.70 14,890 0.57 
Health Care EquipmentHealth Care Equipment22,374 0.68 24,353 0.93 
Real Estate DevelopmentReal Estate Development19,567 0.59 — — 
Interactive Media & ServicesInteractive Media & Services18,963 0.58 — — 
Hotels, Resorts & Cruise LinesHotels, Resorts & Cruise Lines17,221 0.52 13,960 0.53 
Consumer FinanceConsumer Finance16,411 0.50 14,492 0.55 
Education ServicesEducation Services15,660 0.48 9,080 0.35 
IT Consulting & Other ServicesIT Consulting & Other Services15,434 0.47 11,697 0.45 
RestaurantsRestaurants12,589 0.38 9,338 0.36 
Movies & EntertainmentMovies & Entertainment12,188 0.37 26,161 1.00 
Health Care SuppliesHealth Care Supplies11,675 0.35 36,471 1.39 
Food DistributorsFood Distributors5,900 0.18 4,646 0.18 
Apparel RetailApparel Retail5,293 0.16 5,268 0.20 
Air Freight & LogisticsAir Freight & Logistics4,925 0.15 7,295 0.28 
Integrated Oil & GasIntegrated Oil & Gas4,887 0.15 4,866 0.19 
Research & Consulting ServicesResearch & Consulting Services4,879 0.15 9,187 0.35 
Cable & SatelliteCable & Satellite4,687 0.14 20,716 0.79 
Other Specialized REITsOther Specialized REITs4,364 0.13 — — 
Paper & Plastic Packaging Products & MaterialsPaper & Plastic Packaging Products & Materials3,262 0.10 — — 
Housewares & SpecialtiesHousewares & Specialties2,908 0.09 2,293 0.09 
Electronic ComponentsElectronic Components2,101 0.06 2,092 0.08 
Leisure ProductsLeisure Products2,039 0.06 — — 
Technology DistributorsTechnology Distributors1,084 0.03 3,163 0.12 
Communications EquipmentCommunications Equipment1,053 0.03 — — 
Industrial MachineryIndustrial Machinery78,306 2.94 88,231 3.47 Industrial Machinery— — 81,787 3.12 
Aerospace & Defense74,567 2.80 67,629 2.66 
Specialized Finance73,757 2.77 68,554 2.70 
Internet & Direct Marketing RetailInternet & Direct Marketing Retail67,975 2.55 62,233 2.45 Internet & Direct Marketing Retail— — 67,926 2.59 
Fertilizers & Agricultural Chemicals64,598 2.42 66,713 2.63 
Construction & Engineering61,195 2.30 61,874 2.44 
Health Care Services59,504 2.23 84,750 3.34 
Automotive Retail59,138 2.22 41,800 1.65 
Internet Services & Infrastructure53,814 2.02 46,917 1.85 
Personal ProductsPersonal Products53,042 1.99 103,642 4.08 Personal Products— — 53,214 2.03 
Metal & Glass ContainersMetal & Glass Containers46,711 1.75 17,443 0.69 Metal & Glass Containers— — 47,704 1.82 
Health Care Distributors46,497 1.74 19,698 0.78 
Home Improvement Retail46,046 1.73 46,487 1.83 
Leisure Facilities42,986 1.61 25,162 0.99 
Airport Services42,900 1.61 41,699 1.64 
Real Estate Services40,293 1.51 40,445 1.59 
Real Estate Operating Companies39,449 1.48 27,531 1.08 
Diversified Support Services38,017 1.43 40,666 1.60 
Specialty Chemicals37,740 1.42 46,731 1.84 
Health Care Supplies36,248 1.36 29,650 1.17 
Insurance Brokers35,652 1.34 25,515 1.00 
Integrated Telecommunication Services34,675 1.30 47,059 1.85 
Soft DrinksSoft Drinks34,607 1.30 33,410 1.32 Soft Drinks— — 34,272 1.31 
Electrical Components & Equipment33,816 1.27 32,127 1.27 
Oil & Gas Storage & Transportation31,419 1.18 36,612 1.44 
Advertising29,930 1.12 28,649 1.13 
Other Diversified Financial ServicesOther Diversified Financial Services29,286 1.10 16,104 0.63 Other Diversified Financial Services— — 29,300 1.12 
Oil & Gas Refining & MarketingOil & Gas Refining & Marketing27,686 1.04 36,044 1.42 Oil & Gas Refining & Marketing— — 8,627 0.33 
Movies & Entertainment26,121 0.98 26,002 1.02 
Distributors25,293 0.95 — — 
Health Care Equipment24,134 0.91 23,674 0.93 
Environmental & Facilities Services19,580 0.73 — — 
Home Furnishings19,547 0.73 19,537 0.77 
Cable & Satellite19,279 0.72 26,730 1.05 
Systems Software14,886 0.56 6,647 0.26 
Consumer Finance14,481 0.54 — — 
Hotels, Resorts & Cruise Lines13,941 0.52 — — 
Auto Parts & Equipment12,472 0.47 12,466 0.49 
IT Consulting & Other Services11,711 0.44 7,598 0.30 
Research & Consulting Services10,138 0.38 7,354 0.29 
Air Freight & Logistics9,664 0.36 4,925 0.19 
Restaurants9,333 0.35 9,317 0.37 
Education Services9,068 0.34 981 0.04 
Trading Companies & DistributorsTrading Companies & Distributors7,616 0.29 — — Trading Companies & Distributors— — 7,628 0.29 
Apparel, Accessories & Luxury GoodsApparel, Accessories & Luxury Goods5,165 0.19 5,165 0.20 Apparel, Accessories & Luxury Goods— — 5,165 0.20 
Integrated Oil & Gas4,860 0.18 4,842 0.19 
Food Distributors4,643 0.17 4,625 0.18 
Apparel Retail4,408 0.17 — — 
Specialized REITsSpecialized REITs4,303 0.16 — — Specialized REITs— — 4,318 0.16 
Communications Equipment3,774 0.14 — — 
Housewares & Specialties3,755 0.14 1,875 0.07 
Diversified BanksDiversified Banks3,515 0.13 3,515 0.14 Diversified Banks— — 3,515 0.13 
Technology Distributors3,163 0.12 3,163 0.12 
Construction MaterialsConstruction Materials2,309 0.09 2,245 0.09 Construction Materials— — 2,331 0.09 
Alternative CarriersAlternative Carriers2,120 0.08 6,578 0.26 Alternative Carriers— — 212 0.01 
Electronic Components2,090 0.08 10,080 0.40 
Independent Power Producers & Energy Traders— — 23,458 0.92 
Airlines— — 22,417 0.88 
Commercial Printing— — 19,685 0.78 
Managed Health Care— — 18,654 0.73 
Thrifts & Mortgage Finance— — 16,079 0.63 
Property & Casualty Insurance— — 9,884 0.39 
Leisure Products— — 6,599 0.26 
Food Retail— — 3,745 0.15 
$2,665,487 100.00 %$2,539,121 100.00 %$3,296,285 100.00 %$2,617,754 100.00 %
4541

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








June 30, 2022September 30, 2021
Fair Value: % of Total Investments% of Net Assets % of Total Investments% of Net Assets
Application Software$403,073 15.69 %31.94 %$372,606 14.58 %28.39 %
Multi-Sector Holdings (1)169,879 6.62 13.44 189,483 7.41 14.43 
Pharmaceuticals121,216 4.73 9.59 142,194 5.56 10.83 
Data Processing & Outsourced Services112,348 4.38 8.89 113,923 4.46 8.68 
Biotechnology101,748 3.97 8.05 113,641 4.44 8.66 
Health Care Technology96,449 3.76 7.63 13,960 0.55 1.06 
Industrial Machinery77,516 3.02 6.13 90,218 3.53 6.87 
Internet & Direct Marketing Retail72,773 2.84 5.76 68,424 2.68 5.21 
Aerospace & Defense72,127 2.81 5.71 69,602 2.72 5.30 
Specialized Finance68,856 2.68 5.45 68,844 2.69 5.24 
Fertilizers & Agricultural Chemicals64,565 2.52 5.11 67,527 2.64 5.14 
Construction & Engineering61,536 2.40 4.87 63,109 2.47 4.81 
Automotive Retail58,201 2.27 4.61 42,133 1.65 3.21 
Internet Services & Infrastructure54,068 2.11 4.28 47,923 1.87 3.65 
Health Care Services52,574 2.05 4.16 84,735 3.31 6.45 
Personal Products52,165 2.03 4.13 105,530 4.13 8.04 
Metal & Glass Containers46,658 1.82 3.69 17,413 0.68 1.33 
Home Improvement Retail45,907 1.79 3.63 46,488 1.82 3.54 
Health Care Distributors44,778 1.75 3.54 19,683 0.77 1.50 
Airport Services42,001 1.64 3.32 40,776 1.59 3.11 
Leisure Facilities41,519 1.62 3.29 22,888 0.90 1.74 
Real Estate Services40,086 1.56 3.17 41,225 1.61 3.14 
Real Estate Operating Companies39,994 1.56 3.17 28,341 1.11 2.16 
Diversified Support Services37,144 1.45 2.94 40,888 1.60 3.11 
Health Care Supplies36,295 1.41 2.87 30,186 1.18 2.30 
Specialty Chemicals35,393 1.38 2.80 46,559 1.82 3.55 
Insurance Brokers34,995 1.36 2.77 27,612 1.08 2.10 
Soft Drinks33,918 1.32 2.68 33,410 1.31 2.54 
Integrated Telecommunication Services33,264 1.30 2.63 49,607 1.94 3.78 
Electrical Components & Equipment32,802 1.28 2.60 32,142 1.26 2.45 
Advertising28,394 1.11 2.25 30,423 1.19 2.32 
Oil & Gas Storage & Transportation28,045 1.09 2.22 34,462 1.35 2.63 
Oil & Gas Refining & Marketing27,465 1.07 2.17 36,546 1.43 2.78 
Movies & Entertainment26,953 1.05 2.13 27,048 1.06 2.06 
Other Diversified Financial Services25,623 1.00 2.03 15,908 0.62 1.21 
Distributors24,579 0.96 1.95 — — — 
Health Care Equipment23,805 0.93 1.88 23,763 0.93 1.81 
Environmental & Facilities Services19,211 0.75 1.52 — — — 
Home Furnishings18,802 0.73 1.49 19,735 0.77 1.50 
Cable & Satellite18,068 0.70 1.43 27,048 1.06 2.06 
Consumer Finance14,317 0.56 1.13 — — — 
Hotels, Resorts & Cruise Lines13,939 0.54 1.10 — — — 
Systems Software12,713 0.50 1.01 6,769 0.26 0.52 
Auto Parts & Equipment11,833 0.46 0.94 12,365 0.48 0.94 
IT Consulting & Other Services10,272 0.40 0.81 7,443 0.29 0.57 
Research & Consulting Services9,479 0.37 0.75 7,606 0.30 0.58 
Air Freight & Logistics9,074 0.35 0.72 4,981 0.19 0.38 
Restaurants8,865 0.35 0.70 9,451 0.37 0.72 
Education Services8,541 0.33 0.68 1,009 0.04 0.08 
Trading Companies & Distributors5,828 0.23 0.46 — — — 
Integrated Oil & Gas4,859 0.19 0.38 4,884 0.19 0.37 
Apparel Retail4,368 0.17 0.35 — — — 
Housewares & Specialties3,948 0.15 0.31 2,003 0.08 0.15 
Communications Equipment3,559 0.14 0.28 — — — 
Specialized REITs3,556 0.14 0.28 — — — 
Food Distributors3,540 0.14 0.28 4,673 0.18 0.36 
Diversified Banks3,310 0.13 0.26 3,562 0.14 0.27 
Technology Distributors3,069 0.12 0.24 3,178 0.12 0.24 
Electronic Components1,957 0.08 0.15 10,127 0.40 0.77 
Construction Materials1,791 0.07 0.14 2,350 0.09 0.18 
Alternative Carriers1,778 0.07 0.14 6,939 0.27 0.53 
Airlines— — — 24,554 0.96 1.87 
Independent Power Producers & Energy Traders— — — 23,552 0.92 1.79 
Commercial Printing— — — 20,100 0.79 1.53 
Managed Health Care— — — 18,840 0.74 1.44 
Thrifts & Mortgage Finance— — — 15,942 0.62 1.21 
Property & Casualty Insurance— — — 9,949 0.39 0.76 
Leisure Products— — — 6,599 0.26 0.50 
Food Retail— — — 3,750 0.15 0.29 
Total$2,565,389 100.00 %203.03 %$2,556,629 100.00 %194.74 %
___________________
(1)This industry includes the Company's investments in the JVs and certain limited partnership interests.

June 30, 2023September 30, 2022
Fair Value: % of Total Investments% of Net Assets % of Total Investments% of Net Assets
Application Software$544,685 17.38 %36.03 %$384,589 15.43 %30.87 %
Multi-Sector Holdings (1)192,160 6.13 12.73 167,248 6.71 13.43 
Biotechnology128,343 4.09 8.50 108,465 4.35 8.71 
Data Processing & Outsourced Services124,548 3.97 8.25 111,335 4.46 8.94 
Pharmaceuticals116,199 3.71 7.70 119,511 4.79 9.59 
Health Care Technology115,659 3.69 7.66 97,315 3.90 7.81 
Aerospace & Defense111,464 3.55 7.38 61,881 2.48 4.97 
Industrial Machinery & Supplies & Components99,021 3.16 6.56 — — — 
Broadline Retail80,882 2.58 5.36 — — — 
Real Estate Operating Companies75,111 2.40 4.98 48,062 1.93 3.86 
Specialized Finance66,333 2.12 4.39 73,087 2.93 5.87 
Fertilizers & Agricultural Chemicals63,185 2.02 4.19 51,972 2.08 4.17 
Internet Services & Infrastructure62,726 2.00 4.16 53,797 2.16 4.32 
Automotive Retail62,356 1.99 4.13 57,629 2.31 4.63 
Health Care Services62,190 1.98 4.12 45,943 1.84 3.69 
Diversified Financial Services61,073 1.95 4.05 — — — 
Personal Care Products60,962 1.94 4.04 — — — 
Auto Parts & Equipment60,809 1.94 4.03 11,469 0.46 0.92 
Health Care Distributors60,340 1.92 4.00 54,662 2.19 4.39 
Airport Services55,221 1.76 3.66 42,883 1.72 3.44 
Insurance Brokers54,680 1.74 3.62 33,081 1.33 2.66 
Home Improvement Retail54,235 1.73 3.59 45,421 1.82 3.65 
Diversified Metals & Mining49,809 1.59 3.30 — — — 
Leisure Facilities46,990 1.50 3.11 39,258 1.57 3.15 
Real Estate Services44,227 1.41 2.93 39,573 1.59 3.18 
Metal, Glass & Plastic Containers43,954 1.40 2.91 — — — 
Soft Drinks & Non-alcoholic Beverages42,798 1.36 2.84 — — — 
Other Specialty Retail41,790 1.33 2.77 — — — 
Diversified Support Services41,302 1.32 2.74 36,712 1.47 2.95 
Distributors36,829 1.17 2.44 24,494 0.98 1.97 
Electrical Components & Equipment32,379 1.03 2.15 32,933 1.32 2.64 
Specialty Chemicals32,231 1.03 2.14 33,969 1.36 2.73 
Integrated Telecommunication Services30,922 0.99 2.05 32,201 1.29 2.59 
Passenger Airlines26,985 0.86 1.79 — — — 
Construction & Engineering26,901 0.86 1.78 61,188 2.45 4.91 
Environmental & Facilities Services25,436 0.81 1.69 20,585 0.83 1.65 
Gold23,292 0.74 1.54 — — — 
Health Care Equipment22,531 0.72 1.49 24,161 0.97 1.94 
Systems Software22,168 0.71 1.47 12,834 0.51 1.03 
Oil & Gas Storage & Transportation21,660 0.69 1.43 20,853 0.84 1.67 
Home Furnishings19,514 0.62 1.29 18,188 0.73 1.46 
Real Estate Development19,246 0.61 1.28 — — — 
Interactive Media & Services19,000 0.61 1.26 — — — 
Advertising18,969 0.60 1.26 26,948 1.08 2.16 
Hotels, Resorts & Cruise Lines17,261 0.55 1.14 13,985 0.56 1.12 
Education Services14,116 0.45 0.94 8,582 0.34 0.69 
Consumer Finance12,616 0.40 0.84 13,284 0.53 1.07 
Restaurants12,168 0.39 0.81 8,692 0.35 0.70 
Movies & Entertainment11,865 0.38 0.79 26,645 1.07 2.14 
Health Care Supplies11,408 0.36 0.76 36,577 1.47 2.94 
IT Consulting & Other Services11,176 0.36 0.74 8,596 0.34 0.69 
Food Distributors5,296 0.17 0.35 3,367 0.13 0.27 
Apparel Retail5,230 0.17 0.35 5,223 0.21 0.42 
Integrated Oil & Gas4,810 0.15 0.32 4,872 0.20 0.39 
Cable & Satellite4,672 0.15 0.31 19,576 0.78 1.57 
Research & Consulting Services4,632 0.15 0.31 8,573 0.34 0.69 
Air Freight & Logistics4,025 0.13 0.27 6,405 0.26 0.51 
Other Specialized REITs3,438 0.11 0.23 — — — 
Paper & Plastic Packaging Products & Materials3,100 0.10 0.21 — — — 
Housewares & Specialties2,858 0.09 0.19 2,456 0.10 0.20 
Leisure Products1,995 0.06 0.13 — — — 
Electronic Components1,834 0.06 0.12 1,890 0.08 0.15 
Technology Distributors1,024 0.03 0.07 2,997 0.12 0.24 
Communications Equipment980 0.03 0.06 — — — 
Industrial Machinery— — — 81,008 3.25 6.50 
Internet & Direct Marketing Retail— — — 70,419 2.82 5.65 
Personal Products— — — 50,150 2.01 4.03 
Metal & Glass Containers— — — 47,599 1.91 3.82 
Soft Drinks— — — 33,670 1.35 2.70 
Other Diversified Financial Services— — — 24,326 0.98 1.95 
4642

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








June 30, 2023September 30, 2022
Fair Value: % of Total Investments% of Net Assets % of Total Investments% of Net Assets
Oil & Gas Refining & Marketing$— — — $8,604 0.34 0.69 
Trading Companies & Distributors— — — 5,567 0.22 0.45 
Diversified Banks— — — 3,402 0.14 0.27 
Specialized REITs— — — 3,264 0.13 0.26 
Construction Materials— — — 1,934 0.08 0.16 
Alternative Carriers— — — 201 0.01 0.02 
Total$3,135,619 100.00 %207.73 %$2,494,111 100.00 %200.24 %
___________________
(1)This industry includes the Company's investments in the JVs.
As of June 30, 20222023 and September 30, 2021,2022, the Company had no single investment that represented greater than 10%of the total investment portfolio at fair value. Income, consisting of interest, dividends, fees, other investment income and realization of gains or losses, may fluctuate and in any given period can be highly concentrated among several investments.


Senior Loan Fund JV I, LLC
In May 2014, the Company entered into an LLC agreement with Kemper to form SLF JV I. The Company co-invests in senior secured loans of middle-market companies and other corporate debt securities with Kemper through its investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by the Company and one representative selected by Kemper (with approval from a representative of each required). Since the Company does not have a controlling financial interest in SLF JV I, the Company does not consolidate SLF JV I.
SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to the Company and Kemper by SLF JV I. The subordinated notes issued by SLF JV I (the "SLF JV I Notes") are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt. As of June 30, 20222023 and September 30, 2021,2022, the Company and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act.
SLF JV I has a senior revolving credit facility with Deutsche Bank AG, New York Branch (as amended, the "SLF JV I Deutsche Bank Facility"), which permitted up to $260.0 million of borrowings (subject to borrowing base and other limitations) as of each of June 30, 20222023 and September 30, 2021.2022. Borrowings under the SLF JV I Deutsche Bank Facility are secured by all of the assets of SLF JV I Funding LLC, a special purpose financing subsidiary of SLF JV I. As of June 30, 2022,2023, the reinvestment period of the SLF JV I Deutsche Bank Facility was scheduled to expire May 3, 20232024 and the maturity date was May 3, 2028. As of June 30, 2022,2023, borrowings under the SLF JV I Deutsche Bank Facility accrued interest at a rate equal to 3-month LIBORSOFR plus 2.00%2.50% until November 3, 2023, 3-month SOFR plus 2.75% per annum during the remainder of the reinvestment period, 3-month LIBORSOFR plus 2.15%3.25% per annum for the first year after the reinvestment period, 3-month LIBORSOFR plus 2.25%3.35% for the following year and 3-month LIBORSOFR plus 2.50%3.60% thereafter, in each case with a 0.125% LIBORSOFR floor. $215.0$200.0 million and $215.6$230.0 million of borrowings were outstanding under the SLF JV I Deutsche Bank Facility as of June 30, 20222023 and September 30, 2021,2022, respectively.
As of June 30, 20222023 and September 30, 2021,2022, SLF JV I had total assets of $365.0$370.2 million and $379.2$385.2 million, respectively. SLF JV I's portfolio primarily consisted of senior secured loans to 5652 and 5560 portfolio companies as of June 30, 20222023 and September 30, 2021,2022, respectively. The portfolio companies in SLF JV I are in industries similar to those in which the Company may invest directly. As of June 30, 2023, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $140.6 million in aggregate, at fair value. As of September 30, 2022, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $119.3 million in aggregate, at fair value. As of September 30, 2021, the Company's investment in SLF JV I consisted of LLC equity interests and SLF JV I Notes of $133.9$117.0 million in aggregate, at fair value.
As of each of June 30, 20222023, the Company and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from the Company. As of September 30, 2021,2022, the Company and Kemper had funded approximately $165.5 million to SLF JV I, of which $144.8 million was from the Company. As of each of June 30, 20222023, the Company had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. During the nine months ended June 30, 2023, the Company contributed $16.4 million to fund additional SLF JV I Notes and approximately $5.5 million to fund additional LLC equity interests in SLF JV I. As of September 30, 2021,2022, the Company had aggregate commitments to fund SLF JV I of $35.0 million, of which approximately $26.2 million was to fund additional SLF JV I Notes and approximately $8.8 million was to fund LLC equity interests in SLF JV I.
43

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Below is a summary of SLF JV I's portfolio, followed by a listing of the individual loans in SLF JV I's portfolio as of June 30, 20222023 and September 30, 2021:2022:
June 30, 2022September 30, 2021June 30, 2023September 30, 2022
Senior secured loans (1)Senior secured loans (1)$357,198$344,196Senior secured loans (1)$350,214$383,194
Weighted average interest rate on senior secured loans (2)Weighted average interest rate on senior secured loans (2)6.79%5.60%Weighted average interest rate on senior secured loans (2)10.40%8.33%
Number of borrowers in SLF JV INumber of borrowers in SLF JV I5655Number of borrowers in SLF JV I5260
Largest exposure to a single borrower (1)Largest exposure to a single borrower (1)$9,650$9,875Largest exposure to a single borrower (1)$11,304$10,093
Total of five largest loan exposures to borrowers (1)Total of five largest loan exposures to borrowers (1)$47,298$46,984Total of five largest loan exposures to borrowers (1)$54,003$48,139
__________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.


44

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




SLF JV I Portfolio as of June 30, 2023
Portfolio CompanyIndustryType of InvestmentIndexSpreadCash Interest Rate (1)(2)PIKMaturity DateSharesPrincipalCostFair Value (3)Notes
Access CIG, LLCDiversified Support ServicesFirst Lien Term LoanL+3.75%8.94%2/27/2025$5,596 $5,559 $5,545 
ADB Companies, LLCConstruction & EngineeringFirst Lien Term LoanSOFR+6.50%12.00%12/18/20256,911 6,832 6,784 (4)
ADB Companies, LLCConstruction & EngineeringFirst Lien Term LoanSOFR+6.50%12.00%12/18/20251,173 1,158 1,152 (4)
Altice France S.A.Integrated Telecommunication ServicesFirst Lien Term LoanL+4.00%9.32%8/14/20262,977 2,850 2,808 
Alvogen Pharma US, Inc.PharmaceuticalsFirst Lien Term LoanSOFR+7.50%12.89%6/30/20258,916 8,845 8,514 (4)
American Rock Salt Company LLCDiversified Metals & MiningFirst Lien Term LoanSOFR+4.00%9.22%6/9/20284,970 4,734 4,692 
American Tire Distributors, Inc.DistributorsFirst Lien Term LoanSOFR+6.25%11.49%10/20/20284,836 4,775 4,219 (4)
Amplify Finco Pty Ltd.Movies & EntertainmentFirst Lien Term LoanSOFR+4.00%9.39%11/26/20267,740 7,663 7,721 
Anastasia Parent, LLCPersonal Care ProductsFirst Lien Term LoanSOFR+3.75%9.25%8/11/20251,527 1,194 1,179 (4)
Apptio, Inc.Application SoftwareFirst Lien Term LoanL+5.00%10.20%1/10/20254,615 4,592 4,615 (4)
Apptio, Inc.Application SoftwareFirst Lien RevolverL+5.00%10.20%1/10/2025115 113 115 (4)(5)
ASP-R-PAC Acquisition Co LLCPaper & Plastic Packaging Products & MaterialsFirst Lien Term LoanSOFR+6.00%11.31%12/29/20274,145 4,083 3,938 (4)
ASP-R-PAC Acquisition Co LLCPaper & Plastic Packaging Products & MaterialsFirst Lien RevolverSOFR+6.00%12/29/2027— (7)(25)(4)(5)
Astra Acquisition Corp.Application SoftwareFirst Lien Term LoanL+5.25%10.44%10/25/20285,052 4,880 3,560 (4)
Asurion, LLCProperty & Casualty InsuranceFirst Lien Term LoanSOFR+4.00%9.20%8/19/20284,963 4,749 4,710 
Asurion, LLCProperty & Casualty InsuranceFirst Lien Term LoanSOFR+4.25%9.47%8/19/20281,995 1,883 1,902 
Asurion, LLCProperty & Casualty InsuranceSecond Lien Term LoanSOFR+5.25%10.47%1/20/20294,346 4,022 3,657 
athenahealth Group Inc.Health Care TechnologyFirst Lien Term LoanSOFR+3.50%8.59%2/15/20294,331 4,079 4,179 
athenahealth Group Inc.Health Care TechnologyFirst Lien Term LoanSOFR+3.50%2/15/2029— (32)(19)(5)
Aurora Lux Finco S.À.R.L.Airport ServicesFirst Lien Term LoanL+6.00%11.27%12/24/20266,289 6,211 6,031 (4)
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanSOFR+5.00%10.50%6/11/20276,322 6,263 6,158 (4)
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanSOFR+5.00%10.50%6/11/20271,759 1,748 1,713 (4)
C5 Technology Holdings, LLCData Processing & Outsourced ServicesCommon Stock171 — — (4)
C5 Technology Holdings, LLCData Processing & Outsourced ServicesPreferred Equity7,193,540 7,194 5,683 (4)
Centerline Communications, LLCWireless Telecommunication ServicesFirst Lien Term LoanSOFR+6.00%11.44%8/10/20271,965 1,938 1,930 
Centerline Communications, LLCWireless Telecommunication ServicesFirst Lien Term LoanSOFR+6.00%11.44%8/10/20272,366 2,332 2,324 
Centerline Communications, LLCWireless Telecommunication ServicesFirst Lien Term LoanSOFR+6.00%11.44%8/10/20271,988 1,957 1,952 
Centerline Communications, LLCWireless Telecommunication ServicesFirst Lien RevolverSOFR+6.00%11.38%8/10/2027200 192 189 (5)
Convergeone Holdings, Inc.IT Consulting & Other ServicesFirst Lien Term LoanL+5.00%10.37%1/4/20267,315 7,188 4,670 (4)
Covetrus, Inc.Health Care DistributorsFirst Lien Term LoanSOFR+5.00%10.24%10/13/20296,359 5,983 5,937 (4)
Curium Bidco S.à.r.l.BiotechnologyFirst Lien Term LoanL+4.00%9.54%7/9/20267,760 7,689 7,730 
Curium Bidco S.à.r.l.BiotechnologyFirst Lien Term LoanL+4.25%9.79%12/2/2027992 974 987 
DirecTV Financing, LLCCable & SatelliteFirst Lien Term LoanSOFR+5.00%10.22%8/2/20275,958 5,869 5,838 (4)
DTI Holdco, Inc.Research & Consulting ServicesFirst Lien Term LoanSOFR+4.75%9.80%4/26/20297,940 7,807 7,411 (4)
Gibson Brands, Inc.Leisure ProductsFirst Lien Term LoanSOFR+5.00%10.25%8/11/20287,388 7,314 5,984 (4)
Harbor Purchaser Inc.Education ServicesFirst Lien Term LoanSOFR+5.25%10.45%4/9/20297,940 7,742 6,818 (4)
45

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Portfolio CompanyIndustryType of InvestmentIndexSpreadCash Interest Rate (1)(2)PIKMaturity DateSharesPrincipalCostFair Value (3)Notes
Indivior Finance S.À.R.L.PharmaceuticalsFirst Lien Term LoanSOFR+5.25%10.75%6/30/2026$7,350 $7,260 $7,359 
INW Manufacturing, LLCPersonal Care ProductsFirst Lien Term LoanL+5.75%11.29%3/25/20279,125 8,950 7,239 (4)
Iris Holding, Inc.Metal, Glass & Plastic ContainersFirst Lien Term LoanSOFR+4.75%9.90%6/28/20284,963 4,638 4,226 
LABL, Inc.Office Services & SuppliesFirst Lien Term LoanSOFR+5.00%10.20%10/29/20283,972 3,817 3,940 
LaserAway Intermediate Holdings II, LLCHealth Care ServicesFirst Lien Term LoanSOFR+5.75%11.08%10/14/20277,388 7,281 7,267 
Lightbox Intermediate, L.P.Real Estate ServicesFirst Lien Term LoanSOFR+5.00%10.50%5/9/202611,279 11,121 10,997 (4)
LogMeIn, Inc.Application SoftwareFirst Lien Term LoanL+4.75%9.94%8/31/20277,800 7,705 4,918 
LTI Holdings, Inc.Electronic ComponentsFirst Lien Term LoanSOFR+3.50%8.72%9/6/20257,308 7,246 7,037 
McAfee Corp.Systems SoftwareFirst Lien Term LoanSOFR+3.75%9.01%3/1/20295,955 5,655 5,713 
Mindbody, Inc.Internet Services & InfrastructureFirst Lien Term LoanL+7.00%12.19%2/14/20254,669 4,644 4,599 (4)
Mindbody, Inc.Internet Services & InfrastructureFirst Lien RevolverL+8.00%2/14/2025— (3)(7)(4)(5)
Mitchell International IncApplication SoftwareFirst Lien Term LoanL+3.75%8.94%10/15/20282,991 2,845 2,931 
MRI Software LLCApplication SoftwareFirst Lien Term LoanSOFR+5.50%10.84%2/10/20268,340 8,172 8,111 (4)
MRI Software LLCApplication SoftwareFirst Lien RevolverSOFR+5.50%2/10/2026— (3)(9)(4)(5)
MRI Software LLCApplication SoftwareFirst Lien Term LoanSOFR+5.50%10.84%2/10/20262,217 2,216 2,156 (4)
Northern Star Industries Inc.Electrical Components & EquipmentFirst Lien Term LoanSOFR+4.50%10.00%3/31/20256,633 6,624 6,583 
OEConnection LLCApplication SoftwareFirst Lien Term LoanL+4.00%9.25%9/25/202611,015 10,845 10,852 
Park Place Technologies, LLCInternet Services & InfrastructureFirst Lien Term LoanSOFR+5.00%10.20%11/10/20279,849 9,495 9,603 (4)
Planview Parent, Inc.Application SoftwareFirst Lien Term LoanSOFR+4.00%9.50%12/17/20272,422 2,297 2,305 
Planview Parent, Inc.Application SoftwareSecond Lien Term LoanSOFR+7.25%12.59%12/18/20284,503 4,435 4,023 (4)
Pluralsight, LLCApplication SoftwareFirst Lien Term LoanSOFR+8.00%13.04%4/6/20278,116 7,831 7,815 (4)
Pluralsight, LLCApplication SoftwareFirst Lien RevolverSOFR+8.00%13.04%4/6/2027254 236 235 (4)(5)
Renaissance Holding Corp.Education ServicesFirst Lien Term LoanSOFR+4.75%9.99%4/5/20305,000 4,855 4,948 
RevSpring, Inc.Commercial PrintingFirst Lien Term LoanL+4.00%9.50%10/11/20259,550 9,536 9,208 
SHO Holding I CorporationFootwearFirst Lien Term LoanL+5.25%10.52%4/27/20248,135 8,132 5,749 
SHO Holding I CorporationFootwearFirst Lien Term LoanL+5.23%10.50%4/27/2024138 138 100 
SM Wellness Holdings, Inc.Health Care ServicesFirst Lien Term LoanSOFR+4.75%9.97%4/17/20282,985 2,564 2,768 (4)
Sorenson Communications, LLCCommunications EquipmentFirst Lien Term LoanL+5.50%10.69%3/17/20262,328 2,305 2,166 (4)
Spanx, LLCApparel RetailFirst Lien Term LoanSOFR+5.50%10.70%11/20/20288,865 8,729 8,655 (4)
SPX Flow, Inc.Industrial Machinery & Supplies & ComponentsFirst Lien Term LoanSOFR+4.50%9.70%4/5/20298,801 8,426 8,710 
TIBCO Software Inc.Application SoftwareFirst Lien Term LoanSOFR+4.50%9.84%3/30/20298,235 7,548 7,722 (4)
Touchstone Acquisition, Inc.Health Care SuppliesFirst Lien Term LoanSOFR+6.00%11.20%12/29/20287,230 7,116 7,050 (4)
Veritas US Inc.Application SoftwareFirst Lien Term LoanL+5.00%10.22%9/1/20256,322 6,266 5,185 
Windstream Services II, LLCIntegrated Telecommunication ServicesFirst Lien Term LoanSOFR+6.25%11.45%9/21/20277,757 7,570 7,263 (4)
WP CPP Holdings, LLCAerospace & DefenseFirst Lien Term LoanL+3.75%9.03%4/30/20251,970 1,917 1,791 (4)
Total Portfolio Investments$350,214 $348,782 $329,809 
_________
(1) Represents the interest rate as of June 30, 2023. All interest rates are payable in cash, unless otherwise noted.
(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each
46

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of June 30, 2023, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54 %, the 180-day LIBOR at 5.73%, the 30-day SOFR at 5.10%, and the 90-day SOFR at 5.24%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(3) Represents the current determination of fair value as of June 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.
(4) This investment was held by both the Company and SLF JV I as of June 30, 2023.
(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
47

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








SLF JV I Portfolio as of JuneSeptember 30, 2022
Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Access CIG, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 2/27/20255.32 %Diversified Support Services$9,038 $9,017 $8,561 
ADB Companies, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 12/18/20258.50 %Construction & Engineering8,641 8,500 8,498 (4)
Alvogen Pharma US, Inc.First Lien Term Loan, LIBOR+5.25% cash due 12/31/20237.50 %Pharmaceuticals9,385 9,273 8,291 (4)
American Tire Distributors, Inc.First Lien Term Loan, LIBOR+6.25% cash due 10/20/20287.00 %Distributors4,885 4,824 4,631 (4)
Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.92 %Movies & Entertainment7,820 7,742 7,631 (4)
Anastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20256.00 %Personal Products1,543 1,206 1,238 (4)
Apptio, Inc.First Lien Term Loan, LIBOR+6.00% cash due 1/10/20257.25 %Application Software4,615 4,576 4,511 (4)
Apptio, Inc.First Lien Revolver, LIBOR+6.00% cash due 1/10/20257.25 %Application Software154 151 145 (4)(5)
Total Apptio, Inc.4,769 4,727 4,656 
ASP-R-PAC Acquisition Co LLCFirst Lien Term Loan, LIBOR+6.00% cash due 12/29/20277.67 %Paper Packaging4,187 4,110 4,086 
ASP-R-PAC Acquisition Co LLCFirst Lien Revolver, LIBOR+6.00% cash due 12/29/2027Paper Packaging— (9)(12)(5)
Total ASP-R-PAC Acquisition Co LLC4,187 4,101 4,074 
Astra Acquisition Corp.First Lien Term Loan, LIBOR+5.25% cash due 10/25/20286.92 %Application Software6,670 6,507 5,831 (4)
Asurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20296.92 %Property & Casualty Insurance1,846 1,828 1,579 
Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.63 %Airport Services6,353 6,252 6,030 (4)
BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20276.67 %Health Care Services6,386 6,327 6,291 
BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20276.60 %Health Care Services1,577 1,558 1,533 (4)(5)
Total BAART Programs, Inc.7,963 7,885 7,824 
Blackhawk Network Holdings, Inc.First Lien Term Loan, LIBOR+3.00% cash due 6/15/20255.05 %Data Processing & Outsourced Services9,600 9,590 9,100 
Brazos Delaware II, LLCFirst Lien Term Loan, LIBOR+4.00% cash due 5/21/20255.60 %Oil & Gas Equipment & Services4,203 4,194 4,059 
BYJU's Alpha, Inc.First Lien Term Loan, LIBOR+5.50% cash due 11/24/20267.01 %Application Software7,463 7,360 6,380 
C5 Technology Holdings, LLC171 Common UnitsData Processing & Outsourced Services— — (4)
C5 Technology Holdings, LLC7,193,539.63 Preferred UnitsData Processing & Outsourced Services7,194 5,683 (4)
Total C5 Technology Holdings, LLC7,194 5,683 
Centerline Communications, LLCFirst Lien Term Loan, SOFR+5.50% cash due 8/10/20277.05 %Wireless Telecommunication Services4,368 4,292 4,291 
Centerline Communications, LLCFirst Lien Delayed Draw Term Loan, SOFR+5.50% cash due 8/10/20277.05 %Wireless Telecommunication Services450 428 414 (5)
Centerline Communications, LLCFirst Lien Revolver, LIBOR+5.50% cash due 8/10/2027Wireless Telecommunication Services— (10)(11)(5)
Total Centerline Communications, LLC4,818 4,710 4,694 
CITGO Petroleum Corp.First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.92 %Oil & Gas Refining & Marketing7,056 6,985 7,014 (4)
City Football Group LimitedFirst Lien Term Loan, LIBOR+3.50% cash due 7/21/20284.60 %Movies & Entertainment6,484 6,451 5,997 

Portfolio CompanyIndustryType of InvestmentIndexSpreadCash Interest Rate (1)(2)PIKMaturity DateSharesPrincipalCostFair Value (3)Notes
Access CIG, LLCDiversified Support ServicesFirst Lien Term LoanL+3.75%6.82%2/27/2025$10,093 $10,028 $9,692 
ADB Companies, LLCConstruction & EngineeringFirst Lien Term LoanSOFR+6.25%9.80%12/18/20258,518 8,389 8,371 (4)
Altice France S.A.Integrated Telecommunication ServicesFirst Lien Term LoanL+4.00%6.91%8/14/20263,000 2,841 2,730 
Alvogen Pharma US, Inc.PharmaceuticalsFirst Lien Term LoanSOFR+7.50%11.20%6/30/20259,267 9,166 9,221 (4)
American Tire Distributors, Inc.DistributorsFirst Lien Term LoanL+6.25%9.03%10/20/20284,873 4,812 4,576 (4)
Amplify Finco Pty Ltd.Movies & EntertainmentFirst Lien Term LoanL+4.25%7.92%11/26/20267,800 7,722 7,527 (4)
Anastasia Parent, LLCPersonal ProductsFirst Lien Term LoanL+3.75%7.42%8/11/20251,539 1,203 1,232 (4)
Apptio, Inc.Application SoftwareFirst Lien Term LoanL+6.00%8.46%1/10/20254,615 4,580 4,519 (4)
Apptio, Inc.Application SoftwareFirst Lien RevolverL+6.00%8.46%1/10/2025154 151 146 (4)(5)
ASP-R-PAC Acquisition Co LLCPaper PackagingFirst Lien Term LoanL+6.00%9.67%12/29/20274,176 4,103 4,080 
ASP-R-PAC Acquisition Co LLCPaper PackagingFirst Lien RevolverL+6.00%12/29/2027(9)(11)(5)
Astra Acquisition Corp.Application SoftwareFirst Lien Term LoanL+5.25%8.37%10/25/20285,052 4,858 4,319 (4)
Asurion, LLCProperty & Casualty InsuranceFirst Lien Term LoanSOFR+4.00%7.70%8/19/20285,000 4,753 4,276 
Asurion, LLCProperty & Casualty InsuranceSecond Lien Term LoanL+5.25%8.37%1/20/20294,346 3,981 3,347 
Aurora Lux Finco S.À.R.L.Airport ServicesFirst Lien Term LoanL+6.00%8.78%12/24/20266,338 6,242 6,027 (4)
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanL+5.00%8.12%6/11/20276,371 6,311 6,148 
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanL+5.00%8.12%6/11/20271,771 1,751 1,664 (4)(5)
Blackhawk Network Holdings, Inc.Data Processing & Outsourced ServicesFirst Lien Term LoanL+3.00%6.03%6/15/20259,575 9,566 8,977 
BYJU's Alpha, Inc.Application SoftwareFirst Lien Term LoanL+6.00%8.98%11/24/20267,444 7,347 5,455 
C5 Technology Holdings, LLCData Processing & Outsourced ServicesCommon Stock171 — — (4)
C5 Technology Holdings, LLCData Processing & Outsourced ServicesPreferred Equity7,193,540 7,194 5,683 (4)
Centerline Communications, LLCWireless Telecommunication ServicesFirst Lien Term LoanSOFR+5.50%9.12%8/10/20274,358 4,286 4,280 
Centerline Communications, LLCWireless Telecommunication ServicesFirst Lien Term LoanSOFR+5.50%9.12%8/10/2027449 432 413 
Centerline Communications, LLCWireless Telecommunication ServicesFirst Lien RevolverSOFR+5.50%8/10/2027— (10)(11)(5)
CITGO Petroleum Corp.Oil & Gas Refining & MarketingFirst Lien Term LoanL+6.25%9.37%3/28/20247,038 6,967 7,057 (4)
City Football Group LimitedMovies & EntertainmentFirst Lien Term LoanL+3.50%6.48%7/21/20286,451 6,419 6,166 
Convergeone Holdings, Inc.IT Consulting & Other ServicesFirst Lien Term LoanL+5.00%8.12%1/4/20267,373 7,206 5,320 (4)
Covetrus, Inc.Health Care DistributorsFirst Lien Term LoanSOFR+5.00%7.65%9/20/20295,375 5,053 5,035 (4)
Curium Bidco S.à.r.l.BiotechnologyFirst Lien Term LoanL+4.00%7.67%7/9/20265,820 5,776 5,587 
Dealer Tire, LLCDistributorsFirst Lien Term LoanL+4.25%7.37%12/12/20252,992 2,935 2,924 
Delivery Hero FinCo LLCInternet & Direct Marketing RetailFirst Lien Term LoanSOFR+5.75%8.49%8/12/20276,035 5,876 5,756 (4)
DirecTV Financing, LLCCable & SatelliteFirst Lien Term LoanL+5.00%8.12%8/2/20276,436 6,332 6,012 (4)
Domtar CorporationPaper ProductsFirst Lien Term LoanL+5.50%8.26%11/30/20284,100 4,065 3,921 
DTI Holdco, Inc.Research & Consulting ServicesFirst Lien Term LoanSOFR+4.75%7.33%4/26/20298,000 7,849 7,616 (4)
Eagle Parent Corp.Industrial MachineryFirst Lien Term LoanSOFR+4.25%7.80%4/2/20294,478 4,373 4,367 
eResearch Technology, Inc.Application SoftwareFirst Lien Term LoanL+4.50%7.62%2/4/20277,331 7,258 6,859 
48

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Portfolio CompanyPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)NotesPortfolio CompanyIndustryType of InvestmentIndexSpreadCash Interest Rate (1)(2)PIKMaturity DateSharesPrincipalCostFair Value (3)Notes
Convergeone Holdings, Inc.First Lien Term Loan, LIBOR+5.00% cash due 1/4/20266.67 %IT Consulting & Other Services$7,392 $7,211 $6,357 (4)
Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+3.75% cash due 7/9/20266.00 %Biotechnology5,835 5,791 5,525 
Delivery Hero FinCo LLCFirst Lien Term Loan, SOFR+5.75% cash due 7/9/20276.88 %Internet & Direct Marketing Retail5,050 4,948 4,760 (4)
DirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20276.67 %Cable & Satellite5,595 5,539 5,167 (4)
Domtar CorporationFirst Lien Term Loan, LIBOR+5.50% cash due 11/30/20286.69 %Paper Products4,110 4,075 3,967 
DTI Holdco, Inc.First Lien Term Loan, SOFR+4.75% cash due 4/26/20296.28 %Research & Consulting Services8,000 7,843 7,511 (4)
Eagle Parent Corp.First Lien Term Loan, SOFR+4.25% cash due 4/1/20296.30 %Industrial Machinery4,489 4,380 4,317 
eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20276.17 %Application Software7,350 7,277 6,809 
Gibson Brands, Inc.Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20286.41 %Leisure Products7,463 7,388 6,380 Gibson Brands, Inc.Leisure ProductsFirst Lien Term LoanL+5.00%7.94%8/11/2028$7,444 $7,369 $6,029 
Global Medical Response, Inc.Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.25% cash due 3/14/20255.92 %Health Care Services1,985 1,985 1,852 (4)Global Medical Response, Inc.Health Care ServicesFirst Lien Term LoanL+4.25%7.37%3/14/20251,979 1,979 1,722 (4)
Global Medical Response, Inc.Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.25% cash due 10/2/20255.25 %Health Care Services2,198 2,168 2,050 Global Medical Response, Inc.Health Care ServicesFirst Lien Term LoanL+4.25%6.81%10/2/20252,192 2,165 1,912 
Total Global Medical Response, Inc.4,183 4,153 3,902 
Harbor Purchaser Inc.Harbor Purchaser Inc.First Lien Term Loan, SOFR+5.25% cash due 4/9/20296.88 %Education Services8,000 7,765 7,275 (4)Harbor Purchaser Inc.Education ServicesFirst Lien Term LoanSOFR+5.25%8.38%4/9/20298,000 7,774 7,310 (4)
Indivior Finance S.À.R.L.Indivior Finance S.À.R.L.First Lien Term Loan, SOFR+5.25% cash due 6/30/20267.57 %Pharmaceuticals7,425 7,304 7,252 Indivior Finance S.À.R.L.PharmaceuticalsFirst Lien Term LoanL+5.25%8.80%6/30/20267,406 7,293 7,286 
INW Manufacturing, LLCINW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 3/25/20278.00 %Personal Products9,625 9,391 9,096 (4)INW Manufacturing, LLCPersonal ProductsFirst Lien Term LoanL+5.75%9.42%3/25/20279,500 9,282 8,408 (4)
Iris Holding, Inc.Iris Holding, Inc.First Lien Term Loan, SOFR+4.75% cash due 6/15/20285.25 %Metal & Glass Containers4,000 3,680 3,663 Iris Holding, Inc.Metal & Glass ContainersFirst Lien Term LoanSOFR+4.75%7.89%6/28/20285,000 4,624 4,610 
LaserAway Intermediate Holdings II, LLCLaserAway Intermediate Holdings II, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 10/14/20276.79 %Health Care Services7,463 7,330 7,355 LaserAway Intermediate Holdings II, LLCHealth Care ServicesFirst Lien Term LoanL+5.75%8.23%10/14/20277,444 7,318 7,323 
Lightbox Intermediate, L.P.Lightbox Intermediate, L.P.First Lien Term Loan, LIBOR+5.00% cash due 5/9/20267.25 %Real Estate Services7,386 7,331 7,201 (4)Lightbox Intermediate, L.P.Real Estate ServicesFirst Lien Term LoanL+5.00%8.67%5/9/20267,367 7,315 7,109 (4)
LogMeIn, Inc.LogMeIn, Inc.First Lien Term Loan, LIBOR+4.75% cash due 8/31/20276.35 %Application Software7,880 7,766 6,087 LogMeIn, Inc.Application SoftwareFirst Lien Term LoanL+4.75%7.80%8/31/20277,860 7,751 5,494 
LTI Holdings, Inc.LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.50% cash due 9/6/20255.17 %Electronic Components7,385 7,294 6,891 LTI Holdings, Inc.Electronic ComponentsFirst Lien Term LoanL+3.25%6.37%9/6/20257,366 7,282 6,835 
Mindbody, Inc.Mindbody, Inc.First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/20258.38 %Internet Services & Infrastructure4,669 4,629 4,580 (4)Mindbody, Inc.Internet Services & InfrastructureFirst Lien Term LoanL+7.00%10.64%2/14/20254,687 4,651 4,570 (4)
Mindbody, Inc.Mindbody, Inc.First Lien Revolver, LIBOR+8.00% cash due 2/14/2025Internet Services & Infrastructure— (4)(9)(4)(5)Mindbody, Inc.Internet Services & InfrastructureFirst Lien RevolverL+8.00%2/14/2025— (4)(12)(4)(5)
Total Mindbody, Inc.4,669 4,625 4,571 
MRI Software LLCMRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/20267.75 %Application Software6,154 6,120 6,031 (4)MRI Software LLCApplication SoftwareFirst Lien Term LoanL+5.50%9.17%2/10/20266,139 6,104 5,966 (4)
MRI Software LLCMRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (3)(7)(4)(5)MRI Software LLCApplication SoftwareFirst Lien RevolverL+5.50%2/10/2026(3)(10)(4)(5)
Total MRI Software LLC6,154 6,117 6,024 
Northern Star Industries Inc.Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.50% cash due 3/31/20256.55 %Electrical Components & Equipment6,703 6,689 6,501 Northern Star Industries Inc.Electrical Components & EquipmentFirst Lien Term LoanL+4.75%7.87%3/31/20256,685 6,673 6,484 
OEConnection LLCOEConnection LLCFirst Lien Term Loan, LIBOR+4.00% cash due 9/25/20265.67 %Application Software7,797 7,761 7,270 (4)OEConnection LLCApplication SoftwareFirst Lien Term LoanL+4.00%7.12%9/25/20267,777 7,741 7,505 (4)
Park Place Technologies, LLCPark Place Technologies, LLCFirst Lien Term Loan, SOFR+5.00% cash due 11/10/20276.63 %Internet Services & Infrastructure4,938 4,786 4,761 (4)Park Place Technologies, LLCInternet Services & InfrastructureFirst Lien Term LoanSOFR+5.00%8.13%11/10/20274,925 4,781 4,687 (4)
Peloton Interactive, Inc.Peloton Interactive, Inc.First Lien Term Loan, SOFR+6.50% cash due 5/17/20277.00 %Leisure Products4,000 3,822 3,823 Peloton Interactive, Inc.Leisure ProductsFirst Lien Term LoanSOFR+6.50%8.35%5/25/20275,486 5,251 5,371 
Planview Parent, Inc.Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.92 %Application Software4,503 4,435 4,323 (4)Planview Parent, Inc.Application SoftwareSecond Lien Term LoanL+7.25%10.92%12/18/20284,503 4,435 4,323 (4)
Pluralsight, LLCPluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00 %Application Software6,795 6,687 6,605 (4)Pluralsight, LLCApplication SoftwareFirst Lien Term LoanL+8.00%10.68%4/6/20276,796 6,694 6,582 (4)
Pluralsight, LLCPluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software— (7)(12)(4)(5)Pluralsight, LLCApplication SoftwareFirst Lien RevolverL+8.00%4/6/2027— (6)(13)(4)(5)
Total Pluralsight, LLC6,795 6,680 6,593 
RevSpring, Inc.RevSpring, Inc.Commercial PrintingFirst Lien Term LoanL+4.00%7.67%10/11/20259,625 9,607 9,304 
Sabert CorporationSabert CorporationMetal & Glass ContainersFirst Lien Term LoanL+4.50%7.63%12/10/20262,536 2,511 2,435 (4)
SHO Holding I CorporationSHO Holding I CorporationFootwearFirst Lien Term LoanL+5.25%8.06%4/27/20248,201 8,194 7,176 
SHO Holding I CorporationSHO Holding I CorporationFootwearFirst Lien Term LoanL+5.23%8.04%4/27/2024138 138 121 
Sorenson Communications, LLCSorenson Communications, LLCCommunications EquipmentFirst Lien Term LoanL+5.50%9.17%3/17/20262,553 2,528 2,454 
Spanx, LLCSpanx, LLCApparel RetailFirst Lien Term LoanL+5.25%8.30%11/20/20288,933 8,776 8,721 (4)
SPX Flow, Inc.SPX Flow, Inc.Industrial MachineryFirst Lien Term LoanSOFR+4.50%7.63%4/5/20297,500 7,184 6,966 (4)
Supermoose Borrower, LLCSupermoose Borrower, LLCApplication SoftwareFirst Lien Term LoanL+3.75%7.42%8/29/20257,743 7,479 6,827 (4)
Surgery Center Holdings, Inc.Surgery Center Holdings, Inc.Health Care FacilitiesFirst Lien Term LoanL+3.75%6.51%8/31/20263,377 3,365 3,213 
TIBCO Software Inc.TIBCO Software Inc.Application SoftwareFirst Lien Term LoanSOFR+4.50%8.15%3/30/20296,256 5,693 5,629 (4)
Touchstone Acquisition, Inc.Touchstone Acquisition, Inc.Health Care SuppliesFirst Lien Term LoanL+6.00%9.12%12/29/20287,285 7,155 7,140 (4)
Veritas US Inc.Veritas US Inc.Application SoftwareFirst Lien Term LoanL+5.00%8.67%9/1/20256,365 6,290 5,087 
Windstream Services II, LLCWindstream Services II, LLCIntegrated Telecommunication ServicesFirst Lien Term LoanL+6.25%9.37%9/21/20277,818 7,596 7,115 (4)
WP CPP Holdings, LLCWP CPP Holdings, LLCAerospace & DefenseSecond Lien Term LoanL+7.75%10.56%4/30/20266,000 5,972 5,070 (4)
WP CPP Holdings, LLCWP CPP Holdings, LLCAerospace & DefenseFirst Lien Term LoanL+3.75%6.56%4/30/20251,985 1,910 1,783 (4)
Zayo Group Holdings, Inc.Zayo Group Holdings, Inc.Alternative CarriersFirst Lien Term LoanL+3.00%6.12%3/9/20272,155 2,000 1,812 
Total Portfolio InvestmentsTotal Portfolio Investments$383,194 $382,673 $359,625 

49

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
RevSpring, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/11/20255.67 %Commercial Printing$9,650 $9,630 $9,264 
Sabert CorporationFirst Lien Term Loan, LIBOR+4.50% cash due 12/10/20266.19 %Metal & Glass Containers2,591 2,565 2,468 (4)
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20246.49 %Footwear8,223 8,215 7,483 
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20246.47 %Footwear138 138 125 
Total SHO Holding I Corporation8,361 8,353 7,608 
Sorenson Communications, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 3/17/20267.75 %Communications Equipment2,628 2,602 2,578 
Spanx, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 11/20/20287.10 %Apparel Retail8,955 8,792 8,743 (4)
SPX Flow, Inc.First Lien Term Loan, LIBOR+4.60% cash due 4/5/20296.13 %Industrial Machinery7,453 7,128 6,965 
Supermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20256.00 %Application Software7,763 7,475 7,049 (4)
Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20264.95 %Health Care Facilities3,386 3,374 3,165 
Touchstone Acquisition, Inc.First Lien Term Loan, LIBOR+6.00% cash due 12/29/20287.67 %Health Care Supplies7,304 7,167 7,085 (4)
Veritas US Inc.First Lien Term Loan, LIBOR+5.00% cash due 9/1/20257.25 %Application Software6,365 6,284 5,257 (4)
Windstream Services II, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.92 %Integrated Telecommunication Services7,838 7,604 7,364 (4)
WP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.99 %Aerospace & Defense6,000 5,970 4,965 (4)
WP CPP Holdings, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 4/30/20254.99 %Aerospace & Defense1,990 1,907 1,672 (4)
Total Portfolio Investments$357,198 $358,578 $339,335 
_________
(1) Represents the interest rate as of JuneSeptember 30, 2022. All interest rates are payable in cash, unless otherwise noted.
(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of JuneSeptember 30, 2022, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 1.67%3.12%, the 90-day LIBOR at 2.25%, the 180-day LIBOR at 2.88%, the 360-day LIBOR at 3.61%3.67%, the 30-day SOFR at 1.53% and3.03%, the 90-day SOFR at 2.05%3.55% and the 180-day SOFR at 3.98%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(3) Represents the current determination of fair value as of JuneSeptember 30, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the Company's Board of Directors' valuation process described elsewhere herein.
(4) This investment was held by both the Company and SLF JV I as of JuneSeptember 30, 2022.
(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

50

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Both the cost and fair value of the Company's SLF JV I PortfolioNotes were $112.7 million as of SeptemberJune 30, 2021

Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Access CIG, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 2/27/20253.83 %Diversified Support Services$9,111 $9,084 $9,078 (4)
ADB Companies, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 12/18/20257.25 %Construction & Engineering7,732 7,566 7,644 (4)
Altice France S.A.First Lien Term Loan, LIBOR+4.00% cash due 8/14/20264.12 %Integrated Telecommunication Services2,596 2,468 2,591 
Alvogen Pharma US, Inc.First Lien Term Loan, LIBOR+5.25% cash due 12/31/20236.25 %Pharmaceuticals9,755 9,580 9,443 (4)
Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.00 %Movies & Entertainment7,880 7,801 7,680 (4)
Anastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20253.88 %Personal Products2,799 2,211 2,378 
Apptio, Inc.First Lien Term Loan, LIBOR+7.25% cash due 1/10/20258.25 %Application Software4,615 4,565 4,544 (4)
Apptio, Inc.First Lien Revolver, LIBOR+7.25% cash due 1/10/20258.25 %Application Software154 150 148 (4)(5)
Total Apptio, Inc.4,769 4,715 4,692 
Asurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20295.33 %Property & Casualty Insurance6,000 5,940 5,980 
Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.00 %Airport Services6,403 6,283 6,025 (4)
BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20276.00 %Health Care Services5,985 5,925 5,970 
BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20276.00 %Health Care Services450 436 446 (5)
Total BAART Programs, Inc.6,435 6,361 6,416 
Blackhawk Network Holdings, Inc.First Lien Term Loan, LIBOR+3.00% cash due 6/15/20253.08 %Data Processing & Outsourced Services9,675 9,662 9,615 
Boxer Parent Company Inc.First Lien Term Loan, LIBOR+3.75% cash due 10/2/20253.88 %Systems Software6,643 6,570 6,615 
Brazos Delaware II, LLCFirst Lien Term Loan, LIBOR+4.00% cash due 5/21/20254.08 %Oil & Gas Equipment & Services7,253 7,234 7,158 
C5 Technology Holdings, LLC171 Common UnitsData Processing & Outsourced Services— — (4)
C5 Technology Holdings, LLC7,193,539.63 Preferred UnitsData Processing & Outsourced Services7,194 5,683 (4)
Total C5 Technology Holdings, LLC7,194 5,683 
Centerline Communications, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 8/10/20276.50 %Wireless Telecommunication Services2,000 1,961 1,960 
Centerline Communications, LLCFirst Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 8/10/20236.50 %Wireless Telecommunication Services1,920 1,890 1,889 (5)
Centerline Communications, LLCFirst Lien Revolver, LIBOR+5.50% cash due 8/10/2027Wireless Telecommunication Services— (12)(12)(5)
Total Centerline Communications, LLC3,920 3,839 3,837 
CITGO Petroleum Corp.First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.25 %Oil & Gas Refining & Marketing7,111 7,040 7,134 (4)
City Football Group LimitedFirst Lien Term Loan, LIBOR+3.50% cash due 7/21/20284.00 %Movies & Entertainment6,500 6,468 6,492 
Connect U.S. Finco LLCFirst Lien Term Loan, LIBOR+3.50% cash due 12/11/20264.50 %Alternative Carriers7,362 7,204 7,376 
Convergeone Holdings, Inc.First Lien Term Loan, LIBOR+5.00% cash due 1/4/20265.08 %IT Consulting & Other Services7,449 7,229 7,427 (4)
Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.00% cash due 7/9/20264.13 %Biotechnology5,880 5,836 5,884 
Dcert Buyer, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/16/20264.08 %Internet Services & Infrastructure5,885 5,870 5,893 
DirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20275.75 %Cable & Satellite6,000 5,940 6,011 (4)
Enviva Holdings, LPFirst Lien Term Loan, LIBOR+5.50% cash due 2/17/20266.50 %Forest Products5,878 5,819 5,893 
51

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20275.50 %Application Software$7,406 $7,332 $7,451 
GI Chill Acquisition LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/6/20253.90 %Managed Health Care3,721 3,737 3,712 (4)
GI Chill Acquisition LLCSecond Lien Term Loan, LIBOR+7.50% cash due 8/6/20267.63 %Managed Health Care3,750 3,674 3,731 (4)
Total GI Chill Acquisition LLC7,471 7,411 7,443 
Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20285.75 %Leisure Products7,500 7,425 7,463 
Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.75% cash due 10/2/20255.75 %Health Care Services2,214 2,178 2,226 
Global Medical Response, Inc.First Lien Term Loan, LIBOR+4.25% cash due 3/14/20255.25 %Health Care Services1,995 1,995 2,004 (4)
Total Global Medical Response, Inc.4,209 4,173 4,230 
Grab Holdings Inc.First Lien Term Loan, LIBOR+4.50% cash due 1/29/20265.50 %Interactive Media & Services2,985 2,907 3,025 
Indivior Finance S.À.R.L.First Lien Term Loan, LIBOR+5.25% cash due 6/30/20266.00 %Pharmaceuticals7,481 7,336 7,456 
Intelsat Jackson Holdings S.A.First Lien Term Loan, PRIME+4.75% cash due 11/27/20238.00 %Alternative Carriers3,568 3,550 3,622 
Intelsat Jackson Holdings S.A.First Lien Term Loan, LIBOR+4.75% cash due 7/13/20225.75 %Alternative Carriers5,000 4,935 5,044 
Intelsat Jackson Holdings S.A.First Lien Delayed Draw Term Loan, LIBOR+4.75% cash due 7/13/2022Alternative Carriers— (13)(5)
Total Intelsat Jackson Holdings S.A.8,568 8,472 8,675 
INW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 5/7/20276.50 %Personal Products9,875 9,597 9,678 (4)
Lightbox Intermediate, L.P.First Lien Term Loan, LIBOR+5.00% cash due 5/9/20265.13 %Real Estate Services7,443 7,377 7,405 (4)
LogMeIn, Inc.First Lien Term Loan, LIBOR+4.75% cash due 8/31/20274.83 %Application Software7,940 7,812 7,946 (4)
LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.50% cash due 9/6/20253.58 %Electronic Components7,442 7,329 7,354 
Maravai Intermediate Holdings, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 10/19/20274.75 %Biotechnology6,819 6,751 6,846 
Mindbody, Inc.First Lien Term Loan, LIBOR+7.00% cash 1.50% PIK due 2/14/20258.00 %Internet Services & Infrastructure4,616 4,565 4,528 (4)
Mindbody, Inc.First Lien Revolver, LIBOR+8.00% cash due 2/14/2025Internet Services & Infrastructure— (6)(9)(4)(5)
Total Mindbody, Inc.4,616 4,559 4,519 
MRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/20266.50 %Application Software3,877 3,843 3,875 (4)
MRI Software LLCFirst Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026Application Software— (6)(1)(4)(5)
MRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (3)— (4)(5)
Total MRI Software LLC3,877 3,834 3,874 
Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.50% cash due 3/31/20255.50 %Electrical Components & Equipment6,755 6,738 6,738 
OEConnection LLCFirst Lien Term Loan, LIBOR+4.00% cash due 9/25/20264.08 %Application Software7,852 7,816 7,842 (4)
Olaplex, Inc.First Lien Term Loan, LIBOR+6.25% cash due 1/8/20267.25 %Personal Products6,273 6,189 6,226 (4)
Olaplex, Inc.First Lien Revolver, LIBOR+6.25% cash due 1/8/2025Personal Products— (7)(8)(4)(5)
Total Olaplex, Inc.6,273 6,182 6,218 
Park Place Technologies, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 11/10/20276.00 %Internet Services & Infrastructure4,975 4,801 4,981 (4)
Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.00 %Application Software4,503 4,435 4,514 (4)
52

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
Pluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00 %Application Software$6,796 $6,669 $6,667 (4)
Pluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software— (8)(8)(4)(5)
Total Pluralsight, LLC6,796 6,661 6,659 
Sabert CorporationFirst Lien Term Loan, LIBOR+4.50% cash due 12/10/20265.50 %Metal & Glass Containers2,728 2,700 2,738 (4)
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20246.25 %Footwear8,288 8,277 7,874 
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20246.23 %Footwear138 138 131 
Total SHO Holding I Corporation8,426 8,415 8,005 
Sirva Worldwide, Inc.First Lien Term Loan, LIBOR+5.50% cash due 8/4/20255.58 %Diversified Support Services1,087 1,071 1,027 (4)
Sorenson Communications, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 3/17/20266.25 %Communications Equipment2,854 2,825 2,877 
Star US Bidco LLCFirst Lien Term Loan, LIBOR+4.25% cash due 3/17/20275.25 %Industrial Machinery8,255 8,075 8,289 (4)
Supermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20253.88 %Application Software7,823 7,465 7,294 (4)
Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20264.50 %Health Care Facilities4,911 4,895 4,925 
Trench Plate Rental, Co.First Lien Term Loan, LIBOR+4.75% cash due 12/3/20265.75 %Construction Materials3,942 3,882 3,881 
Trench Plate Rental, Co.First Lien Delayed Draw Term Loan, LIBOR+4.75% cash due 12/3/2026Construction Materials— (11)(12)(5)
Trench Plate Rental, Co.First Lien Revolver, LIBOR+4.75% cash due 12/3/20265.75 %Construction Materials24 15 15 (5)
Total Trench Plate Rental, Co.3,966 3,886 3,884 
Veritas US Inc.First Lien Term Loan, LIBOR+5.00% cash due 9/1/20256.00 %Application Software6,435 6,333 6,473 (4)
Verscend Holding Corp.First Lien Term Loan, LIBOR+4.00% cash due 8/27/20254.08 %Health Care Technology4,080 4,052 4,091 
Waystar Technologies, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/22/20264.08 %Health Care Technology5,910 5,880 5,921 
Windstream Services II, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.25 %Integrated Telecommunication Services7,899 7,629 7,948 (4)
WP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.75 %Aerospace & Defense6,000 5,964 5,931 (4)
Total Portfolio Investments$344,196 $346,052 $346,665 
__________
(1) Represents the interest rate as of September 30, 2021. All interest rates are payable in cash, unless otherwise noted.
(2) The interest rate on the principal balance outstanding for all floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate base rate based on each respective credit agreement and the cash interest rate as of period end. All the LIBOR shown above is in U.S. dollars. As of September 30, 2021, the reference rates for SLF JV I's variable rate loans were the 30-day LIBOR at 0.08%, the 60-day LIBOR at 0.11%, the 90-day LIBOR at 0.13%, the 180-day LIBOR at 0.16%, the 360-day LIBOR at 0.24% and the PRIME at 3.25%. Most loans include an interest floor, which generally ranges from 0% to 1%.
(3) Represents the current determination of fair value as of September 30, 2021 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the Company's Board of Directors' valuation process described elsewhere herein.
(4) This investment was held by both the Company and SLF JV I as of September 30, 2021.
(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

53

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




2023. Both the cost and fair value of the Company's SLF JV I Notes were $96.3 million as of eachSeptember 30, 2022. The Company earned interest income of $3.4 million and $9.2 million on the SLF JV I Notes for the three and nine months ended June 30, 2022 and September 30, 2021.2023, respectively. The Company earned interest income of $1.9 million and $5.8 million on the SLF JV I Notes for the three and nine months ended June 30, 2022, respectively. The Company earned interest income of $1.9 million and $5.4 million on the SLF JV I Notes for the three and nine months ended June 30, 2021, respectively. As of June 30, 2022,2023, the SLF JV I Notes bore interest at a rate of one-month LIBOR plus 7.00% per annum with a LIBOR floor of 1.00% and will mature on December 29, 2028.
The cost and fair value of the LLC equity interests in SLF JV I held by the Company were $49.3$54.8 million and $23.0$28.0 million, respectively, as of June 30, 2022,2023, and $49.3 million and $37.7$20.7 million, respectively, as of September 30, 2021.2022. The Company earned $1.1 million and $3.2 million in dividend income for the three and nine months ended June 30, 2023, respectively, with respect to its investment in the LLC equity interests of SLF JV I. The Company earned $0.9 million and $2.0 million in dividend income for the three and nine months ended June 30, 2022, respectively, with respect to its investment in the LLC equity interests of SLF JV I. The Company earned $0.5 million in dividend income for the three and nine months ended June 30, 2021 with respect to its investment in the LLC equity interests of SLF JV I. The LLC equity interests of SLF JV I are generally dividend producing to the extent SLF JV I has residual cash to be distributed on a quarterly basis.
Below is certain summarized financial information for SLF JV I as of June 30, 20222023 and September 30, 20212022 and for the three and nine months ended June 30, 20222023 and 2021:2022:
June 30, 2022September 30, 2021June 30, 2023September 30, 2022
Selected Balance Sheet Information:Selected Balance Sheet Information:Selected Balance Sheet Information:
Investments at fair value (cost June 30, 2022: $358,578; cost September 30, 2021: $346,052)$339,335 $346,665 
Investments at fair value (cost June 30, 2023:$348,782; cost September 30, 2022: $382,673)Investments at fair value (cost June 30, 2023:$348,782; cost September 30, 2022: $382,673)$329,809 $359,625 
Cash and cash equivalentsCash and cash equivalents14,904 23,446 Cash and cash equivalents21,906 14,274 
Restricted cashRestricted cash4,156 4,517 Restricted cash8,715 5,642 
Other assetsOther assets6,653 4,529 Other assets9,798 5,686 
Total assetsTotal assets$365,048 $379,157 Total assets$370,228 $385,227 
Senior credit facility payableSenior credit facility payable$215,000 $215,620 Senior credit facility payable$200,000 $230,000 
SLF JV I Notes payable at fair value (proceeds June 30, 2022: $110,000; proceeds September 30, 2021: $110,000)110,000 110,000 
SLF JV I Notes payable at fair value (proceeds June 30, 2023: $128,750; proceeds September 30, 2022: $110,000)SLF JV I Notes payable at fair value (proceeds June 30, 2023: $128,750; proceeds September 30, 2022: $110,000)128,750 110,000 
Other liabilitiesOther liabilities13,718 10,507 Other liabilities9,509 21,539 
Total liabilitiesTotal liabilities$338,718 $336,127 Total liabilities$338,259 $361,539 
Members' equityMembers' equity26,330 43,030 Members' equity31,969 23,688 
Total liabilities and members' equityTotal liabilities and members' equity$365,048 $379,157 Total liabilities and members' equity$370,228 $385,227 
Three months ended June 30, 2022Three months ended June 30, 2021Nine months ended June 30, 2022Nine months ended June 30, 2021Three months ended June 30, 2023Three months ended June 30, 2022Nine months ended June 30, 2023Nine months ended June 30, 2022
Selected Statements of Operations Information:Selected Statements of Operations Information:Selected Statements of Operations Information:
Interest incomeInterest income$5,796 $5,247 $16,664 $14,535 Interest income$10,312 $5,796 $29,106 $16,664 
Other incomeOther income32 19 105 546 Other income— 32 62 105 
Total investment incomeTotal investment income5,828 5,266 16,769 15,081 Total investment income10,312 5,828 29,168 16,769 
Senior credit facility interest expenseSenior credit facility interest expense1,929 1,430 4,995 4,222 Senior credit facility interest expense4,190 1,929 12,004 4,995 
SLF JV I Notes interest expenseSLF JV I Notes interest expense2,224 2,224 6,673 6,195 SLF JV I Notes interest expense3,859 2,224 10,511 6,673 
Other expensesOther expenses77 56 198 193 Other expenses73 77 249 198 
Total expenses (1)Total expenses (1)4,230 3,710 11,866 10,610 Total expenses (1)8,122 4,230 22,764 11,866 
Net investment incomeNet investment income2,190 1,598 6,404 4,903 
Net unrealized appreciation (depreciation)Net unrealized appreciation (depreciation)(16,411)1,407 (19,856)13,334 Net unrealized appreciation (depreciation)2,652 (16,411)4,075 (19,856)
Net realized gains (losses)Net realized gains (losses)165 426 568 427 Net realized gains (losses)(2,137)165 (4,850)568 
Net income (loss)Net income (loss)$(14,648)$3,389 $(14,385)$18,232 Net income (loss)$2,705 $(14,648)$5,629 $(14,385)
 __________
(1) There are no management fees or incentive fees charged at SLF JV I.


SLF JV I has elected to fair value the SLF JV I Notes issued to the Company and Kemper under FASB ASC Topic 825, Financial Instruments - Fair Value Option ("ASC 825"). The SLF JV I Notes are valued based on the total assets less the total liabilities senior to the SLF JV I Notes in an amount not exceeding par under the EV technique.
During the nine months ended June 30, 2023, the Company sold $18.8 million of senior secured debt investments to SLF JV I for $18.0 million cash consideration, which represented the fair value at the time of sale. A loss of $0.2 million was recognized by the Company on these transactions. During the nine months ended June 30, 2022, the Company sold $9.7 million of senior secured debt investments to SLF JV I for $9.7 million cash consideration, which represented the fair value at the time of sale. A gain of $0.5 million was recognized by the Company on these transactions. The Company did not sell any senior secured debt investments to SLF JV I during the three months ended June 30, 2022. During the three and nine months ended June 30, 2021, the Company sold $10.5 million and $45.5 million, respectively, of senior secured debt investments to SLF JV I, for $10.3 million and $44.8 million cash consideration, respectively, which represented the fair value at the time of sale.
5451

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








OCSI Glick JV LLC
On March 19, 2021, as a result of the consummation of the Mergers, the Company became party to the LLC agreement of Glick JV. The Company co-invests primarily in senior secured loans of middle-market companies with GF Equity Funding through the Glick JV. The Glick JV is managed by a four person Board of Directors, two of whom are selected by the Company and two of whom are selected by GF Equity Funding. The Glick JV is capitalized as transactions are completed, and portfolio decisions and investment decisions in respect of the Glick JV must be approved by the Glick JV investment committee, which consists of one representative selected by the Company and one representative selected by GF Equity Funding (with approval from a representative of each required). Since the Company does not have a controlling financial interest in the Glick JV, the Company does not consolidate the Glick JV.
The members provide capital to the Glick JV in exchange for LLC equity interests, and the Company and GF Debt Funding 2014 LLC ("GF Debt Funding"), an entity advised by affiliates of GF Equity Funding, provide capital to the Glick JV in exchange for subordinated notes issued by the Glick JV (the "Glick JV Notes"). As of June 30, 20222023 and September 30, 2021,2022, the Company and GF Equity Funding owned 87.5% and 12.5%, respectively, of the outstanding LLC equity interests, and the Company and GF Debt Funding owned 87.5% and 12.5%, respectively, of the Glick JV Notes. The Glick JV is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act.
The Glick JV has a senior revolving credit facility with Deutsche Bank AG, New York Branch (the "Glick JV Deutsche Bank Facility"), which, as of June 30, 2022,2023, had a reinvestment period end date and maturity date of May 3, 20232024 and May 3, 2028, respectively, and permitted borrowings of up to $90.0 million (subject to borrowing base and other limitations). Borrowings under the Glick JV Deutsche Bank Facility are secured by all of the assets of the Glick JV and all of the equity interests in the Glick JV and, as of June 30, 2022,2023, bore interest at a rate equal to 3-month LIBORSOFR plus 2.25%2.50% per annum until November 3, 2023, 3-month SOFR plus 2.75% during the remainder of the reinvestment period, 3-month LIBORSOFR plus 2.40%3.25% for the first year after the end of the reinvestment period, 3-month LIBORSOFR plus 2.50%3.35% for the following year and 3-month LIBORSOFR plus 2.75%3.60% thereafter, in each case with a 0.125% LIBORSOFR floor. $80.1$66.1 million and $71.9$82.1 million of borrowings were outstanding under the Glick JV Deutsche Bank Facility as of June 30, 20222023 and September 30, 2021,2022, respectively.
As of June 30, 20222023 and September 30, 2021,2022, the Glick JV had total assets of $141.5$126.8 million and $141.0$146.8 million, respectively. The Glick JV's portfolio consisted of middle-market and other corporate debt securities of 4337 and 3743 portfolio companies as of June 30, 20222023 and September 30, 2021,2022, respectively. The portfolio companies in the Glick JV are in industries similar to those in which the Company may invest directly.The Company's investment in the Glick JV consisted of LLC equity interests and Glick JV Notes of $50.6$49.6 million and $55.6$50.3 million in the aggregate at fair value as of June 30, 20222023 and September 30, 2021,2022, respectively. The Glick JV Notes are junior in right of payment to the repayment of temporary contributions made by the Company to fund investments of the Glick JV that are repaid when GF Equity Funding and GF Debt Funding make their capital contributions and fund their Glick JV Notes, respectively.
As of each of June 30, 20222023 and September 30, 2021,2022, the Glick JV had total capital commitments of $100.0 million, $87.5 million of which was from the Company and the remaining $12.5 million of which was from GF Equity Funding and GF Debt Funding. Approximately $84.0 million in aggregate commitments were funded as of each of June 30, 20222023 and September 30, 2021,2022, of which $73.5 million was from the Company. As of each of June 30, 20222023 and September 30, 2021,2022, the Company had commitments to fund Glick JV Notes of $78.8 million, of which $12.4 million were unfunded. As of each of June 30, 20222023 and September 30, 2021,2022, the Company had commitments to fund LLC equity interests in the Glick JV of $8.7 million, of which $1.6 million were unfunded.


52

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of June 30, 2023 and September 30, 2022:
June 30, 2023September 30, 2022
Senior secured loans (1)$123,126$143,225
Weighted average current interest rate on senior secured loans (2)10.66%8.52%
Number of borrowers in the Glick JV3743
Largest loan exposure to a single borrower (1)$6,313$6,562
Total of five largest loan exposures to borrowers (1)$28,457$28,973
__________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

Glick JV Portfolio as of June 30, 2023

Portfolio CompanyIndustryInvestment TypeIndexSpread Cash Interest Rate (1)(2)PIKMaturity DatePrincipalCostFair Value (3)Notes
ADB Companies, LLCConstruction & EngineeringFirst Lien Term LoanSOFR+6.50%12.00%12/18/2025$587 $579 $576 (4)
ADB Companies, LLCConstruction & EngineeringFirst Lien Term LoanSOFR+6.50%12.00%12/18/20253,824 3,782 3,753 (4)
Alvogen Pharma US, Inc.PharmaceuticalsFirst Lien Term LoanSOFR+7.50%12.89%6/30/20256,313 6,261 6,029 (4)
American Rock Salt Company LLCDiversified Metals & MiningFirst Lien Term LoanSOFR+4.00%9.22%6/9/20282,485 2,367 2,346 
American Tire Distributors, Inc.DistributorsFirst Lien Term LoanSOFR+6.25%11.49%10/20/20282,868 2,832 2,502 (4)
Amplify Finco Pty Ltd.Movies & EntertainmentFirst Lien Term LoanSOFR+4.00%9.39%11/26/20262,903 2,873 2,895 
Amynta Agency Borrower Inc.Property & Casualty InsuranceFirst Lien Term LoanSOFR+5.00%10.20%2/28/20283,000 2,915 2,925 
Anastasia Parent, LLCPersonal Care ProductsFirst Lien Term LoanSOFR+3.75%9.25%8/11/2025910 707 702 (4)
ASP-R-PAC Acquisition Co LLCPaper & Plastic Packaging Products & MaterialsFirst Lien Term LoanSOFR+6.00%11.31%12/29/20271,721 1,695 1,635 (4)
ASP-R-PAC Acquisition Co LLCPaper & Plastic Packaging Products & MaterialsFirst Lien RevolverSOFR+6.00%12/29/2027— (3)(10)(4)(5)
Astra Acquisition Corp.Application SoftwareFirst Lien Term LoanL+5.25%10.44%10/25/20282,078 2,037 1,464 (4)
Asurion, LLCProperty & Casualty InsuranceFirst Lien Term LoanSOFR+4.00%9.20%8/19/20281,985 1,900 1,884 
Asurion, LLCProperty & Casualty InsuranceFirst Lien Term LoanSOFR+4.25%9.47%8/19/2028998 941 951 
Asurion, LLCProperty & Casualty InsuranceSecond Lien Term LoanSOFR+5.25%10.47%1/20/20292,423 2,236 2,039 
athenahealth Group Inc.Health Care TechnologyFirst Lien Term LoanSOFR+3.50%8.59%2/15/20291,777 1,674 1,715 
athenahealth Group Inc.Health Care TechnologyFirst Lien Term LoanSOFR+3.50%2/15/2029— (13)(8)(5)
Aurora Lux Finco S.À.R.L.Airport ServicesFirst Lien Term LoanL+6.00%11.27%12/24/20263,628 3,583 3,479 (4)
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanSOFR+5.00%10.50%6/11/20273,372 3,340 3,284 (4)
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanSOFR+5.00%10.50%6/11/2027802 798 782 (4)
Covetrus, Inc.Health Care DistributorsFirst Lien Term LoanSOFR+5.00%10.24%10/13/20292,773 2,607 2,589 (4)
Curium Bidco S.à.r.l.BiotechnologyFirst Lien Term LoanL+4.00%9.54%7/9/20262,848 2,827 2,838 
DirecTV Financing, LLCCable & SatelliteFirst Lien Term LoanSOFR+5.00%10.22%8/2/20272,528 2,502 2,477 (4)
53

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Portfolio CompanyIndustryInvestment TypeIndexSpread Cash Interest Rate (1)(2)PIKMaturity DatePrincipalCostFair Value (3)Notes
DTI Holdco, Inc.Research & Consulting ServicesFirst Lien Term LoanSOFR+4.75%9.80%4/26/2029$2,978 $2,928 $2,779 (4)
Gibson Brands, Inc.Leisure ProductsFirst Lien Term LoanSOFR+5.00%10.25%8/11/20283,940 3,901 3,191 (4)
Harbor Purchaser Inc.Education ServicesFirst Lien Term LoanSOFR+5.25%10.45%4/9/20293,970 3,871 3,409 (4)
Indivior Finance S.À.R.L.PharmaceuticalsFirst Lien Term LoanSOFR+5.25%10.75%6/30/20263,920 3,872 3,925 
INW Manufacturing, LLCPersonal Care ProductsFirst Lien Term LoanL+5.75%11.29%3/25/20272,281 2,238 1,810 (4)
Iris Holding, Inc.Metal, Glass & Plastic ContainersFirst Lien Term LoanSOFR+4.75%9.90%6/28/20281,985 1,852 1,690 
LaserAway Intermediate Holdings II, LLCHealth Care ServicesFirst Lien Term LoanSOFR+5.75%11.08%10/14/20273,940 3,883 3,876 
LTI Holdings, Inc.Electronic ComponentsFirst Lien Term LoanSOFR+3.50%8.72%9/6/20251,347 1,224 1,297 
MRI Software LLCApplication SoftwareFirst Lien Term LoanSOFR+5.50%10.84%2/10/20261,634 1,621 1,589 (4)
MRI Software LLCApplication SoftwareFirst Lien RevolverSOFR+5.50%2/10/2026— (1)(4)(4)(5)
Northern Star Industries Inc.Electrical Components & EquipmentFirst Lien Term LoanSOFR+4.50%10.00%3/31/20255,211 5,205 5,172 
OEConnection LLCApplication SoftwareFirst Lien Term LoanL+4.00%9.25%9/25/20263,858 3,841 3,802 
Planview Parent, Inc.Application SoftwareFirst Lien Term LoanSOFR+4.00%9.50%12/17/2027685 649 652 
Planview Parent, Inc.Application SoftwareSecond Lien Term LoanSOFR+7.25%12.59%12/18/20282,842 2,799 2,539 (4)
Pluralsight, LLCApplication SoftwareFirst Lien Term LoanSOFR+8.00%13.04%4/6/20275,182 5,018 4,990 (4)
Pluralsight, LLCApplication SoftwareFirst Lien RevolverSOFR+8.00%13.04%4/6/2027180 169 167 (4)(5)
SHO Holding I CorporationFootwearFirst Lien Term LoanL+5.25%10.52%4/27/20246,045 6,039 4,272 
SHO Holding I CorporationFootwearFirst Lien Term LoanL+5.23%10.50%4/27/2024102 102 74 
Spanx, LLCApparel RetailFirst Lien Term LoanSOFR+5.50%10.70%11/20/20284,925 4,849 4,808 (4)
SPX Flow, Inc.Industrial Machinery & Supplies & ComponentsFirst Lien Term LoanSOFR+4.50%9.70%4/5/20295,227 5,023 5,174 
TIBCO Software Inc.Application SoftwareFirst Lien Term LoanSOFR+4.50%9.84%3/30/20292,647 2,435 2,483 (4)
Touchstone Acquisition, Inc.Health Care SuppliesFirst Lien Term LoanSOFR+6.00%11.20%12/29/20283,001 2,954 2,926 (4)
Tribe Buyer LLCHuman Resource & Employment ServicesFirst Lien Term LoanL+4.50%9.69%2/16/20241,570 1,570 931 
Windstream Services II, LLCIntegrated Telecommunication ServicesFirst Lien Term LoanSOFR+6.25%11.45%9/21/20274,848 4,731 4,539 (4)
WP CPP Holdings, LLCAerospace & DefenseFirst Lien Term LoanL+3.75%9.03%4/30/2025985 959 895 (4)
Total Portfolio Investments$123,126 $120,172 $113,833 
__________
(1) Represents the interest rate as of June 30, 2023. All interest rates are payable in cash, unless otherwise noted.
(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to SOFR, LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars. As of June 30, 2023, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 5.19%, the 90-day LIBOR at 5.54%, the 30-day SOFR at 5.10% and the 90-day SOFR at 5.24%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(3) Represents the current determination of fair value as of June 30, 2023 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the valuation process described elsewhere herein.
(4) This investment was held by both the Company and the Glick JV as of June 30, 2023.
(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.
54

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





Glick JV Portfolio as of September 30, 2022

Portfolio CompanyIndustryInvestment TypeIndexSpread Cash Interest Rate (1)(2)PIKMaturity DatePrincipalCostFair Value (3)Notes
ADB Companies, LLCConstruction & EngineeringFirst Lien Term LoanL+6.25%9.80%12/18/2025$4,647 $4,579 $4,567 (4)
Alvogen Pharma IncPharmaceuticalsFirst Lien Term LoanSOFR+7.50%11.20%6/30/20256,562 6,489 6,529 (4)
American Tire Distributors, Inc.DistributorsFirst Lien Term LoanL+6.25%9.03%10/20/20282,889 2,853 2,714 (4)
Amplify Finco Pty Ltd.Movies & EntertainmentFirst Lien Term LoanL+4.25%7.92%11/26/20262,925 2,896 2,823 (4)
Anastasia Parent, LLCPersonal ProductsFirst Lien Term LoanL+3.75%7.42%8/11/2025917 712 734 (4)
ASP-R-PAC Acquisition Co LLCPaper PackagingFirst Lien Term LoanL+6.00%9.67%12/29/20271,734 1,704 1,694 
ASP-R-PAC Acquisition Co LLCPaper PackagingFirst Lien RevolverL+6.00%12/29/2027— (4)(5)(5)
Astra Acquisition Corp.Application SoftwareFirst Lien Term LoanL+5.25%8.37%10/25/20282,078 2,033 1,777 (4)
Asurion, LLCProperty & Casualty InsuranceFirst Lien Term LoanSOFR+4.00%7.70%8/19/20282,000 1,901 1,711 
Asurion, LLCProperty & Casualty InsuranceSecond Lien Term LoanL+5.25%8.37%1/20/20292,423 2,212 1,866 
Aurora Lux Finco S.À.R.L.Airport ServicesFirst Lien Term LoanL+6.00%8.78%12/24/20263,656 3,601 3,476 (4)
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanL+5.00%8.12%6/11/20273,398 3,366 3,279 
BAART Programs, Inc.Health Care ServicesFirst Lien Term LoanL+5.00%8.12%6/11/2027808 800 760 (4)(5)
BYJU's Alpha, Inc.Application SoftwareFirst Lien Term LoanL+6.00%8.98%11/24/20263,970 3,919 2,909 
CITGO Petroleum Corp.Oil & Gas Refining & MarketingFirst Lien Term LoanL+6.25%9.37%3/28/20243,519 3,484 3,529 (4)
City Football Group LimitedMovies & EntertainmentFirst Lien Term LoanL+3.50%6.48%7/21/20282,481 2,469 2,372 
Covetrus, Inc.Health Care DistributorsFirst Lien Term LoanSOFR+5.00%7.65%9/20/20292,280 2,143 2,136 (4)
Curium Bidco S.à.r.l.BiotechnologyFirst Lien Term LoanL+4.00%7.67%7/9/20262,870 2,849 2,756 
DirecTV Financing, LLCCable & SatelliteFirst Lien Term LoanL+5.00%8.12%8/2/20272,730 2,703 2,549 (4)
Domtar CorporationPaper ProductsFirst Lien Term LoanL+5.50%8.26%11/30/20282,503 2,478 2,394 
DTI Holdco, Inc.Research & Consulting ServicesFirst Lien Term LoanSOFR+4.75%7.33%4/26/20293,000 2,943 2,856 (4)
Eagle Parent Corp.Industrial MachineryFirst Lien Term LoanSOFR+4.25%7.80%4/2/20292,488 2,429 2,426 
eResearch Technology, Inc.Application SoftwareFirst Lien Term LoanL+4.50%7.62%2/4/20272,444 2,419 2,286 
Gibson Brands, Inc.Leisure ProductsFirst Lien Term LoanL+5.00%7.94%8/11/20283,970 3,930 3,216 
Harbor Purchaser Inc.Education ServicesFirst Lien Term LoanSOFR+5.25%8.38%4/9/20294,000 3,887 3,655 (4)
Indivior Finance S.À.R.L.PharmaceuticalsFirst Lien Term LoanL+5.25%8.80%6/30/20263,950 3,890 3,886 
INW Manufacturing, LLCPersonal ProductsFirst Lien Term LoanL+5.75%9.42%3/25/20272,375 2,320 2,102 (4)
Iris Holding, Inc.Metal & Glass ContainersFirst Lien Term LoanSOFR+4.75%7.89%6/28/20282,000 1,846 1,844 
LaserAway Intermediate Holdings II, LLCHealth Care ServicesFirst Lien Term LoanL+5.75%8.23%10/14/20273,970 3,903 3,905 
LTI Holdings, Inc.Electronic ComponentsFirst Lien Term LoanL+3.25%6.37%9/6/20251,358 1,192 1,260 
55

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Below is a summary of the Glick JV's portfolio, followed by a listing of the individual loans in the Glick JV's portfolio as of June 30, 2022 and September 30, 2021:
June 30, 2022September 30, 2021
Senior secured loans (1)$141,783$126,512
Weighted average current interest rate on senior secured loans (2)6.85%5.86%
Number of borrowers in the Glick JV4337
Largest loan exposure to a single borrower (1)$6,645$6,907
Total of five largest loan exposures to borrowers (1)$28,564$28,324
__________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.

Glick JV Portfolio as of June 30, 2022
Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
ADB Companies, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 12/18/20258.50%Construction & Engineering$4,714 $4,640 $4,636 (4)
Alvogen Pharma US, Inc.First Lien Term Loan, LIBOR+5.25% cash due 12/31/20237.50%Pharmaceuticals6,645 6,564 5,871 (4)
American Tire Distributors, Inc.First Lien Term Loan, LIBOR+6.25% cash due 10/20/20287.00%Distributors2,897 2,861 2,746 (4)
Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.92%Movies & Entertainment2,933 2,903 2,862 (4)
Anastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20256.00%Personal Products919 714 738 (4)
ASP-R-PAC Acquisition Co LLCFirst Lien Term Loan, LIBOR+6.00% cash due 12/29/20277.67%Paper Packaging1,738 1,706 1,696 
ASP-R-PAC Acquisition Co LLCFirst Lien Revolver, LIBOR+6.00% cash due 12/29/2027Paper Packaging— (4)(5)(5)
Total ASP-R-PAC Acquisition Co LLC1,738 1,702 1,691 
Astra Acquisition Corp.First Lien Term Loan, LIBOR+5.25% cash due 10/25/20286.92%Application Software3,155 3,084 2,758 (4)
Asurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20296.92%Property & Casualty Insurance923 914 789 
Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.63%Airport Services3,666 3,607 3,478 (4)
BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20276.67%Health Care Services3,406 3,375 3,355 
BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20276.60%Health Care Services720 712 699 (4)(5)
Total BAART Programs, Inc.4,126 4,087 4,054 
Brazos Delaware II, LLCFirst Lien Term Loan, LIBOR+4.00% cash due 5/21/20255.60%Oil & Gas Equipment & Services2,802 2,796 2,706 
BYJU's Alpha, Inc.First Lien Term Loan, LIBOR+5.50% cash due 11/24/20267.01%Application Software3,980 3,925 3,403 
CITGO Petroleum Corp.First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.92%Oil & Gas Refining & Marketing3,528 3,493 3,507 (4)
City Football Group LimitedFirst Lien Term Loan, LIBOR+3.50% cash due 7/21/20284.60%Movies & Entertainment2,494 2,481 2,307 
Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+3.75% cash due 7/9/20266.00%Biotechnology2,878 2,856 2,725 
DirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20276.67%Cable & Satellite2,798 2,770 2,583 (4)
Domtar CorporationFirst Lien Term Loan, LIBOR+5.50% cash due 11/30/20286.69%Paper Products2,509 2,484 2,421 
DTI Holdco, Inc.First Lien Term Loan, SOFR+4.75% cash due 4/26/20296.28%Research & Consulting Services3,000 2,941 2,817 (4)
Eagle Parent Corp.First Lien Term Loan, SOFR+4.25% cash due 4/1/20294.75%Industrial Machinery2,494 2,433 2,398 
eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20276.17%Application Software2,450 2,426 2,270 
56

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Portfolio CompanyPortfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)NotesPortfolio CompanyIndustryInvestment TypeIndexSpread Cash Interest Rate (1)(2)PIKMaturity DatePrincipalCostFair Value (3)Notes
Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20286.41%Leisure Products$3,980 $3,940 $3,403 
Harbor Purchaser Inc.First Lien Term Loan, SOFR+5.25% cash due 4/9/20296.88%Education Services4,000 3,883 3,638 (4)
Indivior Finance S.À.R.L.First Lien Term Loan, LIBOR+5.51% cash due 6/30/20267.57%Pharmaceuticals3,960 3,895 3,868 
Integro Parent, Inc.First Lien Term Loan, LIBOR+2.50% cash due 10/31/20224.00%Insurance Brokers3,217 3,221 3,041 
INW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 3/25/20278.00%Personal Products2,406 2,348 2,274 (4)
Iris Holding, Inc.First Lien Term Loan, SOFR+4.75% cash due 6/15/20286.86%Metal & Glass Containers2,000 1,840 1,832 
LaserAway Intermediate Holdings II, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 10/14/20276.79%Health Care Services3,980 3,909 3,923 
LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.50% cash due 9/6/20255.17%Electronic Components1,362 1,180 1,271 
MRI Software LLCMRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/20267.75%Application Software1,651 1,636 1,618 (4)MRI Software LLCApplication SoftwareFirst Lien Term LoanL+5.50%9.17%2/10/2026$1,647 $1,632 $1,600 (4)
MRI Software LLCMRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (1)(3)(4)(5)MRI Software LLCApplication SoftwareFirst Lien RevolverL+5.50%2/10/2026— (1)(4)(4)(5)
Total MRI Software LLC1,651 1,635 1,615 
Northern Star Industries Inc.Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.50% cash due 3/31/20256.55%Electrical Components & Equipment5,266 5,256 5,108 Northern Star Industries Inc.Electrical Components & EquipmentFirst Lien Term LoanL+4.75%7.87%3/31/20255,252 5,243 5,095 
OEConnection LLCOEConnection LLCFirst Lien Term Loan, LIBOR+4.00% cash due 9/25/20265.67%Application Software3,898 3,880 3,635 (4)OEConnection LLCApplication SoftwareFirst Lien Term LoanL+4.00%7.12%9/25/20263,888 3,871 3,752 (4)
Planview Parent, Inc.Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.92%Application Software2,842 2,799 2,728 (4)Planview Parent, Inc.Application SoftwareSecond Lien Term LoanL+7.25%10.92%12/18/20282,842 2,799 2,728 (4)
Pluralsight, LLCPluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00%Application Software4,465 4,394 4,340 (4)Pluralsight, LLCApplication SoftwareFirst Lien Term LoanL+8.00%10.68%4/6/20274,465 4,398 4,325 (4)
Pluralsight, LLCPluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software— (5)(9)(4)(5)Pluralsight, LLCApplication SoftwareFirst Lien RevolverL+8.00%4/6/2027— (5)(10)(4)(5)
Total Pluralsight, LLC4,465 4,389 4,331 
Sabert CorporationSabert CorporationFirst Lien Term Loan, LIBOR+4.50% cash due 12/10/20266.19%Metal & Glass Containers1,728 1,710 1,645 (4)Sabert CorporationMetal & Glass ContainersFirst Lien Term LoanL+4.50%7.63%12/10/20261,691 1,674 1,623 (4)
SHO Holding I CorporationSHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20246.49%Footwear6,110 6,097 5,560 SHO Holding I CorporationFootwearFirst Lien Term LoanL+5.25%8.06%4/27/20246,094 6,082 5,332 
SHO Holding I CorporationSHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20246.47%Footwear102 102 93 SHO Holding I CorporationFootwearFirst Lien Term LoanL+5.23%8.04%4/27/2024102 102 90 
Total SHO Holding I Corporation6,212 6,199 5,653 
Spanx, LLCSpanx, LLCFirst Lien Term Loan, LIBOR+5.50% cash due 11/20/20287.10%Apparel Retail4,975 4,884 4,857 (4)Spanx, LLCApparel RetailFirst Lien Term LoanL+5.25%8.30%11/20/20284,962 4,876 4,845 (4)
SPX Flow, Inc.SPX Flow, Inc.First Lien Term Loan, LIBOR+4.60% cash due 4/5/20296.13%Industrial Machinery5,466 5,222 5,108 SPX Flow, Inc.Industrial MachineryFirst Lien Term LoanSOFR+4.50%7.63%4/5/20296,000 5,734 5,572 (4)
Supermoose Borrower, LLCSupermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20256.00%Application Software2,828 2,710 2,567 (4)Supermoose Borrower, LLCApplication SoftwareFirst Lien Term LoanL+3.75%7.42%8/29/20252,820 2,712 2,487 (4)
Surgery Center Holdings, Inc.Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20264.95%Health Care Facilities3,386 3,374 3,165 Surgery Center Holdings, Inc.Health Care FacilitiesFirst Lien Term LoanL+3.75%6.51%8/31/20263,377 3,365 3,213 
TIBCO Software Inc.TIBCO Software Inc.Application SoftwareFirst Lien Term LoanSOFR+4.50%8.15%3/30/20292,654 2,415 2,388 (4)
Touchstone Acquisition, Inc.Touchstone Acquisition, Inc.First Lien Term Loan, LIBOR+6.00% cash due 12/29/20287.67%Health Care Supplies3,031 2,975 2,940 (4)Touchstone Acquisition, Inc.Health Care SuppliesFirst Lien Term LoanL+6.00%9.12%12/29/20283,024 2,970 2,963 (4)
Tribe Buyer LLCTribe Buyer LLCFirst Lien Term Loan, LIBOR+4.50% cash due 2/16/20246.17%Human Resource & Employment Services1,587 1,586 1,326 Tribe Buyer LLCHuman Resource & Employment ServicesFirst Lien Term LoanL+4.50%7.62%2/16/20241,583 1,582 1,266 
Windstream Services II, LLCWindstream Services II, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.92%Integrated Telecommunication Services4,899 4,753 4,603 (4)Windstream Services II, LLCIntegrated Telecommunication ServicesFirst Lien Term LoanL+6.25%9.37%9/21/20274,886 4,747 4,447 (4)
WP CPP Holdings, LLCWP CPP Holdings, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 4/30/20254.99%Aerospace & Defense995 954 836 (4)WP CPP Holdings, LLCAerospace & DefenseFirst Lien Term LoanL+3.75%6.56%4/30/2025993 955 892 (4)
WP CPP Holdings, LLCWP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.99%Aerospace & Defense3,000 2,985 2,482 (4)WP CPP Holdings, LLCAerospace & DefenseSecond Lien Term LoanL+7.75%10.56%4/30/20263,000 2,986 2,534 (4)
Total WP CPP Holdings, LLC3,995 3,939 3,318 
Total Portfolio InvestmentsTotal Portfolio Investments$141,783 $139,208 $132,609 Total Portfolio Investments$143,225 $140,083 $133,144 
__________
(1) Represents the interest rate as of JuneSeptember 30, 2022. All interest rates are payable in cash, unless otherwise noted.
(2) The interest rate on the principal balance outstanding for most of the floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. Certain loans may also be indexed to SOFR. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over the reference rates based on each respective credit agreement and the cash interest rate as of period end. All
57

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




LIBOR shown above is in U.S. dollars. As of JuneSeptember 30, 2022, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 1.67%3.12%, the 90-day LIBOR at 2.25%, the 180-day LIBOR at 2.88% and the 360-day LIBOR at 3.61%3.67%, the 30-day SOFR at 1.53%3.03% and the 90-day SOFR at 2.05%3.55%. Most loans include an interest floor, which generally ranges from 0% to 1%. SOFR based contracts may include a credit spread adjustment that is charged in addition to the base rate and the stated spread.
(3) Represents the current determination of fair value as of JuneSeptember 30, 2022 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the Company's Board of Directors' valuation process described elsewhere herein.
(4) This investment was held by both the Company and the Glick JV as of JuneSeptember 30, 2022.
(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.

Glick JV Portfolio as of September 30, 2021
Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
ADB Companies, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 12/18/20257.25%Construction & Engineering$3,866 $3,783 $3,822 (4)
Alvogen Pharma US, Inc.First Lien Term Loan, LIBOR+5.25% cash due 12/31/20236.25%Pharmaceuticals6,907 6,780 6,687 (4)
Amplify Finco Pty Ltd.First Lien Term Loan, LIBOR+4.25% cash due 11/26/20265.00%Movies & Entertainment2,955 2,925 2,880 (4)
Anastasia Parent, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/11/20253.88%Personal Products1,667 1,310 1,416 
Asurion, LLCSecond Lien Term Loan, LIBOR+5.25% cash due 1/20/20295.33%Property & Casualty Insurance3,000 2,970 2,990 
Aurora Lux Finco S.À.R.L.First Lien Term Loan, LIBOR+6.00% cash due 12/24/20267.00%Airport Services3,694 3,625 3,476 (4)
BAART Programs, Inc.First Lien Term Loan, LIBOR+5.00% cash due 6/11/20276.00%Health Care Services3,192 3,160 3,184 
BAART Programs, Inc.First Lien Delayed Draw Term Loan, LIBOR+5.00% cash due 6/11/20276.00%Health Care Services240 232 238 (5)
Total BAART Programs, Inc.3,432 3,392 3,422 
Brazos Delaware II, LLCFirst Lien Term Loan, LIBOR+4.00% cash due 5/21/20254.08%Oil & Gas Equipment & Services4,835 4,823 4,772 
CITGO Petroleum Corp.First Lien Term Loan, LIBOR+6.25% cash due 3/28/20247.25%Oil & Gas Refining & Marketing3,555 3,520 3,567 (4)
City Football Group LimitedFirst Lien Term Loan, LIBOR+3.50% cash due 7/21/20284.00%Movies & Entertainment2,500 2,488 2,497 
Curium Bidco S.à.r.l.First Lien Term Loan, LIBOR+4.00% cash due 7/9/20264.13%Biotechnology4,900 4,863 4,903 
DirecTV Financing, LLCFirst Lien Term Loan, LIBOR+5.00% cash due 8/2/20275.75%Cable & Satellite3,000 2,970 3,005 (4)
Enviva Holdings, LPFirst Lien Term Loan, LIBOR+5.50% cash due 2/17/20266.50%Forest Products3,919 3,879 3,928 
eResearch Technology, Inc.First Lien Term Loan, LIBOR+4.50% cash due 2/4/20275.50%Application Software2,469 2,444 2,484 
Gibson Brands, Inc.First Lien Term Loan, LIBOR+5.00% cash due 8/11/20285.75%Leisure Products4,000 3,960 3,981 
Houghton Mifflin Harcourt Publishers Inc.First Lien Term Loan, LIBOR+6.25% cash due 11/22/20247.25%Education Services431 420 433 (4)
Indivior Finance S.À.R.L.First Lien Term Loan, LIBOR+5.25% cash due 6/30/20266.00%Pharmaceuticals3,990 3,913 3,977 
Integro Parent, Inc.First Lien Term Loan, LIBOR+5.75% cash due 10/31/20226.75%Insurance Brokers3,229 3,221 3,173 
Intelsat Jackson Holdings S.A.First Lien Term Loan, LIBOR+4.75% cash due 7/13/20225.75%Alternative Carriers4,167 4,112 4,203 
Intelsat Jackson Holdings S.A.First Lien Delayed Draw Term Loan, LIBOR+4.75% cash due 7/13/2022Alternative Carriers— (11)(5)
Total Intelsat Jackson Holdings S.A.4,167 4,101 4,210 
INW Manufacturing, LLCFirst Lien Term Loan, LIBOR+5.75% cash due 5/7/20276.50%Personal Products2,469 2,399 2,419 (4)
Lightstone Holdco LLCFirst Lien Term Loan, LIBOR+3.75% cash due 1/30/20244.75%Electric Utilities3,439 3,115 2,855 
LTI Holdings, Inc.First Lien Term Loan, LIBOR+3.50% cash due 9/6/20253.58%Electronic Components1,372 1,147 1,356 
58

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Portfolio CompanyInvestment Type Cash Interest Rate (1)(2)IndustryPrincipalCostFair Value (3)Notes
MRI Software LLCFirst Lien Term Loan, LIBOR+5.50% cash due 2/10/20266.50%Application Software$1,635 $1,621 $1,634 (4)
MRI Software LLCFirst Lien Delayed Draw Term Loan, LIBOR+5.50% cash due 2/10/2026Application Software— (1)— (4)(5)
MRI Software LLCFirst Lien Revolver, LIBOR+5.50% cash due 2/10/2026Application Software— (1)— (4)(5)
   Total MRI Software LLC1,635 1,619 1,634 
Northern Star Industries Inc.First Lien Term Loan, LIBOR+4.50% cash due 3/31/20255.50%Electrical Components & Equipment5,308 5,294 5,294 
OEConnection LLCFirst Lien Term Loan, LIBOR+4.00% cash due 9/25/20264.08%Application Software3,926 3,908 3,921 (4)
Olaplex, Inc.First Lien Term Loan, LIBOR+6.25% cash due 1/8/20267.25%Personal Products3,502 3,454 3,475 (4)
Olaplex, Inc.First Lien Revolver, LIBOR+6.25% cash due 1/8/2025Personal Products— (4)(5)(4)(5)
Total Olaplex, Inc.3,502 3,450 3,470 
Planview Parent, Inc.Second Lien Term Loan, LIBOR+7.25% cash due 12/18/20288.00%Application Software2,842 2,799 2,849 (4)
Pluralsight, LLCFirst Lien Term Loan, LIBOR+8.00% cash due 4/6/20279.00%Application Software4,465 4,383 4,380 (4)
Pluralsight, LLCFirst Lien Revolver, LIBOR+8.00% cash due 4/6/2027Application Software— (6)(6)(4)(5)
Total Pluralsight, LLC4,465 4,377 4,374 
Sabert CorporationFirst Lien Term Loan, LIBOR+4.50% cash due 12/10/20265.50%Metal & Glass Containers1,819 1,800 1,825 (4)
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.25% cash due 4/27/20246.25%Footwear6,159 6,140 5,851 
SHO Holding I CorporationFirst Lien Term Loan, LIBOR+5.23% cash due 4/27/20246.23%Footwear102 102 97 
Total SHO Holding I Corporation6,261 6,242 5,948 
Supermoose Borrower, LLCFirst Lien Term Loan, LIBOR+3.75% cash due 8/29/20253.88%Application Software2,850 2,703 2,657 (4)
Surgery Center Holdings, Inc.First Lien Term Loan, LIBOR+3.75% cash due 8/31/20264.50%Health Care Facilities4,911 4,895 4,925 
Tribe Buyer LLCFirst Lien Term Loan, LIBOR+4.50% cash due 2/16/20245.50%Human Resource & Employment Services1,599 1,598 1,354 
Verscend Holding Corp.First Lien Term Loan, LIBOR+4.00% cash due 8/27/20254.08%Health Care Technology1,721 1,709 1,725 
Waystar Technologies, Inc.First Lien Term Loan, LIBOR+4.00% cash due 10/22/20264.08%Health Care Technology3,940 3,920 3,947 
Windstream Services II, LLCFirst Lien Term Loan, LIBOR+6.25% cash due 9/21/20277.25%Integrated Telecommunication Services4,937 4,768 4,967 (4)
WP CPP Holdings, LLCSecond Lien Term Loan, LIBOR+7.75% cash due 4/30/20268.75%Aerospace & Defense3,000 2,982 2,965 (4)
Total Portfolio Investments$126,512 $124,112 $124,108 
__________
(1) Represents the interest rate as of September 30, 2021. All interest rates are payable in cash, unless otherwise noted.
(2) The interest rate on the principal balance outstanding for all floating rate loans is indexed to LIBOR and/or an alternate base rate (e.g., prime rate), which typically resets semi-annually, quarterly, or monthly at the borrower's option. The borrower may also elect to have multiple interest reset periods for each loan. For each of these loans, the Company has provided the applicable margin over LIBOR or the alternate base rate based on each respective credit agreement and the cash interest rate as of period end. All LIBOR shown above is in U.S. dollars. As of September 30, 2021, the reference rates for the Glick JV's variable rate loans were the 30-day LIBOR at 0.08%, the 60-day LIBOR at 0.11%, the 90-day LIBOR at 0.13%, the 180-day LIBOR at 0.16% and the 360-day LIBOR at 0.24%. Most loans include an interest floor, which generally ranges from 0% to 1%.
(3) Represents the current determination of fair value as of September 30, 2021 utilizing a similar technique as the Company in accordance with ASC 820. However, the determination of such fair value is not included in the Company's Board of Directors' valuation process described elsewhere herein.
(4) This investment was held by both the Company and the Glick JV as of September 30, 2021.
(5) Investment had undrawn commitments. Unamortized fees are classified as unearned income which reduces cost basis, which may result in a negative cost basis. A negative fair value may result from the unfunded commitment being valued below par.


The cost and fair value of the Company's aggregate investment in the Glick JV was $50.4$50.0 million and $50.6$49.6 million, respectively, as of June 30, 2022.2023. The cost and fair value of the Company's aggregate investment in the Glick JV was
59

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




$50.7 $50.2 million and $55.6$50.3 million, respectively, as of September 30, 2021.2022. For the three and nine months ended June 30, 2023, the Company's investment in the Glick JV Notes earned interest income of $1.8 million and $5.0 million, respectively. For the three and nine months ended June 30, 2022, the Company's investment in the Glick JV Notes earned interest income of $1.2 million and $3.3 million, respectively. For the three months ended June 30, 2021, the Company's investment in the Glick JV Notes earned interest income of $1.0 million. For the period from March 19, 2021 to June 30, 2021, the Company's investment in the Glick JV Notes earned interest income of $1.1 million. The Company did not earn dividend income for the three and nine months ended June 30, 20222023 and for the period from March 19, 2021 to June 30, 20212022 with respect to its investment in the LLC equity interest of the Glick JV. The LLC equity interests of the Glick JV are income producing to the extent there is residual cash to be distributed on a quarterly basis. As of June 30, 2022,2023, the Glick JV Notes bore interest at a rate of one-month LIBOR plus 4.50% per annum and will mature on October 20, 2028.
56

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Below is certain summarized financial information for the Glick JV as of June 30, 20222023 and September 30, 20212022 and for the three and nine months ended June 30, 20222023 and for the three months ended June 30, 2021 and for the period from March 19, 2021 to June 30, 2021:2022:
June 30, 2022September 30, 2021June 30, 2023September 30, 2022
Selected Balance Sheet Information:Selected Balance Sheet Information:Selected Balance Sheet Information:
Investments at fair value (cost June 30, 2022: $139,208; September 30, 2021: $124,112)$132,609 $124,108 
Investments at fair value (cost June 30, 2023: $120,172; September 30, 2022: $140,083)Investments at fair value (cost June 30, 2023: $120,172; September 30, 2022: $140,083)$113,833 $133,144 
Cash and cash equivalentsCash and cash equivalents2,677 14,087 Cash and cash equivalents8,895 7,021 
Restricted cashRestricted cash1,387 1,055 Restricted cash1,812 1,788 
Other assetsOther assets4,792 1,750 Other assets2,284 4,855 
Total assetsTotal assets$141,465 $141,000 Total assets$126,824 $146,808 
Senior credit facility payableSenior credit facility payable$80,082 $71,882 Senior credit facility payable$66,082 $82,082 
Glick JV Notes payable at fair value (proceeds June 30, 2022: $68,885; September 30, 2021: $70,525)57,837 63,522 
Glick JV Notes payable at fair value (proceeds June 30, 2023: $66,684; September 30, 2022: $68,185)Glick JV Notes payable at fair value (proceeds June 30, 2023: $66,684; September 30, 2022: $68,185)56,723 57,463 
Other liabilitiesOther liabilities3,546 5,596 Other liabilities4,019 7,263 
Total liabilitiesTotal liabilities$141,465 $141,000 Total liabilities$126,824 $146,808 
Members' equityMembers' equity— — Members' equity— — 
Total liabilities and members' equityTotal liabilities and members' equity$141,465 $141,000 Total liabilities and members' equity$126,824 $146,808 
Three months ended June 30, 2022Three months ended June 30, 2021Nine months ended June 30, 2022For the period from March 19, 2021 to June 30, 2021For the three months ended June 30, 2023For the three months ended June 30, 2022For the nine months ended June 30, 2023For the nine months ended June 30, 2022
Selected Statements of Operations Information:Selected Statements of Operations Information:Selected Statements of Operations Information:
Interest incomeInterest income$2,416 $2,161 $6,796 $2,465 Interest income$3,576 $2,416 $10,488 $6,796 
Fee incomeFee income47 56 82 59 Fee income— 47 35 82 
Total investment incomeTotal investment income2,463 2,217 6,878 2,524 Total investment income3,576 2,463 10,523 6,878 
Senior credit facility interest expenseSenior credit facility interest expense694 557 1,742 646 Senior credit facility interest expense1,400 694 4,002 1,742 
Glick JV Notes interest expenseGlick JV Notes interest expense860 830 2,479 950 Glick JV Notes interest expense1,577 860 4,394 2,479 
Other expensesOther expenses59 48 127 54 Other expenses70 59 148 127 
Total expenses (1)Total expenses (1)1,613 1,435 4,348 1,650 Total expenses (1)3,047 1,613 8,544 4,348 
Net investment incomeNet investment income529 850 1,979 2,530 
Net unrealized appreciation (depreciation)Net unrealized appreciation (depreciation)(753)(778)(2,549)(902)Net unrealized appreciation (depreciation)431 (753)(159)(2,549)
Realized gain (loss)Realized gain (loss)(97)(4)19 28 Realized gain (loss)(960)(97)(1,820)19 
Net income (loss)Net income (loss)$ $ $ $ Net income (loss)$ $ $ $ 
__________
(1) There are no management fees or incentive fees charged at the Glick JV.
The Glick JV has elected to fair value the Glick JV Notes issued to the Company and GF Debt Funding under FASB ASC Topic 825, Financial Instruments - Fair Value Option.825. The Glick JV Notes are valued based on the total assets less the liabilities senior to the Glick JV Notes in an amount not exceeding par under the EV technique.


During the three and nine months ended June 30, 20222023 and the period from March 19, 2021 to June 30, 2021,2022, the Company did not sell any debt investments to the Glick JV.
57

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





Note 4. Fee Income
For the three and nine months ended June 30, 2023, the Company recorded total fee income of $1.6 million and $6.0 million, respectively, of which $0.2 million and $0.8 million, respectively, was recurring in nature. For the three and nine months ended June 30, 2022, the Company recorded total fee income of $2.3 million and $5.1 million, respectively, of which $0.2 million and $0.7 million, respectively, was recurring in nature. For the three and nine
60

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




months ended June 30, 2021, the Company recorded total fee income of $7.8 million and $13.5 million, respectively, of which $0.1 million and $0.3 million, respectively, was recurring in nature. Recurring fee income primarily consisted of servicing fees and certain exit fees.


Note 5. Share Data and Net Assets
The share and per share information for periods prior to March 31, 2023 disclosed in Note 5 have been retroactively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
Earnings per Share
The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the three and nine months ended June 30, 20222023 and 2021:2022:
(Share amounts in thousands)(Share amounts in thousands)Three months ended
June 30, 2022
Three months ended
June 30, 2021
Nine months ended
June 30, 2022
Nine months ended
June 30, 2021
(Share amounts in thousands)Three months ended
June 30, 2023
Three months ended
June 30, 2022
Nine months ended
June 30, 2023
Nine months ended
June 30, 2022
Earnings (loss) per common share — basic and diluted:Earnings (loss) per common share — basic and diluted:Earnings (loss) per common share — basic and diluted:
Net increase (decrease) in net assets resulting from operationsNet increase (decrease) in net assets resulting from operations$(37,834)$47,038 $16,015 $200,699 Net increase (decrease) in net assets resulting from operations$36,685 $(37,834)$71,379 $16,015 
Weighted average common shares outstanding — basic and dilutedWeighted average common shares outstanding — basic and diluted183,370 180,361 181,778 155,970 Weighted average common shares outstanding — basic and diluted77,080 61,123 70,431 60,593 
Earnings (loss) per common share — basic and dilutedEarnings (loss) per common share — basic and diluted$(0.21)$0.26 $0.09 $1.29 Earnings (loss) per common share — basic and diluted$0.48 $(0.62)$1.01 $0.26 

Changes in Net Assets

The following table presents the changes in net assets for the three and nine months ended June 30, 2022:
Common Stock
(Share amounts in thousands)SharesPar ValueAdditional paid-in-capitalAccumulated Overdistributed EarningsTotal Net Assets
Balance as of September 30, 2021180,361 $1,804 $1,804,354 $(493,335)$1,312,823 
Net investment income32,29532,295
Net unrealized appreciation (depreciation)(4,586)(4,586)
Net realized gains (losses)9,3219,321
(Provision) benefit for taxes on realized and unrealized gains (losses)2,3782,378
Distributions to stockholders(27,956)(27,956)
Issuance of common stock under dividend reinvestment plan1081785786
Balance as of December 31, 2021180,469$1,805$1,805,139$(481,883)$1,325,061
Net investment income— 40,09840,098
Net unrealized appreciation (depreciation)(27,038)(27,038)
Net realized gains (losses)1,4021,402
(Provision) benefit for taxes on realized and unrealized gains (losses)(21)(21)
Distributions to stockholders(29,271)(29,271)
Issuance of common stock in connection with the "at the market" offering2,6322619,35319,379
Issuance of common stock under dividend reinvestment plan1041765766
Balance as of March 31, 2022183,205 $1,832 $1,825,257 $(496,713)$1,330,376 
Net investment income— 40,37040,370
Net unrealized appreciation (depreciation)(86,755)(86,755)
Net realized gains (losses)9,2129,212
(Provision) benefit for taxes on realized and unrealized gains (losses)(661)(661)
Distributions to stockholders(30,256)(30,256)
Issuance of common stock in connection with the "at the market" offering16921,2411,243
Issuance of common stock under dividend reinvestment plan1311873874
Repurchases of common stock under dividend reinvestment plan(131)(1)(873)(874)
Balance as of June 30, 2022183,374 $1,834 $1,826,498 $(564,803)$1,263,529 


6158

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Changes in Net Assets

The following table presents the changes in net assets for the three and nine months ended June 30, 2021:2023:

Common Stock
(Share amounts in thousands)SharesPar ValueAdditional paid-in-capitalAccumulated Overdistributed EarningsTotal Net Assets
Balance as of September 30, 202261,125 $611 $1,827,721 $(582,769)$1,245,563 
Net investment income— 38,80838,808
Net unrealized appreciation (depreciation)(22,982)(22,982)
Net realized gains (losses)(3,203)(3,203)
(Provision) benefit for taxes on realized and unrealized gains (losses)549549
Distributions to stockholders(58,679)(58,679)
Issuance of common stock under dividend reinvestment plan9511,9321,933
Balance as of December 31, 202261,220 $612 $1,829,653 $(628,276)$1,201,989 
Net investment income— 45,97845,978
Net unrealized appreciation (depreciation)(18,279)(18,279)
Net realized gains (losses)(6,111)(6,111)
(Provision) benefit for taxes on realized and unrealized gains (losses)(66)(66)
Distributions to stockholders(42,395)(42,395)
Issuance of common stock in connection with the OSI2 Merger15,860159333,875334,034
Issuance of common stock under dividend reinvestment plan6811,2941,295
Repurchase of common stock under dividend reinvestment plan(68)(1)(1,294)(1,295)
Balance as of March 31, 202377,080 $771 $2,163,528 $(649,149)$1,515,150 
Net investment income— 48,41348,413
Net unrealized appreciation (depreciation)(1,039)(1,039)
Net realized gains (losses)(10,603)(10,603)
(Provision) benefit for taxes on realized and unrealized gains (losses)(86)(86)
Distributions to stockholders(42,394)(42,394)
Issuance of common stock under dividend reinvestment plan5711,1221,123
Repurchase of common stock under dividend reinvestment plan(57)(1)(1,122)(1,123)
Balance as of June 30, 202377,080 $771 $2,163,528 $(654,858)$1,509,441 
Common Stock
(Share amounts in thousands)SharesPar ValueAdditional paid-in-capitalAccumulated Overdistributed EarningsTotal Net Assets
Balance as of September 30, 2020140,961 $1,409 $1,487,774 $(574,304)$914,879 
Net investment income10,01810,018
Net unrealized appreciation (depreciation)47,55647,556
Net realized gains (losses)8,2158,215
Provision for income tax (expense) benefit(245)(245)
Distributions to stockholders(15,506)(15,506)
Issuance of common stock under dividend reinvestment plan941527528
Repurchases of common stock under dividend reinvestment plan(94)(1)(527)(528)
Balance as of December 31, 2020140,961 $1,409 $1,487,774 $(524,266)$964,917 
Net investment income18,11418,114
Net unrealized appreciation (depreciation)65,14465,144
Net realized gains (losses)5,8565,856
Provision for income tax (expense) benefit(997)(997)
Distributions to stockholders(16,915)(16,915)
Issuance of common stock in connection with the Mergers39,400395242,309242,704
Issuance of common stock under dividend reinvestment plan821510511
Repurchases of common stock under dividend reinvestment plan(82)(1)(510)(511)
Balance as of March 31, 2021180,361 $1,804 $1,730,083 $(453,064)$1,278,823 
Net investment income35,93235,932
Net unrealized appreciation (depreciation)3,9173,917
Net realized gains (losses)8,6108,610
(Provision) benefit for taxes on realized and unrealized gains (losses)(1,421)(1,421)
Distributions to stockholders(23,447)(23,447)
Issuance of common stock under dividend reinvestment plan771519520
Repurchases of common stock under dividend reinvestment plan(77)(1)(519)(520)
Balance as of June 30, 2021180,361 $1,804 $1,730,083 $(429,473)$1,302,414 
59

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)





The following table presents the changes in net assets for the three and nine months ended June 30, 2022:
Common Stock
SharesPar ValueAdditional paid-in-capitalAccumulated Overdistributed EarningsTotal Net Assets
Balance as of September 30, 202160,120 $601 $1,805,557 $(493,335)$1,312,823 
Net investment income32,29532,295
Net unrealized appreciation (depreciation)(4,586)(4,586)
Net realized gains (losses)9,3219,321
(Provision) benefit for taxes on realized and unrealized gains (losses)2,3782,378
Distributions to stockholders(27,956)(27,956)
Issuance of common stock under dividend reinvestment plan361785786
Balance as of December 31, 202160,156 $602 $1,806,342 $(481,883)$1,325,061 
Net investment income— 40,09840,098
Net unrealized appreciation (depreciation)(27,038)(27,038)
Net realized gains (losses)1,4021,402
(Provision) benefit for taxes on realized and unrealized gains (losses)(21)(21)
Distributions to stockholders(29,271)(29,271)
Issuance of common stock in connection with the "at the market" offering877919,37019,379
Issuance of common stock under dividend reinvestment plan35766766
Balance as of March 31, 202261,068 $611 $1,826,478 $(496,713)$1,330,376 
Net investment income— 40,37040,370
Net unrealized appreciation (depreciation)(86,755)(86,755)
Net realized gains (losses)9,2129,212
(Provision) benefit for taxes on realized and unrealized gains (losses)(661)(661)
Distributions to stockholders(30,256)(30,256)
Issuance of common stock in connection with the "at the market" offering571,2431,243
Issuance of common stock under dividend reinvestment plan441873874
Repurchases of common stock under dividend reinvestment plan(44)(1)(873)(874)
Balance as of June 30, 202261,125 $611 $1,827,721 $(564,803)$1,263,529 


Distributions
Distributions to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the Board of Directors and is based on management’s estimate of the Company’s annual taxable income. Net realized capital gains, if any, may be distributed to stockholders or retained for reinvestment.
The Company has adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of any distributions the Company declares in cash on behalf of its stockholders, unless a stockholder elects to receive cash. As a result, if the Company’s Board of Directors declares a cash distribution, then the Company’s stockholders who have not “opted out” of the Company’s DRIP will have their cash distribution automatically reinvested in additional shares of the Company’s common stock, rather than receiving the cash distribution. If the Company’s shares are trading at a premium to net asset value, the Company typically issues new shares to implement the DRIP with such shares issued at the greater of the most recently computed net asset value per share of common stock or 95% of the current market price per share of common stock on the payment date for such distribution. If the Company’s shares are trading at a discount to net asset value, the Company typically purchases shares in the open market in connection with the Company’s obligations under the DRIP.


For income tax purposes, the Company has reported its distributions for the 20212022 calendar year as ordinary income. The character of such distributions was appropriately reported to the Internal Revenue Service and stockholders for the 20212022 calendar year. To the extent the Company’s taxable earnings for a fiscal and taxable year fall below the amount of distributions paid for the fiscal and taxable year, a portion of the total amount of the Company’s distributions for the fiscal and taxable year is deemed a return of capital for U.S. federal income tax purposes to the Company’s stockholders.
6260

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the nine months ended June 30, 20222023 and 2021:2022:
Date DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued
DRIP Shares
Value (3)
October 13, 2021December 15, 2021December 31, 2021$0.155 $ 27.2 million107,971 (1)$ 0.8 million
January 28, 2022March 15, 2022March 31, 20220.16 28.5 million104,411 (1)0.8 million
April 29, 2022June 15, 2022June 30, 20220.165 29.4 million131,028 (2)0.9 million
Total for the nine months ended June 30, 2022$0.48 $ 85.1 million343,410 $ 2.4 million
Date DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued (2)
DRIP Shares
Value (3)
November 13, 2020December 15, 2020December 31, 2020$0.11 $ 15.0 million93,964 $ 0.5 million
January 29, 2021March 15, 2021March 31, 20210.12 16.4 million81,702 0.5 million
April 30, 2021June 15, 2021June 30, 20210.13 22.9 million76,979 0.5 million
Total for the nine months ended June 30, 2021$0.36 $ 54.3 million252,645 $ 1.6 million
DistributionDate DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution (3)
DRIP Shares
Issued
DRIP Shares
Value (3)
QuarterlyNovember 10, 2022December 15, 2022December 30, 2022$0.54 $32.0 million53,369 (1)$1.1 million
SpecialNovember 10, 2022December 15, 2022December 30, 20220.42 24.8 million41,510 (1)0.8 million
QuarterlyJanuary 27, 2023March 15, 2023March 31, 20230.55 41.1 million68,412 (2)1.3 million
QuarterlyApril 28, 2023June 15, 2023June 30, 20230.55 41.3 million57,279 (2)1.1 million
Total for the nine months ended June 30, 2023$2.06 $139.1 million220,570 $4.4 million
DistributionDate DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued
DRIP Shares
Value (3)
QuarterlyOctober 13, 2021December 15, 2021December 31, 2021$0.465 $27.2 million35,990 (1)$0.8 million
QuarterlyJanuary 28, 2022March 15, 2022March 31, 20220.48 28.5 million34,804 (1)0.8 million
QuarterlyApril 29, 2022June 15, 2022June 30, 20220.495 29.4 million43,676 (2)0.9 million
Total for the nine months ended June 30, 2022$1.44 $85.1 million114,470 $2.4 million
 __________
(1) New shares were issued and distributed.
(2) Shares were purchased on the open market and distributed.
(3) TotalTotals may not sum due to rounding.

Common Stock Issuances
On January 23, 2023, in connection with the OSI2 Merger, the Company issued an aggregate of 15,860,200 shares of common stock to former OSI2 stockholders. During the three and nine months ended June 30, 2023, the Company issued zero and 94,879 shares of common stock, respectively, as part of the DRIP. During the three and nine months ended June 30, 2022, the Company issued an aggregate of 212,382zero and 70,794 shares of common stock, respectively, as part of the DRIP.
On February 7, 2022, the Company entered into an equity distribution agreement by and among the Company, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by the Company of shares of common stock, having an aggregate offering price of up to $125.0 million. The equity distribution agreement was amended on February 8, 2023 to allow for the sale of shares of the Company’s common stock having an aggregate offering price of up to $125 million under the Company’s current registration statement. Sales of the common stock may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices.
In connection with the "at the market" offering, the Company issued and sold the followingdid not issue or sell any shares of common stock during the nine months ended June 30, 2022:
Number of Shares IssuedGross ProceedsPlacement Agent FeesNet Proceeds (1)Average Sales Price per Share (2)
"At the market" offering2,801,206 $21,049 $210 $20,839 $7.51 
 __________
(1) Net proceeds excludes offering costs of $0.2 million.
(2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.
On March 19, 2021, in2023. In connection with the Mergers,"at the market" offering, the Company issued an aggregate of 39,400,011and sold 2,801,206 shares of common stock to former OCSI stockholders. There were no other common stock issuances during the nine months ended June 30, 2021.2022 for net proceeds of $20.6 million (net of offering costs).
Note 6. Borrowings
Syndicated Facility


On November 30, 2017, the Company entered into a senior secured revolving credit facility (as amended and restated, the “Syndicated Facility”) pursuant to a Senior Secured Revolving Credit Agreement with the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A., as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents. The Syndicated Facility provides that the Company may use the proceeds of the loans and issuances of letters of credit under the Syndicated Facility for general corporate purposes, including acquiring and funding leveraged loans,
6361

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








mezzanine loans, high-yield securities, convertible securities, preferred stock, common stock and other investments. The Syndicated Facility further allows the Company to request letters of credit from ING Capital LLC, as the issuing bank.


On December 10, 2021, the Company entered into an incremental commitment and assumption agreement pursuant to which a new lender provided additional commitments of $50 million under the Syndicated Facility. As of June 30, 2022,2023, the size of the Syndicated Facility was $1.0$1.218 billion. In addition, pursuant to an "accordion" feature, the Company may increase the size of the facility to up to the greater of $1.25 billion and the Company's net worth, as defined in the facility, under certain circumstances.


As of June 30, 2022,2023, (i) the period during which the Company may make drawings with respect to $1.035 billion of commitments will expire on June 23, 2027 and the maturity date is June 23, 2028, (ii) the period during which the Company may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date is May 4, 2026 and (ii)(iii) the interest rate margin for (a) LIBORSOFR loans (which may be 1-, 2-, 3- or 6-month,3-month, at the Company’s option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%.


The Syndicated Facility is secured by substantially all of the Company’s assets (excluding, among other things, investments held in and by certain subsidiaries of the Company (including OCSLOSI 2 Senior Funding IILending SPV, LLC) or investments in certain portfolio companies of the Company) and guaranteed by certain subsidiaries of the Company. As of June 30, 2022,2023, except for assets that were held by OCSLOSI 2 Senior Funding IILending SPV, LLC and certain immaterial subsidiaries, substantially all of the Company's assets are pledged as collateral under the Syndicated Facility.


The Syndicated Facility requires the Company to, among other things, (i) make representations and warranties regarding the collateral as well as each of the Company’s portfolio companies’ businesses, (ii) agree to certain indemnification obligations, and (iii) comply with various affirmative and negative covenants, reporting requirements and other customary requirements for similar revolving credit facilities, including covenants related to: (A) limitations on the incurrence of additional indebtedness and liens, (B) limitations on certain investments, (C) limitations on certain asset transfers and restricted payments, (D) maintaining a certain minimum stockholders’ equity, (E) maintaining a ratio of total assets (less total liabilities) to total indebtedness, of the Company and its subsidiaries (subject to certain exceptions), of not less than 1.50 to 1.00, (F) maintaining a ratio of consolidated EBITDA to consolidated interest expense, of the Company and its subsidiaries (subject to certain exceptions), of not less than 2.25 to 1.00, (G) maintaining a minimum liquidity and net worth, and (H) limitations on the creation or existence of agreements that prohibit liens on certain properties of the Company and certain of its subsidiaries. The Syndicated Facility also includes usual and customary default provisions such as the failure to make timely payments under the facility, the occurrence of a change in control, and the failure by the Company to materially perform under the agreements governing the facility, which, if not complied with, could accelerate repayment under the facility. As of June 30, 2022,2023, the Company was in compliance with all financial covenants under the Syndicated Facility. In addition to the asset coverage ratio described above, borrowings under the Syndicated Facility (and the incurrence of certain other permitted debt) are subject to compliance with a borrowing base that will apply different advance rates to different types of assets in the Company’s portfolio. Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions.


As of June 30, 20222023 and September 30, 2021,2022, the Company had $575.0$800.0 million and $495.0$540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $575.0$800.0 million and $495.0$540.0 million, respectively. The Company's borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 2.406%6.584% and 2.202%2.406% for the nine months ended June 30, 2023 and 2022, respectively. For the three and 2021, respectively.nine months ended June 30, 2023, the Company recorded interest expense (inclusive of fees) of $14.3 million and $37.4 million, respectively, related to the Syndicated Facility. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $4.8 million and $12.6 million, respectively, related to the Syndicated Facility. For the three and nine months ended June 30, 2021, the Company recorded interest expense (inclusive of fees) of $4.0 million and $10.5 million, respectively, related to the Syndicated Facility.
Citibank Facility
On March 19, 2021, as a result of the consummation of the Mergers, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “Citibank Facility”) with OCSL Senior Funding II LLC (formerly OCSI Senior Funding II LLC), the Company’s wholly-owned, special purpose financing subsidiary, as the borrower, the Company, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian.
On November 18, 2021, the Company entered intoMay 25, 2023, in connection with an amendment to the OSI2 Citibank Facility, that, among other things, increased the sizeCitibank Facility was terminated. In connection with the termination of the facility by $50Citibank Facility, the Company accelerated $0.6 million and extendedof deferred financing costs into interest expense during the reinvestment period and final maturity date. three months ended June 30, 2023.
As of JuneSeptember 30, 2022, the Company was able to borrow up to $200had $160.0 million outstanding under the Citibank Facility, (subject to borrowing base and other limitations). Aswhich had a fair value of June 30, 2022, the reinvestment period$160.0 million. The Company's borrowings under the Citibank Facility was scheduled to expire on November 18,bore interest at a weighted average interest rate of 6.762% and 2.563% for the nine months ended June 30, 2023 and 2022, respectively. For the maturity date forthree and nine months ended June 30, 2023, the Citibank Facility was November 18, 2024. Company recorded interest expense (inclusive of fees) of $2.4 million and $8.0 million, respectively, related
6462

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








As of June 30, 2022, borrowings underto the Citibank Facility are subject to certain customary advance rates and accrue interest at a rate equal to LIBOR plus between 1.25% and 2.20% per annum on broadly syndicated loans, subject to observable market depth and pricing, and LIBOR plus 2.25% per annum on all other eligible loans during the reinvestment period. In addition, as of June 30, 2022, for the duration of the reinvestment period there is a non-usage fee payable of 0.50% per annum on the undrawn amount under the Citibank Facility. The minimum asset coverage ratio applicable to the Company under the Citibank Facility is 150% as determined in accordance with the requirements of the Investment Company Act. Borrowings under the Citibank Facility are secured by all of the assets of OCSL Senior Funding II LLC and all of the Company’s equity interests in OCSL Senior Funding II LLC. The Company may use the Citibank Facility to fund a portion of its loan origination activities and for general corporate purposes. Each loan origination under the Citibank Facility is subject to the satisfaction of certain conditions.
As of June 30, 2022 and September 30, 2021, the Company had $170.0 million and $135.0 million outstanding under the Citibank Facility, respectively, which had a fair value of $170.0 million and $135.0 million, respectively. The Company's borrowings under the Citibank Facility bore interest at a weighted average interest rate of 2.563% and 2.198% for the nine months ended June 30, 2022 and the period from March 19, 2021 to June 30, 2021, respectively. For the three and nine months ended June 30, 2022, the Company recorded interest expense (inclusive of fees) of $1.6 million and $3.5 million, respectively, related to the Citibank Facility.
OSI2 Citibank Facility
On January 23, 2023, as a result of the consummation of the OSI2 Merger, the Company became party to a revolving credit facility (as amended and/or restated from time to time, the “OSI2 Citibank Facility”) with OSI 2 Senior Lending SPV, LLC (“OSI 2 SPV”), the Company’s wholly-owned and consolidated subsidiary, as the borrower, the Company, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.
As of June 30, 2023, the Company was able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of June 30, 2023, the OSI2 Citibank Facility has a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% on all other eligible loans and (b) for all other lenders, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, in all cases subject to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.
As of June 30, 2023, the Company had $335.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $335.0 million. The Company’s borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 7.275% for the period from January 23, 2023 to June 30, 2023. For the three months ended June 30, 20212023 and the period from March 19, 2021January 23, 2023 to June 30, 2021,2023, the Company recorded interest expense (inclusive of fees) of $0.8$4.9 million and $0.9$8.0 million, respectively, related to the OSI2 Citibank Facility.
2025 Notes
On February 25, 2020, the Company issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the 2025 Notes.
The 2025 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the fifth supplemental indenture, dated February 25, 2020 (collectively, the "2025 Notes Indenture"), between the Company and Deutsche Bank Trust Company Americas (the "Trustee"). The 2025 Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2025 Notes. The 2025 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2025 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2025 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Interest on the 2025 Notes is paid semi-annually on February 25 and August 25 at a rate of 3.500% per annum. The 2025 Notes mature on February 25, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2025 Notes can require the Company to repurchase the 2025 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2025 Notes Indenture. The 2025 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2022,2023, the Company did not repurchase any of the 2025 Notes in the open market.
63

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The 2025 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the U.S. Securities and Exchange Commission ("SEC")), as well as covenants requiring the Company to provide financial information to the holders of the 2025 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These covenants are subject to limitations and exceptions that are described in the 2025 Notes Indenture.
2027 Notes
On May 18, 2021, the Company issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the 2027 Notes.
The 2027 Notes were issued pursuant to an indenture, dated April 30, 2012, as supplemented by the sixth supplemental indenture, dated May 18, 2021 (collectively, the "2027 Notes Indenture"), between the Company and the Trustee. The 2027
65

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Notes are the Company's general unsecured obligations that rank senior in right of payment to all of the Company's existing and future indebtedness that is expressly subordinated in right of payment to the 2027 Notes. The 2027 Notes rank equally in right of payment with all of the Company's existing and future liabilities that are not so subordinated. The 2027 Notes effectively rank junior to any of the Company's secured indebtedness (including unsecured indebtedness that the Company later secures) to the extent of the value of the assets securing such indebtedness. The 2027 Notes rank structurally junior to all existing and future indebtedness (including trade payables) incurred by the Company's subsidiaries, financing vehicles or similar facilities.
Interest on the 2027 Notes is paid semi-annually on January 15 and July 15, beginning on January 15, 2022, at a rate of 2.700% per annum. The 2027 Notes mature on January 15, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company's option prior to maturity at par plus a “make-whole” premium, if applicable. In addition, holders of the 2027 Notes can require the Company to repurchase the 2027 Notes at 100% of their principal amount upon the occurrence of certain change of control events as described in the 2027 Notes Indenture. The 2027 Notes were issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. During the nine months ended June 30, 2022,2023, the Company did not repurchase any of the 2027 Notes in the open market.
The 2027 Notes Indenture contains certain covenants, including covenants requiring the Company's compliance with the asset coverage requirements set forth in Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act or any successor provisions (but giving effect to any exemptive relief granted to the Company by the SEC), as well as covenants requiring the Company to provide financial information to the holders of the 2027 Notes and the Trustee if the Company ceases to be subject to the reporting requirements of the Exchange Act. These covenants are subject to limitations and exceptions that are described in the 2027 Notes Indenture.
In connection with the 2027 Notes, the Company entered into an interest rate swap to more closely align the interest rates of its liabilities with its investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, the Company receives a fixed interest rate of 2.700% and pays a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. The Company designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship. See Note 12 for more information regarding the interest rate swap.
64

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of June 30, 20222023 and September 30, 2021:2022:
As of June 30, 2022As of September 30, 2021 As of June 30, 2023As of September 30, 2022
($ in millions)($ in millions)2025 Notes2027 Notes2025 Notes2027 Notes($ in millions)2025 Notes2027 Notes2025 Notes2027 Notes
PrincipalPrincipal$300.0 $350.0 $300.0 $350.0 Principal$300.0 $350.0 $300.0 $350.0 
Unamortized financing costs Unamortized financing costs(2.0)(3.4)(2.6)(4.0) Unamortized financing costs(1.2)(2.7)(1.8)(3.2)
Unaccreted discount Unaccreted discount(1.3)(0.8)(1.7)(0.9) Unaccreted discount(0.8)(0.6)(1.2)(0.7)
Interest rate swap fair value adjustment Interest rate swap fair value adjustment— (30.9)— (2.1) Interest rate swap fair value adjustment— (39.6)— (42.0)
Net carrying valueNet carrying value$296.7 $314.9 $295.7 $343.0 Net carrying value$298.0 $307.1 $297.0 $304.1 
Fair ValueFair Value$284.0 $301.1 $314.5 $351.1 Fair Value$285.7 $302.3 $283.1 $294.0 
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2023:
($ in millions)2025 Notes2027 Notes
Three months ended June 30, 2023Nine months ended June 30, 2023Three months ended June 30, 2023Nine months ended June 30, 2023
Coupon interest$2.6 $7.9 $2.4 $7.1 
Amortization of financing costs and discount0.3 0.9 0.2 0.7 
Effect of interest rate swap— — 3.7 9.4 
 Total interest expense$2.9 $8.8 $6.3 $17.2 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %3.500 %6.912 %6.274 %
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2022:
2025 Notes2027 Notes
($ in millions)($ in millions)Three months ended June 30, 2022Nine months ended June 30, 2022Three months ended June 30, 2022Nine months ended June 30, 2022($ in millions)2025 Notes2027 Notes
Three months ended June 30, 2022Nine months ended June 30, 2022Three months ended June 30, 2022Nine months ended June 30, 2022
Coupon interestCoupon interest$2.6 $7.9 $2.4 $7.1 Coupon interest$2.6 $7.9 $2.4 $7.1 
Amortization of financing costs and discountAmortization of financing costs and discount0.3 0.9 0.2 0.7 Amortization of financing costs and discount0.3 0.9 0.2 0.7 
Effect of interest rate swapEffect of interest rate swap— — (0.1)(1.6)Effect of interest rate swap— — (0.1)(1.6)
Total interest expense Total interest expense$2.9 $8.8 $2.5 $6.2  Total interest expense$2.9 $8.8 $2.5 $6.2 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %3.500 %2.572 %2.069 %Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %3.500 %2.572 %2.069 %
66

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2021:
2025 Notes2027 Notes
($ in millions)Three months ended June 30, 2021Nine months ended June 30, 2021Three months ended June 30, 2021Nine months ended June 30, 2021
Coupon interest$2.6 $7.9 $1.1 $1.1 
Amortization of financing costs and discount0.3 0.9 0.1 0.1 
Effect of interest rate swap— — (0.3)(0.3)
 Total interest expense$2.9 $8.8 $0.9 $0.9 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %3.500 %1.813 %1.813 %


Note 7. Taxable/Distributable Income and Dividend Distributions
Taxable income differs from net increase (decrease) in net assets resulting from operations primarily due to: (1) unrealized appreciation (depreciation) on investments and foreign currency, as gains and losses are not included in taxable income until they are realized; (2) origination and exit fees received in connection with investments in portfolio companies; (3) organizational costs; (4) income or loss recognition on exited investments; and (5) recognition of interest income on certain loans.
As of September 30, 2021,2022, the Company had net capital loss carryforwards of $547.9$523.7 million to offset net capital gains that will not expire, to the extent available and permitted by U.S. federal income tax law, of which $69.1$64.5 million are available to offset future short-term capital gains and $478.8$459.2 million are available to offset future long-term capital gains. A portion of such net capital loss carryfowards represented a realized loss under sections 382 and 383 of the Code, which is carried forward to future years to offset future gains subject to certain limitations.
65

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Listed below is a reconciliation of "net increase (decrease) in net assets resulting from operations" to taxable income for the three and nine months ended June 30, 20222023 and 2021.2022.
Three months ended
June 30, 2022
Three months ended
June 30, 2021
Nine months ended
June 30, 2022
Nine months ended
June 30, 2021
Three months ended
June 30, 2023
Three months ended
June 30, 2022
Nine months ended
June 30, 2023
Nine months ended
June 30, 2022
Net increase (decrease) in net assets resulting from operationsNet increase (decrease) in net assets resulting from operations$(37,834)$47,038 $16,015 $200,699 Net increase (decrease) in net assets resulting from operations$36,685 $(37,834)$71,379 $16,015 
Net unrealized (appreciation) depreciationNet unrealized (appreciation) depreciation86,755 (3,917)118,379 (116,617)Net unrealized (appreciation) depreciation1,039 86,755 42,300 118,379 
Book/tax difference due to organizational costsBook/tax difference due to organizational costs(21)— (65)(22)Book/tax difference due to organizational costs— (21)— (65)
Book/tax difference due to interest income on certain loans— 339 — — 
Book/tax difference due to capital losses utilizedBook/tax difference due to capital losses utilized(3,736)(12,728)(19,183)(34,625)Book/tax difference due to capital losses utilized12,118 (3,736)20,380 (19,183)
Other book/tax differencesOther book/tax differences(8,819)(3,785)(18,597)13,847 Other book/tax differences(3,825)(8,819)(14,912)(18,597)
Taxable/Distributable Income (1)Taxable/Distributable Income (1)$36,345 $26,947 $96,549 $63,282 Taxable/Distributable Income (1)$46,017 $36,345 $119,147 $96,549 
 __________
(1) The Company's taxable income for the three and nine months ended June 30, 20222023 is an estimate and will not be finally determined until the Company files its tax return for the fiscal year ending September 30, 2022.2023. Therefore, the final taxable income may be different than the estimate.
The Company uses the liability method to account for its taxable subsidiaries' income taxes. Using this method, the Company recognizes deferred tax assets and liabilities for the estimated future tax effects attributable to temporary differences between financial reporting and tax bases of assets and liabilities. In addition, the Company recognizes deferred tax benefits associated with net loss carry forwards that it may use to offset future tax obligations. The Company measures deferred tax assets and liabilities using the enacted tax rates expected to apply to taxable income in the years in which it expects to recover or settle those temporary differences.
When assessing the realizability of deferred tax assets, the Company considers whether it is probable that some or all of the deferred tax assets will not be realized. In determining whether the deferred tax assets are realizable, the Company considers the period of expiration of the tax asset, historical and projected taxable income and tax liabilities for the tax jurisdiction in which the tax asset is located. The deferred tax asset recognized by the Company, as it relates to the higher tax basis in the carrying value of certain assets compared to the book basis of those assets, will be recognized in future years by these taxable
67

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




entities. Deferred tax assets are based on the amount of the tax benefit that the Company’s management has determined is more likely than not to be realized in future periods. In determining the realizability of this tax benefit, management considered numerous factors that will give rise to pre-tax income in future periods. Among these are the historical and expected future book and tax basis pre-tax income of the Company and unrealized gains in the Company’s assets at the determination date. Based on these and other factors, the Company determined that, as of June 30, 2022, $3.32023, $6.1 million of the $5.0$8.8 million deferred tax assets would not more likely than not be realized in future periods. As of June 30, 2022,2023, the Company recorded a net deferred tax asset of $1.7$2.7 million on the Consolidated Statements of Assets and Liabilities.
For the three months ended June 30, 2022,2023, the Company recognized a total provisionexpense for income tax related to realized and unrealized gains (losses) of $0.7$0.1 million, which was primarily composed of current income tax expense. For the three months ended June 30, 2021, the Company recognized a provision for income tax related to realized and unrealized gains of $1.4 million, which was comprised of (i) a current income tax expense of approximately $1.6$1.0 million and (ii) a deferred income tax benefit of approximately $0.2$0.9 million, which resulted from unrealized depreciation on investments held by the Company’s wholly-owned taxable subsidiaries.
For the nine months ended June 30, 2022,2023, the Company recognized a provision for income tax related to net investment income of $3.3 million, which was all current income tax expense. For the nine months ended June 30, 2022, the Company also recognized a total benefit for income taxestax related to realized and unrealized gains (losses) of $1.7$0.4 million, which was composed of (i) a current income tax benefitexpense of approximately $0.7$0.6 million and (ii) a deferred income tax benefit of approximately $1.0 million, which resulted from unrealized depreciation of investments held by the Company's wholly-owned taxable subsidiaries. For the nine months ended June 30, 2021, the Company recognized a total provision for income tax related to realized and unrealized gains of $2.7 million, which was comprised of (i) a current income tax expense of approximately $2.6 million, and (ii) a deferred income tax expense of approximately $0.1 million, which resulted from unrealized appreciation on investments held by the Company’s wholly-owned taxable subsidiaries.
As of September 30, 2021,2022, the Company's last tax year end, the components of accumulated overdistributed earnings on a tax basis were as follows:
Undistributed ordinary income, net$(20,260)(43,624)
Net realized capital losses497,255 473,274 
Unrealized losses, net16,340 153,119 
Accumulated overdistributed earnings$493,335582,769
The aggregate cost of investments for U.S. federal income tax purposes was $2.6 billion$2,654.3 million as of September 30, 2021.2022. As of September 30, 2021,2022, the aggregate gross unrealized appreciation for all investments in which there was an excess of value over cost for U.S. federal income tax purposes was $409.5$466.9 million. As of September 30, 2021,2022, the aggregate gross unrealized depreciation for all investments in which there was an excess of cost for U.S. federal income tax purposes over value was $425.8
66

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




$620.0 million. Net unrealized depreciation based on the aggregate cost of investments for U.S. federal income tax purposes was $16.3$153.1 million.


Note 8. Realized Gains or Losses and Net Unrealized Appreciation or Depreciation
Realized Gains or Losses
Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption and the cost basis of the investment without regard to unrealized appreciation or depreciation previously recognized, and include investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with the Company's determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.
68

OAKTREE SPECIALTY LENDING CORPORATIONDuring the three months ended June 30, 2023, the Company recorded an aggregate net realized loss of $10.6 million, which consisted of the following:
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Foreign currency forward contracts$(6.3)
Aden & Anais Merger Sub Inc.(5.2)
Radiology Partners Inc.(3.8)
WP CPP Holdings LLC(1.3)
Tersera Therapeutics LLC5.2 
Other, net0.8 
Total, net$(10.6)
During the three months ended June 30, 2022, the Company recorded an aggregate net realized gain of $9.2 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Foreign currency forward contracts$8.8 
Other, net0.4 
Total, net$9.2
During the threenine months ended June 30, 2021,2023, the Company recorded an aggregate net realized gainloss of $8.6$19.9 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Keypath Education Holdings, LLCForeign currency forward contracts$6.8 (5.5)
Signify Health, LLCAden & Anais Merger Sub Inc.0.6 (5.2)
Radiology Partners Inc.(4.2)
Carvana Co.(2.8)
ASP Unifrax Holdings Inc.(2.1)
WP CPP Holdings LLC(1.3)
Global Medical Response Inc.(1.0)
Tersera Therapeutics LLC5.2 
Other, net1.2 (3.0)
Total, net$8.6(19.9)
67

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




During the nine months ended June 30, 2022, the Company recorded an aggregate net realized gain of $19.9 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
Foreign currency forward contracts$12.2 
OmniSYS Acquisition Corporation2.2 
First Star Speir Aviation Limited1.9 
TigerConnect Inc.1.8 
Other, net1.8 
Total, net$19.9
During the nine months ended June 30, 2021, the Company recorded an aggregate net realized gain of $22.7 million, which consisted of the following:
($ in millions)
Portfolio CompanyNet Realized Gain (Loss)
PLATO Learning Inc.$7.8 
Keypath Education Holdings, LLC6.8 
L Squared Capital Partners LLC3.4 
LTI Holdings, Inc.2.6 
BX Commercial Mortgage Trust 2020-VIVA2.6 
California Pizza Kitchen Inc.(1.8)
Other, net1.3 
Total, net$22.7


Net Unrealized Appreciation or Depreciation
Net unrealized appreciation or depreciation reflects the net change in the valuation of the portfolio pursuant to the Company's valuation guidelines and the reclassification of any prior period unrealized appreciation or depreciation.
During the three months ended June 30, 20222023 and 2021,2022, the Company recorded net unrealized appreciation (depreciation)depreciation of $(86.8)$1.0 million and $3.9$86.8 million, respectively. For the three months ended June 30, 2023, this consisted of $9.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation on equity investments, partially offset by $5.0 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $4.6 million of net unrealized appreciation of foreign currency forward contracts. For the three months ended June 30, 2022, this consisted of $66.8 million of net unrealized depreciation on debt investments, $17.9 million of net unrealized depreciation on equity investments, $1.6 million of net unrealized depreciation of foreign currency forward contracts and $0.4 million of net unrealized depreciation
69

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




related to exited investments (a portion of which resulted in a reclassification to realized gains). For the three months ended June 30, 2021, this consisted of $12.3 million of net unrealized appreciation on debt investments, $3.8 million of net unrealized appreciation on equity investments and $1.1 million of net unrealized appreciation of foreign currency forward contracts, partially offset by $13.3 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains).
During the nine months ended June 30, 20222023 and 2021,2022, the Company recorded net unrealized appreciation (depreciation)depreciation of $(118.4)$42.3 million and $116.6$118.4 million, respectively. For the nine months ended June 30, 2023, this consisted of $54.3 million of net unrealized depreciation on debt investments and $4.8 million of net unrealized depreciation of foreign currency forward contracts, partially offset by $11.8 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $5.1 million of net unrealized appreciation on equity investments. For the nine months ended June 30, 2022, this consisted of $84.6 million of net unrealized depreciation on debt investments, $23.8 million of net unrealized depreciation on equity investments, $9.2 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains) and $0.8 million of net unrealized depreciation of foreign currency forward contracts. For
During the nine months ended June 30, 2021, this consisted2023, unrealized depreciation included a one-time unrealized loss of $79.7$20.7 million of net unrealized appreciation on debt investments, $30.7 million of net unrealized appreciation on equity investments, $4.0 million of net unrealized appreciationthat resulted solely from accounting adjustments related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.2 million of net unrealized appreciation of foreign currency forward contracts.

the OSI2 Merger.
Note 9. Concentration of Credit Risks
The Company deposits its cash with financial institutions and at times such balances may beare in excess of the FDIC insurance limit. The Company limits its exposure to credit loss by depositing its cash with high credit quality financial institutions and monitoring their financial stability.

Note 10. Related Party Transactions


As of June 30, 20222023 and September 30, 2021,2022, the Company had a liability on its Consolidated Statements of Assets and Liabilities in the amount of $15.6$20.1 million and $32.6$15.9 million, respectively, reflecting the unpaid portion of the base management fees and incentive fees payable to Oaktree.
Investment Advisory Agreement
The Company is party to the Investment Advisory Agreement. Under the Investment Advisory Agreement, the Company pays Oaktree a fee for its services under the Investment Advisory Agreement consisting of two components: a
68

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




base management fee and an incentive fee. The cost of both the base management fee payable to Oaktree and any incentive fees earned by Oaktree is ultimately borne by common stockholders of the Company.
From October 17, 2017 through May 3, 2020, the Company was externally managed by OCM pursuant to an investment advisory agreement. On May 4, 2020, OCM effected the novation of such investment advisory agreement to Oaktree. Immediately following such novation, the Company and Oaktree entered into a new investment advisory agreement with the same terms, including fee structure, as the investment advisory agreement with OCM. The investment advisory agreement with Oaktree was subsequently amended and restated on March 19, 2021 in connection with the closing of the Mergers.OCSI Merger and on January 23, 2023 in connection with the closing of OSI2 Merger. The term “Investment Advisory Agreement” refers collectively to the agreements with Oaktree and, prior to its novation, with OCM.
Unless earlier terminated as described below, the Investment Advisory Agreement will remain in effect from year-to-year if approved annually by the Board of Directors of the Company or by the affirmative vote of the holders of a majority of the Company’s outstanding voting securities, including, in either case, approval by a majority of the directors of the Company who are not interested persons. The Investment Advisory Agreement will automatically terminate in the event of its assignment. The Investment Advisory Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Investment Advisory Agreement may also be terminated, without penalty, upon the vote of a majority of the outstanding voting securities of the Company.
Base Management Fee


Under the Investment Advisory Agreement, the base management fee is calculated at an annual rate of 1.50% of total gross assets, including any investment made with borrowings, but excluding cash and cash equivalents. The base management fee is payable quarterly in arrears and the fee for any partial month or quarter is appropriately prorated. Effective May 3, 2019, the
70

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




base management fee on the Company’s gross assets, including any investments made with borrowings, but excluding any cash and cash equivalents, that exceed the product of (A) 200% and (B) the Company’s net asset value will be 1.00%. For the avoidance of doubt, the 200% will be calculated in accordance with the Investment Company Act and will give effect to exemptive relief the Company received from the SEC with respect to debentures issued by a small business investment company subsidiary. In connection with the Mergers, the Company andOCSI Merger, Oaktree entered into an amended and restated investment advisory agreement, which among other items, waived an aggregate of $6 million of base management fees otherwise payable to Oaktree in the two years following the closing of the MergersOCSI Merger on March 19, 2021 at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter). In connection with the OSI2 Merger, Oaktree waived an aggregate of $9.0 million of base management fees payable to Oaktree as follows: $6.0 million at a rate of $1.5 million per quarter (with such amount appropriately prorated for any partial quarter) in the first year following closing of the OSI2 Merger on January 23, 2023 and $3.0 million at a rate of $750,000 per quarter (with such amount appropriately prorated for any partial quarter) in the second year following closing of the OSI2 Merger.
For the three and nine months ended June 30, 2023, the base management fee incurred under the Investment Advisory Agreement was $10.5 million (net of waiver) and $29.4 million (net of waiver), respectively. For the three and nine months ended June 30, 2022, the base management fee incurred under the Investment Advisory Agreement was $9.1 million (net of waiver) and $27.6 million (net of waiver), respectively. For the three and nine months ended June 30, 2021, the base management fee incurred under the Investment Advisory Agreement was $8.2 million (net of waiver) and $21.7 million (net of waiver), respectively.
Incentive Fee
The incentive fee consists of two parts. Under the Investment Advisory Agreement, the first part of the incentive fee (the “incentive fee on income” or "Part I incentive fee") is calculated and payable quarterly in arrears based upon the “pre-incentive fee net investment income” of the Company for the immediately preceding quarter. The payment of the incentive fee on income is subject to payment of a preferred return to investors each quarter (i.e., a “hurdle rate”), expressed as a rate of return on the value of the Company’s net assets at the end of the most recently completed quarter, of 1.50%, subject to a “catch up” feature.
For this purpose, “pre-incentive fee net investment income” means interest income, dividend income and any other income (including any other fees such as commitment, origination, structuring, diligence and consulting fees or other fees that the Company receives from portfolio companies, other than fees for providing managerial assistance) accrued during the fiscal quarter, minus the Company’s operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding the incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as OID debt, instruments with PIK interest and zero coupon securities), accrued income that the Company has not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, realized capital losses or unrealized capital appreciation or depreciation. In addition, pre-incentive fee net investment income does not include any amortization or accretion of any purchase premium or purchase discount to interest income resulting solely from
69

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




merger-related accounting adjustments in connection with the assets acquired in the Mergers,OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in pre-incentive fee net investment income.


Under the Investment Advisory Agreement, the calculation of the incentive fee on income for each quarter is as follows:


No incentive fee is payable to Oaktree in any quarter in which the Company’s pre-incentive fee net investment income does not exceed the preferred return rate of 1.50% (the “preferred return”) on net assets;
100% of the Company’s pre-incentive fee net investment income, if any, that exceeds the preferred return but is less than or equal to 1.8182% in any fiscal quarter is payable to Oaktree. This portion of the incentive fee on income is referred to as the “catch-up” provision, and it is intended to provide Oaktree with an incentive fee of 17.5% on all of the Company’s pre-incentive fee net investment income when the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets in any fiscal quarter; and
For any quarter in which the Company’s pre-incentive fee net investment income exceeds 1.8182% on net assets, the incentive fee on income is equal to 17.5% of the amount of the Company’s pre-incentive fee net investment income, as the preferred return and catch-up will have been achieved.


There is no accumulation of amounts on the hurdle rate from quarter to quarter and accordingly there is no clawback of amounts previously paid if subsequent quarters are below the quarterly hurdle.


For the three and nine months ended June 30, 2023, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $9.6 million and $26.3 million, respectively. For the three and nine months ended June 30, 2022, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $6.5 million and $19.7 million, respectively. For the three and nine months ended June 30, 2021, the first part of the incentive fee (incentive fee on income) incurred under the Investment Advisory Agreement was $7.0 million and $15.6 million, respectively.
71

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Under the Investment Advisory Agreement, the second part of the incentive fee (the "capital gains incentive fee") is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Investment Advisory Agreement, as of the termination date) commencing with the fiscal year ended September 30, 2019 and equals 17.5% of the Company’s realized capital gains, if any, on a cumulative basis from the beginning of the fiscal year ended September 30, 2019 through the end of each subsequent fiscal year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees under the Investment Advisory Agreement. Any realized capital gains, realized capital losses, unrealized capital appreciation and unrealized capital depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the calculations of the second part of the incentive fee. In addition, the calculation of realized capital gains, realized capital losses and unrealized capital depreciation does (1) not include any such amounts resulting solely from merger-related accounting adjustments in connection with the assets acquired in the Mergers,OCSI Merger or in the OSI2 Merger, in each case, including any premium or discount paid for the acquisition of such assets, solely to the extent that the inclusion of such merger-related accounting adjustments, in the aggregate, would result in an increase in the capital gains incentive fee, and (2) include any such amounts associated with the investments acquired in the MergersOCSI Merger for the period from October 1, 2018 to the date of closing of the Mergers,OCSI Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee and (3) include any such amounts associated with the investments acquired in the OSI2 Merger for the period from August 6, 2018 to the date of closing of the OSI2 Merger, solely to the extent that the exclusion of such amounts, in the aggregate, would result in an increase in the capital gains incentive fee. As of June 30, 2022,2023, the Company paid $9.6 million of capital gains incentive fees cumulatively under the Investment Advisory Agreement (net of waivers). ForPart II incentive fees are contractually calculated and paid at the three and nine months endedend of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of June 30, 2022, the Company did not incur any capital gains incentive fees2023 under the Investment Advisory Agreement.Agreement, no Part II incentive fees would be payable.


GAAP requires that the capital gains incentive fee accrual consider the cumulative aggregate unrealized capital appreciation in the calculation, as a capital gains incentive fee would be payable if such unrealized capital appreciation were realized on a theoretical "liquidation basis." A fee so calculated and accrued would not be payable under applicable law and may never be paid based upon the computation of capital gains incentive fees in subsequent periods. Amounts ultimately paid under the Investment Advisory Agreement will be consistent with the formula reflected in the Investment Advisory Agreement. This GAAP accrual is calculated using the aggregate cumulative realized capital gains and losses and aggregate cumulative unrealized capital depreciation included in the calculation of the capital gains incentive fee plus the aggregate cumulative unrealized capital appreciation. Any realized capital gains and losses and cumulative unrealized capital appreciation and depreciation with respect to the Company’s portfolio as of the end of the fiscal year ended September 30, 2018 are excluded from the GAAP accrual. If such amount is positive at the end of a period, then GAAP requires the Company to record a capital
70

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




gains incentive fee equal to 17.5% of such cumulative amount, less the aggregate amount of actual capital gains incentive fees payable or capital gains incentive fees accrued under GAAP in all prior periods. The resulting accrual for any capital gains incentive fee under GAAP in a given period may result in an additional expense if such cumulative amount is greater than in the prior period or a reversal of previously recorded expense if such cumulative amount is less than in the prior period. If such cumulative amount is negative, then there is no accrual. There can be no assurance that such unrealized capital appreciation will be realized in the future or any accrued capital gains incentive fee will become payable under the Investment Advisory Agreement. For the three and nine months ended June 30, 2023, there were no accrued capital gains incentive fees. For the three and nine months ended June 30, 2022, $6.8 million and $8.8 million of accrued capital gains incentive fees were reversed, respectively. For the three and nine months ended June 30, 2021, $2.8 million and $16.0 million of accrued capital gains incentive fees were expensed, respectively. As of June 30, 2022,2023, the total accrued capital gains incentive fee liability was zero. Part II incentive fees are contractually calculated and paid at the end of the fiscal year in accordance with the Investment Advisory Agreement, which, as described above, differs from Part II incentive fees accrued under GAAP. Hypothetically, if Part II incentive fees were calculated as of June 30, 2022 under the Investment Advisory Agreement, there would be no amounts payable.
Indemnification


The Investment Advisory Agreement provides that, absent willful misfeasance, bad faith or gross negligence in the performance of their respective duties or by reason of the reckless disregard of their respective duties and obligations, Oaktree and its officers, managers, partners, members (and their members, including the owners of their members), agents, employees, controlling persons and any other person or entity affiliated with it, are entitled to indemnification from the Company for any damages, liabilities, costs and expenses (including reasonable attorneys' fees and amounts reasonably paid in settlement) arising from the rendering of Oaktree's services under the Investment Advisory Agreement or otherwise as investment adviser.
Administrative Services
The Company is party to the Administration Agreement with Oaktree Administrator. Pursuant to the Administration Agreement, Oaktree Administrator provides administrative services to the Company necessary for the operations of the Company, which include providing office facilities, equipment, clerical, bookkeeping and record keeping services at such facilities and such other services as Oaktree Administrator, subject to review by the Company’s Board of Directors, shall from time to time deem to be necessary or useful to perform its obligations under the Administration Agreement. Oaktree
72

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Administrator may, on behalf of the Company, conduct relations and negotiate agreements with custodians, trustees, depositories, attorneys, underwriters, brokers and dealers, corporate fiduciaries, insurers, banks and such other persons in any such other capacity deemed to be necessary or desirable. Oaktree Administrator makes reports to the Company’s Board of Directors of its performance of obligations under the Administration Agreement and furnishes advice and recommendations with respect to such other aspects of the Company’s business and affairs, in each case, as it shall determine to be desirable or as reasonably required by the Company’s Board of Directors; provided that Oaktree Administrator shall not provide any investment advice or recommendation.
Oaktree Administrator also provides portfolio collection functions for interest income, fees and warrants and is responsible for the financial and other records that the Company is required to maintain and prepares, prints and disseminates reports to the Company’s stockholders and all other materials filed with the SEC. In addition, Oaktree Administrator assists the Company in determining and publishing the Company’s net asset value, overseeing the preparation and filing of the Company’s tax returns, and generally overseeing the payment of the Company’s expenses and the performance of administrative and professional services rendered to the Company by others. Oaktree Administrator may also offer to provide, on the Company’s behalf, managerial assistance to the Company’s portfolio companies.
For providing these services, facilities and personnel, the Company reimburses Oaktree Administrator the allocable portion of overhead and other expenses incurred by Oaktree Administrator in performing its obligations under the Administration Agreement, including the Company’s allocable portion of the rent of the Company’s principal executive offices (which are located in a building owned by a Brookfield affiliate) at market rates and the Company’s allocable portion of the costs of compensation and related expenses of its Chief Financial Officer, Chief Compliance Officer, their staffs and other non-investment professionals at Oaktree that perform duties for the Company. Such reimbursement is at cost, with no profit to, or markup by, Oaktree Administrator. The Administration Agreement may be terminated by either party without penalty upon 60 days’ written notice to the other. The Administration Agreement may also be terminated, without penalty, upon the vote of a majority of the Company’s outstanding voting securities.
For the three months ended June 30, 20222023 and 2021,2022, the Company accrued administrative expenses of $0.3$0.4 million and $0.5$0.3 million, respectively, including $0.1 million and $0.1 million of general and administrative expenses, respectively. For the nine months ended June 30, 20222023 and 2021,2022, the Company accrued administrative expenses of $1.2 million and $1.2 million, respectively, including $0.2 million and $0.1$0.2 million of general and administrative expenses, respectively.
71

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




As of June 30, 20222023 and September 30, 2021, $3.52022, $7.7 million and $4.4$3.2 million, respectively, was included in “Due to affiliate” in the Consolidated Statements of Assets and Liabilities, reflecting the unpaid portion of administrative expenses and other reimbursable expenses payable to Oaktree Administrator.

7372

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








Note 11. Financial Highlights
(Share amounts in thousands)(Share amounts in thousands)Three months ended
June 30, 2022
Three months ended
June 30, 2021
Nine months ended
June 30, 2022
Nine months ended
June 30, 2021
(Share amounts in thousands)Three months ended
June 30, 2023
Three months ended
June 30, 2022 (7)
Nine months ended
June 30, 2023
Nine months ended
June 30, 2022 (7)
Net asset value per share at beginning of periodNet asset value per share at beginning of period$7.26$7.09$7.28$6.49Net asset value per share at beginning of period$19.66$21.79$20.38$21.84
Net investment income (1)Net investment income (1)0.220.200.620.41Net investment income (1)0.630.661.891.86
Net unrealized appreciation (depreciation) (1)(8)Net unrealized appreciation (depreciation) (1)(8)(0.47)0.02(0.65)0.74Net unrealized appreciation (depreciation) (1)(8)(0.02)(1.42)(0.36)(1.95)
Net realized gains (losses) (1)Net realized gains (losses) (1)0.050.050.110.15Net realized gains (losses) (1)(0.14)0.15(0.28)0.33
(Provision) benefit for taxes on realized and unrealized gains (losses) (1)(Provision) benefit for taxes on realized and unrealized gains (losses) (1)(0.01)0.01(0.02)(Provision) benefit for taxes on realized and unrealized gains (losses) (1)(0.01)0.010.03
Distributions of net investment income to stockholdersDistributions of net investment income to stockholders(0.17)(0.13)(0.48)(0.36)Distributions of net investment income to stockholders(0.55)(0.50)(2.06)(1.44)
Issuance of common stock(0.19)
Net asset value per share at end of periodNet asset value per share at end of period6.897.226.897.22Net asset value per share at end of period$19.58$20.67$19.58$20.67
Per share market value at beginning of periodPer share market value at beginning of period$7.37$6.20$7.06$4.84Per share market value at beginning of period$18.77$22.11$18.00$21.18
Per share market value at end of periodPer share market value at end of period6.556.696.55$6.69Per share market value at end of period$19.43$19.65$19.4319.65
Total return (2)Total return (2)(8.93)%9.98%(0.79)%46.39%Total return (2)6.42%(8.93)%19.58%(0.79)%
Common shares outstanding at beginning of periodCommon shares outstanding at beginning of period183,205180,361180,361140,961Common shares outstanding at beginning of period77,08061,06861,12560,120
Common shares outstanding at end of periodCommon shares outstanding at end of period183,374180,361183,374180,361Common shares outstanding at end of period77,08061,12577,08061,125
Net assets at beginning of periodNet assets at beginning of period$1,330,376$1,278,823$1,312,823$914,879Net assets at beginning of period$1,515,150$1,330,376$1,245,563$1,312,823
Net assets at end of periodNet assets at end of period$1,263,529$1,302,414$1,263,529$1,302,414Net assets at end of period$1,509,441$1,263,529$1,509,441$1,263,529
Average net assets (3)Average net assets (3)$1,306,727$1,298,995$1,323,232$1,094,761Average net assets (3)$1,526,644$1,306,727$1,407,814$1,323,232
Ratio of net investment income to average net assets (4)Ratio of net investment income to average net assets (4)12.39%11.09%11.39%7.82%Ratio of net investment income to average net assets (4)12.72%12.39%12.65%11.39%
Ratio of total expenses to average net assets (4)Ratio of total expenses to average net assets (4)7.22%9.23%7.94%10.02%Ratio of total expenses to average net assets (4)14.45%7.22%14.07%7.94%
Ratio of net expenses to average net assets (4)Ratio of net expenses to average net assets (4)6.99%9.00%7.71%9.91%Ratio of net expenses to average net assets (4)14.05%6.99%13.69%7.71%
Ratio of portfolio turnover to average investments at fair valueRatio of portfolio turnover to average investments at fair value4.73%7.43%21.44%31.59%Ratio of portfolio turnover to average investments at fair value7.48%4.73%18.43%21.44%
Weighted average outstanding debt (5)Weighted average outstanding debt (5)$1,369,615$1,140,774$1,358,150$884,525Weighted average outstanding debt (5)$1,756,758$1,369,615$1,640,062$1,358,150
Average debt per share (1)Average debt per share (1)$7.47$6.32$7.47$5.67Average debt per share (1)$22.79$22.41$23.29$22.41
Asset coverage ratio at end of period (6)Asset coverage ratio at end of period (6)187.82%216.01%187.82%216.01%Asset coverage ratio at end of period (6)182.05%187.82%182.05%187.82%
 __________
(1)Calculated based upon weighted average shares outstanding for the period.
(2)Total return equals the increase or decrease of ending market value over beginning market value, plus distributions, divided by the beginning market value, assuming dividend reinvestment prices obtained under the Company's DRIP. Total return does not include sales load.
(3)Calculated based upon the weighted average net assets for the period.
(4)Interim periods are annualized.
(5)Calculated based upon the weighted average of principal debt outstanding for the period.
(6)Based on outstanding senior securities of $1,395.0$1,785.0 million and $1,114.1$1,395.0 million as of June 30, 2023 and 2022, respectively.
(7)The share and 2021, respectively.per share information disclosed in this table has been retrospectively adjusted to reflect the Company's 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
(8)For the nine months ended June 30, 2023, the amount shown for net unrealized appreciation (depreciation) includes the effect of the timing of common stock issuances in connection with the OSI2 Merger.



7473

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)










Note 12. Derivative Instruments
The Company enters into foreign currency forward contracts from time to time to help mitigate the impact that an adverse change in foreign exchange rates would have on the value of the Company’s investments denominated in foreign currencies. In order to better define its contractual rights and to secure rights that will help the Company mitigate its counterparty risk, the Company entered into an International Swaps and Derivatives Association, Inc. Master Agreement (the "ISDA Master Agreement") with its derivative counterparty, JPMorgan Chase Bank, N.A. The ISDA Master Agreement permits a single net payment in the event of a default or similar event. As of June 30, 2022,2023, no cash collateral has been pledged to cover obligations and no cash collateral has been received from the counterparty with respect to the Company's forward currency contracts.
In connection with the issuance of the 2027 Notes, the Company entered into an interest rate swap agreement with the Royal Bank of Canada pursuant to an ISDA Master Agreement. As of June 30, 2022,2023, the Company paid $36.3$40.0 million to the Royal Bank of Canada to cover collateral obligations under the terms of the interest swap agreement, which is included in due from broker on the Consolidated Statement of Assets and Liabilities.
Certain information related to the Company’s foreign currency forward contracts is presented below as of June 30, 2022.2023.
DescriptionDescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net AmountsDescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Foreign currency forward contractForeign currency forward contract$46,196 43,643 8/11/2022$440 $— Derivative assetForeign currency forward contract$78,866 71,658 8/10/2023$531 $— Derivative asset
Foreign currency forward contractForeign currency forward contract$49,442 £40,109 8/11/2022$694 $— Derivative assetForeign currency forward contract$71,438 £56,556 8/10/2023$— $482 Derivative asset
$1,134 $ $531 $482 
Certain information related to the Company’s foreign currency forward contracts is presented below as of September 30, 2021.2022.
DescriptionDescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net AmountsDescriptionNotional Amount to be PurchasedNotional Amount to be SoldMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Foreign currency forward contractForeign currency forward contract$52,186 £37,709 11/12/2021$1,339 $— Derivative assetForeign currency forward contract$43,179 41,444 11/10/2022$2,466 $— Derivative asset
Foreign currency forward contractForeign currency forward contract$46,663 39,736 11/12/2021$573 $— Derivative assetForeign currency forward contract$45,692 £37,033 11/10/2022$4,323 $— Derivative asset
$1,912 $ $6,789 $ 
Certain information related to the Company’s interest rate swap is presented below as of June 30, 2022.2023.
DescriptionDescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net AmountsDescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Interest rate swapInterest rate swap$350,000 1/15/2027$— $30,866 Derivative liabilityInterest rate swap$350,000 1/15/2027$— $39,567 Derivative liability
$ $30,866 $ $39,567 
Certain information related to the Company’s interest rate swap is presented below as of September 30, 2021.2022.
DescriptionDescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net AmountsDescriptionNotional AmountMaturity DateGross Amount of Recognized AssetsGross Amount of Recognized LiabilitiesBalance Sheet Location of Net Amounts
Interest rate swapInterest rate swap$350,000 1/15/2027$— $2,108 Derivative liabilityInterest rate swap$350,000 1/15/2027$— $41,969 Derivative liability
$ $2,108 $ $41,969 





Note 13. Commitments and Contingencies
Off-Balance Sheet Arrangements
The Company may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of its portfolio companies. As of June 30, 2022,2023, the Company's only off-balance sheet arrangements consisted of $232.1$274.4 million of unfunded commitments, which was comprised of $183.1$247.3 million to provide debt and equity financing to certain of its portfolio companies and $49.0 million to provide financing to the JVs. As of September 30, 2021, the
7574

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)








financing to certain of its portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, the Company's only off-balance sheet arrangements consisted of $264.9$224.2 million of unfunded commitments, which was comprised of $212.4$175.2 million to provide debt and equity financing to certain of its portfolio companies and $49.0 million to provide financing to the JVs and $3.5 million related to unfunded limited partnership interests.JVs. Such commitments are subject to the portfolio companies' satisfaction of certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Consolidated Statements of Assets and Liabilities.
76

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




A list of unfunded commitments by investment (consisting of revolvers, term loans with delayed draw components, subordinated notes and LLC equity interests in the JVs, preferred stock and limited partnership interests) as of June 30, 20222023 and September 30, 20212022 is shown in the table below:
June 30, 2022September 30, 2021
Senior Loan Fund JV I, LLC$35,000 $35,000 
Fairbridge Strategic Capital Funding LLC32,250 — 
Athenex, Inc.21,072 21,072 
BioXcel Therapeutics, Inc.14,066 — 
OCSI Glick JV LLC13,998 13,998 
Dominion Diagnostics, LLC11,148 11,148 
BAART Programs, Inc.9,562 3,583 
MRI Software LLC6,800 2,699 
Innocoll Pharmaceuticals Limited6,292 — 
Marinus Pharmaceuticals, Inc.5,734 18,349 
Establishment Labs Holdings Inc.5,075 — 
Accupac, Inc.5,014 3,267 
RumbleOn, Inc.4,822 16,301 
Assembled Brands Capital LLC4,746 24,868 
Ardonagh Midco 3 PLC4,372 14,892 
Grove Hotel Parcel Owner, LLC4,293 — 
Mindbody, Inc.4,000 4,000 
OTG Management, LLC3,789 3,789 
Mesoblast, Inc.3,553 — 
Pluralsight, LLC3,532 3,532 
Dialyze Holdings, LLC3,431 3,431 
Spanx, LLC3,092 — 
Thrasio, LLC2,578 2,578 
PRGX Global, Inc.2,518 2,518 
Liquid Environmental Solutions Corporation2,324 — 
Relativity ODA LLC2,218 2,218 
Acquia Inc.1,971 2,061 
Tahoe Bidco B.V.1,741 — 
PFNY Holdings, LLC1,527 — 
CorEvitas, LLC1,526 3,235 
MHE Intermediate Holdings, LLC1,429 3,466 
Apptio, Inc.1,338 1,338 
LSL Holdco, LLC1,282 — 
Kings Buyer, LLC1,208 — 
Berner Food & Beverage, LLC1,114 2,475 
Telestream Holdings Corporation1,055 1,266 
Coyote Buyer, LLC933 1,333 
Digital.AI Software Holdings, Inc.826 898 
109 Montgomery Owner LLC513 937 
GKD Index Partners, LLC320 320 
Gulf Operating, LLC— 10,064 
Coty Inc.— 9,886 
Latam Airlines Group S.A.— 7,267 
Sunland Asphalt & Construction, LLC— 6,492 
NeuAG, LLC— 5,441 
Olaplex, Inc.— 4,806 
Pingora MSR Opportunity Fund I-A, LP— 3,500 
SIO2 Medical Products, Inc.— 3,406 
SumUp Holdings Luxembourg S.À.R.L.— 3,350 
4 Over International, LLC— 2,300 
The Avery— 1,850 
Ministry Brands, LLC— 1,100 
Thermacell Repellents, Inc.— 833 
CircusTrix Holdings, LLC— 37 
Total$232,062 $264,904 
75

OAKTREE SPECIALTY LENDING CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




June 30, 2023September 30, 2022
107-109 Beech OAK22 LLC$30,922 $— 
Fairbridge Strategic Capital Funding LLC20,382 22,150 
Delta Leasing SPV II LLC18,822 27,187 
BioXcel Therapeutics, Inc.14,543 11,785 
OCSI Glick JV LLC13,998 13,998 
Senior Loan Fund JV I, LLC13,125 35,000 
SiO2 Medical Products, Inc.10,765 — 
MND Holdings III Corp8,470 — 
Seres Therapeutics, Inc.8,090 — 
iCIMs, Inc.7,704 6,930 
Dominion Diagnostics, LLC7,664 11,148 
Marinus Pharmaceuticals, Inc.7,139 5,734 
Assembled Brands Capital LLC7,062 2,008 
Grove Hotel Parcel Owner, LLC5,286 4,293 
scPharmaceuticals Inc.5,212 — 
Innocoll Pharmaceuticals Limited5,200 4,195 
Avalara, Inc.5,047 — 
Mindbody, Inc.4,762 4,000 
Accupac, Inc.4,500 4,605 
Mesoblast, Inc.4,405 3,553 
107 Fair Street LLC4,322 — 
Harrow Health, Inc.4,011 — 
Inventus Power, Inc.3,792 — 
Establishment Labs Holdings Inc.3,384 5,075 
MRI Software LLC3,302 5,196 
OTG Management, LLC3,190 3,789 
PRGX Global, Inc.3,127 2,518 
Salus Workers' Compensation, LLC3,102 — 
ADC Therapeutics SA3,020 3,020 
Relativity ODA LLC2,762 2,218 
112-126 Van Houten Real22 LLC2,703 — 
LSL Holdco, LLC2,650 427 
Supreme Fitness Group NY Holdings, LLC2,540 1,527 
Pluralsight, LLC2,395 3,532 
SCP Eye Care Services, LLC2,356 — 
Spanx, LLC2,185 2,226 
Tahoe Bidco B.V.2,162 1,741 
Coupa Holdings, LLC2,075 — 
Galileo Parent, Inc.2,061 — 
Oranje Holdco, Inc.1,904 — 
Apptio, Inc.1,885 1,338 
Kings Buyer, LLC1,771 1,537 
MHE Intermediate Holdings, LLC1,536 1,429 
PPW Aero Buyer, Inc.1,466 — 
Liquid Environmental Solutions Corporation1,383 1,115 
Berner Food & Beverage, LLC1,314 1,392 
CorEvitas, LLC1,251 915 
Digital.AI Software Holdings, Inc.1,156 826 
Coyote Buyer, LLC800 1,333 
Telestream Holdings Corporation678 528 
Acquia Inc.596 1,326 
ASP-R-PAC Acquisition Co LLC396 — 
BAART Programs, Inc.— 8,645 
RumbleOn, Inc.— 4,822 
Ardonagh Midco 3 PLC— 4,372 
Dialyze Holdings, LLC— 3,431 
Thrasio, LLC— 2,578 
109 Montgomery Owner LLC— 477 
GKD Index Partners, LLC— 320 
Total$274,373 $224,239 

76

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)




Note 14. Merger with OSI2
On January 23, 2023, the Company completed its previously announced acquisition of OSI2. The Company was the accounting survivor of the OSI2 Merger. In accordance with the terms of the OSI2 Merger Agreement, at the effective time of the OSI2 Merger, each outstanding share of OSI2 common stock was converted into the right to receive 0.9115 shares of the Company’s common stock (with OSI2’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Merger, the Company issued an aggregate of 15,860,200 shares of its common stock to former OSI2 stockholders.
The OSI2 Merger was accounted for as an asset acquisition in accordance with the asset acquisition method of accounting as detailed in ASC 805-50, Business Combinations—Related Issues (“ASC 805”). The Company determined the fair value of the shares of the Company’s common stock that were issued to former OSI2 stockholders pursuant to the OSI2 Merger Agreement plus transaction costs to be the consideration paid in connection with the OSI2 Merger under ASC 805. The consideration paid to OSI2 stockholders, as determined in accordance with ASC 805, was more than the aggregate fair values of the assets acquired and liabilities assumed, which resulted in a purchase premium (the “purchase premium”). The consideration paid was allocated to the individual assets acquired and liabilities assumed based on the relative fair values of net identifiable assets acquired other than “non-qualifying” assets (for example, cash). As a result, the purchase premium was allocated to the cost basis of the OSI2 investments acquired by the Company on a pro-rata basis based on their relative fair values as of the effective time of the OSI2 Merger. Immediately following the OSI2 Merger, the investments were marked to their respective fair values in accordance with ASC 820 which resulted in $20.7 million of unrealized depreciation in the Consolidated Statement of Operations as a result of the OSI2 Merger. The purchase premium allocated to the debt investments acquired will amortize over the life of each respective debt investment through interest income, with a corresponding adjustment recorded to unrealized depreciation on such investment acquired through its ultimate disposition. The purchase premium allocated to equity investments acquired will not amortize over the life of such investments through interest income and, assuming no subsequent change to the fair value of the equity investments acquired and disposition of such equity investments at fair value, the Company will recognize a realized loss with a corresponding reversal of the unrealized depreciation on disposition of such equity investments acquired. The OSI2 Merger was considered a tax-free reorganization, and the Company has elected to carry forward the historical cost basis of the acquired OSI2 investments for tax purposes.
The following table summarizes the allocation of the consideration paid to the assets acquired and liabilities assumed as a result of the OSI2 Merger:

Common stock issued by the Company (1)
$334,034 
Transaction costs1,932 
   Consideration paid$335,966
Investments$592,809 
Cash and cash equivalents22,317 
Other assets6,679 
   Total assets acquired621,805
Debt225,000 
Other liabilities60,839 
   Total liabilities acquired285,839
       Total net assets acquired$335,966
__________
(1) Common stock issued by the Company includes $19 of cash paid in lieu of issuing fractional shares.


77

OAKTREE SPECIALTY LENDING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts, percentages and as otherwise indicated)










Note 14.15. Subsequent Events
The Company’s management evaluated subsequent events through the date of issuance of the Consolidated Financial Statements. There have been no subsequent events that occurred during such period that would require disclosure in, or would be required to be recognized in the Consolidated Financial Statements as of and for the three and nine months ended June 30, 2022,2023, except as discussed below.
Distribution Declaration
On July 29, 2022,28, 2023, the Company’s Board of Directors declared a quarterly distribution of $0.17$0.55 per share, payable in cash on September 30, 202229, 2023 to stockholders of record on September 15, 2022.2023.






78



Schedule 12-14
Oaktree Specialty Lending Corporation
Schedule of Investments in and Advances to Affiliates
(in thousands, except share and per share amounts, percentages and as otherwise indicated)
Nine months ended June 30, 20222023
(unaudited)
Portfolio Company/Type of Investment (1) Cash Interest RateIndustryPrincipalNet Realized Gain (Loss)Amount of
Interest,
Fees or
Dividends
Credited in
Income (2)
Fair Value
as of October 1,
2021
Gross
Additions (3)
Gross
Reductions (4)
Fair Value
as of June 30, 2022
% of Total Net Assets
Control Investments
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— $— $— $— $— — %
34,984,460.37 Preferred Units— — 27,638 — — 27,638 2.2 %
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20247.26 %$16,074 — 1,078 27,381 — (11,307)16,074 1.3 %
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — 42 — — — — — %
30,030.8 Common Units in DD Healthcare Services Holdings, LLC— 3,308 18,065 — (8,798)9,267 0.7 %
First Star Speir Aviation Limited (5)Airlines
First Lien Term Loan, 9.00% cash due 12/15/2025— 7,500 — 7,500 — (7,500)— — %
100% equity interest(5,632)158 698 — (698)— — %
OCSI Glick JV LLC (6)Multi-Sector Holdings
Subordinated Debt, LIBOR+4.50% cash due 10/20/20284.94 %60,274 — 3,292 55,582 1,123 (6,099)50,606 4.0 %
87.5% equity interest— — — — — — — %
Senior Loan Fund JV I, LLC (7)Multi-Sector Holdings
Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.00 %96,250 — 5,839 96,250 — — 96,250 7.6 %
87.5% LLC equity interest— 2,026 37,651 — (14,628)23,023 1.8 %
Total Control Investments$172,598 $1,868 $15,743 $270,765 $1,123 $(49,030)$222,858 17.6 %
Affiliate Investments
Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.75% cash due 10/17/20239.00 %$21,754 $— $1,185 $15,712 $11,585 $(6,037)$21,260 1.7 %
1,609,201 Class A Units— — 587 — (24)563 — %
1,019,168.80 Preferred Units, 6%— — 1,152 51 — 1,203 0.1 %
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — — — — — — %
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%— — — 838 — (437)401 — %
Total Affiliate Investments$21,754 $ $1,185 $18,289 $11,636 $(6,498)$23,427 1.9 %
Total Control & Affiliate Investments$194,352 $1,868 $16,928 $289,054 $12,759 $(55,528)$246,285 19.5 %


Portfolio CompanyIndustryInvestment TypeIndexSpreadCashPIK RateMaturity DateSharesPrincipalNet Realized Gain (Loss)Amount of Interest, Fees or Dividends Credited in Income (2)Fair Value at October 1, 2022Gross Additions (3)Gross Reductions (4)Fair Value at June 30, 2023% of Total Net Assets
Control Investments
C5 Technology Holdings, LLCData Processing & Outsourced ServicesCommon Stock829 $— $— $— $— $— $— $— — %
C5 Technology Holdings, LLCData Processing & Outsourced ServicesPreferred Equity34,984,460 — — — 27,638 — — 27,638 1.8 %
Dominion Diagnostics, LLCHealth Care ServicesFirst Lien Term LoanSOFR+5.00 %10.39 %8/28/202514,102 — 1,070 14,333 — (231)14,102 0.9 %
Dominion Diagnostics, LLCHealth Care ServicesFirst Lien Term LoanSOFR+5.00 %8/28/2025— — — — — — — — %
Dominion Diagnostics, LLCHealth Care ServicesFirst Lien RevolverSOFR+5.00 %10.24 %8/28/20253,484 — 136 — 3,484 — 3,484 0.2 %
Dominion Diagnostics, LLCHealth Care ServicesCommon Stock30,031 — — — 4,946 — (2,235)2,711 0.2 %
OCSI Glick JV LLC (5)Multi-Sector HoldingsSubordinated DebtL+4.50 %9.36 %10/20/202858,349 — 4,961 50,283 1,116 (1,767)49,632 3.3 %
OCSI Glick JV LLC (5)Multi-Sector HoldingsMembership Interest87.50 %— — — — — — — — %
Senior Loan Fund JV I, LLC (6)Multi-Sector HoldingsSubordinated DebtL+7.00 %11.86 %12/29/2028112,656 — 9,197 96,250 16,406 — 112,656 7.5 %
Senior Loan Fund JV I, LLC (6)Multi-Sector HoldingsMembership Interest87.50 %— — 3,150 20,715 7,258 — 27,973 1.9 %
Total Control Investments$188,591 $ $18,514 $214,165 $28,264 $(4,233)$238,196 15.8 %
Affiliate Investments
Assembled Brands Capital LLCSpecialized FinanceFirst Lien RevolverL+6.75 %12.29 %10/17/202322,304 — 1,985 24,225 2,378 (4,417)22,186 1.5 %
Assembled Brands Capital LLCSpecialized FinanceCommon Stock1,783,332 — — — 370 40 (410)— — %
Assembled Brands Capital LLCSpecialized FinancePreferred Equity1,129,453 — — — 1,223 189 — 1,412 0.1 %
Assembled Brands Capital LLCSpecialized FinanceWarrants78,045 — — — — — — — — %
Caregiver Services, Inc.Health Care ServicesPreferred Equity1,080,399 — — — 378 — (65)313 — %
Total Affiliate Investments$22,304 $ $1,985 $26,196 $2,607 $(4,892)$23,911 1.6 %
Total Control & Affiliate Investments$210,895 $ $20,499 $240,361 $30,871 $(9,125)$262,107 17.4 %

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.
______________________
(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments.
(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.
(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.
79


(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.
(5)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).
(6)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).
79


Schedule 12-14
Oaktree Specialty Lending Corporation
Schedule of Investments in and Advances to Affiliates
(in thousands, except share and per share amounts, percentages and as otherwise indicated)
Nine months ended June 30, 2022
(unaudited)

Portfolio CompanyIndustryInvestment TypeIndexSpreadCashPIK RateMaturity DateSharesPrincipalNet Realized Gain (Loss)Amount of Interest, Fees or Dividends Credited in Income (2)Fair Value at October 1, 2021Gross Additions (3)Gross Reductions (4)Fair Value at June 30, 2022% of Total Net Assets
Control Investments
C5 Technology Holdings, LLCData Processing & Outsourced ServicesCommon Stock829 $— $— $— $— $— $— $— — %
C5 Technology Holdings, LLCData Processing & Outsourced ServicesPreferred Equity34,984,460 — — — 27,638 — — 27,638 2.2 %
Dominion Diagnostics, LLCHealth Care ServicesFirst Lien Term LoanL+5.00 %7.26 %2/28/202416,074 — 1,078 27,381 — (11,307)16,074 1.3 %
Dominion Diagnostics, LLCHealth Care ServicesFirst Lien RevolverL+5.00 %2/28/2024— — 42 — — — — — %
Dominion Diagnostics, LLCHealth Care ServicesCommon Stock30,031 — — 3,308 18,065 — (8,798)9,267 0.7 %
First Star Speir Aviation Limited (5)AirlinesFirst Lien Term Loan9.00 %12/15/2025— 7,500 — 7,500 — (7,500)— — %
First Star Speir Aviation Limited (5)AirlinesMembership Interest100.00 %— (5,632)158 698 — (698)— — %
OCSI Glick JV LLC (6)Multi-Sector HoldingsSubordinated DebtL+4.50 %4.94 %10/20/202860,274 — 3,292 55,582 1,123 (6,099)50,606 4.0 %
OCSI Glick JV LLC (6)Multi-Sector HoldingsMembership Interest87.50 %— — — — — — — — %
Senior Loan Fund JV I, LLC (7)Multi-Sector HoldingsSubordinated DebtL+7.00 %8.00 %12/29/202896,250 — 5,839 96,250 — — 96,250 7.6 %
Senior Loan Fund JV I, LLC (7)Multi-Sector HoldingsMembership Interest87.50 %— — 2,026 37,651 — (14,628)23,023 1.8 %
Total Control Investments$172,598 $1,868 $15,743 $270,765 $1,123 $(49,030)$222,858 17.6 %
Affiliate Investments
Assembled Brands Capital LLCSpecialized FinanceFirst Lien RevolverL+6.75 %9.00 %10/17/202321,754 — 1,185 15,712 11,585 (6,037)21,260 1.7 %
Assembled Brands Capital LLCSpecialized FinanceCommon Stock1,609,201 — — — 587 — (24)563 — %
Assembled Brands Capital LLCSpecialized FinancePreferred Equity1,019,169 — — — 1,152 51 — 1,203 0.1 %
Assembled Brands Capital LLCSpecialized FinanceWarrants70,425 — — — — — — —  %
Caregiver Services, Inc.Health Care ServicesPreferred Equity1,080,399 — — — 838 — (437)401 — %
Total Affiliate Investments$21,754 $ $1,185 $18,289 $11,636 $(6,498)$23,427 1.9 %
Total Control & Affiliate Investments$194,352 $1,868 $16,928 $289,054 $12,759 $(55,528)$246,285 19.5 %

This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.
______________________
(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments included in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2022.
(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.
(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.
(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.
(5)First Star Speir Aviation Limited is a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the
80


wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities.
(6)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).
(7)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).






80


Schedule 12-14
Oaktree Specialty Lending Corporation
Schedule of Investments in and Advances to Affiliates
(in thousands, except share and per share amounts, percentages and as otherwise indicated)
Nine months ended June 30, 2021
(unaudited)


Portfolio Company/Type of Investment (1) Cash Interest RateIndustryPrincipalNet Realized Gain (Loss)Amount of
Interest,
Fees or
Dividends
Credited in
Income (2)
Fair Value
as of October 1,
2020
Gross
Additions (3)
Gross
Reductions (4)
Fair Value
as of June 30, 2021
% of Total Net Assets
Control Investments
C5 Technology Holdings, LLCData Processing & Outsourced Services
829 Common Units$— $— $— $— $— $— — %
34,984,460.37 Preferred Units— — 27,638 — — 27,638 2.1 %
Dominion Diagnostics, LLCHealth Care Services
First Lien Term Loan, LIBOR+5.00% cash due 2/28/20246.00 %$27,451 — 1,293 27,660 — (209)27,451 2.1 %
First Lien Revolver, LIBOR+5.00% cash due 2/28/2024— — 261 5,260 2,439 (7,699)— — %
30,030.8 Common Units in DD Healthcare Services Holdings, LLC— 358 7,667 10,398 — 18,065 1.4 %
 First Star Speir Aviation Limited (5)Airlines
First Lien Term Loan, 9.00% cash due 12/15/20257,500 — — 11,510 — (4,010)7,500 0.6 %
100% equity interest— 550 1,622 1,021 (2,161)482 — %
New IPT, Inc.Oil & Gas Equipment & Services
First Lien Term Loan, LIBOR+5.00% cash due 3/17/2021— — 42 1,800 504 (2,304)— — %
First Lien Revolver, LIBOR+5.00% cash due 3/17/2021— — 17 788 221 (1,009)— — %
50.087 Class A Common Units in New IPT Holdings, LLC— — — — — — — %
OCSI Glick JV LLC (6)Multi-Sector Holdings
Subordinated Debt, LIBOR+4.50% cash due 10/20/20284.70 %62,296 — 1,134 — 55,923 (526)55,397 4.3 %
87.5% equity interest— — — — — — — %
 Senior Loan Fund JV I, LLC (7)Multi-Sector Holdings
Subordinated Debt, LIBOR+7.00% cash due 12/29/20288.00 %96,250 — 5,420 96,250 — — 96,250 7.4 %
87.5% LLC equity interest— 451 21,190 15,505 — 36,695 2.8 %
Total Control Investments$193,497 $ $9,526 $201,385 $86,011 $(17,918)$269,478 20.7 %
Affiliate Investments
 Assembled Brands Capital LLCSpecialized Finance
First Lien Revolver, LIBOR+6.00% cash due 10/17/20237.00 %$11,924 $— $452 $4,194 $7,996 $(510)$11,680 0.9 %
1,609,201 Class A Units— — 483 96 — 579 — %
1,019,168.80 Preferred Units, 6%— — 1,091 40 — 1,131 0.1 %
70,424.5641 Class A Warrants (exercise price $3.3778) expiration date 9/9/2029— — — — — — — %
Caregiver Services, Inc.Health Care Services
1,080,399 shares of Series A Preferred Stock, 10%— — — 741 — (172)569 — %
Total Affiliate Investments$11,924 $ $452 $6,509 $8,132 $(682)$13,959 1.1 %
Total Control & Affiliate Investments$205,421 $ $9,978 $207,894 $94,143 $(18,600)$283,437 21.8 %


81


This schedule should be read in connection with the Company's Consolidated Financial Statements, including the Consolidated Schedules of Investments and Notes to the Consolidated Financial Statements.
______________________
(1)The principal amount and ownership detail are shown in the Company's Consolidated Schedules of Investments, included in the Company's quarterly report on Form 10-Q for the quarter ended June 30, 2021.
(2)Represents the total amount of interest (net of non-accrual amounts), fees and dividends credited to income for the portion of the period an investment was included in the Control or Affiliate categories.
(3)Gross additions include increases in the cost basis of investments resulting from new portfolio investments, follow-on investments, accrued PIK interest (net of non-accrual amounts) and the exchange of one or more existing securities for one or more new securities. Gross additions also include net increases in unrealized appreciation or net decreases in unrealized depreciation as well as the movement of an existing portfolio company into this category or out of a different category.
(4)Gross reductions include decreases in the cost basis of investments resulting from principal payments or sales and exchanges of one or more existing securities for one or more new securities. Gross reductions also include net increases in unrealized depreciation or net decreases in unrealized appreciation as well as the movement of an existing portfolio company out of this category and into a different category.
(5)First Star Speir Aviation Limited is a wholly-owned holding company formed by the Company in order to facilitate its investment strategy. In accordance with ASU 2013-08, the Company has deemed the holding company to be an investment company under GAAP and therefore deemed it appropriate to consolidate the financial results and financial position of the holding company and to recognize dividend income versus a combination of interest income and dividend income. Accordingly, the debt and equity investments in the wholly-owned holding company are disregarded for accounting purposes since the economic substance of these instruments are equity investments in the operating entities.
(6)Together with GF Equity Funding, the Company co-invests through Glick JV. Glick JV is capitalized as transactions are completed and all portfolio and investment decisions in respect to Glick JV must be approved by the Glick JV investment committee consisting of representatives of the Company and GF Equity Funding (with approval from a representative of each required).
(7)Together with Kemper, the Company co-invests through SLF JV I. SLF JV I is capitalized as transactions are completed and all portfolio and investment decisions in respect to SLF JV I must be approved by the SLF JV I investment committee consisting of representatives of the Company and Kemper (with approval from a representative of each required).




82



Item 2.     Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in connection with our Consolidated Financial Statements and the notes thereto included elsewhere in this quarterly report on Form 10-Q.
Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements because they relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q may include statements as to:


our future operating results and distribution projections;
the ability of Oaktree Fund Advisors, LLC, or Oaktree, to reposition our portfolio and to implement Oaktree's future plans with respect to our business;
the ability of Oaktree and its affiliates to attract and retain highly talented professionals;
our business prospects and the prospects of our portfolio companies;
the impact of the investments that we expect to make;
the ability of our portfolio companies to achieve their objectives;
our expected financings and investments and additional leverage we may seek to incur in the future;
the adequacy of our cash resources and working capital;
the timing of cash flows, if any, from the operations of our portfolio companies; and
the cost or potential outcome of any litigation to which we may be a party.
In addition, words such as “anticipate,” “believe,” “expect,” “seek,” “plan,” “should,” “estimate,” “project” and “intend” indicate forward-looking statements, although not all forward-looking statements include these words. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties. Our actual results could differ materially from those implied or expressed in the forward-looking statements for any reason, including the factors set forth in “Item 1A. Risk Factors” in our annual report on Form 10-K for the year ended September 30, 20212022 and elsewhere in this quarterly report on Form 10-Q.
Other factors that could cause actual results to differ materially include:
changes or potential disruptions in our operations, the economy, financial markets or political environment, including the impacts of inflation and rising interest rates;
risks associated with possible disruption in our operations or the economy generally due to terrorism, war or other geopolitical conflict (including the current conflict between Russia and Ukraine), natural disasters or the COVID-19 pandemic;pandemics;
future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities) and conditions in our operating areas, particularly with respect to Business Development Companies or, regulated investment companies, or RICs;
general considerations associated with the COVID-19 pandemic;
the ability to realize the anticipated benefits of the MergersOSI2 Merger (as defined below); and
other considerations that may be disclosed from time to time in our publicly disseminated documents and filings.
We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the Securities and Exchange Commission, or the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.
All dollar amounts in tables are in thousands, except share and per share amounts and as otherwise indicated.
Business Overview
We are a specialty finance company dedicated to providing customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. We are a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a Business Development Company under the Investment Company Act of 1940, as amended, or the Investment Company Act. In addition, we have qualified and elected to be treated as a RIC under the Internal Revenue Code of 1986, as amended, or the Code, for U.S. federal income tax purposes.
We are externally managed by Oaktree pursuant to an investment advisory agreement, as amended from time to time, or the Investment Advisory Agreement. Oaktree Fund Administration, LLC, or Oaktree Administrator, an affiliate of Oaktree,
82


provides certain administrative and other
83


services necessary for us to operate pursuant to an administration agreement, as amended from time to time, or the Administration Agreement.
Our investment objective is to generate current income and capital appreciation by providing companies with flexible and innovative financing solutions, including first and second lien loans, unsecured and mezzanine loans, bonds, preferred equity and certain equity co-investments. We may also seek to generate capital appreciation and income through secondary investments at discounts to par in either private or syndicated transactions. Our portfolio may also include certain structured finance and other non-traditional structures. We invest in companies that typically possess resilient business models with strong underlying fundamentals. We intend to deploy capital across credit and economic cycles with a focus on long-term results, which we believe will enable us to build lasting partnerships with financial sponsors and management teams, and we may seek to opportunistically take advantage of dislocations in the financial markets and other situations that may benefit from Oaktree’s credit and structuring expertise. Sponsors may include financial sponsors, such as an institutional investor or a private equity firm, or a strategic entity seeking to invest in a portfolio company. Oaktree is generally focused on middle-market companies, which we define as companies with enterprise values of between $100 million and $750 million. We generally invest in securities that are rated below investment grade by rating agencies or that would be rated below investment grade if they were rated. Below investment grade securities, which are often referred to as “high yield” and “junk,” have predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal.
In the current market environment, Oaktree intends to focus on the following areas,area, in which Oaktree believes there is less competition and thus potential for greater returns, for our new investment opportunities: (1) situational lending, which we define to include directly originated loans to non-sponsor companies that are hard to understand and value using traditional underwriting techniques, (2) select sponsor lending, which we define to include financing to support leveraged buyouts of companies with specialized sponsors that have expertise in certain industries, and (3) stressed sector and rescue lending, which we define to include opportunistic private loans in industries experiencing stress or limited access to capital.
Oaktree intends to continue to rotate our portfolio into investments that are better aligned with Oaktree's overall approach to credit investing and that it believes have the potential to generate attractive returns across market cycles (which we call "core investments"). Oaktree has performed a comprehensive review of our portfolio and categorized our portfolio into core investments, non-core performing investments and underperforming investments. Certain additional information on such categorization and our portfolio composition is included in investor presentations that we file with the SEC. Since an Oaktree affiliate became our investment adviser in October 2017, Oaktree and its affiliates have reduced the investments identified as non-core by approximately $800 million at fair value. Over time, Oaktree intends to rotate us out of the remaining non-core investments, which were approximately $77$67 million at fair value as of June 30, 2022.2023. Oaktree periodically reviews designations of investments as core and non-core and may change such designations over time.


On March 19, 2021, we acquired Oaktree Strategic Income Corporation, or OCSI, pursuant to an agreement and plan or merger, or the OCSI Merger Agreement, dated as of October 28, 2020, by and among OCSI, us, Lion Merger Sub, Inc., our wholly-owned subsidiary, or Merger Sub, and, solely for the limited purposes set forth therein, Oaktree. Pursuant to the OCSI Merger Agreement, Merger SubOCSI was first merged with and into OCSI, with OCSI as the surviving corporation, or the Merger, and, immediately following the Merger, OCSI was then merged with and into us in a two-step transaction with us as the surviving company, or together with the OCSI Merger.

On January 23, 2023, we acquired Oaktree Strategic Income II, Inc., or OSI2, pursuant to that certain Agreement and Plan of Merger, or the Mergers. In accordance with the terms of theOSI2 Merger Agreement, atdated as of September 14, 2022, by and among OSI2, us, Project Superior Merger Sub, Inc., a wholly-owned subsidiary of us, and, solely for the effective time oflimited purposes set forth therein, Oaktree. Pursuant to the OSI2 Merger each outstanding share of OCSI’s common stockAgreement, OSI2 was convertedmerged with and into us in a two-step transaction with us as the right to receive 1.3371 shares of our common stock (with OCSI’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result ofsurviving company, or the Mergers, we issued an aggregate of 39,400,011 shares of our common stock to former OCSI stockholders.OSI2 Merger.
83


Business Environment and Developments


Global financial markets have experienced an increase in volatility as concerns about the impact of higher inflation, rising interest rates, a potential recession and the current conflict in Ukraine and the ongoing uncertainty related to the COVID-19 pandemic have weighed on market participants. These factors have created disruptions in supply chains and economic activity and have had a particularly adverse impact on certain companies in the energy, raw materials and transportation sectors, among others. These uncertainties can ultimately impact the overall supply and demand of the market through changing spreads, deal terms and structures and equity purchase price multiples.


We are unable to predict the full effects of these macroeconomic events or how long any further market disruptions or volatility might last. We continue to closely monitor the impact these events have on our business, industry and portfolio companies and will provide constructive solutions where necessary.


Against this uncertain macroeconomic backdrop, we believe attractive risk-adjusted returns can be achieved by making loans to middle market companies that typically possess resilient business models with strong underlying fundamentals. Given the breadth of the investment platform and decades of credit investing experience of Oaktree and its affiliates, we believe that
84


we have the resources and experience to source, diligence and structure investments in these companies and are well placed to generate attractive returns for investors.
As of June 30, 2022, 87.8%2023, 86.0% of our debt investment portfolio (at fair value) and 87.6%85.8% of our debt investment portfolio (at cost) bore interest at floating rates. Most of our floating rate loans are indexed to the LIBOR and/Secured Overnight Financing Rate, or an alternate base rate (e.g., prime rate),SOFR, or the London Interbank Offered Rate, or LIBOR, which typically resets semi-annually, quarterly or monthly at the borrower’s option. Certain loans mayare also be indexed to the Secured Overnight Financing Rate, or SOFR, a new index calculated by short-term repurchase agreements, backed by Treasury securities,an alternate base rate (e.g., prime rate) or the Sterling Overnight Index Average, or SONIA, an alternative reference rate that is based on transactions. In July 2017, the head of the United Kingdom Financial Conduct Authority, or the FCA, announced the desire to phase out the use of LIBOR by the end of 2021. However, in March 2021 the FCA announced that mostSONIA. Most U.S. dollar LIBOR would continue torates are no longer published after June 30, 2023 although certain synthetic rates will be published through JuneSeptember 30, 2023 effectively extending the LIBOR transition period to June 30, 2023. However, the FCA no longer compels panel banks to continue to contribute to LIBOR and the Federal Reserve Board, the Office of the Comptroller of the Currency, and the Federal Deposit Insurance Corporation have encouraged banks to cease entering into new contracts that use U.S. dollar LIBOR as a reference rate no later than December 31, 2021.2024. The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, supports replacing U.S.-dollar LIBOR with SOFR. Although there have been issuances utilizing SOFR or SONIA, it is unknown whether these alternative reference rates will attain market acceptance as replacements for LIBOR. In anticipation ofconnection with the cessation of LIBOR, we may need to renegotiate any credit agreements extending beyond the applicable phase out date with our prospective portfolio companies that utilize LIBOR as a factor in determining the interest rate. Certain of the loan agreements with our portfolio companies have included fallback language in the event thatto address when LIBOR becomes unavailable. This language generally provides that the administrative agent may identify a replacement reference rate, typically with the consent of (or prior consultation with) the borrower. In certain cases, the administrative agent will be required to obtain the consent of either a majority of the lenders under the facility, or the consent of each lender, prior to identifying a replacement reference rate. Certain of the loan agreements with our portfolio companies do not include any fallback language providing a mechanism for the parties to negotiate a new reference interest rate and will instead revert to the base rate in the event LIBOR ceases to exist.


Critical Accounting Estimates
Investment Valuation
We value our investments in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 820, Fair Value Measurements and Disclosures, or ASC 820, which defines fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A liability’s fair value is defined as the amount that would be paid to transfer the liability to a new obligor, not the amount that would be paid to settle the liability with the creditor. ASC 820 prioritizes the use of observable market prices over entity-specific inputs. Where observable prices or inputs are not available or reliable, valuation techniques are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the investments or market and the investments’ complexity.
Hierarchical levels, defined by ASC 820 and directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:
 
Level 1 — Unadjusted, quoted prices in active markets for identical assets or liabilities as of the measurement date.
Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data at the measurement date for substantially the full term of the assets or liabilities.
Level 3 — Unobservable inputs that reflect management’sOaktree’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.
If inputs used to measure fair value fall into different levels of the fair value hierarchy, an investment's level is based on the lowest level of input that is significant to the fair value measurement. OurOaktree's assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.
84


This includes investment securities that are valued using "bid" and "ask" prices obtained from independent third party pricing services or directly from brokers. These investments may be classified as Level 3 because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities or may require adjustments for investment-specific factors or restrictions.
Financial instruments with readily available quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment inherent in measuring fair value. As such, Oaktree obtains and analyzes readily
85


available market quotations provided by pricing vendors and brokers for all of our investments for which quotations are available. In determining the fair value of a particular investment, pricing vendors and brokers use observable market information, including both binding and non-binding indicative quotations.
We seekOaktree seeks to obtain at least two quotations for the subject or similar securities, typically from pricing vendors. If we areOaktree is unable to obtain two quotes from pricing vendors, or if the prices obtained from pricing vendors are not within our set threshold, we seekOaktree seeks to obtain a quote directly from a broker making a market for the asset. Oaktree evaluates the quotations provided by pricing vendors and brokers based on available market information, including trading activity of the subject or similar securities, or by performing a comparable security analysis to ensure that fair values are reasonably estimated. Oaktree also performs back-testing of valuation information obtained from pricing vendors and brokers against actual prices received in transactions. In addition to ongoing monitoring and back-testing, Oaktree performs due diligence procedures over pricing vendors to understand their methodology and controls to support their use in the valuation process. Generally, we doOaktree does not adjust any of the prices received from these sources.
If the quotations obtained from pricing vendors or brokers are determined to not be reliable or are not readily available, we valueOaktree values such investments using any of three different valuation techniques. The first valuation technique is the transaction precedent technique, which utilizes recent or expected future transactions of the investment to determine fair value, to the extent applicable. The second valuation technique is an analysis of the enterprise value, or EV, of the portfolio company. EV means the entire value of the portfolio company to a market participant, including the sum of the values of debt and equity securities used to capitalize the enterprise at a point in time. The EV analysis is typically performed to determine (i) the value of equity investments, (ii) whether there is credit impairment for debt investments and (iii) the value for debt investments that we are deemed to control under the Investment Company Act. To estimate the EV of a portfolio company, Oaktree analyzes various factors, including the portfolio company’s historical and projected financial results, macroeconomic impacts on the company and competitive dynamics in the company’s industry. Oaktree also utilizes some or all of the following information based on the individual circumstances of the portfolio company: (i) valuations of comparable public companies, (ii) recent sales of private and public comparable companies in similar industries or having similar business or earnings characteristics, (iii) purchase prices as a multiple of their earnings or cash flow, (iv) the portfolio company’s ability to meet its forecasts and its business prospects, (v) a discounted cash flow analysis, (vi) estimated liquidation or collateral value of the portfolio company’s assets and (vii) offers from third parties to buy the portfolio company. WeOaktree may probability weight potential sale outcomes with respect to a portfolio company when uncertainty exists as of the valuation date. Under the EV technique, the significant unobservable input used in the fair value measurement of our investments in debt or equity securities is the EBITDA, revenue or asset multiple, as applicable. Increases or decreases in the valuation multiples in isolation may result in a higher or lower fair value measurement, respectively. The third valuation technique is a market yield technique, which is typically performed for non-credit impaired debt investments. In the market yield technique, a current price is imputed for the investment based upon an assessment of the expected market yield for a similarly structured investment with a similar level of risk, and we consider the current contractual interest rate, the capital structure and other terms of the investment relative to risk of the company and the specific investment. A key determinant of risk, among other things, is the leverage through the investment relative to the EV of the portfolio company. As debt investments held by us are substantially illiquid with no active transaction market, we dependOaktree depends on primary market data, including newly funded transactions and industry-specific market movements, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. Under the market yield technique, the significant unobservable input used in the fair value measurement of the Company'sour investments in debt securities is the market yield. Increases or decreases in the market yield may result in a lower or higher fair value measurement, respectively.
In accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. Consistent with FASB guidance under ASC 820, these investments are excluded from the hierarchical levels. These investments are generally not redeemable.
We estimateOaktree estimates the fair value of certain privately held warrants using a Black Scholes pricing model, which includes an analysis of various factors and subjective assumptions, including the current stock price (by using an EV analysis as described above), the expected period until exercise, expected volatility of the underlying stock price, expected dividends and the risk-free rate. Changes in the subjective input assumptions can materially affect the fair value estimates.
The fair value of our investments as of June 30, 20222023 and September 30, 20212022 was determined in good faith by Oaktree, as our Board of Directors.valuation designee. We have and will continue to engage independent valuation firms to provide assistance regarding the determination of the fair value of a portion of our portfolio securities for which market quotations are not readily available or
85


are readily available but deemed not reflective of the fair value of the investment each quarter, and the Board of Directors may reasonably rely on that assistance.quarter. As of June 30, 2022, 89.0%2023, 90.3% of our portfolio at fair value was valued either based on market quotations, the transactions precedent approach or corroborated by independent valuation firms. However, our Board of Directors is responsible for the ultimate valuation of the portfolio investments at fair value as determined in good faith pursuant to our valuation policy and a consistently applied valuation process.
86


Certain factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s earnings and its ability to make payments on its indebtedness, the markets in which the portfolio company does business, comparison to comparable publicly-traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Due to these uncertainties, ourOaktree's fair value determinations may cause our net asset value on a given date to materially understate or overstate the value that we may ultimately realize upon the sale of one or more of our investments.
As of June 30, 2022,2023, we held $2,565.4$3,135.6 million of investments at fair value, up from $2,556.6$2,494.1 million held at September 30, 2021,2022, primarily driven by new originations and partially offset by unrealized losses related to credit spread widening.the growth in assets that resulted from the completion of the OSI2 Merger during the quarter ended March 31, 2023. As of June 30, 20222023 and September 30, 2021,2022, approximately 95.4%94.0% and 97.0%94.2%, respectively, of our total assets represented investments at fair value.
Revenue Recognition
Interest Income
Interest income, adjusted for accretion of original issue discount, or OID, is recorded on an accrual basis to the extent that such amounts are expected to be collected. We stop accruing interest on investments when it is determined that interest is no longer collectible. Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when there is reasonable doubt that principal or interest cash payments will be collected. Cash interest payments received on investments may be recognized as income or a return of capital depending upon management’s judgment. A non-accrual investment is restored to accrual status if past due principal and interest are paid in cash, and the portfolio company, in management’s judgment, is likely to continue timely payment of its remaining obligations. As of each of June 30, 20222023, there were five investments on non-accrual status that in the aggregate represented 3.6% and 3.1% of total debt investments at cost and fair value, respectively. As of September 30, 2021,2022, there were no investments on non-accrual status.
In connection with our investment in a portfolio company, we sometimes receive nominal cost equity that is valued as part of the negotiation process with the portfolio company. When we receive nominal cost equity, we allocate our cost basis in the investment between debt securities and the nominal cost equity at the time of origination. Any resulting discount from recording the loan, or otherwise purchasing a security at a discount, is accreted into interest income over the life of the loan.
PIK Interest Income
Our investments in debt securities may contain payment-in-kind, or PIK, interest provisions. PIK interest, which typically represents contractually deferred interest added to the loan balance that is generally due at the end of the loan term, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We generally cease accruing PIK interest if there is insufficient value to support the accrual or if we do not expect the portfolio company to be able to pay all principal and interest due. Our decision to cease accruing PIK interest on a loan or debt security involves subjective judgments and determinations based on available information about a particular portfolio company, including whether the portfolio company is current with respect to its payment of principal and interest on its loans and debt securities; financial statements and financial projections for the portfolio company; our assessment of the portfolio company's business development success; information obtained by us in connection with periodic formal update interviews with the portfolio company's management and, if appropriate, the private equity sponsor; and information about the general economic and market conditions in which the portfolio company operates. Our determination to cease accruing PIK interest is generally made well before our full write-down of a loan or debt security. In addition, if it is subsequently determined that we will not be able to collect any previously accrued PIK interest, the fair value of the loans or debt securities would be reduced by the amount of such previously accrued, but uncollectible, PIK interest. The accrual of PIK interest on our debt investments increases the recorded cost bases of these investments in our Consolidated Financial Statements including for purposes of computing the capital gains incentive fee payable by us to Oaktree. To maintain our status as a RIC, certain income from PIK interest may be required to be distributed to our stockholders, even though we have not yet collected the cash and may never do so.
8786



Portfolio Composition
Our investments principally consist of loans, common and preferred equity and warrants in privately-held companies, Senior Loan Fund JV I, LLC, or SLF JV I, a joint venture through which we and Trinity Universal Insurance Company, a subsidiary of Kemper Corporation, or Kemper, co-invest in senior secured loans of middle-market companies and other corporate debt securities, and OCSI Glick JV LLC, or the Glick JV, a joint venture through which we and GF Equity Funding 2014 LLC, or GF Equity Funding, co-invest primarily in senior secured loans of middle-market companies. We refer to SLF JV I and the Glick JV collectively as the JVs. Our loans are typically secured by a first, second or subordinated lien on the assets of the portfolio company and generally have terms of up to ten years (but an expected average life of between three and four years).
DuringExcluding the investments acquired in connection with the OSI2 Merger, during the nine months ended June 30, 2022,2023, we originated $659.7$625.1 million of investment commitments in 4030 new and 3414 existing portfolio companies and funded $607.0$621.3 million of investments.
During the nine months ended June 30, 2022,2023, we received $545.0$527.5 million of proceeds from prepayments, exits, other paydowns and sales and exited 2732 portfolio companies.
A summary of the composition of our investment portfolio at cost and fair value as a percentage of total investments is shown in the following tables:
June 30, 2022September 30, 2021June 30, 2023September 30, 2022
Cost:Cost:Cost:
Senior secured debtSenior secured debt85.14 %85.85 %Senior secured debt87.59 %85.08 %
Debt investments in the JVsDebt investments in the JVs5.50 5.79 Debt investments in the JVs4.93 5.59 
Preferred equityPreferred equity3.18 2.60 Preferred equity3.02 3.26 
Subordinated debtSubordinated debt2.76 1.67 Subordinated debt1.68 2.57 
LLC equity interests of the JVsLLC equity interests of the JVs1.85 1.94 LLC equity interests of the JVs1.66 1.88 
Common equity and warrantsCommon equity and warrants1.57 2.15 Common equity and warrants1.12 1.62 
TotalTotal100.00 %100.00 %Total100.00 %100.00 %
 
June 30, 2022September 30, 2021June 30, 2023September 30, 2022
Fair value:Fair value:Fair value:
Senior secured debtSenior secured debt86.60 %86.72 %Senior secured debt88.48 %86.86 %
Debt investments in the JVsDebt investments in the JVs5.72 5.94 Debt investments in the JVs5.18 5.88 
Preferred equityPreferred equity3.18 2.49 Preferred equity2.94 3.19 
Subordinated debtSubordinated debt2.49 1.67 Subordinated debt1.66 2.28 
LLC equity interests of the JVsLLC equity interests of the JVs1.11 1.47 LLC equity interests of the JVs0.89 0.83 
Common equity and warrantsCommon equity and warrants0.90 1.71 Common equity and warrants0.85 0.96 
TotalTotal100.00 %100.00 %Total100.00 %100.00 %




8887



The industry composition of our portfolio at cost and fair value as a percentage of total investments was as follows:
June 30, 2022September 30, 2021June 30, 2023September 30, 2022
Cost:Cost:Cost:
Application SoftwareApplication Software15.30 %14.49 %Application Software16.98 %14.98 %
Multi-Sector Holdings (1)Multi-Sector Holdings (1)7.35 7.73 Multi-Sector Holdings (1)6.65 7.48 
Data Processing & Outsourced ServicesData Processing & Outsourced Services4.05 4.60 
Health Care TechnologyHealth Care Technology3.92 3.82 
BiotechnologyBiotechnology3.86 4.20 
PharmaceuticalsPharmaceuticals4.84 5.44 Pharmaceuticals3.69 4.83 
Data Processing & Outsourced Services4.52 4.74 
Biotechnology3.85 4.41 
Health Care Technology3.69 0.55 
Aerospace & DefenseAerospace & Defense3.36 2.37 
Industrial Machinery & Supplies & ComponentsIndustrial Machinery & Supplies & Components3.01 — 
Broadline RetailBroadline Retail2.52 — 
Health Care ServicesHealth Care Services2.35 2.24 
Real Estate Operating CompaniesReal Estate Operating Companies2.32 1.82 
Specialized FinanceSpecialized Finance2.10 3.09 
Personal Care ProductsPersonal Care Products2.08 — 
Automotive RetailAutomotive Retail1.97 2.26 
Fertilizers & Agricultural ChemicalsFertilizers & Agricultural Chemicals1.96 1.88 
Internet Services & InfrastructureInternet Services & Infrastructure1.91 2.07 
Health Care DistributorsHealth Care Distributors1.88 2.18 
Diversified Financial ServicesDiversified Financial Services1.87 — 
Auto Parts & EquipmentAuto Parts & Equipment1.85 0.48 
Metal, Glass & Plastic ContainersMetal, Glass & Plastic Containers1.76 — 
Airport ServicesAirport Services1.70 1.65 
Home Improvement RetailHome Improvement Retail1.67 1.75 
Insurance BrokersInsurance Brokers1.61 1.36 
Diversified Metals & MiningDiversified Metals & Mining1.51 — 
Leisure FacilitiesLeisure Facilities1.50 1.52 
Real Estate ServicesReal Estate Services1.36 1.54 
Soft Drinks & Non-alcoholic BeveragesSoft Drinks & Non-alcoholic Beverages1.31 — 
Diversified Support ServicesDiversified Support Services1.30 1.45 
Other Specialty RetailOther Specialty Retail1.27 — 
Specialty ChemicalsSpecialty Chemicals1.16 1.43 
DistributorsDistributors1.14 0.97 
Integrated Telecommunication ServicesIntegrated Telecommunication Services1.02 1.32 
Electrical Components & EquipmentElectrical Components & Equipment0.98 1.29 
Construction & EngineeringConstruction & Engineering0.83 2.33 
Environmental & Facilities ServicesEnvironmental & Facilities Services0.79 0.80 
AdvertisingAdvertising0.78 1.08 
Passenger AirlinesPassenger Airlines0.76 — 
Oil & Gas Storage & TransportationOil & Gas Storage & Transportation0.74 0.85 
Home FurnishingsHome Furnishings0.72 0.75 
GoldGold0.71 — 
Systems SoftwareSystems Software0.70 0.57 
Health Care EquipmentHealth Care Equipment0.68 0.93 
Real Estate DevelopmentReal Estate Development0.59 — 
Interactive Media & ServicesInteractive Media & Services0.58 — 
Hotels, Resorts & Cruise LinesHotels, Resorts & Cruise Lines0.52 0.53 
Consumer FinanceConsumer Finance0.50 0.55 
Education ServicesEducation Services0.48 0.35 
IT Consulting & Other ServicesIT Consulting & Other Services0.47 0.45 
RestaurantsRestaurants0.38 0.36 
Movies & EntertainmentMovies & Entertainment0.37 1.00 
Health Care SuppliesHealth Care Supplies0.35 1.39 
Food DistributorsFood Distributors0.18 0.18 
Apparel RetailApparel Retail0.16 0.20 
Air Freight & LogisticsAir Freight & Logistics0.15 0.28 
Integrated Oil & GasIntegrated Oil & Gas0.15 0.19 
Research & Consulting ServicesResearch & Consulting Services0.15 0.35 
Cable & SatelliteCable & Satellite0.14 0.79 
Other Specialized REITsOther Specialized REITs0.13 — 
Paper & Plastic Packaging Products & MaterialsPaper & Plastic Packaging Products & Materials0.10 — 
Housewares & SpecialtiesHousewares & Specialties0.09 0.09 
Electronic ComponentsElectronic Components0.06 0.08 
Leisure ProductsLeisure Products0.06 — 
Technology DistributorsTechnology Distributors0.03 0.12 
Communications EquipmentCommunications Equipment0.03 — 
Industrial MachineryIndustrial Machinery2.94 3.47 Industrial Machinery— 3.12 
Aerospace & Defense2.80 2.66 
Specialized Finance2.77 2.70 
Internet & Direct Marketing RetailInternet & Direct Marketing Retail2.55 2.45 Internet & Direct Marketing Retail— 2.59 
Fertilizers & Agricultural Chemicals2.42 2.63 
Construction & Engineering2.30 2.44 
Health Care Services2.23 3.34 
Automotive Retail2.22 1.65 
Internet Services & Infrastructure2.02 1.85 
Personal ProductsPersonal Products1.99 4.08 Personal Products— 2.03 
Metal & Glass ContainersMetal & Glass Containers1.75 0.69 Metal & Glass Containers— 1.82 
Health Care Distributors1.74 0.78 
Home Improvement Retail1.73 1.83 
Leisure Facilities1.61 0.99 
Airport Services1.61 1.64 
Real Estate Services1.51 1.59 
Real Estate Operating Companies1.48 1.08 
Diversified Support Services1.43 1.60 
Specialty Chemicals1.42 1.84 
Health Care Supplies1.36 1.17 
Insurance Brokers1.34 1.00 
Integrated Telecommunication Services1.30 1.85 
Soft DrinksSoft Drinks1.30 1.32 Soft Drinks— 1.31 
Electrical Components & Equipment1.27 1.27 
Oil & Gas Storage & Transportation1.18 1.44 
Advertising1.12 1.13 
Other Diversified Financial ServicesOther Diversified Financial Services1.10 0.63 Other Diversified Financial Services— 1.12 
Oil & Gas Refining & MarketingOil & Gas Refining & Marketing1.04 1.42 Oil & Gas Refining & Marketing— 0.33 
Movies & Entertainment0.98 1.02 
Distributors0.95 — 
Health Care Equipment0.91 0.93 
Environmental & Facilities Services0.73 — 
Home Furnishings0.73 0.77 
Cable & Satellite0.72 1.05 
Systems Software0.56 0.26 
Consumer Finance0.54 — 
Hotels, Resorts & Cruise Lines0.52 — 
Auto Parts & Equipment0.47 0.49 
IT Consulting & Other Services0.44 0.30 
Research & Consulting Services0.38 0.29 
Air Freight & Logistics0.36 0.19 
Restaurants0.35 0.37 
Education Services0.34 0.04 
Trading Companies & DistributorsTrading Companies & Distributors0.29 — Trading Companies & Distributors— 0.29 
Apparel, Accessories & Luxury GoodsApparel, Accessories & Luxury Goods0.19 0.20 Apparel, Accessories & Luxury Goods— 0.20 
Integrated Oil & Gas0.18 0.19 
Food Distributors0.17 0.18 
Apparel Retail0.17 — 
Specialized REITsSpecialized REITs0.16 — Specialized REITs— 0.16 
Communications Equipment0.14 — 
Housewares & Specialties0.14 0.07 
Diversified BanksDiversified Banks0.13 0.14 Diversified Banks— 0.13 
Technology Distributors0.12 0.12 
Construction MaterialsConstruction Materials0.09 0.09 Construction Materials— 0.09 
Alternative CarriersAlternative Carriers0.08 0.26 Alternative Carriers— 0.01 
Electronic Components0.08 0.40 
Independent Power Producers & Energy Traders— 0.92 
Airlines— 0.88 
Commercial Printing— 0.78 
Managed Health Care— 0.73 
Thrifts & Mortgage Finance— 0.63 
Property & Casualty Insurance— 0.39 
Leisure Products— 0.26 
Food Retail— 0.15 
TotalTotal100.00 %100.00 %Total100.00 %100.00 %
8988



June 30, 2022September 30, 2021June 30, 2023September 30, 2022
Fair value:Fair value:Fair value:
Application SoftwareApplication Software15.69 %14.58 %Application Software17.38 %15.43 %
Multi-Sector Holdings (1)Multi-Sector Holdings (1)6.62 7.41 Multi-Sector Holdings (1)6.13 6.71 
BiotechnologyBiotechnology4.09 4.35 
Data Processing & Outsourced ServicesData Processing & Outsourced Services3.97 4.46 
PharmaceuticalsPharmaceuticals4.73 5.56 Pharmaceuticals3.71 4.79 
Data Processing & Outsourced Services4.38 4.46 
Biotechnology3.97 4.44 
Health Care TechnologyHealth Care Technology3.76 0.55 Health Care Technology3.69 3.90 
Aerospace & DefenseAerospace & Defense3.55 2.48 
Industrial Machinery & Supplies & ComponentsIndustrial Machinery & Supplies & Components3.16 — 
Broadline RetailBroadline Retail2.58 — 
Real Estate Operating CompaniesReal Estate Operating Companies2.40 1.93 
Specialized FinanceSpecialized Finance2.12 2.93 
Fertilizers & Agricultural ChemicalsFertilizers & Agricultural Chemicals2.02 2.08 
Internet Services & InfrastructureInternet Services & Infrastructure2.00 2.16 
Automotive RetailAutomotive Retail1.99 2.31 
Health Care ServicesHealth Care Services1.98 1.84 
Diversified Financial ServicesDiversified Financial Services1.95 — 
Personal Care ProductsPersonal Care Products1.94 — 
Auto Parts & EquipmentAuto Parts & Equipment1.94 0.46 
Health Care DistributorsHealth Care Distributors1.92 2.19 
Airport ServicesAirport Services1.76 1.72 
Insurance BrokersInsurance Brokers1.74 1.33 
Home Improvement RetailHome Improvement Retail1.73 1.82 
Diversified Metals & MiningDiversified Metals & Mining1.59 — 
Leisure FacilitiesLeisure Facilities1.50 1.57 
Real Estate ServicesReal Estate Services1.41 1.59 
Metal, Glass & Plastic ContainersMetal, Glass & Plastic Containers1.40 — 
Soft Drinks & Non-alcoholic BeveragesSoft Drinks & Non-alcoholic Beverages1.36 — 
Other Specialty RetailOther Specialty Retail1.33 — 
Diversified Support ServicesDiversified Support Services1.32 1.47 
DistributorsDistributors1.17 0.98 
Electrical Components & EquipmentElectrical Components & Equipment1.03 1.32 
Specialty ChemicalsSpecialty Chemicals1.03 1.36 
Integrated Telecommunication ServicesIntegrated Telecommunication Services0.99 1.29 
Passenger AirlinesPassenger Airlines0.86 — 
Construction & EngineeringConstruction & Engineering0.86 2.45 
Environmental & Facilities ServicesEnvironmental & Facilities Services0.81 0.83 
GoldGold0.74 — 
Health Care EquipmentHealth Care Equipment0.72 0.97 
Systems SoftwareSystems Software0.71 0.51 
Oil & Gas Storage & TransportationOil & Gas Storage & Transportation0.69 0.84 
Home FurnishingsHome Furnishings0.62 0.73 
Real Estate DevelopmentReal Estate Development0.61 — 
Interactive Media & ServicesInteractive Media & Services0.61 — 
AdvertisingAdvertising0.60 1.08 
Hotels, Resorts & Cruise LinesHotels, Resorts & Cruise Lines0.55 0.56 
Education ServicesEducation Services0.45 0.34 
Consumer FinanceConsumer Finance0.40 0.53 
RestaurantsRestaurants0.39 0.35 
Movies & EntertainmentMovies & Entertainment0.38 1.07 
Health Care SuppliesHealth Care Supplies0.36 1.47 
IT Consulting & Other ServicesIT Consulting & Other Services0.36 0.34 
Food DistributorsFood Distributors0.17 0.13 
Apparel RetailApparel Retail0.17 0.21 
Integrated Oil & GasIntegrated Oil & Gas0.15 0.20 
Cable & SatelliteCable & Satellite0.15 0.78 
Research & Consulting ServicesResearch & Consulting Services0.15 0.34 
Air Freight & LogisticsAir Freight & Logistics0.13 0.26 
Other Specialized REITsOther Specialized REITs0.11 — 
Paper & Plastic Packaging Products & MaterialsPaper & Plastic Packaging Products & Materials0.10 — 
Housewares & SpecialtiesHousewares & Specialties0.09 0.10 
Leisure ProductsLeisure Products0.06 — 
Electronic ComponentsElectronic Components0.06 0.08 
Technology DistributorsTechnology Distributors0.03 0.12 
Communications EquipmentCommunications Equipment0.03 — 
Industrial MachineryIndustrial Machinery3.02 3.53 Industrial Machinery— 3.25 
Internet & Direct Marketing RetailInternet & Direct Marketing Retail2.84 2.68 Internet & Direct Marketing Retail— 2.82 
Aerospace & Defense2.81 2.72 
Specialized Finance2.68 2.69 
Fertilizers & Agricultural Chemicals2.52 2.64 
Construction & Engineering2.40 2.47 
Automotive Retail2.27 1.65 
Internet Services & Infrastructure2.11 1.87 
Health Care Services2.05 3.31 
Personal ProductsPersonal Products2.03 4.13 Personal Products— 2.01 
Metal & Glass ContainersMetal & Glass Containers1.82 0.68 Metal & Glass Containers— 1.91 
Home Improvement Retail1.79 1.82 
Health Care Distributors1.75 0.77 
Airport Services1.64 1.59 
Leisure Facilities1.62 0.90 
Real Estate Services1.56 1.61 
Real Estate Operating Companies1.56 1.11 
Diversified Support Services1.45 1.60 
Health Care Supplies1.41 1.18 
Specialty Chemicals1.38 1.82 
Insurance Brokers1.36 1.08 
Soft DrinksSoft Drinks1.32 1.31 Soft Drinks— 1.35 
Integrated Telecommunication Services1.30 1.94 
Electrical Components & Equipment1.28 1.26 
Advertising1.11 1.19 
Oil & Gas Storage & Transportation1.09 1.35 
Other Diversified Financial ServicesOther Diversified Financial Services— 0.98 
Oil & Gas Refining & MarketingOil & Gas Refining & Marketing1.07 1.43 Oil & Gas Refining & Marketing— 0.34 
Movies & Entertainment1.05 1.06 
Other Diversified Financial Services1.00 0.62 
Distributors0.96 — 
Health Care Equipment0.93 0.93 
Environmental & Facilities Services0.75 — 
Home Furnishings0.73 0.77 
Cable & Satellite0.70 1.06 
Consumer Finance0.56 — 
Hotels, Resorts & Cruise Lines0.54 — 
Systems Software0.50 0.26 
Auto Parts & Equipment0.46 0.48 
IT Consulting & Other Services0.40 0.29 
Research & Consulting Services0.37 0.30 
Air Freight & Logistics0.35 0.19 
Restaurants0.35 0.37 
Education Services0.33 0.04 
Trading Companies & DistributorsTrading Companies & Distributors0.23 — Trading Companies & Distributors— 0.22 
Integrated Oil & Gas0.19 0.19 
Apparel Retail0.17 — 
Housewares & Specialties0.15 0.08 
Communications Equipment0.14 — 
Diversified BanksDiversified Banks— 0.14 
Specialized REITsSpecialized REITs0.14 — Specialized REITs— 0.13 
Food Distributors0.14 0.18 
Diversified Banks0.13 0.14 
Technology Distributors0.12 0.12 
Electronic Components0.08 0.40 
Construction MaterialsConstruction Materials0.07 0.09 Construction Materials— 0.08 
Alternative CarriersAlternative Carriers0.07 0.27 Alternative Carriers— 0.01 
Airlines— 0.96 
Independent Power Producers & Energy Traders— 0.92 
Commercial Printing— 0.79 
Managed Health Care— 0.74 
Thrifts & Mortgage Finance— 0.62 
Property & Casualty Insurance— 0.39 
Leisure Products— 0.26 
Food Retail— 0.15 
TotalTotal100.00 %100.00 %Total100.00 %100.00 %
___________________
(1)This industry includes our investments in the JVs and certain limited partnership interests.JVs.


9089




The Joint Ventures


Senior Loan Fund JV I, LLC


In May 2014, we entered into a limited liability company, or LLC, agreement with Kemper to form SLF JV I. We co-invest in senior secured loans of middle-market companies and other corporate debt securities with Kemper through our investment in SLF JV I. SLF JV I is managed by a four person Board of Directors, two of whom are selected by us and two of whom are selected by Kemper. All portfolio decisions and investment decisions in respect of SLF JV I must be approved by the SLF JV I investment committee, which consists of one representative selected by us and one representative selected by Kemper (with approval from a representative of each required). Since we do not have a controlling financial interest in SLF JV I, we do not consolidate SLF JV I. SLF JV I is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. SLF JV I is capitalized pro rata with LLC equity interests as transactions are completed and may be capitalized with additional subordinated notes issued to us and Kemper by SLF JV I. The subordinated notes issued by SLF JV I are referred to as the SLF JV I Notes. The SLF JV I Notes are senior in right of payment to SLF JV I LLC equity interests and subordinated in right of payment to SLF JV I’s secured debt.
As of June 30, 20222023 and September 30, 2021,2022, we and Kemper owned, in the aggregate, 87.5% and 12.5%, respectively, of the LLC equity interests of SLF JV I and the outstanding SLF JV I Notes. As of each of June 30, 20222023, we and Kemper had funded approximately $190.5 million to SLF JV I, of which $166.7 million was from us. As of September 30, 2021,2022, we and Kemper had funded approximately $165.5 million to SLF JV I, of which $144.8 million was from us. As of each of June 30, 20222023, we had aggregate commitments to fund SLF JV I of $13.1 million, of which approximately $9.8 million was to fund additional SLF JV I Notes and approximately $3.3 million was to fund LLC equity interests in SLF JV I. During the nine months ended June 30, 2023, we contributed $16.4 million to fund additional SLF JV I Notes and approximately $5.5 million to fund additional LLC equity interests in SLF JV I. As of September 30, 2021,2022, we had aggregate commitments to fund SLF JV I of $35.0 million, of which approximately $26.2 million was to fund additional SLF JV I Notes and approximately $8.8 million was to fund LLC equity interests in SLF JV I.
Both the cost and fair value of our SLF JV I Notes were $112.7 million as of June 30, 2023. Both the cost and fair value of our SLF JV I Notes were $96.3 million as of eachSeptember 30, 2022. We earned interest income of $3.4 million and $9.2 million on the SLF JV I Notes for the three and nine months ended June 30, 2022 and September 30, 2021.2023, respectively. We earned interest income of $1.9 million and $5.8 million on the SLF JV I Notes for the three and nine months ended June 30, 2022, respectively. We earned interest income of $1.9 million and $5.4 million on the SLF JV I Notes for the three and nine months ended June 30, 2021, respectively. As of June 30, 2022,2023, the SLF JV I Notes bore interest at a rate of one-month LIBOR plus 7.00% per annum with a LIBOR floor of 1.00% and will mature on December 29, 2028.
The cost and fair value of the LLC equity interests in SLF JV I held by us was $49.3$54.8 million and $23.0$28.0 million, respectively, as of June 30, 2022,2023, and $49.3 million and $37.7$20.7 million, respectively, as of September 30, 2021.2022. We earned $1.1 million and $3.2 million in dividend income for the three and nine months ended June 30, 2023, respectively, with respect to our investment in the LLC equity interests of SLF JV I. We earned $0.9 million and $2.0 million in dividend income for the three and nine months ended June 30, 2022, respectively, with respect to our investment in the LLC equity interests of SLF JV I. We earned $0.5 million in dividend income for the three and nine months ended June 30, 2021 with respect to our investment in the LLC equity interests of SLF JV I. The LLC equity interests of SLF JV I are dividend producing to the extent SLF JV I has residual cash to be distributed on a quarterly basis.
Below is a summary of SLF JV I's portfolio as of June 30, 20222023 and September 30, 2021:2022:
June 30, 2022September 30, 2021June 30, 2023September 30, 2022
Senior secured loans (1)Senior secured loans (1)$357,198$344,196Senior secured loans (1)$350$383,194
Weighted average interest rate on senior secured loans (2)Weighted average interest rate on senior secured loans (2)6.79%5.60%Weighted average interest rate on senior secured loans (2)10.40%8.33%
Number of borrowers in SLF JV INumber of borrowers in SLF JV I5655Number of borrowers in SLF JV I5260
Largest exposure to a single borrower (1)Largest exposure to a single borrower (1)$9,650$9,875Largest exposure to a single borrower (1)$11,304$10,093
Total of five largest loan exposures to borrowers (1)Total of five largest loan exposures to borrowers (1)$47,298$46,984Total of five largest loan exposures to borrowers (1)$54,003$48,139
__________________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.


See "Note 3. Portfolio Investments" in the notes to the accompanying financial statements for more information on SLF JV I and its portfolio.
9190



OCSI Glick JV LLC
On March 19, 2021, as a result of the consummation of the Mergers, we became party to the LLC agreement of the Glick JV. The Glick JV invests primarily in senior secured loans of middle-market companies. We co-invest in these securities with GF Equity Funding through the Glick JV. The Glick JV is managed by a four person Board of Directors, two of whom are selected by us and two of whom are selected by GF Equity Funding. All portfolio decisions and investment decisions in respect of the Glick JV must be approved by the Glick JV investment committee, consisting of one representative selected by us and one representative selected by GF Equity Funding (with approval from a representative of each required). Since we do not have a controlling financial interest in the Glick JV, we do not consolidate the Glick JV. The Glick JV is not an "eligible portfolio company" as defined in section 2(a)(46) of the Investment Company Act. The Glick JV is capitalized as transactions are completed. The members provide capital to the Glick JV in exchange for LLC equity interests, and we and GF Debt Funding, 2014 LLC, or GF Debt Funding, an entity advised by affiliates of GF Equity Funding, provide capital to the Glick JV in exchange for subordinated notes issued by the Glick JV, or the Glick JV Notes. The Glick JV Notes are junior in right of payment to the repayment of temporary contributions made by us to fund investments of the Glick JV that are repaid when GF Equity Funding and GF Debt Funding make their capital contributions and fund their Glick JV Notes, respectively.
As of June 30, 20222023 and September 30, 2021,2022, we and GF Equity Funding owned 87.5% and 12.5%, respectively, of the outstanding LLC equity interests, and we and GF Debt Funding owned 87.5% and 12.5%, respectively, of the Glick JV Notes. Approximately $84.0 million in aggregate commitments was funded as of each of June 30, 20222023 and September 30, 2021,2022, of which $73.5 million was from us. As of June 30, 20222023 and September 30, 2021,2022, we had commitments to fund Glick JV Notes of $78.8 million, of which $12.4 million was unfunded. As of each of June 30, 20222023 and September 30, 2021,2022, we had commitments to fund LLC equity interests in the Glick JV of $8.7 million, of which $1.6 million was unfunded.


The cost and fair value of our aggregate investment in the Glick JV was $50.4$50.0 million and $50.6$49.6 million, respectively, as of June 30, 20222023. The cost and fair value of our aggregate investment in the Glick JV was $50.7$50.2 million and $55.6$50.3 million, respectively, as of September 30, 20212022. For the three and nine months ended June 30, 2023, our investment in the Glick JV Notes earned interest income of $1.8 million and $5.0 million, respectively. For the three and nine months ended June 30, 2022, our investment in the Glick JV Notes earned interest income of $1.2 million and $3.3 million, respectively. For the three months ended June 30, 2021, our investment in the Glick JV Notes earned interest income of $1.0 million. For the period from March 19, 2021 to June 30, 2021, our investment in the Glick JV Notes earned interest income of $1.1 million. We did not earn any dividend income for the three and nine months ended June 30, 20222023 and for the period from March 19, 2021 to June 30, 20212022 with respect to our investment in the LLC equity interests of the Glick JV. The LLC equity interests of the Glick JV are income producing to the extent there is residual cash to be distributed on a quarterly basis.
Below is a summary of the Glick JV's portfolio as of June 30, 20222023 and September 30, 2021:2022:
June 30, 2022September 30, 2021June 30, 2023September 30, 2022
Senior secured loans (1)Senior secured loans (1)$141,783$126,512Senior secured loans (1)$123,126$143,225
Weighted average current interest rate on senior secured loans (2)Weighted average current interest rate on senior secured loans (2)6.85%5.86%Weighted average current interest rate on senior secured loans (2)10.66%8.52%
Number of borrowers in the Glick JVNumber of borrowers in the Glick JV4337Number of borrowers in the Glick JV3743
Largest loan exposure to a single borrower (1)Largest loan exposure to a single borrower (1)$6,645$6,907Largest loan exposure to a single borrower (1)$6,313$6,562
Total of five largest loan exposures to borrowers (1)Total of five largest loan exposures to borrowers (1)$28,564$28,324Total of five largest loan exposures to borrowers (1)$28,457$28,973
__________
(1) At principal amount.
(2) Computed using the weighted average annual interest rate on accruing senior secured loans at fair value.
See "Note 3. Portfolio Investments" in the notes to the accompanying financial statements for more information on the Glick JV and its portfolio.
9291



Discussion and Analysis of Results and Operations
Results of Operations
Net increase (decrease) in net assets resulting from operations includes net investment income, net realized gains (losses) and net unrealized appreciation (depreciation). Net investment income is the difference between our income from interest, dividends and fees and net expenses. Net realized gains (losses) is the difference between the proceeds received from dispositions of investment related assets and liabilities and their stated costs. Net unrealized appreciation (depreciation) is the net change in the fair value of our investment related assets and liabilities carried at fair value during the reporting period, including the reversal of previously recorded unrealized appreciation (depreciation) when gains or losses are realized.
Comparison of three and nine months ended June 30, 20222023 and June 30, 20212022
Total Investment Income
Total investment income includes interest on our investments, fee income and dividend income.
Total investment income for the three months ended June 30, 2023 and 2022 was $101.9 million and 2021 was $63.1 million, respectively. For the three months ended June 30, 2023, this amount consisted of $99.3 million of interest income from portfolio investments (which included $4.0 million of PIK interest), $1.6 million of fee income and $65.4$1.1 million respectively.of dividend income. For the three months ended June 30, 2022, this amount consisted of $59.9 million of interest income from portfolio investments (which included $5.2 million of PIK interest), $2.3 million of fee income and $1.0 million of dividend income. For the three months ended June 30, 2021, this amount consistedThe increase of $56.6 million of interest income from portfolio investments (which included $4.6 million of PIK interest), $7.8 million of fee income and $1.0 million of dividend income. The decrease of $2.3$38.8 million, or 3.5%61.4%, in our total investment income for the three months ended June 30, 2022,2023, as compared to the three months ended June 30, 2021,2022, was due primarily to a $5.5$39.4 million increase in interest income, which was primarily driven by the growth in assets that resulted from the completion of the OSI2 Merger during the prior quarter, new originations and the impact of higher reference rates on our floating rate investments. That was partially offset by a $0.7 million decrease in fee income resulting fromprimarily due to lower prepayment and amendment fees, partially offset by a $3.3 million increase in interest income, primarily resulting from a larger investment portfolio and the impact of rising reference rates on interest income, partially offset by lower OID acceleration from exited investments.fees.
Total investment income for the nine months ended June 30, 2023 and 2022 was $277.4 million and 2021 was $192.4 million, respectively. For the nine months ended June 30, 2023, this amount consisted of $268.3 million of interest income from portfolio investments (which included $14.2 million of PIK interest), $6.0 million of fee income and $145.6$3.2 million respectively.of dividend income. For the nine months ended June 30, 2022, this amount consisted of $181.7 million of interest income from portfolio investments (which included $14.5 million of PIK interest), $5.1 million of fee income and $5.6 million of dividend income. For the nine months ended June 30, 2021, this amount consisted of $130.8 million of interest income from portfolio investments (which included $11.5 million of PIK interest), $13.5 million of fee income and $1.4 million of dividend income. The increase of $46.8$85.0 million, or 32.1%44.2%, in our total investment income for the nine months ended June 30, 2022,2023, as compared to the nine months ended June 30, 2021,2022, was due primarily to (1) a $50.9$86.5 million increase in interest income, which was primarily driven by a larger average investment portfolio as a resultthe growth in assets that resulted from the completion of the increase in assets resulting fromOSI2 Merger during the Mergers andquarter ended March 31, 2023, new originations and the impact of risinghigher reference rates on interest incomeour floating rate investments and (2) a $4.2$0.9 million increase in dividendfee income mainly driven by larger dividends received from two investments as compared with the prior year.primarily due to higher commitment fees and amendment fees. This was partially offset by a $8.4$2.4 million decrease in fee income primarily due to lower prepayment and amendment fees.dividend income.
Expenses
Net expenses (expenses net of fee waivers) for the three months ended June 30, 2023 and 2022 and 2021 were $22.8$53.5 million and $29.1$22.8 million, respectively. Net expenses decreasedincreased for the three months ended June 30, 2022,2023, as compared to the three months ended June 30, 2021,2022, by $6.4$30.7 million, or 21.9%134.9%, primarily due to (1) $9.6 million of lower accrued Part II incentive fees as a result of a reversal of previously accrued capital gains incentive fees, (2) a $0.5 million decrease in Part I incentive fees mainly due to higher interest expense and management fees and (3) a $0.2 million decrease in professional fees, partially offset by a $3.0 million increase in interest expense due to higher borrowings outstanding and the impact of rising reference rates and $0.9 million of higher base management fees (net of management fee waivers) resulting from a larger investment portfolio.
Net expenses (expenses net of fee waivers) for the nine months ended June 30, 2022 and 2021 were $76.3 million and $81.2 million, respectively. Net expenses decreased for the nine months ended June 30, 2022, as compared to the nine months ended June 30, 2021, by $4.9 million, or 6.0%, primarily due to $24.8 million of lower accrued Part II incentive fees as a result of a reversal of previously accrued capital gains incentive fees driven by unrealized losses during the current period, partially offset by (1) a $9.7$18.9 million increase in interest expense due to higher borrowings outstanding and the impact of rising reference rates, (2) $5.9a $6.8 million of higher base managementreversal of accrued Part II incentive fees (net of management fee waivers) primarily as a result of a larger investment portfolio andin the prior period, (3) a $4.1$3.1 million increase in Part I incentive fees mainly due to higher total investment income, partially offset(4) a $1.4 million increase in base management fees as a result of a larger investment portfolio and (5) a $0.5 million increase in professional fees.
Net expenses (expenses net of fee waivers) for the nine months ended June 30, 2023 and 2022 were $144.1 million and $76.3 million, respectively. Net expenses increased for the nine months ended June 30, 2023, as compared to the nine months ended June 30, 2022, by higher$67.8 million, or 88.9%, primarily due to (1) a $48.1 million increase in interest expense due to higher borrowings outstanding and the impact of rising reference rates, (2) a $6.6 million increase in Part I incentive fees mainly due to higher total investment income, (3) a $8.8 million of reversal of accrued Part II incentive fees in the prior period, (4) a $1.9 million increase in professional fees and (5) a $1.8 million increase in base management fees.fees as a result of a larger investment portfolio.
9392



Net Investment Income
Primarily as a result of the $2.3$38.8 million decreaseincrease in total investment income and the $6.4$30.7 million decreaseincrease in net expenses, and a $0.4 million decrease in provision for taxes on net investment income, net investment income for the three months ended June 30, 20222023 increased by $4.4$8.0 million compared to the three months ended June 30, 2021.2022.
Primarily as a result of the $46.8$85.0 million increase in total investment income, the $4.9$67.8 million decreaseincrease in net expenses and a $3.0$3.3 million increasedecrease in the provision for taxes on net investment income, net investment income for the nine months ended June 30, 20222023 increased by $48.7$20.4 million compared to the nine months ended June 30, 2021.2022.
Realized Gain (Loss)
Realized gains or losses are measured by the difference between the net proceeds from the sale or redemption of investments and foreign currency and the cost basis without regard to unrealized appreciation or depreciation previously recognized, and includes investments written-off during the period, net of recoveries. Realized losses may also be recorded in connection with our determination that certain investments are considered worthless securities and/or meet the conditions for loss recognition per the applicable tax rules.
During the three months ended June 30, 20222023 and 2021,2022, we recorded aggregate net realized gains (losses) of $9.2$(10.6) million and $8.6$9.2 million, respectively, in connection with the exits of various investments and foreign currency forward contracts. During the nine months ended June 30, 20222023 and 2021,2022, we recorded aggregate net realized gains (losses) of $19.9$(19.9) million and $22.7$19.9 million, respectively, in connection with the exits of various investments and foreign currency forward contracts. See “Note 8. Realized Gains or Losses and Net Unrealized Appreciation or Depreciation” in the notes to the accompanying Consolidated Financial Statements for more details regarding investment realization events for the three and nine months ended June 30, 20222023 and 2021.2022.
Net Unrealized Appreciation (Depreciation)
Net unrealized appreciation or depreciation is the net change in the fair value of our investments and foreign currency during the reporting period, including the reversal of previously recorded unrealized appreciation or depreciation when gains or losses are realized.
During the three months ended June 30, 20222023 and 2021,2022, we recorded net unrealized appreciation (depreciation)depreciation of $(86.8)$1.0 million and $3.9$86.8 million, respectively. For the three months ended June 30, 2023, this consisted of $9.8 million of net unrealized depreciation on debt investments and $0.8 million of net unrealized depreciation on equity investments, partially offset by $5.0 million of net unrealized appreciation related to exited investments (a portion of which resulted in a reclassification to realized losses) and $4.6 million of net unrealized appreciation of foreign currency forward contracts. For the three months ended June 30, 2022, this consisted of $66.8 million of net unrealized depreciation on debt investments, $17.9 million of net unrealized depreciation on equity investments, $1.6 million of net unrealized depreciation of foreign currency forward contracts and $0.4 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains). For
During the threenine months ended June 30, 2021,2023 and 2022, we recorded net unrealized depreciation of $42.3 million and $118.4 million, respectively. For the nine months ended June 30, 2023, this consisted of $12.3$54.3 million of net unrealized appreciationdepreciation on debt investments $3.8and $4.8 million of net unrealized appreciation on equity investments and $1.1 million of net unrealized appreciationdepreciation of foreign currency forward contracts, partially offset by $13.3$11.8 million of net unrealized depreciationappreciation related to exited investments (a portion of which resulted in a reclassification to realized gains).
During the nine months ended June 30, 2022losses) and 2021, we recorded$5.1 million of net unrealized appreciation (depreciation) of $(118.4) million and $116.6 million, respectively.on equity investments. For the nine months ended June 30, 2022, this consisted of $84.6 million of net unrealized depreciation on debt investments, $23.8 million of net unrealized depreciation on equity investments, $9.2 million of net unrealized depreciation related to exited investments (a portion of which resulted in a reclassification to realized gains) and $0.8 million of net unrealized depreciation of foreign currency forward contracts. For
During the nine months ended June 30, 2021, this consisted2023, unrealized depreciation included a one-time unrealized loss of $79.7$20.7 million of net unrealized appreciation on debt investments, $30.7 million of net unrealized appreciation on equity investments, $4.0 million of net unrealized appreciationthat resulted solely from accounting adjustments related to exited investments (a portion of which resulted in a reclassification to realized losses) and $2.2 million of net unrealized appreciation of foreign currency forward contracts.the OSI2 Merger.
Financial Condition, Liquidity and Capital Resources
We have a number of alternatives available to fund our investment portfolio and our operations, including raising equity, increasing or refinancing debt and funding from operational cash flow. We generally expect to fund the growth of our investment portfolio through additional debt and equity capital, which may include securitizing a portion of our investments. We cannot assure you, however, that our efforts to grow our portfolio will be successful. For example, our common stock has generally traded at prices below net asset value for the past several years, and we may not be able to raise additional equity at prices below the then-current net asset value per share. We intend to continue to generate cash primarily from cash flows from operations, including interest earned, and future borrowings or equity offerings. We intend to fund our future distribution
9493



obligations through operating cash flow or with funds obtained through future equity and debt offerings or credit facilities, as we deem appropriate.
Our primary uses of funds are investments in our targeted asset classes and cash distributions to holders of our common stock. We may also from time to time repurchase or redeem some or all of our outstanding notes. At a special meeting of our stockholders held on June 28, 2019, our stockholders approved the application of the reduced asset coverage requirements in Section 61(a)(2) of the Investment Company Act to us effective as of June 29, 2019. As a result of the reduced asset coverage requirement, we can incur $2 of debt for each $1 of equity as compared to $1 of debt for each $1 of equity. As of June 30, 2022,2023, we had $1,395.0$1,785.0 million in senior securities and our asset coverage ratio was 187.8%182.0%. During the quarter, the Companyyear ended September 30, 2022, we increased itsour target debt to equity ratio from 0.85x to 1.0x to 0.90x to 1.25x (i.e., one dollar of equity for each $0.90 to $1.25 of debt outstanding) to provide the Companyus with increased capacity to opportunistically deploy capital into the markets. As of June 30, 2022,2023, our net debt to equity ratio was 1.10x.1.14x.
For the nine months ended June 30, 2023, we experienced a net increase in cash and cash equivalents (including restricted cash) of $46.3 million. During that period, net cash used in operating activities was $15.0 million, primarily from funding $597.7 million of investments and $58.8 million of net increase in net receivables from unsettled transactions, partially offset by $521.2 million of principal payments and sale proceeds received, the cash activities related to $133.2 million of net investment income, $22.3 million of cash received in connection with the OSI2 merger and a $20.5 million decrease in due from portfolio companies. During the same period, net cash provided by financing activities was $61.0 million, primarily consisting of $210.0 million of net borrowings under the credit facilities, partially offset by $139.1 million of cash distributions paid to our stockholders.
For the nine months ended June 30, 2022, we experienced a net increase in cash and cash equivalents (including restricted cash) of $4.7 million. During that period, we used $43.8 million of net cash from operating activities, primarily from funding $620.8 million of investments and $34.7 million of increase in due from broker (cash held at a broker to cover collateral obligations under the interest swap agreement), partially offset by $554.9 million of principal payments and sale proceeds received, $5.3 million of net decrease in receivables from unsettled transactions and the cash activities related to $112.8 million of net investment income. During the same period, net cash provided by financing activities was $49.4 million, primarily consisting of $115.0 million of net borrowings under the credit facilities and $20.6 million of proceeds (net of offering costs) from shares issued under the "at the market" offering, partially offset by $85.1 million of cash distributions paid to our stockholders, $0.9 million of repurchases of common stock under our dividend reinvestment plan, DRIP, and $0.3 million of deferred financing costs paid.
For the nine months ended June 30, 2021, we experienced a net increase in cash and cash equivalents (including restricted cash) of $48.4 million. During that period, we used $35.9 million of net cash from operating activities, primarily from funding $714.8 million of investments, partially offset by $586.8 million of principal payments and sale proceeds received, $20.9 million of cash acquired in the Mergers, the cash activities related to $64.1 million of net investment income and $18.3 million of net increase in payables from unsettled transactions. During the same period, net cash provided by financing activities was $85.4 million, primarily consisting of $349.0 million of borrowings of unsecured notes (net of OID), partially offset by $190.5 million of net repayments under the credit facilities, $54.3 million of cash distributions paid to our stockholders, $9.3 million of repayments of secured borrowings, $1.6 million of repurchases of common stock under our DRIP, and $7.8 million of deferred financing costs paid.
As of June 30, 2022,2023, we had $36.3$72.7 million in cash and cash equivalents (including $2.0$13.0 million of restricted cash), portfolio investments (at fair value) of $2.6$3.1 billion, $29.1$29.5 million of interest, dividends and fees receivable, $455.0$2.1 million of due from portfolio companies, $482.5 million of undrawn capacity on our credit facilities (subject to borrowing base and other limitations), $5.3$36.5 million of net payablesreceivables from unsettled transactions, $745.0$1,135.0 million of borrowings outstanding under our credit facilities and $611.6$605.1 million of unsecured notes payable (net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment).
As of September 30, 2021,2022, we had $31.6$26.4 million in cash and cash equivalents (including $2.3$2.8 million of restricted cash), portfolio investments (at fair value) of $2.6$2.5 billion, $22.1$35.6 million of interest, dividends and fees receivable, $470.0$22.5 million of due from portfolio companies, $500.0 million of undrawn capacity on our credit facilities (subject to borrowing base and other limitations), $0.1$22.3 million of net receivablespayables from unsettled transactions, $630.0$700.0 million of borrowings outstanding under our credit facilities and $638.7$601.0 million of unsecured notes payable (net of unamortized financing costs, unaccreted discount and interest rate swap fair value adjustment).
We may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of our portfolio companies. As of June 30, 2022,2023, our only off-balance sheet arrangements consisted of $232.1$274.4 million of unfunded commitments, which was comprised of $183.1$247.3 million to provide debt and equity financing to certain of our portfolio companies and $27.1 million to provide financing to the JVs. As of September 30, 2022, our only off-balance
94


sheet arrangements consisted of $224.2 million of unfunded commitments, which was comprised of $175.2 million to provide debt and equity financing to certain of our portfolio companies and $49.0 million to provide financing to the JVs. As of September 30, 2021, our only off-balance sheet arrangements consisted of $264.9 million of unfunded commitments, which was comprised of $212.4 million to provide debt and equity financing to certain of our portfolio companies, $49.0 million to provide financing to the JVs and $3.5 million related to unfunded limited partnership interests. Such commitments are subject to our portfolio companies' satisfaction of
95


certain financial and nonfinancial covenants and may involve, to varying degrees, elements of credit risk in excess of the amount recognized in our Consolidated Statements of Assets and Liabilities.
As of June 30, 2022,2023, we have analyzed cash and cash equivalents, availability under our credit facilities, the ability to rotate out of certain assets and amounts of unfunded commitments that could be drawn and believe our liquidity and capital resources are sufficient to take advantage of market opportunities in the current economic climate.
Contractual Obligations
The following table reflects information pertaining to our principal debt outstanding under the Syndicated Facility (as defined below), Citibank Facility (as defined below), OSI2 Citibank Facility (as defined below), our 3.500% notes due 2025, or the 2025 Notes, and our 2.700% notes due 2027, or the 2027 Notes:
Debt Outstanding
as of September 30, 2021
Debt Outstanding
as of June 30, 2022
Weighted average debt
outstanding for the
nine months ended
June 30, 2022
Maximum debt
outstanding for the nine months ended
June 30, 2022
Debt Outstanding
as of September 30, 2022
Debt Outstanding
as of June 30, 2023
Weighted average debt
outstanding for the
nine months ended
June 30, 2023
Maximum debt
outstanding for the nine months ended
June 30, 2023
Syndicated FacilitySyndicated Facility$495,000 $575,000 $548,846 $620,000 Syndicated Facility$540,000 $800,000 $710,018 $840,000 
Citibank FacilityCitibank Facility135,000 170,000 159,304 185,000 Citibank Facility160,000 — 138,689 175,000 
OSI2 Citibank FacilityOSI2 Citibank Facility— 335,000 141,355 355,000 
2025 Notes2025 Notes300,000 300,000 300,000 300,000 2025 Notes300,000 300,000 300,000 300,000 
2027 Notes2027 Notes350,000 350,000 350,000 350,000 2027 Notes350,000 350,000 350,000 350,000 
Total debtTotal debt$1,280,000 $1,395,000 $1,358,150 Total debt$1,350,000 $1,785,000 $1,640,062 
 
The following table reflects our contractual obligations arising from the Syndicated Facility, OSI2 Citibank Facility, 2025 Notes and 2027 Notes:
 
Payments due by period as of June 30, 2022 Payments due by period as of June 30, 2023
Contractual ObligationsContractual ObligationsTotalLess than 1 year1-3 years3-5 yearsContractual ObligationsTotalLess than 1 year1-3 years3-5 years
Syndicated FacilitySyndicated Facility$575,000 $— $— $575,000 Syndicated Facility$800,000 $— $— $800,000 
Interest due on Syndicated FacilityInterest due on Syndicated Facility69,984 18,194 36,388 15,402 Interest due on Syndicated Facility287,144 57,587 115,174 114,383 
Citibank Facility170,000 — 170,000 — 
Interest due on Citibank Facility16,900 7,074 9,826 — 
OSI2 Citibank FacilityOSI2 Citibank Facility335,000 — — 335,000 
Interest due on OSI2 Citibank FacilityInterest due on OSI2 Citibank Facility88,801 24,818 49,636 14,347 
2025 Notes2025 Notes300,000 — 300,000 — 2025 Notes300,000 — 300,000 — 
Interest due on 2025 NotesInterest due on 2025 Notes27,933 10,500 17,433 — Interest due on 2025 Notes17,433 10,500 6,933 — 
2027 Notes2027 Notes350,000 — — 350,000 2027 Notes350,000 — — 350,000 
Interest due on 2027 Notes (a)Interest due on 2027 Notes (a)43,015 9,458 18,916 14,641 Interest due on 2027 Notes (a)85,910 24,214 48,428 13,268 
TotalTotal$1,552,832 $45,226 $552,563 $955,043 Total$2,264,288 $117,119 $520,171 $1,626,998 
__________ 
(a) The interest due on the 2027 Notes was calculated net of the interest rate swap.
Equity Issuances
On January 23, 2023, in connection with the OSI2 Merger, we issued an aggregate of 15,860,200 shares of common stock to former OSI2 stockholders.
During the three and nine months ended June 30, 2022,2023, we issued an aggregate of 212,382zero and 94,879 shares of common stock, respectively, as part of the DRIP.
On February 7, 2022, we entered into an equity distribution agreement by and among us, Oaktree, Oaktree Administrator and Keefe, Bruyette & Woods, Inc., JMP Securities LLC, Raymond James & Associates, Inc. and SMBC Nikko Securities America, Inc., as placement agents, in connection with the issuance and sale by us of shares of common stock, having an aggregate offering price of up to $125.0 million. The equity distribution agreement was amended on February 8, 2023 to allow for the sale of shares of our common stock having an aggregate offering price of up to $125 million under our current registration statement. Sales of the common stock, if any, may be made in negotiated transactions or transactions that are deemed to be “at the market,” as defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Global Select Market or similar securities exchanges or sales made to or through a market maker other than on an exchange, at prices related to the prevailing market prices or at negotiated prices.
9695



In connection with the "at the market" offering, we issued and sold the followingdid not issue or sell any shares of common stock during the three and nine months ended June 30, 2022:2023.
Number of Shares IssuedGross ProceedsPlacement Agent FeesNet Proceeds (1)Average Sales Price per Share (2)
"At the market" offering2,801,206 $21,049 $210 $20,839 $7.51 
 __________
(1) Net proceeds excludes offering costs of $0.2 million.
(2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.
On March 19, 2021, in connection with the Mergers, we issued an aggregate of 39,400,011 shares of common stock to former OCSI stockholders. There were no other common stock issuances during the nine months ended June 30, 2021.

Significant Capital TransactionsDistributions
The following table reflects the distributions per share that we have paid, including shares issued under our DRIP, on our common stock since October 1, 2019:2020. The distributions per share and shares issued under our DRIP information disclosed in this table for dates prior to January 23, 2023 have been retrospectively adjusted to reflect our 1-for-3 reverse stock split completed on January 20, 2023 and effective as of the commencement of trading on January 23, 2023.
Date DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued (1)
DRIP Shares
Value
November 12, 2019December 13, 2019December 31, 2019$0.095 $ 12.9 million87,747 $ 0.5 million
January 31, 2020March 13, 2020March 31, 20200.095 12.9 million157,523 0.5 million
April 30, 2020June 15, 2020June 30, 20200.095 13.0 million87,351 0.4 million
July 31, 2020September 15, 2020September 30, 20200.105 14.3 million102,404 0.5 million
November 13, 2020December 15, 2020December 31, 20200.11 15.0 million93,964 0.5 million
January 29, 2021March 15, 2021March 31, 20210.12 16.4 million81,702 0.5 million
April 30, 2021June 15, 2021June 30, 20210.13 22.9 million76,979 0.5 million
July 30, 2021September 15, 2021September 30, 20210.145 25.5 million85,075 0.6 million
October 13, 2021December 15, 2021December 31, 20210.155 27.2 million107,971 0.8 million
January 28, 2022March 15, 2022March 31, 20220.16 28.5 million104,411 0.8 million
April 29, 2022June 15, 2022June 30, 20220.165 29.4 million131,028 0.9 million
DistributionDate DeclaredRecord DatePayment DateAmount
per Share
Cash
Distribution
DRIP Shares
Issued (1)
DRIP Shares
Value
QuarterlyNovember 13, 2020December 15, 2020December 31, 2020$0.33 $ 15.0 million31,321 $ 0.5 million
QuarterlyJanuary 29, 2021March 15, 2021March 31, 20210.36 16.4 million27,234 0.5 million
QuarterlyApril 30, 2021June 15, 2021June 30, 20210.39 22.9 million25,660 0.5 million
QuarterlyJuly 30, 2021September 15, 2021September 30, 20210.435 25.5 million28,358 0.6 million
QuarterlyOctober 13, 2021December 15, 2021December 31, 20210.465 27.2 million35,990 0.8 million
QuarterlyJanuary 28, 2022March 15, 2022March 31, 20220.48 28.5 million34,804 0.8 million
QuarterlyApril 29, 2022June 15, 2022June 30, 20220.495 29.4 million43,676 0.9 million
QuarterlyJuly 29, 2022September 15, 2022September 30, 20220.51 30.2 million51,181 1.0 million
QuarterlyNovember 10, 2022December 15, 2022December 30, 20220.54 32.0 million53,369 1.1 million
SpecialNovember 10, 2022December 15, 2022December 30, 20220.42 24.8 million41,510 0.8 million
QuarterlyJanuary 27, 2023March 15, 2023March 31, 20230.55 41.1 million68,412 1.3 million
QuarterlyApril 28, 2023June 15, 2023June 30, 20230.55 41.3 million57,279 1.1 million
 ______________
(1)Shares were purchased on the open market and distributed other than with respect to the distributions paid on December 31, 2021, and March 31, 2022 and December 30, 2022. New shares were issued and distributed during the quarters endedwith respect to distributions paid on December 31, 2021, and March 31, 2022 and December 30, 2022.



Indebtedness
See “Note 6. Borrowings” in the Consolidated Financial Statements for more details regarding our indebtedness.
Syndicated Facility


As of June 30, 2022,2023, (i) the size of our senior secured revolving credit facility, or, as amended and/or restated from time to time, the Syndicated Facility, pursuant to a senior secured revolving credit agreement, with the lenders, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N.A., BofA Securities, Inc. and MUFG Union Bank, N.A. as joint lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A. and Bank of America, N.A., as syndication agents, was $1.0$1.218 billion (with an “accordion” feature that permits us, under certain circumstances, to increase the size of the facility to up to the greater of $1.25 billion and our net worth (as defined in the Syndicated Facility) on the date of such increase), (ii) the period during which we may make drawings on $1.035 billion of commitments will expire on June 23, 2027 and the maturity date was June 23, 2028, (iii) the period during which we may make drawings with respect to the remaining commitments will expire on May 4, 2025 and the maturity date wasis May 4, 2026 and (iii)(iv) the interest rate margin for (a) LIBORSOFR loans (which may be 1-, 2-, 3- or 6-month,3-month, at our option) was 2.00% plus a SOFR adjustment which ranges between 0.11448% and 0.26161% and (b) alternate base rate loans was 1.00%.


Each loan or letter of credit originated or assumed under the Syndicated Facility is subject to the satisfaction of certain conditions. Borrowings under the Syndicated Facility are subject to the facility’s various covenants and the leverage restrictions contained in the Investment Company Act. We cannot assure you that we will be able to borrow funds under the Syndicated Facility at any particular time or at all.
9796



The following table describes significant financial covenants, as of June 30, 2022,2023, with which we must comply under the Syndicated Facility on a quarterly basis:
Financial CovenantDescriptionTarget ValueMarch 31, 20222023 Reported Value (1)
Minimum shareholders' equityNet assets shall not be less than the sum of (x) $600 million, plus (y) 50% of the aggregate net proceeds of all sales of equity interests after May 6, 2020

$610768 million$1,3301,515 million
Asset coverage ratioAsset coverage ratio shall not be less than the greater of 1.50:1 and the statutory test applicable to us1.50:11.93:1.83:1
Interest coverage ratioInterest coverage ratio shall not be less than 2.25:12.25:14.85:2.95:1
Minimum net worthNet worth shall not be less than $550 million$550 million$1,1551,130 million
 ___________ 
(1) As contractually required, we report financial covenants based on the last filed quarterly or annual report, in this case our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022.2023. We were in compliance with all financial covenants under the Syndicated Facility based on the financial information contained in this Quarterly Report on Form 10-Q.

As of June 30, 20222023 and September 30, 2021,2022, we had $575.0$800.0 million and $495.0$540.0 million of borrowings outstanding under the Syndicated Facility, respectively, which had a fair value of $575.0$800.0 million and $495.0$540.0 million, respectively. Our borrowings under the Syndicated Facility bore interest at a weighted average interest rate of 2.406%6.584% and 2.202%2.406% for the nine months ended June 30, 2023 and 2022, respectively. For the three and 2021, respectively.nine months ended June 30, 2023, we recorded interest expense (inclusive of fees) of $14.3 million and $37.4 million, respectively, related to the Syndicated Facility. For the three and nine months ended June 30, 2022, we recorded interest expense (inclusive of fees) of $4.8 million and $12.6 million, respectively, related to the Syndicated Facility. For the three and nine months ended June 30, 2021, we recorded interest expense (inclusive of fees) of $4.0 million and $10.5 million, respectively, related to the Syndicated Facility.
Citibank Facility
On March 19, 2021, as a result of the consummation of the Mergers, we became party to a revolving credit facility, or, as amended and/or restated from time to time, the Citibank Facility, with OCSL Senior Funding II LLC, our wholly-owned, special purpose financing subsidiary, as the borrower, us, as collateral manager and seller, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Wells Fargo Bank, National Association, as collateral agent and custodian. As of June 30, 2022, we were ableOn May 25, 2023, in connection with an amendment to borrow up to $200 million under the OSI2 Citibank Facility, (subject to borrowing base and other limitations). As of June 30, 2022, the reinvestment period under the Citibank Facility was scheduled to expire on November 18, 2023 andterminated. In connection with the maturity date fortermination of the Citibank Facility, was November 18, 2024.we accelerated $0.6 million of deferred financing costs into interest expense during the three months ended June 30, 2023.
As of JuneSeptember 30, 2022, borrowings under the Citibank Facility are subject to certain customary advance rates and accrue interest at a rate equal to LIBOR plus between 1.25% and 2.20% per annum on broadly syndicated loans, subject to observable market depth and pricing, and LIBOR plus 2.25% per annum on all other eligible loans during the reinvestment period. In addition, as of June 30, 2022, for the duration of the reinvestment period there is a non-usage fee payable of 0.50% per annum on the undrawn amount under the Citibank Facility. The minimum asset coverage ratio applicable to us under the Citibank Facility is 150% as determined in accordance with the requirements of the Investment Company Act. Borrowings under the Citibank Facility are secured by all of the assets of OCSL Senior Funding II LLC and all of our equity interests in OCSL Senior Funding II LLC. We may use the Citibank Facility to fund a portion of our loan origination activities and for general corporate purposes. Each loan origination under the Citibank Facility is subject to the satisfaction of certain conditions.
As of June 30, 2022 and September 30, 2021, we had $170.0 million and $135.0$160.0 million outstanding under the Citibank Facility, respectively, which had a fair value of $170.0 million and $135.0 million, respectively.$160.0 million. Our borrowings under the Citibank Facility bore interest at a weighted average interest rate of 2.563%6.762% and 2.198%2.563% for the nine months ended June 30, 20222023 and the period from March 19, 2021 to June 30, 2021,2022, respectively. For the three and nine months ended June 30, 2023, we recorded interest expense (inclusive of fees) of $2.4 million and $8.0 million, respectively, related to the Citibank Facility. For the three and nine months ended June 30, 2022, we recorded interest expense (inclusive of fees) of $1.6 million and $3.5 million respectively, related to the Citibank Facility.

OSI2 Citibank Facility
On January 23, 2023, as a result of the consummation of the OSI2 Merger, we became party to a revolving credit facility, or, as amended and/or restated from time to time, the OSI2 Citibank Facility, with OSI 2 Senior Lending SPV, LLC, or OSI 2 SPV, our wholly-owned and consolidated subsidiary, as the borrower, us, as collateral manager, each of the lenders from time to time party thereto, Citibank, N.A., as administrative agent, and Deutsche Bank Trust Company Americas, as collateral agent.
As of June 30, 2023, we were able to borrow up to $400 million under the OSI2 Citibank Facility (subject to borrowing base and other limitations). As of June 30, 2023, the OSI2 Citibank Facility has a reinvestment period through May 25, 2025, during which advances may be made, and matures on January 26, 2027. Following the reinvestment period, OSI 2 SPV will be required to make certain mandatory amortization payments. Borrowings under the OSI2 Citibank Facility bear interest payable quarterly at a rate per year equal to (a) in the case of a lender that is identified as a conduit lender, the lesser of (i) the applicable commercial paper rate for such conduit lender and (ii) SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans and (b) for all other lenders under the OSI2 Citibank Facility, SOFR plus 2.00% per annum on broadly syndicated loans and 2.75% per annum on all other eligible loans, subject in all cases to a minimum overall rate of SOFR plus 2.50% per annum. After the reinvestment period, the applicable spread is 4.00% per year. There is also a non-usage fee of 0.50% per year on the unused portion of the OSI2 Citibank Facility, payable quarterly; provided that if the unused portion of the OSI2 Citibank Facility is greater than 30% of the commitments under the OSI2 Citibank Facility, the non-usage fee will be based on an unused portion of 30% of the commitments under the OSI2 Citibank Facility. The OSI2 Citibank Facility is secured by a first priority security interest in substantially all of OSI 2 SPV’s assets. As part of the OSI2 Citibank Facility, OSI 2 SPV is subject to certain limitations as to how borrowed funds may be used and the types of loans that are eligible to be acquired by OSI 2 SPV including restrictions on sector concentrations, loan size, tenor and minimum investment
97


ratings (or estimated ratings). The OSI2 Citibank Facility also contains certain requirements relating to interest coverage, collateral quality and portfolio performance, certain violations of which could result in the acceleration of the amounts due under the OSI2 Citibank Facility.
As of June 30, 2023, we had $335.0 million outstanding under the OSI2 Citibank Facility, which had a fair value of $335.0 million. Our borrowings under the OSI2 Citibank Facility bore interest at a weighted average interest rate of 7.275% for the period from January 23, 2023 to June 30, 2023. For three months ended June 30, 20212023 and the period from March 19, 2021January 23, 2023 to June 30, 2021, the Company2023, we recorded interest expense (inclusive of fees) of $0.8$4.9 million and $0.9$8.0 million, respectively, related to the OSI2 Citibank Facility.
2025 Notes
On February 25, 2020, we issued $300.0 million in aggregate principal amount of the 2025 Notes for net proceeds of $293.8 million after deducting OID of $2.5 million, underwriting commissions and discounts of $3.0 million and offering costs of $0.7 million. The OID on the 2025 Notes is amortized based on the effective interest method over the term of the notes.
98


2027 Notes
On May 18, 2021, we issued $350.0 million in aggregate principal amount of the 2027 Notes for net proceeds of $344.8 million after deducting OID of $1.0 million, underwriting commissions and discounts of $3.5 million and offering costs of $0.7 million. The OID on the 2027 Notes is amortized based on the effective interest method over the term of the notes.
In connection with the 2027 Notes, we entered into an interest rate swap to more closely align the interest rates of our liabilities with our investment portfolio, which consists of predominately floating rate loans. Under the interest rate swap agreement, we receive a fixed interest rate of 2.700% and pay a floating interest rate of the three-month LIBOR plus 1.658% on a notional amount of $350 million. We designated the interest rate swap as the hedging instrument in an effective hedge accounting relationship.
The below table presents the components of the carrying value of the 2025 Notes and the 2027 Notes as of June 30, 20222023 and September 30, 2021:2022:
As of June 30, 2022As of September 30, 2021 As of June 30, 2023As of September 30, 2022
($ in millions)($ in millions)2025 Notes2027 Notes2025 Notes2027 Notes($ in millions)2025 Notes2027 Notes2025 Notes2027 Notes
PrincipalPrincipal$300.0 $350.0 $300.0 $350.0 Principal$300.0 $350.0 $300.0 $350.0 
Unamortized financing costs Unamortized financing costs(2.0)(3.4)(2.6)(4.0) Unamortized financing costs(1.2)(2.7)(1.8)(3.2)
Unaccreted discount Unaccreted discount(1.3)(0.8)(1.7)(0.9) Unaccreted discount(0.8)(0.6)(1.2)(0.7)
Interest rate swap fair value adjustment Interest rate swap fair value adjustment— (30.9)— (2.1) Interest rate swap fair value adjustment— (39.6)— (42.0)
Net carrying valueNet carrying value$296.7 $314.9 $295.7 $343.0 Net carrying value$298.0 $307.1 $297.0 $304.1 
Fair ValueFair Value$284.0 $301.1 $314.5 $351.1 Fair Value$285.7 $302.3 $283.1 $294.0 

98


The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2023:
($ in millions)2025 Notes2027 Notes
Three months ended June 30, 2023Nine months ended June 30, 2023Three months ended June 30, 2023Nine months ended June 30, 2023
Coupon interest$2.6 $7.9 $2.4 $7.1 
Amortization of financing costs and discount0.3 0.9 0.2 0.7 
Effect of interest rate swap— — 3.7 9.4 
 Total interest expense$2.9 $8.8 $6.3 $17.2 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %3.500 %6.912 %6.274 %
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2022:
2025 Notes2027 Notes
($ in millions)($ in millions)Three months ended June 30, 2022Nine months ended June 30, 2022Three months ended June 30, 2022Nine months ended June 30, 2022($ in millions)2025 Notes2027 Notes
Three months ended June 30, 2022Nine months ended June 30, 2022Three months ended June 30, 2022Nine months ended June 30, 2022
Coupon interestCoupon interest$2.6 $7.9 $2.4 $7.1 Coupon interest$2.6 $7.9 $2.4 $7.1 
Amortization of financing costs and discountAmortization of financing costs and discount0.3 0.9 0.2 0.7 Amortization of financing costs and discount0.3 0.9 0.2 0.7 
Effect of interest rate swapEffect of interest rate swap— — (0.1)(1.6)Effect of interest rate swap— — (0.1)(1.6)
Total interest expense Total interest expense$2.9 $8.8 $2.5 $6.2  Total interest expense$2.9 $8.8 $2.5 $6.2 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %3.500 %2.572 %2.069 %Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %3.500 %2.572 %2.069 %
The below table presents the components of interest and other debt expenses related to the 2025 Notes and the 2027 Notes for the three and nine months ended June 30, 2021:
2025 Notes2027 Notes
($ in millions)Three months ended June 30, 2021Nine months ended June 30, 2021Three months ended June 30, 2021Nine months ended June 30, 2021
Coupon interest$2.6 $7.9 $1.1 $1.1 
Amortization of financing costs and discount0.3 0.9 0.1 0.1 
Effect of interest rate swap— — (0.3)(0.3)
 Total interest expense$2.9 $8.8 $0.9 $0.9 
Coupon interest rate (net of effect of interest rate swap for 2027 Notes)3.500 %3.500 %1.813 %1.813 %


Regulated Investment Company Status and Distributions


We have qualified and elected to be treated as a RIC under Subchapter M of the Code for U.S. federal income tax purposes. As long as we continue to qualify as a RIC, we will not be subject to tax on our investment company taxable income
99


(determined (determined without regard to any deduction for dividends paid) or realized net capital gains, to the extent that such taxable income or gains is distributed, or deemed to be distributed as dividends, to stockholders on a timely basis.
Taxable income generally differs from net income for financial reporting purposes due to temporary and permanent differences in the recognition of income and expenses, and generally excludes net unrealized appreciation or depreciation. Distributions declared and paid by us in a taxable year may differ from taxable income for that taxable year as such distributions may include the distribution of taxable income derived from the current taxable year or the distribution of taxable income derived from the prior taxable year carried forward into and distributed in the current taxable year. Distributions also may include returns of capital.
To maintain RIC tax treatment, we must, among other things, distribute dividends, with respect to each taxable year, of an amount at least equal to 90% of our investment company taxable income (i.e., our net ordinary income and our realized net short-term capital gains in excess of realized net long-term capital losses, if any), determined without regard to any deduction for dividends paid. As a RIC, we are also subject to a federal excise tax, based on distribution requirements of our taxable income on a calendar year basis. We anticipate timely distribution of our taxable income in accordance with tax rules. We did not incur a U.S. federal excise tax for calendar years 2020 and 2021 andyear 2021. For the calendar year 2022, we incurred $0.1 million of excise tax. We do not expect to incur a U.S. federal excise tax for calendar year 2022. We may incur a federal excise tax in future years.2023.
We intend to distribute at least 90% of our annual taxable income (which includes our taxable interest and fee income) to our stockholders. The covenants contained in our credit facilities may prohibit us from making distributions to our stockholders, and, as a result, could hinder our ability to satisfy the distribution requirement associated with our ability to be subject to tax as a RIC. In addition, we may retain for investment some or all of our net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) and treat such amounts as deemed distributions to our stockholders. If we do this, our stockholders will be treated as if they received actual distributions of the capital gains we retained and then reinvested the net after-tax proceeds in our common stock. Our stockholders also may be eligible to claim tax credits (or, in certain circumstances, tax refunds) equal to their allocable share of the tax we paid on the capital gains deemed distributed to them. To the extent our taxable earnings for a fiscal and taxable year fall below the total amount of our dividend distributions for that fiscal and taxable year, a portion of those distributions may be deemed a return of capital to our stockholders.
99


We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, we may be limited in our ability to make distributions due to the asset coverage test for borrowings applicable to us as a Business Development Company under the Investment Company Act and due to provisions in our credit facilities and debt instruments. If we do not distribute a certain percentage of our taxable income annually, we will suffer adverse tax consequences, including possible loss of our ability to be subject to tax as a RIC. We cannot assure stockholders that they will receive any distributions or distributions at a particular level.
A RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder elects to receive his or her entire distribution in either cash or stock of the RIC, subject to certain limitations regarding the aggregate amount of cash to be distributed to all stockholders. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.
We may generate qualified net interest income or qualified net short-term capital gains that may be exempt from U.S. withholding tax when distributed to foreign stockholders. A RIC is permitted to designate distributions of qualified net interest income and qualified short-term capital gains as exempt from U.S. withholding tax when paid to non-U.S. shareholders with proper documentation. The following table, which may be subject to change as we finalize our annual tax filings, lists the percentage of qualified net interest income and qualified short-term capital gains for the year ended September 30, 2021.2022.
Year EndedQualified Net Interest IncomeQualified Short-Term Capital Gains
September 30, 2021202289.8 80.8 %— 
We have adopted a DRIP that provides for the reinvestment of any distributions that we declare in cash on behalf of our stockholders, unless a stockholder elects to receive cash. As a result, if our Board of Directors declares a cash distribution, then our stockholders who have not “opted out” of the DRIP will have their cash distributions automatically reinvested in additional shares of our common stock, rather than receiving a cash distribution. If our shares are trading at a premium to net asset value, we typically issue new shares to implement the DRIP, with such shares issued at the greater of the most recently computed net asset value per share of our common stock or 95% of the current market value per share of our common stock on the payment date for such distribution. If our shares are trading at a discount to net asset value, we typically purchase shares in the open market in connection with our obligations under the DRIP.
100


Related Party Transactions
We have entered into the Investment Advisory Agreement with Oaktree and the Administration Agreement with Oaktree Administrator, an affiliate of Oaktree. Mr. John B. Frank, an interested member of our Board of Directors, has an indirect pecuniary interest in Oaktree. Oaktree is a registered investment adviser under the Investment Advisers Act of 1940, as amended, that is partially and indirectly owned by Oaktree Capital Group, LLC. See “Note 10. Related Party Transactions – Investment Advisory Agreement” and “– Administrative Services” in the notes to the accompanying Consolidated Financial Statements.
Recent Developments
Distribution Declaration
On July 29, 2022,28, 2023, our Board of Directors declared a quarterly distribution of $0.17$0.55 per share, payable in cash on September 30, 202229, 2023 to stockholders of record on September 15, 2022.2023.
Rule 2a-5


On July 29, 2022, the Board of Directors appointed Oaktree as the valuation designee under Rule 2a-5 of the Investment Company Act effective September 8, 2022 for purposes of determining the fair value of our investments.






101100





Item 3. Quantitative and Qualitative Disclosures about Market Risk


We are subject to financial market risks, including changes in the valuations of our investment portfolio and interest rates.
Valuation Risk
Our investments may not have a readily available market price, and we value these investments at fair value as determined in good faith by Oaktree, as our Board of Directors, with the assistance of the Audit Committee and Oaktree.valuation designee. There is no single standard for determining fair value in good faith and valuation methodologies involve a significant degree of management judgment. In addition, our valuation methodology utilizes discount rates in part in valuing our investments, and changes in those discount rates may have an impact on the valuation of our investments. Accordingly, valuations by usOaktree do not necessarily represent the amounts which may eventually be realized from sales or other dispositions of investments. Estimated fair values may differ from the values that would have been used had a ready market for the investment existed, and the differences could be material to the financial statements.
Interest Rate Risk
We are subject to financial market risks, including changes in interest rates. Changes in interest rates may affect both our cost of funding and our interest income from portfolio investments, cash and cash equivalents and idle fund investments. Our risk management procedures are designed to identify and analyze our risk, to set appropriate policies and to continually monitor these risks. Our investment income will be affected by changes in various interest rates, including SOFR, LIBOR, SOFR, SONIA and prime rates, to the extent our debt investments include floating interest rates.
As of June 30, 2022, 87.8%2023, 86.0% of our debt investment portfolio (at fair value) and 87.6%85.8% of our debt investment portfolio (at cost) bore interest at floating rates. As of September 30, 2021, 91.5%2022, 86.5% of our debt investment portfolio (at fair value) and 91.8%86.3% of our debt investment portfolio (at cost) bore interest at floating rates. The composition of our floating rate debt investments by interest rate floor as of June 30, 20222023 and September 30, 2021,2022, was as follows:
June 30, 2022September 30, 2021 June 30, 2023September 30, 2022
($ in thousands)($ in thousands)Fair Value% of Floating Rate PortfolioFair Value% of Floating Rate Portfolio($ in thousands)Fair Value% of Floating Rate PortfolioFair Value% of Floating Rate Portfolio
0%0%$256,910 11.9 %$322,222 14.6 %0%$230,265 9.0 %$228,186 11.1 %
>0% and <1%>0% and <1%362,178 17.0 %283,065 12.8 %>0% and <1%341,280 13.3 %388,458 19.0 %
1%1%1,452,203 68.0 %1,507,977 68.4 %1%1,525,626 59.3 %1,364,668 66.6 %
>1%>1%65,328 3.1 %92,384 4.2 %>1%474,287 18.4 %68,332 3.3 %
Total Floating Rate InvestmentsTotal Floating Rate Investments$2,136,619 100.0 %$2,205,648 100.0 %Total Floating Rate Investments$2,571,458 100.0 %$2,049,644 100.0 %


Based on our Consolidated Statement of Assets and Liabilities as of June 30, 2022,2023, the following table shows the approximate annualized net increase (decrease) in net assets resulting from operations (excluding the impact of any potential incentive fees) of hypothetical base rate changes in interest rates, assuming no changes in our investment and capital structure. However, there can be no assurances our portfolio companies will be able to meet their contractual obligations at any or all levels on increases in interest rates.
($ in thousands) Basis point increase($ in thousands) Basis point increaseIncrease in Interest Income(Increase) in Interest ExpenseNet increase in net assets resulting from operations($ in thousands) Basis point increaseIncrease in Interest Income(Increase) in Interest ExpenseNet increase in net assets resulting from operations
250250$54,812 $(27,375)$27,437 250$66,346 $(37,125)$29,221 
20020043,780 (21,900)21,880 20053,072 (29,700)23,372 
15015032,802 (16,425)16,377 15039,798 (22,275)17,523 
10010021,866 (10,950)10,916 10026,523 (14,850)11,673 
505010,933 (5,475)5,458 5013,262 (7,425)5,837 



102101



($ in thousands) Basis point decrease($ in thousands) Basis point decrease(Decrease) in Interest IncomeDecrease in Interest ExpenseNet (decrease) in net assets resulting from operations($ in thousands) Basis point decrease(Decrease) in Interest IncomeDecrease in Interest ExpenseNet (decrease) in net assets resulting from operations
5050$(10,789)$5,475 $(5,314)50$(13,262)$7,425 $(5,837)
100100(19,446)10,950 (8,496)100(26,523)14,850 (11,673)
150150(24,552)12,892 (11,660)150(39,785)22,275 (17,510)
200200(26,628)13,742 (12,886)200(53,033)29,700 (23,333)
250250(66,142)37,125 (29,017)
We regularly measure exposure to interest rate risk. We assess interest rate risk and manage our interest rate exposure on an ongoing basis by comparing our interest rate sensitive assets to our interest rate sensitive liabilities. Based on this review, we determine whether or not any hedging transactions are necessary to mitigate exposure to changes in interest rates. The following table shows a comparison of the interest rate base for our interest-bearing cash and outstanding investments, at principal, and our outstanding borrowings as of June 30, 20222023 and September 30, 2021:2022:
June 30, 2022September 30, 2021 June 30, 2023September 30, 2022
($ in thousands)($ in thousands)Interest Bearing
Cash and
Investments
BorrowingsInterest Bearing
Cash and
Investments
Borrowings($ in thousands)Interest Bearing
Cash and
Investments
BorrowingsInterest Bearing
Cash and
Investments
Borrowings
Money market rateMoney market rate$8,657 $— $23,600 $— Money market rate$5,193 $— $5,262 $— 
Prime ratePrime rate2,285 — 305 10,000 Prime rate3,778 — 2,618 — 
LIBORLIBORLIBOR
30 day30 day797,277 575,000 674,613 485,000 30 day431,019 — 669,273 540,000 
90 day (a)90 day (a)831,103 520,000 1,037,019 485,000 90 day (a)535,860 350,000 928,978 510,000 
180 day180 day300,499 — 323,869 — 180 day18,060 — 199,301 — 
360 day33,861 — 96,095 — 
EURIBOREURIBOREURIBOR
30 day30 day25,967 — 28,786 — 30 day29,985 — 24,838 — 
90 day90 day17,680 — 19,599 — 90 day25,731 — 16,911 — 
180 day180 day2,053 — 18,516 — 180 day6,666 — 1,964 — 
SOFRSOFRSOFR
30 day30 day82,763 — — — 30 day$479,666 800,000 $50,099 — 
90 day90 day88,208 — — — 90 day1,108,422 335,000 190,799 — 
180 day180 day10,519 — 18,390 — 
SONIASONIASONIA£53,250 — £40,137 — 
30 day26,112 — — — 
180 day22,633 — — — 
Fixed rateFixed rate318,859 300,000 200,599 300,000 Fixed rate$466,429 300,000 $341,749 300,000 
Total$2,557,957 $1,395,000 $2,423,001 $1,280,000 
__________ 
(a)Borrowings include the 2027 Notes, which pay interest at a floating rate under the terms of the interest rate swap.
103102



Item 4. Controls and Procedures


(a) Evaluation of Disclosure Controls and Procedures


Management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2022.2023. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives. Based on the evaluation of our disclosure controls and procedures as of June 30, 2022,2023, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective, at the reasonable assurance level, in timely identifying, recording, processing, summarizing and reporting any material information relating to us that is required to be disclosed in the reports we file or submit under the Exchange Act.


There were no changes in our internal control over financial reporting that occurred during the three months ended June 30, 20222023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.



PART II


Item 1.     Legal Proceedings
We are currently not a party to any pending material legal proceedings.

Item 1A. Risk Factors
Except as set forth below, thereThere have been no material changes during the three months ended June 30, 2023 to the risk factors discussed in Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended September 30, 2021.
Our business, financial condition and results of operations could be adversely affected by disruptions in the global economy caused by the ongoing conflict between Russia and Ukraine.

The global economy has been negatively impacted by the military conflict between Russia and Ukraine. Furthermore, governments in the U.S., United Kingdom, and European Union have each imposed export controls on certain products and financial and economic sanctions on certain industry sectors and parties in Russia. We do not currently have investments in companies headquartered or that operate primarily in Russia or Ukraine. However, businesses in the United States and globally have experienced shortages in materials and increased costs for transportation, energy, and raw material due in part to the negative impact of the Russia-Ukraine military conflict on the global economy, all of which could have an indirect impact on our portfolio companies. Further escalation of geopolitical tensions related to the military conflict, including increased trade barriers or restrictions on global trade, could result in, among other things, cyberattacks, supply disruptions, lower consumer demand, and changes to foreign exchange rates and financial markets, any of which may adversely affect our business, financial condition and results of operations and that of our portfolio companies. In addition, the effects of the ongoing conflict could heighten many of our known risks described in the Company's Annual Report on Form 10-K for the year ended September 30, 2021.2022.
Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds.
None.


Item 3. Defaults Upon Senior Securities
None.
Item 4.     Mine Safety Disclosures
104


Not applicable.


Item 5. Other Information
None.

During the three months ended June 30, 2023, none of our officers or directors adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement”.

103



Item 6. Exhibits

Sixth Amendment to Loan and Security Agreement, dated as of May 25, 2023, by and among the Registrant, OSI 2 Senior Lending SPV, LLC, and Citibank, N.A. (incorporated by reference to Exhibit 1.1 filed with the Registrant’s Form 8-K (File No. 814-00755) filed on May 30, 2023).
Amendment No. 6 to Amended and Restated Senior Secured Revolving Credit Agreement, dated as of June 23, 2023, by and among the Registrant, as borrower, the lenders party thereto and ING Capital LLC, as administrative agent (incorporated by reference to Exhibit 10.1 filed with the Registrant’s Form 8-K (File No. 814-00755) filed on June 26, 2023).
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934.
Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).
101.INS*Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
*Filed herewith.








104



SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
OAKTREE SPECIALTY LENDING CORPORATION
By:/s/   Armen Panossian
Armen Panossian
Chief Executive Officer
By:/s/   Christopher McKown
Christopher McKown
Chief Financial Officer and Treasurer
Date: August 3, 20222, 2023









105